<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><style scope="figure-callout">figure-callout:not([filenames=""]) a.figure-callout {
  cursor: zoom-in;
  text-decoration: underline;
  text-decoration-color: #ddd;
}</style><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><style scope="iron-dropdown">iron-dropdown {
  position: fixed;
}

#contentWrapper.iron-dropdown  > * {
  overflow: auto;
}

#contentWrapper.animating.iron-dropdown  > * {
  overflow: hidden;
}</style><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><style scope="dropdown-menu">dropdown-menu {
  display: inline-block;
        line-height: 24px;
}

.label.dropdown-menu {
  cursor: pointer;
        color: #666;
        align-items: center;
        margin-right: 8px;
        display: inline-block;
        padding: 2px 0;
}

#selected.dropdown-menu {
  color: #212121;
}

.label[open].dropdown-menu {
  border-color: #e0e0e0;
}

iron-dropdown.dropdown-menu {
  margin-top: 26px;
}

iron-icon.dropdown-menu {
  height: 15px;
        width: 15px;
}

#menu.dropdown-menu {
  max-height: 300px;
        padding: 8px 0;
        background: white;
        display: block;
        border-radius: 2px;
        box-shadow: 0 0 2px rgba(0,0,0,0.12), 0 2px 2px rgba(0,0,0,0.24);
}

.item.dropdown-menu {
  cursor: pointer;
        color: rgba(0,0,0,.87);
        font-size: 13px;
        line-height: 18px;
        padding: 6px 18px;
}

.item.dropdown-menu:hover {
  background-color: #e0e0e0;
}

.item[selected].dropdown-menu {
  background-color: #e0e0e0;
}

[multi].dropdown-menu .item.dropdown-menu {
  padding: 6px 18px 6px 34px;
}

[multi].dropdown-menu .item[selected].dropdown-menu {
  background-image: url('https://www.gstatic.com/images/icons/material/system/2x/done_grey600_24dp.png');
        background-position: 8px center;
        background-size: 16px;
        background-repeat: no-repeat;
}</style><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><style scope="image-carousel">image-carousel {
  display: block;
}

.thumbnails.image-carousel {
  display: block;
        background-color: transparent;
        padding: 7px;
        white-space: nowrap;
        overflow: auto;
        font-size: 0;
}

.thumbnails.image-carousel img.image-carousel {
  margin-right: 7px;
        cursor: zoom-in;
}

.thumbnails.image-carousel img[selected].image-carousel {
  outline: solid 3px #4285f4;
}

.thumbnails.image-carousel img.image-carousel:last-of-type {
  margin-right: 0;
}</style><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><style scope="para-num">para-num {
  display: block;
}</style><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>US20190307890A1 - Pyrrolobenzodiazepine conjugates 
      - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/US20190307890A1/en">
    <meta name="description" content="
     A conjugate of formula (I):L-(D L ) p , wherein L is a Ligand unit, D is a Drug Linker unit of formula IIa, IIb or IIc, wherein p is an integer of from 1 to 20. 
     
       
         
         
             
             
         
       
     
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="Pyrrolobenzodiazepine conjugates 
     ">
    <meta name="DC.date" content="2017-11-17" scheme="dateSubmitted">
    <meta name="DC.description" content="
     A conjugate of formula (I):L-(D L ) p , wherein L is a Ligand unit, D is a Drug Linker unit of formula IIa, IIb or IIc, wherein p is an integer of from 1 to 20. 
     
       
         
         
             
             
         
       
     
   
   ">
    <meta name="citation_patent_application_number" content="US:16/349,228">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/51/29/1f/cdd486514e6d71/US20190307890A1.pdf">
    <meta name="citation_patent_publication_number" content="US:20190307890:A1">
    <meta name="DC.date" content="2019-10-10">
    <meta name="DC.contributor" content="Philip Wilson Howard" scheme="inventor">
    <meta name="DC.contributor" content="Thais Cailleau" scheme="inventor">
    <meta name="DC.contributor" content="MedImmune Ltd" scheme="assignee">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            Pyrrolobenzodiazepine conjugates 
     </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA327955760" lang="EN" load-source="patent-office" class="style-scope patent-text">
    <div id="p-0001" num="0000" class="abstract style-scope patent-text">A conjugate of formula (I):L-(D<sup class="style-scope patent-text">L</sup>)<sub class="style-scope patent-text">p</sub>, wherein L is a Ligand unit, D is a Drug Linker unit of formula IIa, IIb or IIc, wherein p is an integer of from 1 to 20.</div>
    <div id="p-0002" num="0000" class="abstract style-scope patent-text">
      <chemistry id="CHEM-US-00001" num="00001" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/db/3d/a5/c24963c7f89914/US20190307890A1-20191010-C00001.png" class="style-scope patent-text"><img id="EMI-C00001" he="101.09mm" wi="75.61mm" file="US20190307890A1-20191010-C00001.TIF" alt="Figure US20190307890A1-20191010-C00001" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="302" height="404" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/db/3d/a5/c24963c7f89914/US20190307890A1-20191010-C00001.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00001" attachment-type="cdx" file="US20190307890A1-20191010-C00001.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00001" attachment-type="mol" file="US20190307890A1-20191010-C00001.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
  </abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              
                <section id="thumbnails" class="style-scope patent-result">
                  <h3 class="style-scope patent-result">Images (<span class="style-scope patent-result">2</span>)</h3>
                  <image-carousel id="figures" class="style-scope patent-result">
    
    
      <div class="thumbnails style-scope image-carousel">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/63/cd/54/104536c4f35007/US20190307890A1-20191010-D00001.png">
        
          <img class="style-scope image-carousel" src="https://patentimages.storage.googleapis.com/31/e8/a4/228a9e027f338d/US20190307890A1-20191010-D00002.png">
        <template is="dom-repeat" as="img" class="style-scope image-carousel"></template>
      </div>
    <template is="dom-if" class="style-scope image-carousel"></template>
  </image-carousel>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6835"><a id="link" href="#" class="style-scope state-modifier">A61K47/6835</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6851"><a id="link" href="#" class="style-scope state-modifier">A61K47/6851</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="A61K47/6855"><a id="link" href="#" class="style-scope state-modifier">A61K47/6855</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from breast cancer cell</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/00"><a id="link" href="#" class="style-scope state-modifier">A61K31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations containing organic active ingredients</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/33"><a id="link" href="#" class="style-scope state-modifier">A61K31/33</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/395"><a id="link" href="#" class="style-scope state-modifier">A61K31/395</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/55"><a id="link" href="#" class="style-scope state-modifier">A61K31/55</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/551"><a id="link" href="#" class="style-scope state-modifier">A61K31/551</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/5513"><a id="link" href="#" class="style-scope state-modifier">A61K31/5513</a></state-modifier>
                  <span class="description style-scope classification-tree">1,4-Benzodiazepines, e.g. diazepam or clozapine</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K31/5517"><a id="link" href="#" class="style-scope state-modifier">A61K31/5517</a></state-modifier>
                  <span class="description style-scope classification-tree">1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6801"><a id="link" href="#" class="style-scope state-modifier">A61K47/6801</a></state-modifier>
                  <span class="description style-scope classification-tree">Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6803"><a id="link" href="#" class="style-scope state-modifier">A61K47/6803</a></state-modifier>
                  <span class="description style-scope classification-tree">Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6835"><a id="link" href="#" class="style-scope state-modifier">A61K47/6835</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6851"><a id="link" href="#" class="style-scope state-modifier">A61K47/6851</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6863"><a id="link" href="#" class="style-scope state-modifier">A61K47/6863</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a determinant of a tumour cell the tumour determinant being from stomach or intestines cancer cell</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K"><a id="link" href="#" class="style-scope state-modifier">A61K</a></state-modifier>
                  <span class="description style-scope classification-tree">PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/00"><a id="link" href="#" class="style-scope state-modifier">A61K47/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/50"><a id="link" href="#" class="style-scope state-modifier">A61K47/50</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/51"><a id="link" href="#" class="style-scope state-modifier">A61K47/51</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/68"><a id="link" href="#" class="style-scope state-modifier">A61K47/68</a></state-modifier>
                  <span class="description style-scope classification-tree">Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61K47/6889"><a id="link" href="#" class="style-scope state-modifier">A61K47/6889</a></state-modifier>
                  <span class="description style-scope classification-tree">Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P35/00"><a id="link" href="#" class="style-scope state-modifier">A61P35/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antineoplastic agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K"><a id="link" href="#" class="style-scope state-modifier">C07K</a></state-modifier>
                  <span class="description style-scope classification-tree">PEPTIDES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/00"><a id="link" href="#" class="style-scope state-modifier">C07K5/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/04"><a id="link" href="#" class="style-scope state-modifier">C07K5/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/06"><a id="link" href="#" class="style-scope state-modifier">C07K5/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Dipeptides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/06008"><a id="link" href="#" class="style-scope state-modifier">C07K5/06008</a></state-modifier>
                  <span class="description style-scope classification-tree">Dipeptides with the first amino acid being neutral</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/06017"><a id="link" href="#" class="style-scope state-modifier">C07K5/06017</a></state-modifier>
                  <span class="description style-scope classification-tree">Dipeptides with the first amino acid being neutral and aliphatic</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/06034"><a id="link" href="#" class="style-scope state-modifier">C07K5/06034</a></state-modifier>
                  <span class="description style-scope classification-tree">Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07K5/06052"><a id="link" href="#" class="style-scope state-modifier">C07K5/06052</a></state-modifier>
                  <span class="description style-scope classification-tree">Val-amino acid</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 6 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Health &amp; Medical Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Health &amp; Medical Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Life Sciences &amp; Earth Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Life Sciences &amp; Earth Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">US20190307890A1</h2>
                  <p class="tagline style-scope patent-result">United States</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Patent application publication</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/51/29/1f/cdd486514e6d71/US20190307890A1.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;antibody&quot;,&quot;genbank&quot;,&quot;seq&quot;,&quot;update date&quot;,&quot;record update&quot;]" data-before="20161117"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/US20190307890A1"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Philip Wilson Howard"><a id="link" href="#" class="style-scope state-modifier">Philip Wilson Howard</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Thais Cailleau"><a id="link" href="#" class="style-scope state-modifier">Thais Cailleau</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  
                  <dt class="style-scope patent-result">
                    <span class="tooltip-hint style-scope patent-result" id="assigneeWarning">Current Assignee</span>
                    <overlay-tooltip positioning-target="#assigneeWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                      The listed assignees may be inaccurate.<br class="style-scope patent-result">
                      Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.
                    
    </div>
  </overlay-tooltip>
                  </dt>
                  <dd class="style-scope patent-result">
                    
    MedImmune Ltd
  
                  </dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2016</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/GB201619490D0/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">GB</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: GBGB1619490.4A</div>
                <div class="style-scope application-timeline">Filing date: 2016-11-17</div>
                <div class="style-scope application-timeline">Legal status: Ceased</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2017</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20190307890A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline" this="">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US16/349,228</div>
                <div class="style-scope application-timeline">Filing date: 2017-11-17</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO2018091646A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/EP2017/079572</div>
                <div class="style-scope application-timeline">Filing date: 2017-11-17</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP3541428A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP17807771.5A</div>
                <div class="style-scope application-timeline">Filing date: 2017-11-17</div>
                <div class="style-scope application-timeline">Legal status: Withdrawn</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application US16/349,228 events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2017-11-17</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="MedImmune Ltd"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by MedImmune Ltd</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="reassignment style-scope application-timeline">2019-06-03</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="MEDIMMUNE LIMITED"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Assigned to MEDIMMUNE LIMITED</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><iron-icon id="icon" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><overlay-tooltip positioning-target="#icon" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      <div class="description-item style-scope application-timeline">ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).</div><div class="description-item style-scope application-timeline">Assignors: HOWARD, PHILIP WILSON, CAILLEAU, Thais</div><template is="dom-repeat" class="style-scope application-timeline"></template>
    </div>
  </overlay-tooltip><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2019-10-10</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US20190307890A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of US20190307890A1</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" current="" critical=""><div date="" class="legal-status style-scope application-timeline">Status</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Abandoned</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (10)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (3)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#legalEvents" class="style-scope patent-result">Legal events</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&amp;Sect2=HITOFF&amp;p=1&amp;u=/netahtml/PTO/srchnum.html&amp;r=1&amp;f=G&amp;l=50&amp;d=PG01&amp;s1=20190307890.PGNR.">USPTO</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patentcenter.uspto.gov/applications/16349228">USPTO PatentCenter</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://assignment.uspto.gov/patent/index.html#/patent/search/resultFilter?searchInput=20190307890">USPTO Assignment</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=US&amp;NR=2019307890A1&amp;KC=A1&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/US/20190307890/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/US20190307890">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><ul mxw-id="PDES211520545" lang="EN" load-source="patent-office" class="description style-scope patent-text">
    
    <li class="style-scope patent-text"> <para-num num="[0001]" class="style-scope patent-text">
    
    [0001]
  </para-num> <div id="p-0003" num="0001" class="description-line style-scope patent-text">The present invention relates to conjugates comprising specific pyrrolobenzodiazepines (PBD), and the precursor drug linker used to make such conjugates.</div>
    </li> <heading id="h-0001" class="style-scope patent-text">BACKGROUND TO THE INVENTION</heading>
    <li class="style-scope patent-text"> <para-num num="[0002]" class="style-scope patent-text">
    
    [0002]
  </para-num> <div id="p-0004" num="0002" class="description-line style-scope patent-text">Some pyrrolobenzodiazepines (PBDs) have the ability to recognise and bond to specific sequences of DNA; the preferred sequence is PuGPu. The first PBD antitumour antibiotic, anthramycin, was discovered in 1965 (Leimgruber, et al., <i class="style-scope patent-text">J. Am. Chem. Soc., </i>87, 5793-5795 (1965); Leimgruber, et al., <i class="style-scope patent-text">J. Am. Chem. Soc., </i>87, 5791-5793 (1965)). Since then, a number of naturally occurring PBDs have been reported, and over 10 synthetic routes have been developed to a variety of analogues (Thurston, et al., <i class="style-scope patent-text">Chem. Rev. </i>1994, 433-465 (1994)). Family members include abbeymycin (Hochlowski, et al., <i class="style-scope patent-text">J. Antibiotics, </i>40, 145-148 (1987)), chicamycin (Konishi, et al., <i class="style-scope patent-text">J. Antibiotics, </i>37, 200-206 (1984)), DC-81 (Japanese Patent 58-180 487; Thurston, et al., <i class="style-scope patent-text">Chem. Brit., </i>26, 767-772 (1990); Bose, et al., <i class="style-scope patent-text">Tetrahedron, </i>48, 751-758 (1992)), mazethramycin (Kuminoto, et al., <i class="style-scope patent-text">J. Antibiotics, </i>33, 665-667 (1980)), neothramycins A and B (Takeuchi, et al., <i class="style-scope patent-text">J. Antibiotics, </i>29, 93-96 (1976)), porothramycin (Tsunakawa, et al., <i class="style-scope patent-text">J. Antibiotics, </i>41, 1366-1373 (1988)), prothracarcin (Shimizu, et al, <i class="style-scope patent-text">J. Antibiotics, </i>29, 2492-2503 (1982); Langley and Thurston, <i class="style-scope patent-text">J. Org. Chem., </i>52, 91-97 (1987)), sibanomicin (DC-102)(Hara, et al., <i class="style-scope patent-text">J. Antibiotics, </i>41, 702-704 (1988); Itoh, et al., <i class="style-scope patent-text">J. Antibiotics, </i>41, 1281-1284 (1988)), sibiromycin (Leber, et al., <i class="style-scope patent-text">J. Am. Chem. Soc., </i>110, 2992-2993 (1988)) and tomamycin (Arima, et al., <i class="style-scope patent-text">J. Antibiotics, </i>25, 437-444 (1972)). PBDs are of the general structure:</div>
    </li> <li class="style-scope patent-text"> <div id="p-0005" num="0000" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00002" num="00002" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/df/30/63/53f09f31e76719/US20190307890A1-20191010-C00002.png" class="style-scope patent-text"><img id="EMI-C00002" he="23.88mm" wi="31.92mm" file="US20190307890A1-20191010-C00002.TIF" alt="Figure US20190307890A1-20191010-C00002" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="128" height="96" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/df/30/63/53f09f31e76719/US20190307890A1-20191010-C00002.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00002" attachment-type="cdx" file="US20190307890A1-20191010-C00002.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00002" attachment-type="mol" file="US20190307890A1-20191010-C00002.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0003]" class="style-scope patent-text">
    
    [0003]
  </para-num> <div id="p-0006" num="0003" class="description-line style-scope patent-text">They differ in the number, type and position of substituents, in both their aromatic A rings and pyrrolo C rings, and in the degree of saturation of the C ring. In the B-ring there is either an imine (N═C), a carbinolamine(NH—CH(OH)), or a carbinolamine methyl ether (NH—CH(OMe)) at the N10-C11 position which is the electrophilic centre responsible for alkylating DNA. All of the known natural products have an (S)-configuration at the chiral C11a position which provides them with a right-handed twist when viewed from the C ring towards the A ring. This gives them the appropriate three-dimensional shape for isohelicity with the minor groove of B-form DNA, leading to a snug fit at the binding site (Kohn, In <i class="style-scope patent-text">Antibiotics III. Springer</i>-<i class="style-scope patent-text">Verlag, New York, pp. </i>3-11 (1975); Hurley and Needham-VanDeventer, <i class="style-scope patent-text">Acc. Chem. Res., </i>19, 230-237 (1986)). Their ability to form an adduct in the minor groove, enables them to interfere with DNA processing, hence their use as antitumour agents.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0004]" class="style-scope patent-text">
    
    [0004]
  </para-num> <div id="p-0007" num="0004" class="description-line style-scope patent-text">It has been previously disclosed that the biological activity of this molecules can be potentiated by joining two PBD units together through their C8/C′-hydroxyl functionalities via a flexible alkylene linker (Bose, D. S., et al., <i class="style-scope patent-text">J. Am. Chem. Soc., </i>114, 4939-4941 (1992); Thurston, D. E., et al., <i class="style-scope patent-text">J. Org. Chem., </i>61, 8141-8147 (1996)). The PBD dimers are thought to form sequence-selective DNA lesions such as the palindromic 5′-Pu-GATC-Py-3′ interstrand cross-link (Smellie, M., et al., <i class="style-scope patent-text">Biochemistry, </i>42, 8232-8239 (2003); Martin, C., et al., <i class="style-scope patent-text">Biochemistry, </i>44, 4135-4147) which is thought to be mainly responsible for their biological activity.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0005]" class="style-scope patent-text">
    
    [0005]
  </para-num> <div id="p-0008" num="0005" class="description-line style-scope patent-text">One example of a PBD dimer is SG2000 (SJG-136):</div>
    </li> <li class="style-scope patent-text"> <div id="p-0009" num="0000" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00003" num="00003" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/2b/cf/72/6b0a4a675a6967/US20190307890A1-20191010-C00003.png" class="style-scope patent-text"><img id="EMI-C00003" he="15.83mm" wi="75.18mm" file="US20190307890A1-20191010-C00003.TIF" alt="Figure US20190307890A1-20191010-C00003" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="301" height="63" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/2b/cf/72/6b0a4a675a6967/US20190307890A1-20191010-C00003.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00003" attachment-type="cdx" file="US20190307890A1-20191010-C00003.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00003" attachment-type="mol" file="US20190307890A1-20191010-C00003.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0006]" class="style-scope patent-text">
    
    [0006]
  </para-num> <div id="p-0010" num="0006" class="description-line style-scope patent-text">(Gregson, S., et al., <i class="style-scope patent-text">J. Med. Chem., </i>44, 737-748 (2001); Alley, M. C., et al., <i class="style-scope patent-text">Cancer Research, </i>64, 6700-6706 (2004); Hartley, J. A., et al., <i class="style-scope patent-text">Cancer Research, </i>64, 6693-6699 (2004)) which has been involved in clinical trials as a standalone agent, for example, NCT02034227 investigating its use in treating Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia (see: https://www.clinicaltrials.gov/ct2/show/NCT02034227).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0007]" class="style-scope patent-text">
    
    [0007]
  </para-num> <div id="p-0011" num="0007" class="description-line style-scope patent-text">Dimeric PBD compounds bearing C2 aryl substituents, such as SG2202 (ZC-207), are disclosed in WO 2005/085251:</div>
    </li> <li class="style-scope patent-text"> <div id="p-0012" num="0000" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00004" num="00004" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/56/70/9b/ec315813128b1e/US20190307890A1-20191010-C00004.png" class="style-scope patent-text"><img id="EMI-C00004" he="29.04mm" wi="145.29mm" file="US20190307890A1-20191010-C00004.TIF" alt="Figure US20190307890A1-20191010-C00004" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="581" height="116" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/56/70/9b/ec315813128b1e/US20190307890A1-20191010-C00004.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00004" attachment-type="cdx" file="US20190307890A1-20191010-C00004.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00004" attachment-type="mol" file="US20190307890A1-20191010-C00004.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0008]" class="style-scope patent-text">
    
    [0008]
  </para-num> <div id="p-0013" num="0008" class="description-line style-scope patent-text">and in WO2006/111759, bisulphites of such PBD compounds, for example SG2285 (ZC-423):</div>
    </li> <li class="style-scope patent-text"> <div id="p-0014" num="0000" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00005" num="00005" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/11/53/b0/6f1ab48b7b03b1/US20190307890A1-20191010-C00005.png" class="style-scope patent-text"><img id="EMI-C00005" he="31.75mm" wi="144.70mm" file="US20190307890A1-20191010-C00005.TIF" alt="Figure US20190307890A1-20191010-C00005" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="579" height="127" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/11/53/b0/6f1ab48b7b03b1/US20190307890A1-20191010-C00005.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00005" attachment-type="cdx" file="US20190307890A1-20191010-C00005.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00005" attachment-type="mol" file="US20190307890A1-20191010-C00005.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0009]" class="style-scope patent-text">
    
    [0009]
  </para-num> <div id="p-0015" num="0009" class="description-line style-scope patent-text">These compounds have been shown to be highly useful cytotoxic agents (Howard, P. W., et al., <i class="style-scope patent-text">Bioorg. Med. Chem. </i>(2009), doi: 10.1016/j.bmcl.2009.09.012).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0010]" class="style-scope patent-text">
    
    [0010]
  </para-num> <div id="p-0016" num="0010" class="description-line style-scope patent-text">WO2010/043880 discloses PBD dimers bearing a anchor for the attachment of another moiety, and WO2011/130613 discloses the use of such modified PBD dimers in antibody drug conjugates. One of the conjugates disclosed, that comprising:</div>
    </li> <li class="style-scope patent-text"> <div id="p-0017" num="0000" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00006" num="00006" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/57/bb/16/0498e03552a43c/US20190307890A1-20191010-C00006.png" class="style-scope patent-text"><img id="EMI-C00006" he="23.62mm" wi="157.06mm" file="US20190307890A1-20191010-C00006.TIF" alt="Figure US20190307890A1-20191010-C00006" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="628" height="94" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/57/bb/16/0498e03552a43c/US20190307890A1-20191010-C00006.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00006" attachment-type="cdx" file="US20190307890A1-20191010-C00006.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00006" attachment-type="mol" file="US20190307890A1-20191010-C00006.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0011]" class="style-scope patent-text">
    
    [0011]
  </para-num> <div id="p-0018" num="0011" class="description-line style-scope patent-text">(termed SGN-CD33A) is undergoing clinical trials in patients with CD33—Postiive Acute Myeloid Leukemia (AML). The pre-clinical development of SGN-CD33A is described in Kung Sutherland, M., et al., <i class="style-scope patent-text">Blood, </i>2013; 122(8) 1455-1463 (doi:10.1182/blood-2013-03-491506). An initial report of the clinical trials was provided at the 56<sup class="style-scope patent-text">th </sup>ASH Annual Meeting, 6-9 Dec. 2014 (Stein, E., et al., Session 616 -Abstract 623).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0012]" class="style-scope patent-text">
    
    [0012]
  </para-num> <div id="p-0019" num="0012" class="description-line style-scope patent-text">More recent publications have described the following conjugates comprising PBD dimers, for example, WO2014/057073 describes:</div>
    </li> <li class="style-scope patent-text"> <div id="p-0020" num="0000" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00007" num="00007" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/47/c5/da/1cacdd75e81fe2/US20190307890A1-20191010-C00007.png" class="style-scope patent-text"><img id="EMI-C00007" he="238.17mm" wi="158.33mm" file="US20190307890A1-20191010-C00007.TIF" alt="Figure US20190307890A1-20191010-C00007" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="633" height="953" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/47/c5/da/1cacdd75e81fe2/US20190307890A1-20191010-C00007.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00007" attachment-type="cdx" file="US20190307890A1-20191010-C00007.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00007" attachment-type="mol" file="US20190307890A1-20191010-C00007.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
      <chemistry id="CHEM-US-00008" num="00008" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/1c/10/26/ac6637a00cdc08/US20190307890A1-20191010-C00008.png" class="style-scope patent-text"><img id="EMI-C00008" he="48.43mm" wi="157.65mm" file="US20190307890A1-20191010-C00008.TIF" alt="Figure US20190307890A1-20191010-C00008" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="631" height="194" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/1c/10/26/ac6637a00cdc08/US20190307890A1-20191010-C00008.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00008" attachment-type="cdx" file="US20190307890A1-20191010-C00008.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00008" attachment-type="mol" file="US20190307890A1-20191010-C00008.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <heading id="h-0002" class="style-scope patent-text">DISCLOSURE OF THE INVENTION</heading>
    <li class="style-scope patent-text"> <para-num num="[0013]" class="style-scope patent-text">
    
    [0013]
  </para-num> <div id="p-0021" num="0013" class="description-line style-scope patent-text">The present inventors have developed further drug linkers and conjugates comprising said drug linkers. These drug linker replace the methoxy group in the drug linker present in SGN-CD33A with either a fluoro, trifluoromethoxy or methyl group. Such groups will increase the Log P of the drug linkers.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0014]" class="style-scope patent-text">
    
    [0014]
  </para-num> <div id="p-0022" num="0014" class="description-line style-scope patent-text">Such an increase in Log P would be expected to make the drug linker and its conjugates more hydrophobic and more aggregative. In addition, the increase in hydrophobicity would be expected to lead to more rapid clearance in vivo, and hence a reduced active. Surprisingly, this does not appear to be the case in vivo for at least some of the conjugates herein.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0015]" class="style-scope patent-text">
    
    [0015]
  </para-num> <div id="p-0023" num="0015" class="description-line style-scope patent-text">Furthermore, the conjugates of the newly developed drug linker appear to show a reduced activity in vitro to those including the drug linker from SGN-CD33A, which would discourage further testing, but a surprising comparable in vivo activity, for at least some of the conjugates herein.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0016]" class="style-scope patent-text">
    
    [0016]
  </para-num> <div id="p-0024" num="0016" class="description-line style-scope patent-text">In a first aspect, the present invention provides Conjugates of formula I:</div>
    </li> <li class="style-scope patent-text"> <div id="p-0025" num="0000" class="description-line style-scope patent-text"> <br class="style-scope patent-text">L-(D<sup class="style-scope patent-text">L</sup>)<sub class="style-scope patent-text">p </sub>  (I)
</div>
    </li> <li class="style-scope patent-text"> <div id="p-0026" num="0000" class="description-line style-scope patent-text">wherein Lisa Ligand unit (i.e., a targeting agent), D is a Drug Linker unit of formula IIa, IIb or IIc:</div>
    </li> <li class="style-scope patent-text"> <div id="p-0027" num="0000" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00009" num="00009" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/07/2a/e3/d4514c1a6e05a5/US20190307890A1-20191010-C00009.png" class="style-scope patent-text"><img id="EMI-C00009" he="188.21mm" wi="158.75mm" file="US20190307890A1-20191010-C00009.TIF" alt="Figure US20190307890A1-20191010-C00009" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="635" height="753" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/07/2a/e3/d4514c1a6e05a5/US20190307890A1-20191010-C00009.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00009" attachment-type="cdx" file="US20190307890A1-20191010-C00009.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00009" attachment-type="mol" file="US20190307890A1-20191010-C00009.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <li class="style-scope patent-text"> <div id="p-0028" num="0000" class="description-line style-scope patent-text">wherein p is an integer of from 1 to 20.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0017]" class="style-scope patent-text">
    
    [0017]
  </para-num> <div id="p-0029" num="0017" class="description-line style-scope patent-text">The Ligand unit, described more fully below, is a targeting agent that binds to a target moiety. The Ligand unit can, for example, specifically bind to a cell component (a Cell</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0018]" class="style-scope patent-text">
    
    [0018]
  </para-num> <div id="p-0030" num="0018" class="description-line style-scope patent-text">Binding Agent) or to other target molecules of interest. The Ligand unit can be, for example, a protein, polypeptide or peptide, such as an antibody, an antigen-binding fragment of an antibody, or other binding agent, such as an Fc fusion protein.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0019]" class="style-scope patent-text">
    
    [0019]
  </para-num> <div id="p-0031" num="0019" class="description-line style-scope patent-text">A second aspect of the present invention provides a compound of formula IIIa, IIIb or IIIc:</div>
    </li> <li class="style-scope patent-text"> <div id="p-0032" num="0000" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00010" num="00010" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/49/74/1f/ad57f86b93cba1/US20190307890A1-20191010-C00010.png" class="style-scope patent-text"><img id="EMI-C00010" he="196.00mm" wi="158.75mm" file="US20190307890A1-20191010-C00010.TIF" alt="Figure US20190307890A1-20191010-C00010" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="635" height="784" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/49/74/1f/ad57f86b93cba1/US20190307890A1-20191010-C00010.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00010" attachment-type="cdx" file="US20190307890A1-20191010-C00010.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00010" attachment-type="mol" file="US20190307890A1-20191010-C00010.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[0020]" class="style-scope patent-text">
    
    [0020]
  </para-num> <div id="p-0033" num="0020" class="description-line style-scope patent-text">A third aspect of the present invention provides the use of a conjugate of the first aspect of the invention in the manufacture of a medicament for treating a proliferative disease. The third aspect also provides a conjugate of the first aspect of the invention for use in the treatment of a proliferative disease. The third aspect also provides a method of treating a proliferative disease comprising administering a therapeutically effective amount of a conjugate of the first aspect of the invention to a patient in need thereof.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0021]" class="style-scope patent-text">
    
    [0021]
  </para-num> <div id="p-0034" num="0021" class="description-line style-scope patent-text">One of ordinary skill in the art is readily able to determine whether or not a candidate conjugate treats a proliferative condition for any particular cell type. For example, assays which may conveniently be used to assess the activity offered by a particular compound are described in the examples below.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0022]" class="style-scope patent-text">
    
    [0022]
  </para-num> <div id="p-0035" num="0022" class="description-line style-scope patent-text">A fourth aspect of the present invention provides the synthesis of a conjugate of the first aspect of the invention comprising conjugating an appropriate compound (drug linker) of the second aspect of the invention with a Ligand Unit</div>
    
    
    </li> <description-of-drawings class="style-scope patent-text">
      <heading id="h-0003" class="style-scope patent-text">BRIEF DESCRIPTION OF FIGURES</heading>
      <li class="style-scope patent-text"> <para-num num="[0023]" class="style-scope patent-text">
    
    [0023]
  </para-num> <div id="p-0036" num="0023" class="description-line style-scope patent-text"> <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref> shows the effect on volume of NCI-N87 tumours following treatment with conjugates of the present invention;</div>
      </li> <li class="style-scope patent-text"> <para-num num="[0024]" class="style-scope patent-text">
    
    [0024]
  </para-num> <div id="p-0037" num="0024" class="description-line style-scope patent-text"> <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 2</figref> shows the effect on volume of NCI-N87 tumours following treatment with a conjugate of the present invention;</div>
      </li> <li class="style-scope patent-text"> <para-num num="[0025]" class="style-scope patent-text">
    
    [0025]
  </para-num> <div id="p-0038" num="0025" class="description-line style-scope patent-text"> <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 3</figref> shows the effect on volume of a JIMT-1 tumour following treatment with a conjugate of the present invention.</div>
    </li> </description-of-drawings>
    
    
    <li class="style-scope patent-text"> <para-num num="[0026]" class="style-scope patent-text">
    
    [0026]
  </para-num> <div id="p-0039" num="0026" class="description-line style-scope patent-text">Ligand Unit</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0027]" class="style-scope patent-text">
    
    [0027]
  </para-num> <div id="p-0040" num="0027" class="description-line style-scope patent-text">The Ligand Unit may be of any kind, and include a protein, polypeptide, peptide and a non-peptidic agent that specifically binds to a target molecule. In some embodiments, the Ligand unit may be a protein, polypeptide or peptide. In some embodiments, the Ligand unit may be a cyclic polypeptide. These Ligand units can include antibodies or a fragment of an antibody that contains at least one target molecule-binding site, lymphokines, hormones, growth factors, or any other cell binding molecule or substance that can specifically bind to a target.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0028]" class="style-scope patent-text">
    
    [0028]
  </para-num> <div id="p-0041" num="0028" class="description-line style-scope patent-text">The terms “specifically binds” and “specific binding” refer to the binding of an antibody or other protein, polypeptide or peptide to a predetermined molecule (e.g., an antigen). Typically, the antibody or other molecule binds with an affinity of at least about 1×10<sup class="style-scope patent-text">7 </sup>M<sup class="style-scope patent-text">−1</sup>, and binds to the predetermined molecule with an affinity that is at least two-fold greater than its affinity for binding to a non-specific molecule (e.g., BSA, casein) other than the predetermined molecule or a closely-related molecule.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0029]" class="style-scope patent-text">
    
    [0029]
  </para-num> <div id="p-0042" num="0029" class="description-line style-scope patent-text">Examples of Ligand units include those agents described for use in WO 2007/085930, which is incorporated herein.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0030]" class="style-scope patent-text">
    
    [0030]
  </para-num> <div id="p-0043" num="0030" class="description-line style-scope patent-text">In some embodiments, the Ligand unit is a Cell Binding Agent that binds to an extracellular target on a cell. Such a Cell Binding Agent can be a protein, polypeptide, peptide or a non-peptidic agent. In some embodiments, the Cell Binding Agent may be a protein, polypeptide or peptide. In some embodiments, the Cell Binding Agent may be a cyclic polypeptide. The Cell Binding Agent also may be antibody or an antigen-binding fragment of an antibody. Thus, in one embodiment, the present invention provides an antibody-drug conjugate (ADC).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0031]" class="style-scope patent-text">
    
    [0031]
  </para-num> <div id="p-0044" num="0031" class="description-line style-scope patent-text">Cell Binding Agent</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0032]" class="style-scope patent-text">
    
    [0032]
  </para-num> <div id="p-0045" num="0032" class="description-line style-scope patent-text">A cell binding agent may be of any kind, and include peptides and non-peptides. These can include antibodies or a fragment of an antibody that contains at least one binding site, lymphokines, hormones, hormone mimetics, vitamins, growth factors, nutrient-transport molecules, or any other cell binding molecule or substance.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0033]" class="style-scope patent-text">
    
    [0033]
  </para-num> <div id="p-0046" num="0033" class="description-line style-scope patent-text">Peptides</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0034]" class="style-scope patent-text">
    
    [0034]
  </para-num> <div id="p-0047" num="0034" class="description-line style-scope patent-text">In one embodiment, the cell binding agent is a linear or cyclic peptide comprising 4-30, preferably 6-20, contiguous amino acid residues. In this embodiment, it is preferred that one cell binding agent is linked to one monomer or dimer pyrrolobenzodiazepine compound.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0035]" class="style-scope patent-text">
    
    [0035]
  </para-num> <div id="p-0048" num="0035" class="description-line style-scope patent-text">In one embodiment the cell binding agent comprises a peptide that binds integrin α<sub class="style-scope patent-text">v</sub>β<sub class="style-scope patent-text">6. </sub>The peptide may be selective for α<sub class="style-scope patent-text">v</sub>β<sub class="style-scope patent-text">6 </sub>over XYS.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0036]" class="style-scope patent-text">
    
    [0036]
  </para-num> <div id="p-0049" num="0036" class="description-line style-scope patent-text">In one embodiment the cell binding agent comprises the A20FMDV-Cys polypeptide. The A20FMDV-Cys has the sequence: NAVPNLRGDLQVLAQKVARTC. Alternatively, a variant of the A20FMDV-Cys sequence may be used wherein one, two, three, four, five, six, seven, eight, nine or ten amino acid residues are substituted with another amino acid residue. Furthermore, the polypeptide may have the sequence NAVXXXXXXXXXXXXXXXRTC.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0037]" class="style-scope patent-text">
    
    [0037]
  </para-num> <div id="p-0050" num="0037" class="description-line style-scope patent-text">Antibodies</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0038]" class="style-scope patent-text">
    
    [0038]
  </para-num> <div id="p-0051" num="0038" class="description-line style-scope patent-text">The term “antibody” herein is used in the broadest sense and specifically covers monoclonal antibodies, polyclonal antibodies, dimers, multimers, multispecific antibodies (e.g., bispecific antibodies), and antibody fragments, so long as they exhibit the desired biological activity (Miller et al (2003) <i class="style-scope patent-text">Jour. of Immunology </i>170:4854-4861). Antibodies may be murine, human, humanized, chimeric, or derived from other species. An antibody is a protein generated by the immune system that is capable of recognizing and binding to a specific antigen. (Janeway, C., Travers, P., Walport, M., Shlomchik (2001) <i class="style-scope patent-text">Immuno Biology, </i>5th Ed., Garland Publishing, New York). A target antigen generally has numerous binding sites, also called epitopes, recognized by CDRs on multiple antibodies. Each antibody that specifically binds to a different epitope has a different structure. Thus, one antigen may have more than one corresponding antibody. An antibody includes a full-length immunoglobulin molecule or an immunologically active portion of a full-length immunoglobulin molecule, i.e., a molecule that contains an antigen binding site that immunospecifically binds an antigen of a target of interest or part thereof, such targets including but not limited to, cancer cell or cells that produce autoimmune antibodies associated with an autoimmune disease. The immunoglobulin can be of any type (e.g. IgG, IgE, IgM, IgD, and IgA), class (e.g. IgG1, IgG2, IgG3, IgG4, IgA1 and IgA2) or subclass of immunoglobulin molecule. The immunoglobulins can be derived from any species, including human, murine, or rabbit origin.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0039]" class="style-scope patent-text">
    
    [0039]
  </para-num> <div id="p-0052" num="0039" class="description-line style-scope patent-text">“Antibody fragments” comprise a portion of a full length antibody, generally the antigen binding or variable region thereof. Examples of antibody fragments include Fab, Fab′, F(ab′)<sub class="style-scope patent-text">2, </sub>and scFv fragments; diabodies; linear antibodies; fragments produced by a Fab expression library, anti-idiotypic (anti-Id) antibodies, CDR (complementary determining region), and epitope-binding fragments of any of the above which immunospecifically bind to cancer cell antigens, viral antigens or microbial antigens, single-chain antibody molecules; and multispecific antibodies formed from antibody fragments.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0040]" class="style-scope patent-text">
    
    [0040]
  </para-num> <div id="p-0053" num="0040" class="description-line style-scope patent-text">The term “monoclonal antibody” as used herein refers to an antibody obtained from a population of substantially homogeneous antibodies, i.e. the individual antibodies comprising the population are identical except for possible naturally occurring mutations that may be present in minor amounts. Monoclonal antibodies are highly specific, being directed against a single antigenic site. Furthermore, in contrast to polyclonal antibody preparations which include different antibodies directed against different determinants (epitopes), each monoclonal antibody is directed against a single determinant on the antigen. In addition to their specificity, the monoclonal antibodies are advantageous in that they may be synthesized uncontaminated by other antibodies. The modifier “monoclonal” indicates the character of the antibody as being obtained from a substantially homogeneous population of antibodies, and is not to be construed as requiring production of the antibody by any particular method. For example, the monoclonal antibodies to be used in accordance with the present invention may be made by the hybridoma method first described by Kohler et al (1975) <i class="style-scope patent-text">Nature </i>256:495, or may be made by recombinant DNA methods (see, U.S. Pat. No. 4,816,567). The monoclonal antibodies may also be isolated from phage antibody libraries using the techniques described in Clackson et al (1991) <i class="style-scope patent-text">Nature, </i>352:624-628; Marks et al (1991) <i class="style-scope patent-text">J.Mol. Biol., </i>222:581-597 or from transgenic mice carrying a fully human immunoglobulin system (Lonberg (2008) <i class="style-scope patent-text">Curr. Opinion </i>20(4):450-459).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0041]" class="style-scope patent-text">
    
    [0041]
  </para-num> <div id="p-0054" num="0041" class="description-line style-scope patent-text">The monoclonal antibodies herein specifically include “chimeric” antibodies in which a portion of the heavy and/or light chain is identical with or homologous to corresponding sequences in antibodies derived from a particular species or belonging to a particular antibody class or subclass, while the remainder of the chain(s) is identical with or homologous to corresponding sequences in antibodies derived from another species or belonging to another antibody class or subclass, as well as fragments of such antibodies, so long as they exhibit the desired biological activity (U.S. Pat. No. 4,816,567; and Morrison et al (1984) <i class="style-scope patent-text">Proc. Natl. Acad. Sci. USA, </i>81:6851-6855). Chimeric antibodies include “primatized” antibodies comprising variable domain antigen-binding sequences derived from a non-human primate (e.g. Old World Monkey or Ape) and human constant region sequences.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0042]" class="style-scope patent-text">
    
    [0042]
  </para-num> <div id="p-0055" num="0042" class="description-line style-scope patent-text">An “intact antibody” herein is one comprising a VL and VH domains, as well as a light chain constant domain (CL) and heavy chain constant domains, CH1, CH2 and CH3. The constant domains may be native sequence constant domains (e.g. human native sequence constant domains) or amino acid sequence variant thereof. The intact antibody may have one or more “effector functions” which refer to those biological activities attributable to the Fc region (a native sequence Fc region or amino acid sequence variant Fc region) of an antibody. Examples of antibody effector functions include C1q binding; complement dependent cytotoxicity; Fc receptor binding; antibody-dependent cell-mediated cytotoxicity (ADCC); phagocytosis; and down regulation of cell surface receptors such as B cell receptor and BCR.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0043]" class="style-scope patent-text">
    
    [0043]
  </para-num> <div id="p-0056" num="0043" class="description-line style-scope patent-text">Depending on the amino acid sequence of the constant domain of their heavy chains, intact antibodies can be assigned to different “classes.” There are five major classes of intact antibodies: IgA, IgD, IgE, IgG, and IgM, and several of these may be further divided into “subclasses” (isotypes), e.g., IgG1, IgG2, IgG3, IgG4, IgA, and IgA2. The heavy-chain constant domains that correspond to the different classes of antibodies are called α, β, ϵ, γ, and μ, respectively. The subunit structures and three-dimensional configurations of different classes of immunoglobulins are well known.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0044]" class="style-scope patent-text">
    
    [0044]
  </para-num> <div id="p-0057" num="0044" class="description-line style-scope patent-text">Humanisation</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0045]" class="style-scope patent-text">
    
    [0045]
  </para-num> <div id="p-0058" num="0045" class="description-line style-scope patent-text">Techniques to reduce the in vivo immunogenicity of a non-human antibody or antibody fragment include those termed “humanisation”.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0046]" class="style-scope patent-text">
    
    [0046]
  </para-num> <div id="p-0059" num="0046" class="description-line style-scope patent-text">A “humanized antibody” refers to a polypeptide comprising at least a portion of a modified variable region of a human antibody wherein a portion of the variable region, preferably a portion substantially less than the intact human variable domain, has been substituted by the corresponding sequence from a non-human species and wherein the modified variable region is linked to at least another part of another protein, preferably the constant region of a human antibody. The expression “humanized antibodies” includes human antibodies in which one or more complementarity determining region (“CDR”) amino acid residues and/or one or more framework region (“FW” or “FR”) amino acid residues are substituted by amino acid residues from analogous sites in rodent or other non-human antibodies. The expression “humanized antibody” also includes an immunoglobulin amino acid sequence variant or fragment thereof that comprises an FR having substantially the amino acid sequence of a human immunoglobulin and a CDR having substantially the amino acid sequence of a non-human immunoglobulin.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0047]" class="style-scope patent-text">
    
    [0047]
  </para-num> <div id="p-0060" num="0047" class="description-line style-scope patent-text">“Humanized” forms of non-human (e.g., murine) antibodies are chimeric antibodies that contain minimal sequence derived from non-human immunoglobulin. Or, looked at another way, a humanized antibody is a human antibody that also contains selected sequences from non-human (e.g. murine) antibodies in place of the human sequences. A humanized antibody can include conservative amino acid substitutions or non-natural residues from the same or different species that do not significantly alter its binding and/or biologic activity. Such antibodies are chimeric antibodies that contain minimal sequence derived from non-human immunoglobulins.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0048]" class="style-scope patent-text">
    
    [0048]
  </para-num> <div id="p-0061" num="0048" class="description-line style-scope patent-text">There are a range of humanisation techniques, including ‘CDR grafting’, ‘guided selection’, ‘deimmunization’, ‘resurfacing’ (also known as ‘veneering’), ‘composite antibodies’, ‘Human String Content Optimisation’ and framework shuffling.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0049]" class="style-scope patent-text">
    
    [0049]
  </para-num> <div id="p-0062" num="0049" class="description-line style-scope patent-text">CDR Grafting</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0050]" class="style-scope patent-text">
    
    [0050]
  </para-num> <div id="p-0063" num="0050" class="description-line style-scope patent-text">In this technique, the humanized antibodies are human immunoglobulins (recipient antibody) in which residues from a complementary-determining region (CDR) of the recipient antibody are replaced by residues from a CDR of a non-human species (donor antibody) such as mouse, rat, camel, bovine, goat, or rabbit having the desired properties (in effect, the non-human CDRs are ‘grafted’ onto the human framework). In some instances, framework region (FR) residues of the human immunoglobulin are replaced by corresponding non-human residues (this may happen when, for example, a particular FR residue has significant effect on antigen binding).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0051]" class="style-scope patent-text">
    
    [0051]
  </para-num> <div id="p-0064" num="0051" class="description-line style-scope patent-text">Furthermore, humanized antibodies can comprise residues that are found neither in the recipient antibody nor in the imported CDR or framework sequences. These modifications are made to further refine and maximize antibody performance. Thus, in general, a humanized antibody will comprise all of at least one, and in one aspect two, variable domains, in which all or all of the hypervariable loops correspond to those of a non-human immunoglobulin and all or substantially all of the FR regions are those of a human immunoglobulin sequence. The humanized antibody optionally also will comprise at least a portion of an immunoglobulin constant region (Fc), or that of a human immunoglobulin.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0052]" class="style-scope patent-text">
    
    [0052]
  </para-num> <div id="p-0065" num="0052" class="description-line style-scope patent-text">Guided Selection</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0053]" class="style-scope patent-text">
    
    [0053]
  </para-num> <div id="p-0066" num="0053" class="description-line style-scope patent-text">The method consists of combining the VH or VL domain of a given non-human antibody specific for a particular epitope with a human VH or VL library and specific human V domains are selected against the antigen of interest. This selected human VH is then combined with a VL library to generate a completely human VH×VL combination. The method is described in Nature Biotechnology (N.Y.) 12, (1994) 899-903.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0054]" class="style-scope patent-text">
    
    [0054]
  </para-num> <div id="p-0067" num="0054" class="description-line style-scope patent-text">Composite Antibodies</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0055]" class="style-scope patent-text">
    
    [0055]
  </para-num> <div id="p-0068" num="0055" class="description-line style-scope patent-text">In this method, two or more segments of amino acid sequence from a human antibody are combined within the final antibody molecule. They are constructed by combining multiple human VH and VL sequence segments in combinations which limit or avoid human T cell epitopes in the final composite antibody V regions. Where required, T cell epitopes are limited or avoided by, exchanging V region segments contributing to or encoding a T cell epitope with alternative segments which avoid T cell epitopes. This method is described in US 2008/0206239 A1.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0056]" class="style-scope patent-text">
    
    [0056]
  </para-num> <div id="p-0069" num="0056" class="description-line style-scope patent-text">Deimmunization</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0057]" class="style-scope patent-text">
    
    [0057]
  </para-num> <div id="p-0070" num="0057" class="description-line style-scope patent-text">This method involves the removal of human (or other second species) T-cell epitopes from the V regions of the therapeutic antibody (or other molecule). The therapeutic antibodies V-region sequence is analysed for the presence of MHC class II-binding motifs by, for example, comparison with databases of MHC-binding motifs (such as the “motifs” database hosted at www.wehi.edu.au). Alternatively, MHC class II-binding motifs may be identified using computational threading methods such as those devised by Altuvia et al. (<i class="style-scope patent-text">J. Mol. Biol. </i>249 244-250 (1995)); in these methods, consecutive overlapping peptides from the V-region sequences are testing for their binding energies to MHC class II proteins. This data can then be combined with information on other sequence features which relate to successfully presented peptides, such as amphipathicity, Rothbard motifs, and cleavage sites for cathepsin B and other processing enzymes.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0058]" class="style-scope patent-text">
    
    [0058]
  </para-num> <div id="p-0071" num="0058" class="description-line style-scope patent-text">Once potential second species (e.g. human) T-cell epitopes have been identified, they are eliminated by the alteration of one or more amino acids. The modified amino acids are usually within the T-cell epitope itself, but may also be adjacent to the epitope in terms of the primary or secondary structure of the protein (and therefore, may not be adjacent in the primary structure). Most typically, the alteration is by way of substitution but, in some circumstances amino acid addition or deletion will be more appropriate.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0059]" class="style-scope patent-text">
    
    [0059]
  </para-num> <div id="p-0072" num="0059" class="description-line style-scope patent-text">All alterations can be accomplished by recombinant DNA technology, so that the final molecule may be prepared by expression from a recombinant host using well established methods such as Site Directed Mutagenesis. However, the use of protein chemistry or any other means of molecular alteration is also possible.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0060]" class="style-scope patent-text">
    
    [0060]
  </para-num> <div id="p-0073" num="0060" class="description-line style-scope patent-text">Resurfacing</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0061]" class="style-scope patent-text">
    
    [0061]
  </para-num> <div id="p-0074" num="0061" class="description-line style-scope patent-text">This method involves:
</div> </li> <ul class="style-scope patent-text"> <li id="ul0001-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0002-0001" num="0062" class="style-scope patent-text">(a) determining the conformational structure of the variable region of the non-human (e.g. rodent) antibody (or fragment thereof) by constructing a three-dimensional model of the non-human antibody variable region;</li> <li id="ul0002-0002" num="0063" class="style-scope patent-text">(b) generating sequence alignments using relative accessibility distributions from x-ray crystallographic structures of a sufficient number of non-human and human antibody variable region heavy and light chains to give a set of heavy and light chain framework positions wherein the alignment positions are identical in 98% of the sufficient number of non-human antibody heavy and light chains;</li> <li id="ul0002-0003" num="0064" class="style-scope patent-text">(c) defining for the non-human antibody to be humanized, a set of heavy and light chain surface exposed amino acid residues using the set of framework positions generated in step (b);</li> <li id="ul0002-0004" num="0065" class="style-scope patent-text">(d) identifying from human antibody amino acid sequences a set of heavy and light chain surface exposed amino acid residues that is most closely identical to the set of surface exposed amino acid residues defined in step (c), wherein the heavy and light chain from the human antibody are or are not naturally paired;</li> <li id="ul0002-0005" num="0066" class="style-scope patent-text">(e) substituting, in the amino acid sequence of the non-human antibody to be humanized, the set of heavy and light chain surface exposed amino acid residues defined in step (c) with the set of heavy and light chain surface exposed amino acid residues identified in step (d);</li> <li id="ul0002-0006" num="0067" class="style-scope patent-text">(f) constructing a three-dimensional model of the variable region of the non-human antibody resulting from the substituting specified in step (e);</li> <li id="ul0002-0007" num="0068" class="style-scope patent-text">(g) identifying, by comparing the three-dimensional models constructed in steps (a) and (f), any amino acid residues from the sets identified in steps (c) or (d), that are within 5 Angstroms of any atom of any residue of the complementarity determining regions of the non-human antibodt to be humanized; and</li> <li id="ul0002-0008" num="0069" class="style-scope patent-text">(h) changing any residues identified in step (g) from the human to the original non-human amino acid residue to thereby define a non-human antibody humanizing set of surface exposed amino acid residues; with the proviso that step (a) need not be conducted first, but must be conducted prior to step (g).</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0070]" class="style-scope patent-text">
    
    [0070]
  </para-num> <div id="p-0075" num="0070" class="description-line style-scope patent-text">Superhumanization</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0071]" class="style-scope patent-text">
    
    [0071]
  </para-num> <div id="p-0076" num="0071" class="description-line style-scope patent-text">The method compares the non-human sequence with the functional human germline gene repertoire. Those human genes encoding canonical structures identical or closely related to the non-human sequences are selected. Those selected human genes with highest homology within the CDRs are chosen as FR donors. Finally, the non-human CDRs are grafted onto these human FRs. This method is described in patent WO 2005/079479 A2.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0072]" class="style-scope patent-text">
    
    [0072]
  </para-num> <div id="p-0077" num="0072" class="description-line style-scope patent-text">Human String Content Optimization</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0073]" class="style-scope patent-text">
    
    [0073]
  </para-num> <div id="p-0078" num="0073" class="description-line style-scope patent-text">This method compares the non-human (e.g. mouse) sequence with the repertoire of human germline genes and the differences are scored as Human String Content (HSC) that quantifies a sequence at the level of potential MHC/T-cell epitopes. The target sequence is then humanized by maximizing its HSC rather than using a global identity measure to generate multiple diverse humanized variants (described in Molecular Immunology, 44, (2007) 1986-1998).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0074]" class="style-scope patent-text">
    
    [0074]
  </para-num> <div id="p-0079" num="0074" class="description-line style-scope patent-text">Framework Shuffling</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0075]" class="style-scope patent-text">
    
    [0075]
  </para-num> <div id="p-0080" num="0075" class="description-line style-scope patent-text">The CDRs of the non-human antibody are fused in-frame to cDNA pools encompassing all known heavy and light chain human germline gene frameworks. Humanised antibodies are then selected by e.g. panning of the phage displayed antibody library. This is described in <i class="style-scope patent-text"> <figure-callout id="36" label="Methods" filenames="US20190307890A1-20191010-D00001.png,US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Methods</a></figure-callout> </i>36, 43-60 (2005). Examples of cell binding agents include those agents described for use in WO2007/085930, which is incorporated herein.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0076]" class="style-scope patent-text">
    
    [0076]
  </para-num> <div id="p-0081" num="0076" class="description-line style-scope patent-text">Tumour-associate antigens and cognate antibodies for use in embodiments of the present invention are listed below.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0077]" class="style-scope patent-text">
    
    [0077]
  </para-num> <div id="p-0082" num="0077" class="description-line style-scope patent-text">Tumor-Associated Antigens and Cognate Antibodies</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0078]" class="style-scope patent-text">
    
    [0078]
  </para-num> <div id="p-0083" num="0078" class="description-line style-scope patent-text">(1) BMPR1B (bone morphogenetic protein receptor-type IB)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0079]" class="style-scope patent-text">
    
    [0079]
  </para-num> <div id="p-0084" num="0079" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0080]" class="style-scope patent-text">
    
    [0080]
  </para-num> <div id="p-0085" num="0080" class="description-line style-scope patent-text">Genbank accession no. NM_001203</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0081]" class="style-scope patent-text">
    
    [0081]
  </para-num> <div id="p-0086" num="0081" class="description-line style-scope patent-text">Genbank version no. NM_001203.2 GI:169790809</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0082]" class="style-scope patent-text">
    
    [0082]
  </para-num> <div id="p-0087" num="0082" class="description-line style-scope patent-text">Genbank record update date: Sep. 23, 2012 02:06 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0083]" class="style-scope patent-text">
    
    [0083]
  </para-num> <div id="p-0088" num="0083" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0084]" class="style-scope patent-text">
    
    [0084]
  </para-num> <div id="p-0089" num="0084" class="description-line style-scope patent-text">Genbank accession no. NP_001194</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0085]" class="style-scope patent-text">
    
    [0085]
  </para-num> <div id="p-0090" num="0085" class="description-line style-scope patent-text">Genbank version no. NP_001194.1 GI:4502431</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0086]" class="style-scope patent-text">
    
    [0086]
  </para-num> <div id="p-0091" num="0086" class="description-line style-scope patent-text">Genbank record update date: Sep. 23, 2012 02:06 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0087]" class="style-scope patent-text">
    
    [0087]
  </para-num> <div id="p-0092" num="0087" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0088]" class="style-scope patent-text">
    
    [0088]
  </para-num> <div id="p-0093" num="0088" class="description-line style-scope patent-text">ten Dijke,P., et al <i class="style-scope patent-text">Science </i>264 (5155): 101-104 (1994), <i class="style-scope patent-text">Oncogene </i>14 (11):1377-1382 (1997)); WO2004/063362 (claim 2); WO2003/042661 (claim 12);</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0089]" class="style-scope patent-text">
    
    [0089]
  </para-num> <div id="p-0094" num="0089" class="description-line style-scope patent-text">US2003/134790-A1 (Page 38-39); WO2002/102235 (claim 13; Page 296); WO2003/055443 (Page 91-92); WO2002/99122 (Example 2; Page 528-530); WO2003/029421 (claim 6); WO2003/024392 (claim 2; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 112</figref>); WO2002/98358 (claim 1; Page 183); WO2002/54940 (Page 100-101); WO2002/59377 (Page 349-350); WO2002/30268 (<figure-callout id="27" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 27; Page 376); WO2001/48204 (Example; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 4</figref>); NP_001194 bone morphogenetic protein receptor, type IB /pid=NP_001194.1.; MIM:603248; AY065994 (2) E16 (LAT1, SLC7A5)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0090]" class="style-scope patent-text">
    
    [0090]
  </para-num> <div id="p-0095" num="0090" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0091]" class="style-scope patent-text">
    
    [0091]
  </para-num> <div id="p-0096" num="0091" class="description-line style-scope patent-text">Genbank accession no. NM_003486</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0092]" class="style-scope patent-text">
    
    [0092]
  </para-num> <div id="p-0097" num="0092" class="description-line style-scope patent-text">Genbank version no. NM_003486.5 GI:71979931</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0093]" class="style-scope patent-text">
    
    [0093]
  </para-num> <div id="p-0098" num="0093" class="description-line style-scope patent-text">Genbank record update date: Jun. 27, 2012 12:06 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0094]" class="style-scope patent-text">
    
    [0094]
  </para-num> <div id="p-0099" num="0094" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0095]" class="style-scope patent-text">
    
    [0095]
  </para-num> <div id="p-0100" num="0095" class="description-line style-scope patent-text">Genbank accession no. NP_003477</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0096]" class="style-scope patent-text">
    
    [0096]
  </para-num> <div id="p-0101" num="0096" class="description-line style-scope patent-text">Genbank version no. NP_003477.4 GI:71979932</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0097]" class="style-scope patent-text">
    
    [0097]
  </para-num> <div id="p-0102" num="0097" class="description-line style-scope patent-text">Genbank record update date: Jun. 27, 2012 12:06 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0098]" class="style-scope patent-text">
    
    [0098]
  </para-num> <div id="p-0103" num="0098" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0099]" class="style-scope patent-text">
    
    [0099]
  </para-num> <div id="p-0104" num="0099" class="description-line style-scope patent-text">Biochem. Biophys. Res. <i class="style-scope patent-text">Commun. </i>255 (2), 283-288 (1999), <i class="style-scope patent-text">Nature </i>395 (6699):288-291 (1998), Gaugitsch, H. W., et al (1992) <i class="style-scope patent-text">J.Biol. Chem. </i>267 (16):11267-11273); WO2004/048938 (Example 2); WO2004/032842 (Example IV); WO2003/042661 (claim 12); WO2003/016475 (claim 1); WO2002/78524 (Example 2); WO2002/99074 (claim 19; Page 127-129); WO2002/86443 (<figure-callout id="27" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 27; Pages 222, 393); WO2003/003906 (claim 10; Page 293); WO2002/64798 (<figure-callout id="33" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 33; Page 93-95); WO2000/14228 (claim 5; Page 133-136); US2003/224454 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 3</figref>); WO2003/025138 (<figure-callout id="12" label="claim" filenames="US20190307890A1-20191010-D00001.png,US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 12; Page 150); NP_003477 solute carrier family 7 (cationic amino acid transporter, y+system), member 5 /pid=NP_003477.3-Homo sapiens; MIM:600182;; NM_015923.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0100]" class="style-scope patent-text">
    
    [0100]
  </para-num> <div id="p-0105" num="0100" class="description-line style-scope patent-text">(3) STEAP1 (six transmembrane epithelial antigen of prostate) Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0101]" class="style-scope patent-text">
    
    [0101]
  </para-num> <div id="p-0106" num="0101" class="description-line style-scope patent-text">Genbank accession no. NM_012449</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0102]" class="style-scope patent-text">
    
    [0102]
  </para-num> <div id="p-0107" num="0102" class="description-line style-scope patent-text">Genbank version no. NM_012449.2 GI:22027487</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0103]" class="style-scope patent-text">
    
    [0103]
  </para-num> <div id="p-0108" num="0103" class="description-line style-scope patent-text">Genbank record update date: Sep. 9, 2012 02:57 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0104]" class="style-scope patent-text">
    
    [0104]
  </para-num> <div id="p-0109" num="0104" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0105]" class="style-scope patent-text">
    
    [0105]
  </para-num> <div id="p-0110" num="0105" class="description-line style-scope patent-text">Genbank accession no. NP_036581</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0106]" class="style-scope patent-text">
    
    [0106]
  </para-num> <div id="p-0111" num="0106" class="description-line style-scope patent-text">Genbank version no. NP_036581.1 GI:9558759</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0107]" class="style-scope patent-text">
    
    [0107]
  </para-num> <div id="p-0112" num="0107" class="description-line style-scope patent-text">Genbank record update date: Sep. 9, 2012 02:57 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0108]" class="style-scope patent-text">
    
    [0108]
  </para-num> <div id="p-0113" num="0108" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0109]" class="style-scope patent-text">
    
    [0109]
  </para-num> <div id="p-0114" num="0109" class="description-line style-scope patent-text"> <i class="style-scope patent-text">Cancer Res. </i>61 (15), 5857-5860 (2001), Hubert, R. S., et al (1999) <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>96 (25):14523-14528); WO2004/065577 (claim 6); WO2004/027049 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 14</figref> EP1394274 (Example 11); WO2004/016225 (claim 2); WO2003/042661 (claim 12); US2003/157089 (Example 5); US2003/185830 (Example 5); US2003/064397 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 2</figref>); WO2002/89747 (Example 5; Page 618-619); WO2003/022995 (Example 9; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 13A</figref>, Example 53; Page 173, Example 2; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 2A</figref>); six transmembrane epithelial antigen of the prostate; MIM:604415.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0110]" class="style-scope patent-text">
    
    [0110]
  </para-num> <div id="p-0115" num="0110" class="description-line style-scope patent-text">(4) 0772P (CA125, MUC16)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0111]" class="style-scope patent-text">
    
    [0111]
  </para-num> <div id="p-0116" num="0111" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0112]" class="style-scope patent-text">
    
    [0112]
  </para-num> <div id="p-0117" num="0112" class="description-line style-scope patent-text">Genbank accession no. AF361486</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0113]" class="style-scope patent-text">
    
    [0113]
  </para-num> <div id="p-0118" num="0113" class="description-line style-scope patent-text">Genbank version no. AF361486.3 GI:34501466</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0114]" class="style-scope patent-text">
    
    [0114]
  </para-num> <div id="p-0119" num="0114" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 07:56 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0115]" class="style-scope patent-text">
    
    [0115]
  </para-num> <div id="p-0120" num="0115" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0116]" class="style-scope patent-text">
    
    [0116]
  </para-num> <div id="p-0121" num="0116" class="description-line style-scope patent-text">Genbank accession no. AAK74120</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0117]" class="style-scope patent-text">
    
    [0117]
  </para-num> <div id="p-0122" num="0117" class="description-line style-scope patent-text">Genbank version no. AAK74120.3 GI:34501467</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0118]" class="style-scope patent-text">
    
    [0118]
  </para-num> <div id="p-0123" num="0118" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 07:56 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0119]" class="style-scope patent-text">
    
    [0119]
  </para-num> <div id="p-0124" num="0119" class="description-line style-scope patent-text">Cross References <i class="style-scope patent-text">J. Biol. Chem. </i>276 (29):27371-27375 (2001)); WO2004/045553 (claim 14); WO2002/92836 (<figure-callout id="6" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 6; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 12</figref>); WO2002/83866 (<figure-callout id="15" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 15; Page 116-121); US2003/124140 (Example 16); GI:34501467;</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0120]" class="style-scope patent-text">
    
    [0120]
  </para-num> <div id="p-0125" num="0120" class="description-line style-scope patent-text">(5) MPF (MPF, MSLN, SMR, megakaryocyte potentiating factor, mesothelin)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0121]" class="style-scope patent-text">
    
    [0121]
  </para-num> <div id="p-0126" num="0121" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0122]" class="style-scope patent-text">
    
    [0122]
  </para-num> <div id="p-0127" num="0122" class="description-line style-scope patent-text">Genbank accession no. NM_005823</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0123]" class="style-scope patent-text">
    
    [0123]
  </para-num> <div id="p-0128" num="0123" class="description-line style-scope patent-text">Genbank version no. NM_005823.5 GI:293651528</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0124]" class="style-scope patent-text">
    
    [0124]
  </para-num> <div id="p-0129" num="0124" class="description-line style-scope patent-text">Genbank record update date: Sep. 2, 2012 01:47 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0125]" class="style-scope patent-text">
    
    [0125]
  </para-num> <div id="p-0130" num="0125" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0126]" class="style-scope patent-text">
    
    [0126]
  </para-num> <div id="p-0131" num="0126" class="description-line style-scope patent-text">Genbank accession no. NP_005814</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0127]" class="style-scope patent-text">
    
    [0127]
  </para-num> <div id="p-0132" num="0127" class="description-line style-scope patent-text">Genbank version no. NP_005814.2 GI:53988378</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0128]" class="style-scope patent-text">
    
    [0128]
  </para-num> <div id="p-0133" num="0128" class="description-line style-scope patent-text">Genbank record update date: Sep. 2, 2012 01:47 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0129]" class="style-scope patent-text">
    
    [0129]
  </para-num> <div id="p-0134" num="0129" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0130]" class="style-scope patent-text">
    
    [0130]
  </para-num> <div id="p-0135" num="0130" class="description-line style-scope patent-text">Yamaguchi, N., et al <i class="style-scope patent-text">Biol. Chem. </i>269 (2), 805-808 (1994), <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>96 (20):11531-11536 (1999), <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>93 (1):136-140 (1996), <i class="style-scope patent-text">J.Biol. Chem. </i>270 (37):21984-21990 (1995)); WO2003/101283 (claim 14); (WO2002/102235 (claim 13; Page 287-288); WO2002/101075 (<figure-callout id="4" label="claim" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 4; Page 308-309); WO2002/71928 (Page 320-321); WO94/10312 (Page 52-57); IM:601051.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0131]" class="style-scope patent-text">
    
    [0131]
  </para-num> <div id="p-0136" num="0131" class="description-line style-scope patent-text">(6) Napi3b (NAPI-3B, NPTIIb, SLC34A2, solute carrier family 34 (sodium phosphate), member 2, type II sodium-dependent phosphate transporter 3b)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0132]" class="style-scope patent-text">
    
    [0132]
  </para-num> <div id="p-0137" num="0132" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0133]" class="style-scope patent-text">
    
    [0133]
  </para-num> <div id="p-0138" num="0133" class="description-line style-scope patent-text">Genbank accession no. NM_006424</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0134]" class="style-scope patent-text">
    
    [0134]
  </para-num> <div id="p-0139" num="0134" class="description-line style-scope patent-text">Genbank version no. NM_006424.2 GI:110611905</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0135]" class="style-scope patent-text">
    
    [0135]
  </para-num> <div id="p-0140" num="0135" class="description-line style-scope patent-text">Genbank record update date: Jul. 22, 2012 03:39 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0136]" class="style-scope patent-text">
    
    [0136]
  </para-num> <div id="p-0141" num="0136" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0137]" class="style-scope patent-text">
    
    [0137]
  </para-num> <div id="p-0142" num="0137" class="description-line style-scope patent-text">Genbank accession no. NP_006415</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0138]" class="style-scope patent-text">
    
    [0138]
  </para-num> <div id="p-0143" num="0138" class="description-line style-scope patent-text">Genbank version no. NP_006415.2 GI:110611906</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0139]" class="style-scope patent-text">
    
    [0139]
  </para-num> <div id="p-0144" num="0139" class="description-line style-scope patent-text">Genbank record update date: Jul. 22, 2012 03:39 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0140]" class="style-scope patent-text">
    
    [0140]
  </para-num> <div id="p-0145" num="0140" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0141]" class="style-scope patent-text">
    
    [0141]
  </para-num> <div id="p-0146" num="0141" class="description-line style-scope patent-text"> <i class="style-scope patent-text">J.Biol. Chem. </i>277 (22):19665-19672 (2002), <i class="style-scope patent-text">Genomics </i>62 (2):281-284 (1999), Feild, J. A., et al (1999) <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>258 (3):578-582); WO2004/022778 (claim 2); EP1394274 (Example 11); WO2002/102235 (claim 13; Page 326); EP0875569 (claim 1; Page 17-19); WO2001/57188 (<figure-callout id="20" label="claim" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 20; Page 329); WO2004/032842 (Example IV); WO2001/75177 (<figure-callout id="24" label="claim" filenames="US20190307890A1-20191010-D00001.png,US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 24; Page 139-140); MIM:604217.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0142]" class="style-scope patent-text">
    
    [0142]
  </para-num> <div id="p-0147" num="0142" class="description-line style-scope patent-text">(7) Sema 5b (FLJ10372, KIAA1445, Mm.42015, SEMA58, SEMAG, Semaphorin 5b Hlog, sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 58)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0143]" class="style-scope patent-text">
    
    [0143]
  </para-num> <div id="p-0148" num="0143" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0144]" class="style-scope patent-text">
    
    [0144]
  </para-num> <div id="p-0149" num="0144" class="description-line style-scope patent-text">Genbank accession no. AB040878</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0145]" class="style-scope patent-text">
    
    [0145]
  </para-num> <div id="p-0150" num="0145" class="description-line style-scope patent-text">Genbank version no. AB040878.1 GI:7959148</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0146]" class="style-scope patent-text">
    
    [0146]
  </para-num> <div id="p-0151" num="0146" class="description-line style-scope patent-text">Genbank record update date: Aug. 2, 2006 05:40 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0147]" class="style-scope patent-text">
    
    [0147]
  </para-num> <div id="p-0152" num="0147" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0148]" class="style-scope patent-text">
    
    [0148]
  </para-num> <div id="p-0153" num="0148" class="description-line style-scope patent-text">Genbank accession no. BAA95969</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0149]" class="style-scope patent-text">
    
    [0149]
  </para-num> <div id="p-0154" num="0149" class="description-line style-scope patent-text">Genbank version no. BAA95969.1 GI:7959149</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0150]" class="style-scope patent-text">
    
    [0150]
  </para-num> <div id="p-0155" num="0150" class="description-line style-scope patent-text">Genbank record update date: Aug. 2, 2006 05:40 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0151]" class="style-scope patent-text">
    
    [0151]
  </para-num> <div id="p-0156" num="0151" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0152]" class="style-scope patent-text">
    
    [0152]
  </para-num> <div id="p-0157" num="0152" class="description-line style-scope patent-text">Nagase T., et al (2000) DNA Res. 7 (2):143-150); WO2004/000997 (claim 1); WO2003/003984 (claim 1); WO2002/06339 (claim 1; Page 50); WO2001/88133 (claim 1; Page 41-43, 48-58); WO2003/054152 (claim 20); WO2003/101400 (claim 11); Accession: Q9P283; Genew; HGNC:10737</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0153]" class="style-scope patent-text">
    
    [0153]
  </para-num> <div id="p-0158" num="0153" class="description-line style-scope patent-text">(8) PSCA hlg (2700050C12Rik, C530008O16Rik, RIKEN cDNA 2700050C12, RIKEN cDNA 2700050C12 gene)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0154]" class="style-scope patent-text">
    
    [0154]
  </para-num> <div id="p-0159" num="0154" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0155]" class="style-scope patent-text">
    
    [0155]
  </para-num> <div id="p-0160" num="0155" class="description-line style-scope patent-text">Genbank accession no. AY358628</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0156]" class="style-scope patent-text">
    
    [0156]
  </para-num> <div id="p-0161" num="0156" class="description-line style-scope patent-text">Genbank version no. AY358628.1 GI:37182377</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0157]" class="style-scope patent-text">
    
    [0157]
  </para-num> <div id="p-0162" num="0157" class="description-line style-scope patent-text">Genbank record update date: Dec. 1, 2009 04:15 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0158]" class="style-scope patent-text">
    
    [0158]
  </para-num> <div id="p-0163" num="0158" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0159]" class="style-scope patent-text">
    
    [0159]
  </para-num> <div id="p-0164" num="0159" class="description-line style-scope patent-text">Genbank accession no. AAQ88991</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0160]" class="style-scope patent-text">
    
    [0160]
  </para-num> <div id="p-0165" num="0160" class="description-line style-scope patent-text">Genbank version no. AAQ88991.1 GI:37182378</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0161]" class="style-scope patent-text">
    
    [0161]
  </para-num> <div id="p-0166" num="0161" class="description-line style-scope patent-text">Genbank record update date: Dec. 1, 2009 04:15 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0162]" class="style-scope patent-text">
    
    [0162]
  </para-num> <div id="p-0167" num="0162" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0163]" class="style-scope patent-text">
    
    [0163]
  </para-num> <div id="p-0168" num="0163" class="description-line style-scope patent-text">Ross et al (2002) <i class="style-scope patent-text">Cancer Res. </i>62:2546-2553; US2003/129192 (claim 2); US2004/044180 (claim 12); US2004/044179 (claim 11); US2003/096961 (claim 11); US2003/232056 (Example 5); WO2003/105758 16 (claim 12); US2003/206918 (Example 5); EP1347046 (claim 1); WO2003/025148 (claim 20); GI:37182378.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0164]" class="style-scope patent-text">
    
    [0164]
  </para-num> <div id="p-0169" num="0164" class="description-line style-scope patent-text">(9) ETBR (Endothelin type B receptor)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0165]" class="style-scope patent-text">
    
    [0165]
  </para-num> <div id="p-0170" num="0165" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0166]" class="style-scope patent-text">
    
    [0166]
  </para-num> <div id="p-0171" num="0166" class="description-line style-scope patent-text">Genbank accession no. AY275463</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0167]" class="style-scope patent-text">
    
    [0167]
  </para-num> <div id="p-0172" num="0167" class="description-line style-scope patent-text">Genbank version no. AY275463.1 GI:30526094</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0168]" class="style-scope patent-text">
    
    [0168]
  </para-num> <div id="p-0173" num="0168" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 02:26 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0169]" class="style-scope patent-text">
    
    [0169]
  </para-num> <div id="p-0174" num="0169" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0170]" class="style-scope patent-text">
    
    [0170]
  </para-num> <div id="p-0175" num="0170" class="description-line style-scope patent-text">Genbank accession no. AAP32295</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0171]" class="style-scope patent-text">
    
    [0171]
  </para-num> <div id="p-0176" num="0171" class="description-line style-scope patent-text">Genbank version no. AAP32295.1 GI:30526095</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0172]" class="style-scope patent-text">
    
    [0172]
  </para-num> <div id="p-0177" num="0172" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 02:26 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0173]" class="style-scope patent-text">
    
    [0173]
  </para-num> <div id="p-0178" num="0173" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0174]" class="style-scope patent-text">
    
    [0174]
  </para-num> <div id="p-0179" num="0174" class="description-line style-scope patent-text">Nakamuta M., et al <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>177, 34-39, 1991; Ogawa Y., et al <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>178, 248-255, 1991; Arai H., et al <i class="style-scope patent-text">Jpn. Circ. J.</i>56, 1303-1307, 1992; Arai H., et al <i class="style-scope patent-text">J.Biol. Chem. </i>268, 3463-3470, 1993; Sakamoto A., Yanagisawa M., et al <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>178, 656-663, 1991; Elshourbagy N.A., et al <i class="style-scope patent-text">J. Biol. Chem. </i>268, 3873-3879, 1993; Haendler B., et al <i class="style-scope patent-text">J.Cardiovasc. Pharmacol. </i>20, sl-S4, 1992; Tsutsumi M., et al <i class="style-scope patent-text">Gene </i>228, 43-49, 1999; Strausberg R. L., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>99, 16899-16903, 2002; Bourgeois C., et al <i class="style-scope patent-text">J. Clin. Endocrinol. Metab. </i>82, 3116-3123, 1997; Okamoto Y., et al <i class="style-scope patent-text">Biol. Chem. </i>272, 21589-21596, 1997; Verheij J. B., et al <i class="style-scope patent-text">Am. J. Med. Genet. </i>108, 223-225, 2002; Hofstra R. M. W., et al <i class="style-scope patent-text">Eur. J. Hum. Genet. </i>5, 180-185, 1997; Puffenberger E. G., et al <i class="style-scope patent-text">Cell </i>79, 1257-1266, 1994; Attie T., et al, <i class="style-scope patent-text">Hum. Mol. Genet. </i>4, 2407-2409, 1995; Auricchio A., et al <i class="style-scope patent-text">Hum. Mol. Genet. </i>5:351-354, 1996; Amiel J., et al <i class="style-scope patent-text">Hum. Mol. Genet. </i>5, 355-357, 1996; Hofstra R. M. W., et al <i class="style-scope patent-text">Nat. Genet. </i>12, 445-447, 1996; Svensson P. J., et al <i class="style-scope patent-text">Hum. Genet. </i>103, 145-148, 1998; Fuchs S., et al <i class="style-scope patent-text">Mol. Med. </i>7, 115-124, 2001; Pingault V., et al (2002) <i class="style-scope patent-text">Hum. Genet. </i>111, 198-206; WO2004/045516 (claim 1); WO2004/048938 (Example 2); WO2004/040000 (claim 151); WO2003/087768 (claim 1); WO2003/016475 (claim 1); WO2003/016475 (claim 1); WO2002/61087 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref>); WO2003/016494 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 6</figref>); WO2003/025138 (<figure-callout id="12" label="claim" filenames="US20190307890A1-20191010-D00001.png,US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 12; Page 144); WO2001/98351 (claim 1; Page 124-125); EP0522868 (<figure-callout id="8" label="claim" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 8; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 2</figref>); WO2001/77172 (claim 1; Page 297-299); US2003/109676; U.S. Pat. No. 6,518,404 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 3</figref>); U.S. Pat. No. 5,773,223 (Claim 1a; Col 31-34); WO2004/001004.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0175]" class="style-scope patent-text">
    
    [0175]
  </para-num> <div id="p-0180" num="0175" class="description-line style-scope patent-text">(10) MSG783 (RNF124, hypothetical protein FLJ20315)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0176]" class="style-scope patent-text">
    
    [0176]
  </para-num> <div id="p-0181" num="0176" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0177]" class="style-scope patent-text">
    
    [0177]
  </para-num> <div id="p-0182" num="0177" class="description-line style-scope patent-text">Genbank accession no. NM_017763</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0178]" class="style-scope patent-text">
    
    [0178]
  </para-num> <div id="p-0183" num="0178" class="description-line style-scope patent-text">Genbank version no. NM_017763.4 GI:167830482</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0179]" class="style-scope patent-text">
    
    [0179]
  </para-num> <div id="p-0184" num="0179" class="description-line style-scope patent-text">Genbank record update date: Jul. 22, 2012 12:34 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0180]" class="style-scope patent-text">
    
    [0180]
  </para-num> <div id="p-0185" num="0180" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0181]" class="style-scope patent-text">
    
    [0181]
  </para-num> <div id="p-0186" num="0181" class="description-line style-scope patent-text">Genbank accession no. NP_060233</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0182]" class="style-scope patent-text">
    
    [0182]
  </para-num> <div id="p-0187" num="0182" class="description-line style-scope patent-text">Genbank version no. NP_060233.3 GI:56711322</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0183]" class="style-scope patent-text">
    
    [0183]
  </para-num> <div id="p-0188" num="0183" class="description-line style-scope patent-text">Genbank record update date: Jul. 22, 2012 12:34 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0184]" class="style-scope patent-text">
    
    [0184]
  </para-num> <div id="p-0189" num="0184" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0185]" class="style-scope patent-text">
    
    [0185]
  </para-num> <div id="p-0190" num="0185" class="description-line style-scope patent-text">WO2003/104275 (claim 1); WO2004/046342 (Example 2); WO2003/042661 (claim 12);</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0186]" class="style-scope patent-text">
    
    [0186]
  </para-num> <div id="p-0191" num="0186" class="description-line style-scope patent-text">WO2003/083074 (claim 14; Page 61); WO2003/018621 (claim 1); WO2003/024392 (claim 2; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 93</figref>); WO2001/66689 (Example 6); LocusID:54894.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0187]" class="style-scope patent-text">
    
    [0187]
  </para-num> <div id="p-0192" num="0187" class="description-line style-scope patent-text">(11) STEAP2 (HGNC_8639, IPCA-1, PCANAP1, STAMP1, STEAP2, STMP, prostate cancer</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0188]" class="style-scope patent-text">
    
    [0188]
  </para-num> <div id="p-0193" num="0188" class="description-line style-scope patent-text">associated gene 1, prostate cancer associated protein 1, six transmembrane epithelial antigen of prostate 2, six transmembrane prostate protein)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0189]" class="style-scope patent-text">
    
    [0189]
  </para-num> <div id="p-0194" num="0189" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0190]" class="style-scope patent-text">
    
    [0190]
  </para-num> <div id="p-0195" num="0190" class="description-line style-scope patent-text">Genbank accession no. AF455138</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0191]" class="style-scope patent-text">
    
    [0191]
  </para-num> <div id="p-0196" num="0191" class="description-line style-scope patent-text">Genbank version no. AF455138.1 GI:22655487</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0192]" class="style-scope patent-text">
    
    [0192]
  </para-num> <div id="p-0197" num="0192" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 01:54 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0193]" class="style-scope patent-text">
    
    [0193]
  </para-num> <div id="p-0198" num="0193" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0194]" class="style-scope patent-text">
    
    [0194]
  </para-num> <div id="p-0199" num="0194" class="description-line style-scope patent-text">Genbank accession no. AAN04080</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0195]" class="style-scope patent-text">
    
    [0195]
  </para-num> <div id="p-0200" num="0195" class="description-line style-scope patent-text">Genbank version no. AAN04080.1 GI:22655488</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0196]" class="style-scope patent-text">
    
    [0196]
  </para-num> <div id="p-0201" num="0196" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 01:54 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0197]" class="style-scope patent-text">
    
    [0197]
  </para-num> <div id="p-0202" num="0197" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0198]" class="style-scope patent-text">
    
    [0198]
  </para-num> <div id="p-0203" num="0198" class="description-line style-scope patent-text">Lab. Invest. 82 (11):1573-1582 (2002)); WO2003/087306; US2003/064397 (claim 1; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref>); WO2002/72596 (claim 13; Page 54-55); WO2001/72962 (claim 1; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 4B</figref>);</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0199]" class="style-scope patent-text">
    
    [0199]
  </para-num> <div id="p-0204" num="0199" class="description-line style-scope patent-text">WO2003/104270 (claim 11); WO2003/104270 (claim 16); US2004/005598 (claim 22); WO2003/042661 (claim 12); US2003/060612 (<figure-callout id="12" label="claim" filenames="US20190307890A1-20191010-D00001.png,US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 12; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 10</figref>); WO2002/26822 (claim 23; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 2</figref>); WO2002/16429 (<figure-callout id="12" label="claim" filenames="US20190307890A1-20191010-D00001.png,US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 12; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 10</figref>); GI:22655488.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0200]" class="style-scope patent-text">
    
    [0200]
  </para-num> <div id="p-0205" num="0200" class="description-line style-scope patent-text">(12) TrpM4 (BR22450, FLJ20041, TRPM4, TRPM4B, transient receptor potential cation 5 channel, subfamily M, member 4)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0201]" class="style-scope patent-text">
    
    [0201]
  </para-num> <div id="p-0206" num="0201" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0202]" class="style-scope patent-text">
    
    [0202]
  </para-num> <div id="p-0207" num="0202" class="description-line style-scope patent-text">Genbank accession no. NM_017636</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0203]" class="style-scope patent-text">
    
    [0203]
  </para-num> <div id="p-0208" num="0203" class="description-line style-scope patent-text">Genbank version no. NM_017636.3 GI:304766649</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0204]" class="style-scope patent-text">
    
    [0204]
  </para-num> <div id="p-0209" num="0204" class="description-line style-scope patent-text">Genbank record update date: Jun. 29, 2012 11:27 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0205]" class="style-scope patent-text">
    
    [0205]
  </para-num> <div id="p-0210" num="0205" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0206]" class="style-scope patent-text">
    
    [0206]
  </para-num> <div id="p-0211" num="0206" class="description-line style-scope patent-text">Genbank accession no. NP_060106</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0207]" class="style-scope patent-text">
    
    [0207]
  </para-num> <div id="p-0212" num="0207" class="description-line style-scope patent-text">Genbank version no. NP_060106.2 GI:21314671</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0208]" class="style-scope patent-text">
    
    [0208]
  </para-num> <div id="p-0213" num="0208" class="description-line style-scope patent-text">Genbank record update date: Jun. 29, 2012 11:27 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0209]" class="style-scope patent-text">
    
    [0209]
  </para-num> <div id="p-0214" num="0209" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0210]" class="style-scope patent-text">
    
    [0210]
  </para-num> <div id="p-0215" num="0210" class="description-line style-scope patent-text">Xu, X.Z., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>98 (19):10692-10697 (2001), <i class="style-scope patent-text">Cell </i>109 (3):397-407 (2002), <i class="style-scope patent-text">J.Biol. Chem. </i>278 (33):30813-30820 (2003)); US2003/143557 (claim 4); WO2000/40614 (claim 14; Page 100-103); WO2002/10382 (claim 1; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 9A</figref>); WO2003/042661 (claim 12); WO2002/30268 (<figure-callout id="27" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 27; Page 391); US2003/219806 (claim 4); WO2001/62794 (claim 14; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1A-D</figref>); MIM:606936.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0211]" class="style-scope patent-text">
    
    [0211]
  </para-num> <div id="p-0216" num="0211" class="description-line style-scope patent-text">(13) CRIPTO (CR, CR1, CRGF, CRIPTO, TDGF1, teratocarcinoma-derived growth factor)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0212]" class="style-scope patent-text">
    
    [0212]
  </para-num> <div id="p-0217" num="0212" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0213]" class="style-scope patent-text">
    
    [0213]
  </para-num> <div id="p-0218" num="0213" class="description-line style-scope patent-text">Genbank accession no. NM_003212</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0214]" class="style-scope patent-text">
    
    [0214]
  </para-num> <div id="p-0219" num="0214" class="description-line style-scope patent-text">Genbank version no. NM_003212.3 GI:292494881</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0215]" class="style-scope patent-text">
    
    [0215]
  </para-num> <div id="p-0220" num="0215" class="description-line style-scope patent-text">Genbank record update date: Sep. 23, 2012 02:27 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0216]" class="style-scope patent-text">
    
    [0216]
  </para-num> <div id="p-0221" num="0216" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0217]" class="style-scope patent-text">
    
    [0217]
  </para-num> <div id="p-0222" num="0217" class="description-line style-scope patent-text">Genbank accession no. NP_003203</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0218]" class="style-scope patent-text">
    
    [0218]
  </para-num> <div id="p-0223" num="0218" class="description-line style-scope patent-text">Genbank version no. NP_003203.1 GI:4507425</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0219]" class="style-scope patent-text">
    
    [0219]
  </para-num> <div id="p-0224" num="0219" class="description-line style-scope patent-text">Genbank record update date: Sep. 23, 2012 02:27 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0220]" class="style-scope patent-text">
    
    [0220]
  </para-num> <div id="p-0225" num="0220" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0221]" class="style-scope patent-text">
    
    [0221]
  </para-num> <div id="p-0226" num="0221" class="description-line style-scope patent-text">Ciccodicola, A., et al <i class="style-scope patent-text">EMBO J.</i>8 (7):1987-1991 (1989), <i class="style-scope patent-text">Am. J.Hum. Genet. </i>49 (3):555-565 (1991)); US2003/224411 (claim 1); WO2003/083041 (Example 1); WO2003/034984 (claim 12); WO2002/88170 (claim 2; Page 52-53); WO2003/024392 (claim 2; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 58</figref>); WO2002/16413 (claim 1; Page 94-95, 105); WO2002/22808 (claim 2; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref>); U.S. Pat. No. 5,854,399 (Example 2; Col 17-18); U.S. Pat. No. 5,792,616 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 2</figref>); MIM:187395.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0222]" class="style-scope patent-text">
    
    [0222]
  </para-num> <div id="p-0227" num="0222" class="description-line style-scope patent-text">(14) CD21 (CR2 (Complement receptor 2) or C3DR (C3d/Epstein Barr virus receptor) or Hs. 73792)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0223]" class="style-scope patent-text">
    
    [0223]
  </para-num> <div id="p-0228" num="0223" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0224]" class="style-scope patent-text">
    
    [0224]
  </para-num> <div id="p-0229" num="0224" class="description-line style-scope patent-text">Genbank accession no M26004</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0225]" class="style-scope patent-text">
    
    [0225]
  </para-num> <div id="p-0230" num="0225" class="description-line style-scope patent-text">Genbank version no. M26004.1 GI:181939</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0226]" class="style-scope patent-text">
    
    [0226]
  </para-num> <div id="p-0231" num="0226" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:47 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0227]" class="style-scope patent-text">
    
    [0227]
  </para-num> <div id="p-0232" num="0227" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0228]" class="style-scope patent-text">
    
    [0228]
  </para-num> <div id="p-0233" num="0228" class="description-line style-scope patent-text">Genbank accession no. AAA35786</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0229]" class="style-scope patent-text">
    
    [0229]
  </para-num> <div id="p-0234" num="0229" class="description-line style-scope patent-text">Genbank version no. AAA35786.1 GI:181940</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0230]" class="style-scope patent-text">
    
    [0230]
  </para-num> <div id="p-0235" num="0230" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:47 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0231]" class="style-scope patent-text">
    
    [0231]
  </para-num> <div id="p-0236" num="0231" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0232]" class="style-scope patent-text">
    
    [0232]
  </para-num> <div id="p-0237" num="0232" class="description-line style-scope patent-text">Fujisaku et al (1989) <i class="style-scope patent-text">J.Biol. Chem. </i>264 (4):2118-2125); Weis J. J., et al <i class="style-scope patent-text">J.Exp. Med. </i>167, 1047-1066, 1988; Moore M., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>84, 9194-9198, 1987; Barel M., et al <i class="style-scope patent-text">Mol. Immunol. </i>35, 1025-1031, 1998; Weis J. J., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>83, 5639-5643, 1986; Sinha S. K., et al (1993) <i class="style-scope patent-text">J. Immunol. </i>150, 5311-5320; WO2004/045520 (Example 4); US2004/005538 (Example 1); WO2003/062401 (claim 9); WO2004/045520 (Example 4); WO91/02536 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 9.1-9.9</figref>); WO2004/020595 (claim 1); Accession: P20023; Q13866; Q14212; <i class="style-scope patent-text">EMBL; M </i>26004; AAA35786.1.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0233]" class="style-scope patent-text">
    
    [0233]
  </para-num> <div id="p-0238" num="0233" class="description-line style-scope patent-text">(15) CD79b (CD79, βCD79β, IGb (immunoglobulin-associated beta), B29)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0234]" class="style-scope patent-text">
    
    [0234]
  </para-num> <div id="p-0239" num="0234" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0235]" class="style-scope patent-text">
    
    [0235]
  </para-num> <div id="p-0240" num="0235" class="description-line style-scope patent-text">Genbank accession no NM_000626</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0236]" class="style-scope patent-text">
    
    [0236]
  </para-num> <div id="p-0241" num="0236" class="description-line style-scope patent-text">Genbank version no. NM_000626.2 GI:90193589</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0237]" class="style-scope patent-text">
    
    [0237]
  </para-num> <div id="p-0242" num="0237" class="description-line style-scope patent-text">Genbank record update date: Jun. 26, 2012 01:53 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0238]" class="style-scope patent-text">
    
    [0238]
  </para-num> <div id="p-0243" num="0238" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0239]" class="style-scope patent-text">
    
    [0239]
  </para-num> <div id="p-0244" num="0239" class="description-line style-scope patent-text">Genbank accession no. NP_000617</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0240]" class="style-scope patent-text">
    
    [0240]
  </para-num> <div id="p-0245" num="0240" class="description-line style-scope patent-text">Genbank version no. NP_000617.1 GI:11038674</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0241]" class="style-scope patent-text">
    
    [0241]
  </para-num> <div id="p-0246" num="0241" class="description-line style-scope patent-text">Genbank record update date: Jun. 26, 2012 01:53 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0242]" class="style-scope patent-text">
    
    [0242]
  </para-num> <div id="p-0247" num="0242" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0243]" class="style-scope patent-text">
    
    [0243]
  </para-num> <div id="p-0248" num="0243" class="description-line style-scope patent-text"> <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>(2003) 100 (7):4126-4131, <i class="style-scope patent-text">Blood </i>(2002) 100 (9):3068-3076, Muller et al (1992) <i class="style-scope patent-text">Eur. J. Immunol. </i>22 (6):1621-1625); WO2004/016225 (claim 2, <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 140</figref>); WO2003/087768, US2004/101874 (claim 1, page 102); WO2003/062401 (claim 9); WO2002/78524 (Example 2); US2002/150573 (claim 35 5, page 15); U.S. Pat. No. 5,644,033; WO2003/048202 (claim 1, pages 306 and 309); WO 99/58658, U.S. Pat. No. 6,534,482 (claim 13, <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 17A</figref>/B); WO2000/55351 (claim 11, pages 1145-1146); MIM:147245</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0244]" class="style-scope patent-text">
    
    [0244]
  </para-num> <div id="p-0249" num="0244" class="description-line style-scope patent-text">(16) FcRH2 (IFGP4, IRTA4, SPAP1A (SH2 domain containing phosphatase anchor protein 1a), SPAP1B, SPAP1C)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0245]" class="style-scope patent-text">
    
    [0245]
  </para-num> <div id="p-0250" num="0245" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0246]" class="style-scope patent-text">
    
    [0246]
  </para-num> <div id="p-0251" num="0246" class="description-line style-scope patent-text">Genbank accession no NM_030764</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0247]" class="style-scope patent-text">
    
    [0247]
  </para-num> <div id="p-0252" num="0247" class="description-line style-scope patent-text">Genbank version no. NM_030764.3 GI:227430280</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0248]" class="style-scope patent-text">
    
    [0248]
  </para-num> <div id="p-0253" num="0248" class="description-line style-scope patent-text">Genbank record update date: Jun. 30, 2012 12:30 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0249]" class="style-scope patent-text">
    
    [0249]
  </para-num> <div id="p-0254" num="0249" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0250]" class="style-scope patent-text">
    
    [0250]
  </para-num> <div id="p-0255" num="0250" class="description-line style-scope patent-text">Genbank accession no. NP__110391</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0251]" class="style-scope patent-text">
    
    [0251]
  </para-num> <div id="p-0256" num="0251" class="description-line style-scope patent-text">Genbank version no. NP__110391.2 GI:19923629</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0252]" class="style-scope patent-text">
    
    [0252]
  </para-num> <div id="p-0257" num="0252" class="description-line style-scope patent-text">Genbank record update date: Jun. 30, 2012 12:30 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0253]" class="style-scope patent-text">
    
    [0253]
  </para-num> <div id="p-0258" num="0253" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0254]" class="style-scope patent-text">
    
    [0254]
  </para-num> <div id="p-0259" num="0254" class="description-line style-scope patent-text">AY358130); Genome Res. 13 (10):2265-2270 (2003),<i class="style-scope patent-text">Immunogenetics </i>54 (2):87-95 (2002), <i class="style-scope patent-text">Blood </i>99 (8):2662-2669 (2002), <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>98 (17)9772-9777 (2001), Xu, M. J., et al (2001) <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>280 (3):768-775; WO2004/016225 (claim 2); WO2003/077836; WO2001/38490 (claim 5; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 18D</figref>-1-18D-2); WO2003/097803 (claim 12); WO2003/089624 (claim 25);: MIM:606509.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0255]" class="style-scope patent-text">
    
    [0255]
  </para-num> <div id="p-0260" num="0255" class="description-line style-scope patent-text">(17) HER2 (ErbB2)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0256]" class="style-scope patent-text">
    
    [0256]
  </para-num> <div id="p-0261" num="0256" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0257]" class="style-scope patent-text">
    
    [0257]
  </para-num> <div id="p-0262" num="0257" class="description-line style-scope patent-text">Genbank accession no M11730</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0258]" class="style-scope patent-text">
    
    [0258]
  </para-num> <div id="p-0263" num="0258" class="description-line style-scope patent-text">Genbank version no. M11730.1 GI:183986</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0259]" class="style-scope patent-text">
    
    [0259]
  </para-num> <div id="p-0264" num="0259" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:47 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0260]" class="style-scope patent-text">
    
    [0260]
  </para-num> <div id="p-0265" num="0260" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0261]" class="style-scope patent-text">
    
    [0261]
  </para-num> <div id="p-0266" num="0261" class="description-line style-scope patent-text">Genbank accession no. AAA75493</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0262]" class="style-scope patent-text">
    
    [0262]
  </para-num> <div id="p-0267" num="0262" class="description-line style-scope patent-text">Genbank version no. AAA75493.1 GI:306840</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0263]" class="style-scope patent-text">
    
    [0263]
  </para-num> <div id="p-0268" num="0263" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:47 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0264]" class="style-scope patent-text">
    
    [0264]
  </para-num> <div id="p-0269" num="0264" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0265]" class="style-scope patent-text">
    
    [0265]
  </para-num> <div id="p-0270" num="0265" class="description-line style-scope patent-text">Coussens L., et al <i class="style-scope patent-text">Science </i>(1985) 230(4730):1132-1139); Yamamoto T., et al <i class="style-scope patent-text">Nature </i>319, 230-234, 1986; Semba K., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>82, 6497-6501, 1985; Swiercz J. M., et al <i class="style-scope patent-text">J. Cell Biol. </i>165, 869-880, 2004; Kuhns J. J., et al <i class="style-scope patent-text">J. Biol. Chem. </i>274, 36422-36427, 1999; Cho H.-S., et al <i class="style-scope patent-text">Nature </i>421, 756-760, 2003; Ehsani A., et al (1993) <i class="style-scope patent-text"> <figure-callout id="15" label="Genomics" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Genomics</a></figure-callout> </i>15, 426-429; WO2004/048938 (Example 2); WO2004/027049 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 11</figref>); WO2004/009622; WO2003/081210;WO2003/089904 (claim 9); WO2003/016475 (claim 1); US2003/118592; WO2003/008537 (claim 1); WO2003/055439 (claim 29; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1A-B</figref>); WO2003/025228 (claim 37; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 5C</figref>); WO2002/22636 (Example 13; Page 95-107); WO2002/12341 (<figure-callout id="68" label="claim" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 68; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 7</figref>); WO2002/13847 (Page 71-74); WO2002/14503 (Page 114-117); WO2001/53463 (claim 2; Page 41-46); WO2001/41787 (Page 15); WO2000/44899 (<figure-callout id="52" label="claim" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 52; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 7</figref>); WO2000/20579 (<figure-callout id="3" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 3; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 2</figref>); U.S. Pat. No. 5,869,445 (<figure-callout id="3" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 3; Col 31-38); WO9630514 (claim 2; Page 56-61); EP1439393 (claim 7); WO2004/043361 (claim 7); WO2004/022709; WO2001/00244 (Example 3; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 4</figref>); Accession: P04626; <i class="style-scope patent-text">EMBL; M</i>11767; AAA35808.1. <i class="style-scope patent-text">EMBL; M</i>11761; AAA35808.1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0266]" class="style-scope patent-text">
    
    [0266]
  </para-num> <div id="p-0271" num="0266" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0267]" class="style-scope patent-text">
    
    [0267]
  </para-num> <div id="p-0272" num="0267" class="description-line style-scope patent-text">Abbott: US20110177095
</div> </li> <ul class="style-scope patent-text"> <li id="ul0003-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0004-0001" num="0268" class="style-scope patent-text">For example, an antibody comprising CDRs having overall at least 80% sequence identity to CDRs having amino acid sequences of SEQ ID NO:3 (CDR-H1), SEQ ID NO:4 (CDR-H2), SEQ ID NO:5 (CDR-H3), SEQ ID NO:104 and/or SEQ ID NO:6 (CDR-L1), SEQ ID NO:7 (CDR-L2), and SEQ ID NO:8 (CDR-L3), wherein the anti-HER2 antibody or anti-HER2 binding fragment has reduced immunogenicity as compared to an antibody having a VH of SEQ ID NO:1 and a VL of SEQ ID NO:2.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0269]" class="style-scope patent-text">
    
    [0269]
  </para-num> <div id="p-0273" num="0269" class="description-line style-scope patent-text">Biogen: US20100119511
</div> </li> <ul class="style-scope patent-text"> <li id="ul0005-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0006-0001" num="0270" class="style-scope patent-text">For example, ATCC accession numbers: PTA-10355, PTA-10356, PTA-10357, PTA-10358</li> <li id="ul0006-0002" num="0271" class="style-scope patent-text">For example, a purified antibody molecule that binds to HER2 comprising a all six CDR's from an antibody selected from the group consisting of BIIB71F10 (SEQ ID NOs:11, 13), BIIB69A09 (SEQ ID NOs:15, 17); BIIB67F10 (SEQ ID NOs:19, 21); BIIB67F11 (SEQ ID NOs:23, 25), BIIB66A12 (SEQ ID NOs:27, 29), BIIB66C01 (SEQ ID NOs:31, 33), BIIB65C10 (SEQ ID NOs:35, 37), BIIB65H09 (SEQ ID NOs:39, 41) and BIIB65B03 (SEQ ID NOs:43, 45), or CDRs which are identical or which have no more than two alterations from said CDRs.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0272]" class="style-scope patent-text">
    
    [0272]
  </para-num> <div id="p-0274" num="0272" class="description-line style-scope patent-text">Herceptin (Genentech)-U.S. Pat. No. 6,054,297; ATCC accession no. CRL-10463 (Genentech)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0273]" class="style-scope patent-text">
    
    [0273]
  </para-num> <div id="p-0275" num="0273" class="description-line style-scope patent-text">Pertuzumab (Genentech)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0007-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0008-0001" num="0274" class="style-scope patent-text">US20110117097
        <ul class="style-scope patent-text"> <li id="ul0009-0001" num="0275" class="style-scope patent-text">for example, see SEQ IDs No. 15&amp;16, SEQ IDs No. 17&amp;18, SEQ IDs No. 23&amp;24 &amp; ATCC accession numbers HB-12215, HB-12216, CRL 10463, HB-12697.</li> </ul>
        </li> <li id="ul0008-0002" num="0276" class="style-scope patent-text">US20090285837</li> <li id="ul0008-0003" num="0277" class="style-scope patent-text">US20090202546
        <ul class="style-scope patent-text"> <li id="ul0010-0001" num="0278" class="style-scope patent-text">for example, ATCC accession numbers: HB-12215, HB-12216, CRL 10463, HB-12698.</li> </ul>
        </li> <li id="ul0008-0004" num="0279" class="style-scope patent-text">US20060088523
        <ul class="style-scope patent-text"> <li id="ul0011-0001" num="0280" class="style-scope patent-text">for example, ATCC accession numbers: HB-12215, HB-12216</li> <li id="ul0011-0002" num="0281" class="style-scope patent-text">for example, an antibody comprising the variable light and variable heavy amino acid sequences in SEQ ID Nos. 3 and 4, respectively.</li> <li id="ul0011-0003" num="0282" class="style-scope patent-text">for example, an antibody comprising a light chain amino acid sequence selected from SEQ ID No. 15 and 23, and a heavy chain amino acid sequence selected from SEQ ID No. 16 and 24</li> </ul>
        </li> <li id="ul0008-0005" num="0283" class="style-scope patent-text">US20060018899
        <ul class="style-scope patent-text"> <li id="ul0012-0001" num="0284" class="style-scope patent-text">for example, ATCC accession numbers: (7C2) HB-12215, (7F3) HB-12216, (4D5) CRL-10463, (2C4) HB-12697.</li> <li id="ul0012-0002" num="0285" class="style-scope patent-text">for example, an antibody comprising the amino acid sequence in SEQ ID No. 23, or a deamidated and/or oxidized variant thereof.</li> </ul>
        </li> <li id="ul0008-0006" num="0286" class="style-scope patent-text">US2011/0159014
        <ul class="style-scope patent-text"> <li id="ul0013-0001" num="0287" class="style-scope patent-text">for example, an antibody having a light chain variable domain comprising the hypervariable regions of SEQ ID NO: 1″.</li> <li id="ul0013-0002" num="0288" class="style-scope patent-text">for example, an antibody having a heavy chain variable domain comprising the hypervariable regions of SEQ ID NO: 2.</li> </ul>
        </li> <li id="ul0008-0007" num="0289" class="style-scope patent-text">US20090187007</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0290]" class="style-scope patent-text">
    
    [0290]
  </para-num> <div id="p-0276" num="0290" class="description-line style-scope patent-text">Glycotope: TrasGEX antibody http://www.glycotope.com/pipeline
</div> </li> <ul class="style-scope patent-text"> <li id="ul0014-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0015-0001" num="0291" class="style-scope patent-text">For example, see International Joint Cancer Institute and Changhai Hospital Cancer Cent: HMTI-Fc Ab-Gao J., et al <i class="style-scope patent-text">BMB Rep. </i>2009 Oct. 31; 42(10):636-41.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0292]" class="style-scope patent-text">
    
    [0292]
  </para-num> <div id="p-0277" num="0292" class="description-line style-scope patent-text">Symphogen: US20110217305</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0293]" class="style-scope patent-text">
    
    [0293]
  </para-num> <div id="p-0278" num="0293" class="description-line style-scope patent-text">Union Stem Cell &amp;Gene Engineering, China-Liu H Q., et al Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 May; 26(5):456-8.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0294]" class="style-scope patent-text">
    
    [0294]
  </para-num> <div id="p-0279" num="0294" class="description-line style-scope patent-text">(18) NCA (CEACAM6)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0295]" class="style-scope patent-text">
    
    [0295]
  </para-num> <div id="p-0280" num="0295" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0296]" class="style-scope patent-text">
    
    [0296]
  </para-num> <div id="p-0281" num="0296" class="description-line style-scope patent-text">Genbank accession no M18728</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0297]" class="style-scope patent-text">
    
    [0297]
  </para-num> <div id="p-0282" num="0297" class="description-line style-scope patent-text">Genbank version no. M18728.1 GI:189084</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0298]" class="style-scope patent-text">
    
    [0298]
  </para-num> <div id="p-0283" num="0298" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:48 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0299]" class="style-scope patent-text">
    
    [0299]
  </para-num> <div id="p-0284" num="0299" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0300]" class="style-scope patent-text">
    
    [0300]
  </para-num> <div id="p-0285" num="0300" class="description-line style-scope patent-text">Genbank accession no. AAA59907</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0301]" class="style-scope patent-text">
    
    [0301]
  </para-num> <div id="p-0286" num="0301" class="description-line style-scope patent-text">Genbank version no. AAA59907.1 GI:189085</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0302]" class="style-scope patent-text">
    
    [0302]
  </para-num> <div id="p-0287" num="0302" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:48 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0303]" class="style-scope patent-text">
    
    [0303]
  </para-num> <div id="p-0288" num="0303" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0304]" class="style-scope patent-text">
    
    [0304]
  </para-num> <div id="p-0289" num="0304" class="description-line style-scope patent-text">Barnett T., et al <figure-callout id="3" label="Genomics" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Genomics</a></figure-callout> 3, 59-66, 1988; Tawaragi Y., et al <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>150, 89-96, 1988; Strausberg R. L., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>99:16899-16903, 2002; WO2004/063709; EP1439393 (claim 7); WO2004/044178 (Example 4); WO2004/031238; WO2003/042661 (claim 12); WO2002/78524 (Example 2); WO2002/86443 (<figure-callout id="27" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 27; Page 427); WO2002/60317 (claim 2); Accession: P40199; Q14920; <i class="style-scope patent-text">EMBL; M</i>29541; AAA59915.1. <i class="style-scope patent-text">EMBL; M</i>18728.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0305]" class="style-scope patent-text">
    
    [0305]
  </para-num> <div id="p-0290" num="0305" class="description-line style-scope patent-text">(19) MDP (DPEP1)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0306]" class="style-scope patent-text">
    
    [0306]
  </para-num> <div id="p-0291" num="0306" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0307]" class="style-scope patent-text">
    
    [0307]
  </para-num> <div id="p-0292" num="0307" class="description-line style-scope patent-text">Genbank accession no BC017023</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0308]" class="style-scope patent-text">
    
    [0308]
  </para-num> <div id="p-0293" num="0308" class="description-line style-scope patent-text">Genbank version no. BC017023.1 GI:16877538</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0309]" class="style-scope patent-text">
    
    [0309]
  </para-num> <div id="p-0294" num="0309" class="description-line style-scope patent-text">Genbank record update date: Mar. 6, 2012 01:00 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0310]" class="style-scope patent-text">
    
    [0310]
  </para-num> <div id="p-0295" num="0310" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0311]" class="style-scope patent-text">
    
    [0311]
  </para-num> <div id="p-0296" num="0311" class="description-line style-scope patent-text">Genbank accession no. AAH17023</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0312]" class="style-scope patent-text">
    
    [0312]
  </para-num> <div id="p-0297" num="0312" class="description-line style-scope patent-text">Genbank version no. AAH17023.1 GI:16877539</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0313]" class="style-scope patent-text">
    
    [0313]
  </para-num> <div id="p-0298" num="0313" class="description-line style-scope patent-text">Genbank record update date: Mar. 6, 2012 01:00 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0314]" class="style-scope patent-text">
    
    [0314]
  </para-num> <div id="p-0299" num="0314" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0315]" class="style-scope patent-text">
    
    [0315]
  </para-num> <div id="p-0300" num="0315" class="description-line style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. 99 (26):16899-16903 (2002)); WO2003/016475 (claim 1); WO2002/64798 (<figure-callout id="33" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 33; Page 85-87); JP05003790 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 6-8</figref>); WO99/46284 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 9</figref>); MIM:179780.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0316]" class="style-scope patent-text">
    
    [0316]
  </para-num> <div id="p-0301" num="0316" class="description-line style-scope patent-text">(20) IL20R-alpha (IL20Ra, ZCYTOR7)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0317]" class="style-scope patent-text">
    
    [0317]
  </para-num> <div id="p-0302" num="0317" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0318]" class="style-scope patent-text">
    
    [0318]
  </para-num> <div id="p-0303" num="0318" class="description-line style-scope patent-text">Genbank accession no AF184971</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0319]" class="style-scope patent-text">
    
    [0319]
  </para-num> <div id="p-0304" num="0319" class="description-line style-scope patent-text">Genbank version no. AF184971.1 GI:6013324</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0320]" class="style-scope patent-text">
    
    [0320]
  </para-num> <div id="p-0305" num="0320" class="description-line style-scope patent-text">Genbank record update date: Mar. 10, 2010 10:00 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0321]" class="style-scope patent-text">
    
    [0321]
  </para-num> <div id="p-0306" num="0321" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0322]" class="style-scope patent-text">
    
    [0322]
  </para-num> <div id="p-0307" num="0322" class="description-line style-scope patent-text">Genbank accession no. AAF01320</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0323]" class="style-scope patent-text">
    
    [0323]
  </para-num> <div id="p-0308" num="0323" class="description-line style-scope patent-text">Genbank version no. AAF01320.1 GI:6013325</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0324]" class="style-scope patent-text">
    
    [0324]
  </para-num> <div id="p-0309" num="0324" class="description-line style-scope patent-text">Genbank record update date: Mar. 10, 2010 10:00 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0325]" class="style-scope patent-text">
    
    [0325]
  </para-num> <div id="p-0310" num="0325" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0326]" class="style-scope patent-text">
    
    [0326]
  </para-num> <div id="p-0311" num="0326" class="description-line style-scope patent-text">Clark H. F., et al <i class="style-scope patent-text">Genome Res. </i>13, 2265-2270, 2003; Mungall A. J., et al <i class="style-scope patent-text">Nature </i>425, 805-811, 2003; Blumberg H., et al <i class="style-scope patent-text">Cell </i>104, 9-19, 2001; Dumoutier L., et al <i class="style-scope patent-text">J.Immunol. </i>167, 3545-3549, 2001; Parrish-Novak J., et al <i class="style-scope patent-text">J.Biol. Chem. </i>277, 47517-47523, 2002; Pletnev S., et al (2003) <i class="style-scope patent-text">Biochemistry </i>42:12617-12624; Sheikh F., et al (2004) <i class="style-scope patent-text">J. Immunol. </i>172, 2006-2010; EP1394274 (Example 11); US2004/005320 (Example 5); WO2003/029262 (Page 74-75); WO2003/002717 (claim 2; Page 63); WO2002/22153 (Page 45-47); US2002/042366 (Page 20-21); WO2001/46261 (Page 57-59); WO2001/46232 (Page 63-65); WO98/37193 (claim 1; Page 55-59); Accession: Q9UHF4; Q6UWA9; Q96SH8; <i class="style-scope patent-text">EMBL</i>; AF184971; AAF01320.1.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0327]" class="style-scope patent-text">
    
    [0327]
  </para-num> <div id="p-0312" num="0327" class="description-line style-scope patent-text">(21) Brevican (BCAN, BEHAB)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0328]" class="style-scope patent-text">
    
    [0328]
  </para-num> <div id="p-0313" num="0328" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0329]" class="style-scope patent-text">
    
    [0329]
  </para-num> <div id="p-0314" num="0329" class="description-line style-scope patent-text">Genbank accession no AF229053</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0330]" class="style-scope patent-text">
    
    [0330]
  </para-num> <div id="p-0315" num="0330" class="description-line style-scope patent-text">Genbank version no. AF229053.1 GI:10798902</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0331]" class="style-scope patent-text">
    
    [0331]
  </para-num> <div id="p-0316" num="0331" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 12:58 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0332]" class="style-scope patent-text">
    
    [0332]
  </para-num> <div id="p-0317" num="0332" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0333]" class="style-scope patent-text">
    
    [0333]
  </para-num> <div id="p-0318" num="0333" class="description-line style-scope patent-text">Genbank accession no. AAG23135</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0334]" class="style-scope patent-text">
    
    [0334]
  </para-num> <div id="p-0319" num="0334" class="description-line style-scope patent-text">Genbank version no. AAG23135.1 GI:10798903</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0335]" class="style-scope patent-text">
    
    [0335]
  </para-num> <div id="p-0320" num="0335" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 12:58 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0336]" class="style-scope patent-text">
    
    [0336]
  </para-num> <div id="p-0321" num="0336" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0337]" class="style-scope patent-text">
    
    [0337]
  </para-num> <div id="p-0322" num="0337" class="description-line style-scope patent-text">Gary S. C., et al <i class="style-scope patent-text">Gene </i>256, 139-147, 2000; Clark H. F., et al <i class="style-scope patent-text">Genome Res. </i>13, 2265-2270, 2003; Strausberg R. L., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>99, 16899-16903, 2002; US2003/186372 (claim 11); US2003/186373 (claim 11); US2003/119131 (claim 1; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 52</figref>); US2003/119122 (claim 1; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 52</figref>); US2003/119126 (claim 1); US2003/119121 (claim 1; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 52</figref>); US2003/119129 (claim 1); US2003/119130 (claim 1); US2003/119128 (claim 1; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 52</figref>); US2003/119125 (claim 1); WO2003/016475 (claim 1); WO2002/02634 (claim 1)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0338]" class="style-scope patent-text">
    
    [0338]
  </para-num> <div id="p-0323" num="0338" class="description-line style-scope patent-text">(22) EphB2R (DRT, ERK, Hek5, EPHT3, Tyro5)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0339]" class="style-scope patent-text">
    
    [0339]
  </para-num> <div id="p-0324" num="0339" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0340]" class="style-scope patent-text">
    
    [0340]
  </para-num> <div id="p-0325" num="0340" class="description-line style-scope patent-text">Genbank accession no NM_004442</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0341]" class="style-scope patent-text">
    
    [0341]
  </para-num> <div id="p-0326" num="0341" class="description-line style-scope patent-text">Genbank version no. NM_004442.6 GI:111118979</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0342]" class="style-scope patent-text">
    
    [0342]
  </para-num> <div id="p-0327" num="0342" class="description-line style-scope patent-text">Genbank record update date: Sep. 8, 2012 04:43 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0343]" class="style-scope patent-text">
    
    [0343]
  </para-num> <div id="p-0328" num="0343" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0344]" class="style-scope patent-text">
    
    [0344]
  </para-num> <div id="p-0329" num="0344" class="description-line style-scope patent-text">Genbank accession no. NP_004433</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0345]" class="style-scope patent-text">
    
    [0345]
  </para-num> <div id="p-0330" num="0345" class="description-line style-scope patent-text">Genbank version no. NP_004433.2 GI:21396504</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0346]" class="style-scope patent-text">
    
    [0346]
  </para-num> <div id="p-0331" num="0346" class="description-line style-scope patent-text">Genbank record update date: Sep. 8, 2012 04:43 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0347]" class="style-scope patent-text">
    
    [0347]
  </para-num> <div id="p-0332" num="0347" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0348]" class="style-scope patent-text">
    
    [0348]
  </para-num> <div id="p-0333" num="0348" class="description-line style-scope patent-text">Chan, J.and Watt, V. M., Oncogene 6 (6), 1057-1061 (1991) Oncogene 10 (5):897-905 (1995), <i class="style-scope patent-text">Annu. Rev. Neurosci. </i>21:309-345 (1998), <i class="style-scope patent-text">Int. Rev. Cytol. </i>196:177-244 (2000)); WO2003042661 (claim 12); WO200053216 (claim 1; Page 41); WO2004065576 (claim 1); WO2004020583 (claim 9); WO2003004529 (Page 128-132); WO200053216 (claim 1; Page 42); MIM:600997.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0349]" class="style-scope patent-text">
    
    [0349]
  </para-num> <div id="p-0334" num="0349" class="description-line style-scope patent-text">(23) ASLG659 (B7h)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0350]" class="style-scope patent-text">
    
    [0350]
  </para-num> <div id="p-0335" num="0350" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0351]" class="style-scope patent-text">
    
    [0351]
  </para-num> <div id="p-0336" num="0351" class="description-line style-scope patent-text">Genbank accession no. AX092328</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0352]" class="style-scope patent-text">
    
    [0352]
  </para-num> <div id="p-0337" num="0352" class="description-line style-scope patent-text">Genbank version no. AX092328.1 GI:13444478</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0353]" class="style-scope patent-text">
    
    [0353]
  </para-num> <div id="p-0338" num="0353" class="description-line style-scope patent-text">Genbank record update date: Jan. 26, 2011 07:37 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0354]" class="style-scope patent-text">
    
    [0354]
  </para-num> <div id="p-0339" num="0354" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0355]" class="style-scope patent-text">
    
    [0355]
  </para-num> <div id="p-0340" num="0355" class="description-line style-scope patent-text">US2004/0101899 (claim 2); WO2003104399 (claim 11); WO2004000221 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 3</figref>); US2003/165504 (claim 1); US2003/124140 (Example 2); US2003/065143 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 60</figref>); WO2002/102235 (claim 13; Page 299); US2003/091580 (Example 2); WO2002/10187 (<figure-callout id="6" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 6; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 10</figref>); WO2001/94641 (<figure-callout id="12" label="claim" filenames="US20190307890A1-20191010-D00001.png,US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 12; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 7<i class="style-scope patent-text">b</i> </figref>); WO2002/02624 (claim 13; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1A</figref>-1B); US2002/034749 (<figure-callout id="54" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 54; Page 45-46); WO2002/06317 (Example 2; Page 320-321, claim 34; Page 321-322); WO2002/71928 (Page 468-469); WO2002/02587 (Example 1; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref>); WO2001/40269 (Example 3; Pages 190-192); WO2000/36107 (Example 2; Page 205-207); WO2004/053079 (claim 12); WO2003/004989 (claim 1); WO2002/71928 (Page 233-234, 452-453); WO 01/16318.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0356]" class="style-scope patent-text">
    
    [0356]
  </para-num> <div id="p-0341" num="0356" class="description-line style-scope patent-text">(24) PSCA (Prostate stem cell antigen precursor)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0357]" class="style-scope patent-text">
    
    [0357]
  </para-num> <div id="p-0342" num="0357" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0358]" class="style-scope patent-text">
    
    [0358]
  </para-num> <div id="p-0343" num="0358" class="description-line style-scope patent-text">Genbank accession no AJ297436</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0359]" class="style-scope patent-text">
    
    [0359]
  </para-num> <div id="p-0344" num="0359" class="description-line style-scope patent-text">Genbank version no. AJ297436.1 GI:9367211</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0360]" class="style-scope patent-text">
    
    [0360]
  </para-num> <div id="p-0345" num="0360" class="description-line style-scope patent-text">Genbank record update date: Feb. 1, 2011 11:25 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0361]" class="style-scope patent-text">
    
    [0361]
  </para-num> <div id="p-0346" num="0361" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0362]" class="style-scope patent-text">
    
    [0362]
  </para-num> <div id="p-0347" num="0362" class="description-line style-scope patent-text">Genbank accession no. CAB97347</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0363]" class="style-scope patent-text">
    
    [0363]
  </para-num> <div id="p-0348" num="0363" class="description-line style-scope patent-text">Genbank version no. CAB97347.1 GI:9367212</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0364]" class="style-scope patent-text">
    
    [0364]
  </para-num> <div id="p-0349" num="0364" class="description-line style-scope patent-text">Genbank record update date: Feb. 1, 2011 11:25 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0365]" class="style-scope patent-text">
    
    [0365]
  </para-num> <div id="p-0350" num="0365" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0366]" class="style-scope patent-text">
    
    [0366]
  </para-num> <div id="p-0351" num="0366" class="description-line style-scope patent-text">Reiter R. E., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>95, 1735-1740, 1998; Gu Z., et al Oncogene 19, 1288-1296, 2000; <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>(2000) 275(3):783-788; WO2004/022709; EP1394274 (Example 11); US2004/018553 (claim 17); WO2003/008537 (claim 1); WO2002/81646 (claim 1; Page 164); WO2003/003906 (claim 10; Page 288); WO2001/40309 (Example 1; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 17</figref>); US2001/055751 (Example 1; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1<i class="style-scope patent-text">b</i> </figref>); WO2000/32752 (<figure-callout id="18" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 18; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref>); WO98/51805 (claim 17; Page 97); WO98/51824 (claim 10; Page 94); WO98/40403 (claim 2; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1B</figref>); Accession: 043653; EMBL; AF043498; AAC39607.1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0367]" class="style-scope patent-text">
    
    [0367]
  </para-num> <div id="p-0352" num="0367" class="description-line style-scope patent-text">(25) GEDA</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0368]" class="style-scope patent-text">
    
    [0368]
  </para-num> <div id="p-0353" num="0368" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0369]" class="style-scope patent-text">
    
    [0369]
  </para-num> <div id="p-0354" num="0369" class="description-line style-scope patent-text">Genbank accession no AY260763</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0370]" class="style-scope patent-text">
    
    [0370]
  </para-num> <div id="p-0355" num="0370" class="description-line style-scope patent-text">Genbank version no. AY260763.1 GI:30102448</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0371]" class="style-scope patent-text">
    
    [0371]
  </para-num> <div id="p-0356" num="0371" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 02:24 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0372]" class="style-scope patent-text">
    
    [0372]
  </para-num> <div id="p-0357" num="0372" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0373]" class="style-scope patent-text">
    
    [0373]
  </para-num> <div id="p-0358" num="0373" class="description-line style-scope patent-text">Genbank accession no. AAP14954</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0374]" class="style-scope patent-text">
    
    [0374]
  </para-num> <div id="p-0359" num="0374" class="description-line style-scope patent-text">Genbank version no. AAP14954.1 GI:30102449</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0375]" class="style-scope patent-text">
    
    [0375]
  </para-num> <div id="p-0360" num="0375" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 02:24 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0376]" class="style-scope patent-text">
    
    [0376]
  </para-num> <div id="p-0361" num="0376" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0377]" class="style-scope patent-text">
    
    [0377]
  </para-num> <div id="p-0362" num="0377" class="description-line style-scope patent-text">AP14954 lipoma HMGIC fusion-partnerlike protein/pid=AAP14954.1 -Homo sapiens (human); WO2003/054152 (claim 20); WO2003/000842 (claim 1); WO2003/023013 (Example 3, claim 20); US2003/194704 (claim 45); GI:30102449;</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0378]" class="style-scope patent-text">
    
    [0378]
  </para-num> <div id="p-0363" num="0378" class="description-line style-scope patent-text">(26) BAFF-R (B cell-activating factor receptor, <figure-callout id="3" label="BLyS receptor" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">BLyS receptor</a></figure-callout> 3, BR3)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0379]" class="style-scope patent-text">
    
    [0379]
  </para-num> <div id="p-0364" num="0379" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0380]" class="style-scope patent-text">
    
    [0380]
  </para-num> <div id="p-0365" num="0380" class="description-line style-scope patent-text">Genbank accession no AF116456</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0381]" class="style-scope patent-text">
    
    [0381]
  </para-num> <div id="p-0366" num="0381" class="description-line style-scope patent-text">Genbank version no. AF116456.1 GI:4585274</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0382]" class="style-scope patent-text">
    
    [0382]
  </para-num> <div id="p-0367" num="0382" class="description-line style-scope patent-text">Genbank record update date: Mar. 10, 2010 09:44 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0383]" class="style-scope patent-text">
    
    [0383]
  </para-num> <div id="p-0368" num="0383" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0384]" class="style-scope patent-text">
    
    [0384]
  </para-num> <div id="p-0369" num="0384" class="description-line style-scope patent-text">Genbank accession no. AAD25356</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0385]" class="style-scope patent-text">
    
    [0385]
  </para-num> <div id="p-0370" num="0385" class="description-line style-scope patent-text">Genbank version no. AAD25356.1 GI:4585275</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0386]" class="style-scope patent-text">
    
    [0386]
  </para-num> <div id="p-0371" num="0386" class="description-line style-scope patent-text">Genbank record update date: Mar. 10, 2010 09:44 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0387]" class="style-scope patent-text">
    
    [0387]
  </para-num> <div id="p-0372" num="0387" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0388]" class="style-scope patent-text">
    
    [0388]
  </para-num> <div id="p-0373" num="0388" class="description-line style-scope patent-text">BAFF receptor/pid=NP_443177.1-Homo sapiens: Thompson, J. S., et al <i class="style-scope patent-text">Science </i>293 (5537), 2108-2111 (2001); WO2004/058309; WO2004/011611; WO2003/045422 (Example; Page 32-33); WO2003/014294 (claim 35; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 6B</figref>); WO2003/035846 (claim 70; Page 615-616); WO2002/94852 (Col 136-137); WO2002/38766 (<figure-callout id="3" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 3; Page 133); WO2002/24909 (Example 3; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 3</figref>); MIM:606269; NP_443177.1; NM_052945_1; AF132600</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0389]" class="style-scope patent-text">
    
    [0389]
  </para-num> <div id="p-0374" num="0389" class="description-line style-scope patent-text">(27) CD22 (B-cell receptor CD22-B isoform, BL-CAM, Lyb-8, Lyb8, SIGLEC-2, FLJ22814)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0390]" class="style-scope patent-text">
    
    [0390]
  </para-num> <div id="p-0375" num="0390" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0391]" class="style-scope patent-text">
    
    [0391]
  </para-num> <div id="p-0376" num="0391" class="description-line style-scope patent-text">Genbank accession no AK026467</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0392]" class="style-scope patent-text">
    
    [0392]
  </para-num> <div id="p-0377" num="0392" class="description-line style-scope patent-text">Genbank version no. AK026467.1 GI:10439337</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0393]" class="style-scope patent-text">
    
    [0393]
  </para-num> <div id="p-0378" num="0393" class="description-line style-scope patent-text">Genbank record update date: Sep. 11, 2006 11:24 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0394]" class="style-scope patent-text">
    
    [0394]
  </para-num> <div id="p-0379" num="0394" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0395]" class="style-scope patent-text">
    
    [0395]
  </para-num> <div id="p-0380" num="0395" class="description-line style-scope patent-text">Genbank accession no. BAB15489</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0396]" class="style-scope patent-text">
    
    [0396]
  </para-num> <div id="p-0381" num="0396" class="description-line style-scope patent-text">Genbank version no. BAB15489.1 GI:10439338</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0397]" class="style-scope patent-text">
    
    [0397]
  </para-num> <div id="p-0382" num="0397" class="description-line style-scope patent-text">Genbank record update date: Sep. 11, 2006 11:24 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0398]" class="style-scope patent-text">
    
    [0398]
  </para-num> <div id="p-0383" num="0398" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0399]" class="style-scope patent-text">
    
    [0399]
  </para-num> <div id="p-0384" num="0399" class="description-line style-scope patent-text">Wilson et al (1991) <i class="style-scope patent-text">J. Exp. Med. </i>173:137-146; WO2003/072036 (claim 1; <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref>); IM:107266; NP_001762.1; NM_001771_1.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0400]" class="style-scope patent-text">
    
    [0400]
  </para-num> <div id="p-0385" num="0400" class="description-line style-scope patent-text">(27a) CD22 (CD22 molecule)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0401]" class="style-scope patent-text">
    
    [0401]
  </para-num> <div id="p-0386" num="0401" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0402]" class="style-scope patent-text">
    
    [0402]
  </para-num> <div id="p-0387" num="0402" class="description-line style-scope patent-text">Genbank accession no X52785</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0403]" class="style-scope patent-text">
    
    [0403]
  </para-num> <div id="p-0388" num="0403" class="description-line style-scope patent-text">Genbank version no. X52785.1 GI:29778</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0404]" class="style-scope patent-text">
    
    [0404]
  </para-num> <div id="p-0389" num="0404" class="description-line style-scope patent-text">Genbank record update date: Feb. 2, 2011 10:09 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0405]" class="style-scope patent-text">
    
    [0405]
  </para-num> <div id="p-0390" num="0405" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0406]" class="style-scope patent-text">
    
    [0406]
  </para-num> <div id="p-0391" num="0406" class="description-line style-scope patent-text">Genbank accession no. CAA36988</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0407]" class="style-scope patent-text">
    
    [0407]
  </para-num> <div id="p-0392" num="0407" class="description-line style-scope patent-text">Genbank version no. CAA36988.1 GI:29779</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0408]" class="style-scope patent-text">
    
    [0408]
  </para-num> <div id="p-0393" num="0408" class="description-line style-scope patent-text">Genbank record update date: Feb. 2, 2011 10:09 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0409]" class="style-scope patent-text">
    
    [0409]
  </para-num> <div id="p-0394" num="0409" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0410]" class="style-scope patent-text">
    
    [0410]
  </para-num> <div id="p-0395" num="0410" class="description-line style-scope patent-text">Stamenkovic I. et al., <i class="style-scope patent-text">Nature </i>345 (6270), 74-77 (1990)??</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0411]" class="style-scope patent-text">
    
    [0411]
  </para-num> <div id="p-0396" num="0411" class="description-line style-scope patent-text">Other information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0412]" class="style-scope patent-text">
    
    [0412]
  </para-num> <div id="p-0397" num="0412" class="description-line style-scope patent-text">Official Symbol: CD22</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0413]" class="style-scope patent-text">
    
    [0413]
  </para-num> <div id="p-0398" num="0413" class="description-line style-scope patent-text">Other Aliases: SIGLEC-2, SIGLEC2</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0414]" class="style-scope patent-text">
    
    [0414]
  </para-num> <div id="p-0399" num="0414" class="description-line style-scope patent-text">Other Designations: B-cell receptor CD22; B-lymphocyte cell adhesion molecule; BL-CAM; CD22 antigen; T-cell surface antigen Leu-14; sialic acid binding Ig-like lectin 2; sialic acid-binding Ig-like lectin 2</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0415]" class="style-scope patent-text">
    
    [0415]
  </para-num> <div id="p-0400" num="0415" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0416]" class="style-scope patent-text">
    
    [0416]
  </para-num> <div id="p-0401" num="0416" class="description-line style-scope patent-text">G5/44 (Inotuzumab): DiJoseph J F.,et al <i class="style-scope patent-text">Cancer Immunol Immunother. </i>2005 Jan.; 54(1):11-24.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0417]" class="style-scope patent-text">
    
    [0417]
  </para-num> <div id="p-0402" num="0417" class="description-line style-scope patent-text">Epratuzumab-Goldenberg D M., et al <i class="style-scope patent-text">Expert Rev Anticancer Ther. </i>6(10): 1341-53, 2006.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0418]" class="style-scope patent-text">
    
    [0418]
  </para-num> <div id="p-0403" num="0418" class="description-line style-scope patent-text">(28) CD79a (CD79A, CD79alpha), immunoglobulin-associated alpha, a B cell-specific protein that covalently interacts with Ig beta (CD79B) and forms a complex on the surface with Ig M molecules, transduces a signal involved in B-cell differentiation), pl: 4.84, MW: 25028 TM: 2 [P] <i class="style-scope patent-text">Gene Chromosome: </i>19q13.2).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0419]" class="style-scope patent-text">
    
    [0419]
  </para-num> <div id="p-0404" num="0419" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0420]" class="style-scope patent-text">
    
    [0420]
  </para-num> <div id="p-0405" num="0420" class="description-line style-scope patent-text">Genbank accession no NM_001783</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0421]" class="style-scope patent-text">
    
    [0421]
  </para-num> <div id="p-0406" num="0421" class="description-line style-scope patent-text">Genbank version no. NM_001783.3 GI:90193587</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0422]" class="style-scope patent-text">
    
    [0422]
  </para-num> <div id="p-0407" num="0422" class="description-line style-scope patent-text">Genbank record update date: Jun. 26, 2012 01:48 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0423]" class="style-scope patent-text">
    
    [0423]
  </para-num> <div id="p-0408" num="0423" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0424]" class="style-scope patent-text">
    
    [0424]
  </para-num> <div id="p-0409" num="0424" class="description-line style-scope patent-text">Genbank accession no. NP_001774</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0425]" class="style-scope patent-text">
    
    [0425]
  </para-num> <div id="p-0410" num="0425" class="description-line style-scope patent-text">Genbank version no. NP_001774.1 GI:4502685</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0426]" class="style-scope patent-text">
    
    [0426]
  </para-num> <div id="p-0411" num="0426" class="description-line style-scope patent-text">Genbank record update date: Jun. 26, 2012 01:48 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0427]" class="style-scope patent-text">
    
    [0427]
  </para-num> <div id="p-0412" num="0427" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0428]" class="style-scope patent-text">
    
    [0428]
  </para-num> <div id="p-0413" num="0428" class="description-line style-scope patent-text">WO2003/088808, US2003/0228319; WO2003/062401 (claim 9); US2002/150573 (<figure-callout id="4" label="claim" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 4, pages 13-14); WO99/58658 (claim 13, <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 16</figref>); WO92/07574 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref>); US5644033; Ha et al (1992) <i class="style-scope patent-text">J. Immunol. </i>148(5):1526-1531; Muller et al (1992) <i class="style-scope patent-text">Eur. J. Immunol. </i>22:1621-1625; Hashimoto et al (1994) <i class="style-scope patent-text">Immunogenetics </i>40(4):287-295; Preud'homme et al (1992) <i class="style-scope patent-text">Clin. Exp. Immunol. </i>90(1):141-146; Yu et al (1992) <i class="style-scope patent-text">J. Immunol. </i>148(2) 633-637; Sakaguchi et al (1988) <i class="style-scope patent-text">EMBO J.</i>7(11):3457-3464</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0429]" class="style-scope patent-text">
    
    [0429]
  </para-num> <div id="p-0414" num="0429" class="description-line style-scope patent-text">(29) CXCRS (Burkitt's lymphoma receptor 1, a G protein-coupled receptor that is activated by the CXCL13 chemokine, functions in lymphocyte migration and humoral defense, plays a role in HIV-2 infection and perhaps development of AIDS, lymphoma, myeloma, and leukemia); 372 aa, pl: 8.54 MW: 41959 TM: 7 [P]<i class="style-scope patent-text">Gene Chromosome: </i>11q23.3,</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0430]" class="style-scope patent-text">
    
    [0430]
  </para-num> <div id="p-0415" num="0430" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0431]" class="style-scope patent-text">
    
    [0431]
  </para-num> <div id="p-0416" num="0431" class="description-line style-scope patent-text">Genbank accession no NM_001716</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0432]" class="style-scope patent-text">
    
    [0432]
  </para-num> <div id="p-0417" num="0432" class="description-line style-scope patent-text">Genbank version no. NM_001716.4 GI:342307092</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0433]" class="style-scope patent-text">
    
    [0433]
  </para-num> <div id="p-0418" num="0433" class="description-line style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:49 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0434]" class="style-scope patent-text">
    
    [0434]
  </para-num> <div id="p-0419" num="0434" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0435]" class="style-scope patent-text">
    
    [0435]
  </para-num> <div id="p-0420" num="0435" class="description-line style-scope patent-text">Genbank accession no. NP_001707</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0436]" class="style-scope patent-text">
    
    [0436]
  </para-num> <div id="p-0421" num="0436" class="description-line style-scope patent-text">Genbank version no. NP_001707.1 GI:4502415</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0437]" class="style-scope patent-text">
    
    [0437]
  </para-num> <div id="p-0422" num="0437" class="description-line style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:49 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0438]" class="style-scope patent-text">
    
    [0438]
  </para-num> <div id="p-0423" num="0438" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0439]" class="style-scope patent-text">
    
    [0439]
  </para-num> <div id="p-0424" num="0439" class="description-line style-scope patent-text">WO2004/040000; WO2004/015426; US2003/105292 (Example 2); U.S. Pat. No. 6,555,339 (Example 2); WO2002/61087 (<figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref>); WO2001/57188 (<figure-callout id="20" label="claim" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 20, page 269); WO2001/72830 (pages 12-13); WO2000/22129 (Example 1, pages 152-153, Example 2, pages 254-256); WO99/28468 (claim 1, page 38); U.S. Pat. No. 5,440,021 (Example 2, col 49-52); WO94/28931 (pages 56-58); WO92/17497 (claim 7, <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 5</figref>); Dobner et al (1992) <i class="style-scope patent-text">Eur. J. Immunol. </i>22:2795-2799; Barella et al (1995) <i class="style-scope patent-text">Biochem. J.</i>309:773-779</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0440]" class="style-scope patent-text">
    
    [0440]
  </para-num> <div id="p-0425" num="0440" class="description-line style-scope patent-text">(30) HLA-DOB (Beta subunit of MHC class II molecule (la antigen) that binds peptides and presents them to CD4+T lymphocytes); 273 aa, pl: 6.56, MW: 30820. TM: 1 [P] <i class="style-scope patent-text">Gene Chromosome: </i>6p21.3)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0441]" class="style-scope patent-text">
    
    [0441]
  </para-num> <div id="p-0426" num="0441" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0442]" class="style-scope patent-text">
    
    [0442]
  </para-num> <div id="p-0427" num="0442" class="description-line style-scope patent-text">Genbank accession no NM_002120</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0443]" class="style-scope patent-text">
    
    [0443]
  </para-num> <div id="p-0428" num="0443" class="description-line style-scope patent-text">Genbank version no. NM_002120.3 GI:118402587</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0444]" class="style-scope patent-text">
    
    [0444]
  </para-num> <div id="p-0429" num="0444" class="description-line style-scope patent-text">Genbank record update date: Sep. 8, 2012 04:46 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0445]" class="style-scope patent-text">
    
    [0445]
  </para-num> <div id="p-0430" num="0445" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0446]" class="style-scope patent-text">
    
    [0446]
  </para-num> <div id="p-0431" num="0446" class="description-line style-scope patent-text">Genbank accession no. NP_002111</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0447]" class="style-scope patent-text">
    
    [0447]
  </para-num> <div id="p-0432" num="0447" class="description-line style-scope patent-text">Genbank version no. NP_002111.1 GI:4504403</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0448]" class="style-scope patent-text">
    
    [0448]
  </para-num> <div id="p-0433" num="0448" class="description-line style-scope patent-text">Genbank record update date: Sep. 8, 2012 04:46 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0449]" class="style-scope patent-text">
    
    [0449]
  </para-num> <div id="p-0434" num="0449" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0450]" class="style-scope patent-text">
    
    [0450]
  </para-num> <div id="p-0435" num="0450" class="description-line style-scope patent-text">Tonnelle et al (1985) <i class="style-scope patent-text">EMBO J.</i>4(11):2839-2847; Jonsson et al (1989) <i class="style-scope patent-text">Immunogenetics </i>29(6):411-413; Beck et al (1992) <i class="style-scope patent-text">J. Mol. Biol. </i>228:433-441; Strausberg et al (2002) <i class="style-scope patent-text">Proc. Natl. Acad. Sci USA </i>99:16899-16903; Servenius et al (1987) <i class="style-scope patent-text">J. Biol. Chem. </i>262:8759-8766; Beck et al (1996) <i class="style-scope patent-text">J. Mol. Biol. </i>255:1-13; Naruse et al (2002) <i class="style-scope patent-text">Tissue Antigens </i>59:512-519; WO99/58658 (claim 13, <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 15</figref>); US6153408 (Col 35-38); US5976551 (col 168-170); US6011146 (col 145-146); Kasahara et al (1989) <i class="style-scope patent-text">Immunogenetics </i>30(1):66-68; Larhammar et al (1985) <i class="style-scope patent-text">J. Biol. Chem. </i>260(26):14111-14119</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0451]" class="style-scope patent-text">
    
    [0451]
  </para-num> <div id="p-0436" num="0451" class="description-line style-scope patent-text">(31) P2X5 (Purinergic receptor P2X ligand-gated ion channel 5, an ion channel gated by extracellular ATP, may be involved in synaptic transmission and neurogenesis, deficiency may contribute to the pathophysiology of idiopathic detrusor instability); 422 aa), pl: 7.63, MW: 47206 TM: 1 [P] <i class="style-scope patent-text">Gene Chromosome: </i>17p13.3).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0452]" class="style-scope patent-text">
    
    [0452]
  </para-num> <div id="p-0437" num="0452" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0453]" class="style-scope patent-text">
    
    [0453]
  </para-num> <div id="p-0438" num="0453" class="description-line style-scope patent-text">Genbank accession no NM_002561</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0454]" class="style-scope patent-text">
    
    [0454]
  </para-num> <div id="p-0439" num="0454" class="description-line style-scope patent-text">Genbank version no. NM_002561.3 GI:325197202</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0455]" class="style-scope patent-text">
    
    [0455]
  </para-num> <div id="p-0440" num="0455" class="description-line style-scope patent-text">Genbank record update date: Jun. 27, 2012 12:41 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0456]" class="style-scope patent-text">
    
    [0456]
  </para-num> <div id="p-0441" num="0456" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0457]" class="style-scope patent-text">
    
    [0457]
  </para-num> <div id="p-0442" num="0457" class="description-line style-scope patent-text">Genbank accession no. NP_002552</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0458]" class="style-scope patent-text">
    
    [0458]
  </para-num> <div id="p-0443" num="0458" class="description-line style-scope patent-text">Genbank version no. NP_002552.2 GI:28416933</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0459]" class="style-scope patent-text">
    
    [0459]
  </para-num> <div id="p-0444" num="0459" class="description-line style-scope patent-text">Genbank record update date: Jun. 27, 2012 12:41 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0460]" class="style-scope patent-text">
    
    [0460]
  </para-num> <div id="p-0445" num="0460" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0461]" class="style-scope patent-text">
    
    [0461]
  </para-num> <div id="p-0446" num="0461" class="description-line style-scope patent-text">Le et al (1997) <i class="style-scope patent-text">FEBS Lett. </i>418(1-2):195-199; WO2004/047749; WO2003/072035 (claim 10); Touchman et al (2000) <i class="style-scope patent-text">Genome Res. </i>10:165-173; WO2002/22660 (claim 20); WO2003/093444 (claim 1); WO2003/087768 (claim 1); WO2003/029277 (page 82) (32) CD72 (B-cell differentiation antigen CD72, Lyb-2); 359 aa, pl: 8.66, MW: 40225, TM: 1 5 [P] <i class="style-scope patent-text">Gene Chromosome: </i>9p13.3).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0462]" class="style-scope patent-text">
    
    [0462]
  </para-num> <div id="p-0447" num="0462" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0463]" class="style-scope patent-text">
    
    [0463]
  </para-num> <div id="p-0448" num="0463" class="description-line style-scope patent-text">Genbank accession no NM_001782</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0464]" class="style-scope patent-text">
    
    [0464]
  </para-num> <div id="p-0449" num="0464" class="description-line style-scope patent-text">Genbank version no. NM_001782.2 GI:194018444</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0465]" class="style-scope patent-text">
    
    [0465]
  </para-num> <div id="p-0450" num="0465" class="description-line style-scope patent-text">Genbank record update date: Jun. 26, 2012 01:43 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0466]" class="style-scope patent-text">
    
    [0466]
  </para-num> <div id="p-0451" num="0466" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0467]" class="style-scope patent-text">
    
    [0467]
  </para-num> <div id="p-0452" num="0467" class="description-line style-scope patent-text">Genbank accession no. NP_001773</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0468]" class="style-scope patent-text">
    
    [0468]
  </para-num> <div id="p-0453" num="0468" class="description-line style-scope patent-text">Genbank version no. NP_001773.1 GI:4502683</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0469]" class="style-scope patent-text">
    
    [0469]
  </para-num> <div id="p-0454" num="0469" class="description-line style-scope patent-text">Genbank record update date: Jun. 26, 2012 01:43 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0470]" class="style-scope patent-text">
    
    [0470]
  </para-num> <div id="p-0455" num="0470" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0471]" class="style-scope patent-text">
    
    [0471]
  </para-num> <div id="p-0456" num="0471" class="description-line style-scope patent-text">WO2004042346 (claim 65); WO2003/026493 (pages 51-52, 57-58); WO2000/75655 (pages 105-106); Von Hoegen et al (1990) <i class="style-scope patent-text">J. Immunol. </i>144 (12):4870-4877; Strausberg et al (2002) <i class="style-scope patent-text">Proc. Natl. Acad. Sci USA </i>99:16899-16903.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0472]" class="style-scope patent-text">
    
    [0472]
  </para-num> <div id="p-0457" num="0472" class="description-line style-scope patent-text">(33) LY64 (Lymphocyte antigen 64 (RP105), type I membrane protein of the leucine rich repeat (LRR) family, regulates B-cell activation and apoptosis, loss of function is associated with increased disease activity in patients with systemic lupus erythematosis); 661 aa, pl: 6.20, MW: 74147 TM: 1 [P] <i class="style-scope patent-text">Gene Chromosome: </i>5q12).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0473]" class="style-scope patent-text">
    
    [0473]
  </para-num> <div id="p-0458" num="0473" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0474]" class="style-scope patent-text">
    
    [0474]
  </para-num> <div id="p-0459" num="0474" class="description-line style-scope patent-text">Genbank accession no NM_005582</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0475]" class="style-scope patent-text">
    
    [0475]
  </para-num> <div id="p-0460" num="0475" class="description-line style-scope patent-text">Genbank version no. NM_005582.2 GI:167555126</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0476]" class="style-scope patent-text">
    
    [0476]
  </para-num> <div id="p-0461" num="0476" class="description-line style-scope patent-text">Genbank record update date: Sep. 2, 2012 01:50 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0477]" class="style-scope patent-text">
    
    [0477]
  </para-num> <div id="p-0462" num="0477" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0478]" class="style-scope patent-text">
    
    [0478]
  </para-num> <div id="p-0463" num="0478" class="description-line style-scope patent-text">Genbank accession no. NP_005573</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0479]" class="style-scope patent-text">
    
    [0479]
  </para-num> <div id="p-0464" num="0479" class="description-line style-scope patent-text">Genbank version no. NP_005573.2 GI:167555127</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0480]" class="style-scope patent-text">
    
    [0480]
  </para-num> <div id="p-0465" num="0480" class="description-line style-scope patent-text">Genbank record update date: Sep. 2, 2012 01:50 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0481]" class="style-scope patent-text">
    
    [0481]
  </para-num> <div id="p-0466" num="0481" class="description-line style-scope patent-text">Cross References US2002/193567; WO97/07198 (claim 11, pages 39-42); Miura et al (1996) <i class="style-scope patent-text">Genomics </i>38(3):299-304; Miura et al (1998) <i class="style-scope patent-text">Blood </i>92:2815-2822; WO2003/083047; WO97/44452 (<figure-callout id="8" label="claim" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 8, pages 57-61); WO2000/12130 (pages 24-26).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0482]" class="style-scope patent-text">
    
    [0482]
  </para-num> <div id="p-0467" num="0482" class="description-line style-scope patent-text">(34) FcRH1 (Fc receptor-like protein 1, a putative receptor for the immunoglobulin Fc domain that contains C2 type Ig-like and ITAM domains, may have a role in B-lymphocyte differentiation); 429 aa, pl: 5.28, MW: 46925 TM: 1 [P] <i class="style-scope patent-text">Gene Chromosome: </i>1q21-1q22)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0483]" class="style-scope patent-text">
    
    [0483]
  </para-num> <div id="p-0468" num="0483" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0484]" class="style-scope patent-text">
    
    [0484]
  </para-num> <div id="p-0469" num="0484" class="description-line style-scope patent-text">Genbank accession no NM_052938</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0485]" class="style-scope patent-text">
    
    [0485]
  </para-num> <div id="p-0470" num="0485" class="description-line style-scope patent-text">Genbank version no. NM_052938.4 GI:226958543</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0486]" class="style-scope patent-text">
    
    [0486]
  </para-num> <div id="p-0471" num="0486" class="description-line style-scope patent-text">Genbank record update date: Sep. 2, 2012 01:43 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0487]" class="style-scope patent-text">
    
    [0487]
  </para-num> <div id="p-0472" num="0487" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0488]" class="style-scope patent-text">
    
    [0488]
  </para-num> <div id="p-0473" num="0488" class="description-line style-scope patent-text">Genbank accession no. NP_443170</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0489]" class="style-scope patent-text">
    
    [0489]
  </para-num> <div id="p-0474" num="0489" class="description-line style-scope patent-text">Genbank version no. NP_443170.1 GI:16418419</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0490]" class="style-scope patent-text">
    
    [0490]
  </para-num> <div id="p-0475" num="0490" class="description-line style-scope patent-text">Genbank record update date: Sep. 2, 2012 01:43 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0491]" class="style-scope patent-text">
    
    [0491]
  </para-num> <div id="p-0476" num="0491" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0492]" class="style-scope patent-text">
    
    [0492]
  </para-num> <div id="p-0477" num="0492" class="description-line style-scope patent-text">WO2003/077836; WO2001/38490 (<figure-callout id="6" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> 6, <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 18E</figref>-1-18-E-2); Davis et al (2001) <i class="style-scope patent-text">Proc. Natl. Acad. Sci USA </i>98(17):9772-9777; WO2003/089624 (claim 8); EP1347046 (claim 1); WO2003/089624 (claim 7).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0493]" class="style-scope patent-text">
    
    [0493]
  </para-num> <div id="p-0478" num="0493" class="description-line style-scope patent-text">(35) IRTA2 (Immunoglobulin superfamily receptor translocation associated 2, a putative immunoreceptor with possible roles in B cell development and lymphoma genesis; deregulation of the gene by translocation occurs in some B cell malignancies); 977 aa, pl: 6.88, MW: 106468, TM: 1 [P] <i class="style-scope patent-text">Gene Chromosome: </i>1q21)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0494]" class="style-scope patent-text">
    
    [0494]
  </para-num> <div id="p-0479" num="0494" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0495]" class="style-scope patent-text">
    
    [0495]
  </para-num> <div id="p-0480" num="0495" class="description-line style-scope patent-text">Genbank accession no AF343662</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0496]" class="style-scope patent-text">
    
    [0496]
  </para-num> <div id="p-0481" num="0496" class="description-line style-scope patent-text">Genbank version no. AF343662.1 GI:13591709</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0497]" class="style-scope patent-text">
    
    [0497]
  </para-num> <div id="p-0482" num="0497" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 01:16 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0498]" class="style-scope patent-text">
    
    [0498]
  </para-num> <div id="p-0483" num="0498" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0499]" class="style-scope patent-text">
    
    [0499]
  </para-num> <div id="p-0484" num="0499" class="description-line style-scope patent-text">Genbank accession no. AAK31325</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0500]" class="style-scope patent-text">
    
    [0500]
  </para-num> <div id="p-0485" num="0500" class="description-line style-scope patent-text">Genbank version no. AAK31325.1 GI:13591710</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0501]" class="style-scope patent-text">
    
    [0501]
  </para-num> <div id="p-0486" num="0501" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 01:16 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0502]" class="style-scope patent-text">
    
    [0502]
  </para-num> <div id="p-0487" num="0502" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0503]" class="style-scope patent-text">
    
    [0503]
  </para-num> <div id="p-0488" num="0503" class="description-line style-scope patent-text">AF343663, AF343664, AF343665, AF369794, AF397453, AK090423, AK090475, AL834187, AY358085; Mouse:AK089756, AY158090, AY506558; NP_112571.1; WO2003/024392 (claim 2, <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 97</figref>); Nakayama et al (2000) <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>277(1):124-127; WO2003/077836; WO2001/38490 (<figure-callout id="3" label="claim" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">claim</a></figure-callout> <b class="style-scope patent-text">3</b>, <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 18B</figref>-1-18B-2).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0504]" class="style-scope patent-text">
    
    [0504]
  </para-num> <div id="p-0489" num="0504" class="description-line style-scope patent-text">(36) TENB2 (TMEFF2, tomoregulin, TPEF, HPP1, TR, putative transmembrane proteoglycan, related to the EGF/heregulin family of growth factors and follistatin); 374 aa)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0505]" class="style-scope patent-text">
    
    [0505]
  </para-num> <div id="p-0490" num="0505" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0506]" class="style-scope patent-text">
    
    [0506]
  </para-num> <div id="p-0491" num="0506" class="description-line style-scope patent-text">Genbank accession no AF179274</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0507]" class="style-scope patent-text">
    
    [0507]
  </para-num> <div id="p-0492" num="0507" class="description-line style-scope patent-text">Genbank version no. AF179274.2 GI:12280939</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0508]" class="style-scope patent-text">
    
    [0508]
  </para-num> <div id="p-0493" num="0508" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 01:05 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0509]" class="style-scope patent-text">
    
    [0509]
  </para-num> <div id="p-0494" num="0509" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0510]" class="style-scope patent-text">
    
    [0510]
  </para-num> <div id="p-0495" num="0510" class="description-line style-scope patent-text">Genbank accession no. AAD55776</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0511]" class="style-scope patent-text">
    
    [0511]
  </para-num> <div id="p-0496" num="0511" class="description-line style-scope patent-text">Genbank version no. AAD55776.2 GI:12280940</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0512]" class="style-scope patent-text">
    
    [0512]
  </para-num> <div id="p-0497" num="0512" class="description-line style-scope patent-text">Genbank record update date: Mar. 11, 2010 01:05 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0513]" class="style-scope patent-text">
    
    [0513]
  </para-num> <div id="p-0498" num="0513" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0514]" class="style-scope patent-text">
    
    [0514]
  </para-num> <div id="p-0499" num="0514" class="description-line style-scope patent-text">NCBI Accession: AAD55776, AAF91397, AAG49451, NCBI RefSeq: NP_057276; NCBI</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0515]" class="style-scope patent-text">
    
    [0515]
  </para-num> <div id="p-0500" num="0515" class="description-line style-scope patent-text">Gene: 23671; OMIM: 605734; SwissProt Q9UIK5; AY358907, CAF85723, CQ782436; WO2004/074320; JP2004113151; WO2003/042661; WO2003/009814; EP1295944 (pages 69-70); WO2002/30268 (page 329); WO2001/90304; US2004/249130; US2004/022727; WO2004/063355; US2004/197325; US2003/232350; US2004/005563; US2003/124579; Horie et al (2000) <i class="style-scope patent-text">Genomics </i>67:146-152; Uchida et al (1999) <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>266:593-602; Liang et al (2000) <i class="style-scope patent-text">Cancer Res. </i>60:4907-12; Glynne-Jones et al (2001) <i class="style-scope patent-text">Int J Cancer. </i>Oct. 15; 94(2):178-84.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0516]" class="style-scope patent-text">
    
    [0516]
  </para-num> <div id="p-0501" num="0516" class="description-line style-scope patent-text">(37) PSMA—FOLH1 (Folate hydrolase (prostate-specific membrane antigen) 1)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0517]" class="style-scope patent-text">
    
    [0517]
  </para-num> <div id="p-0502" num="0517" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0518]" class="style-scope patent-text">
    
    [0518]
  </para-num> <div id="p-0503" num="0518" class="description-line style-scope patent-text">Genbank accession no M99487</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0519]" class="style-scope patent-text">
    
    [0519]
  </para-num> <div id="p-0504" num="0519" class="description-line style-scope patent-text">Genbank version no. M99487.1 GI:190663</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0520]" class="style-scope patent-text">
    
    [0520]
  </para-num> <div id="p-0505" num="0520" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:48 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0521]" class="style-scope patent-text">
    
    [0521]
  </para-num> <div id="p-0506" num="0521" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0522]" class="style-scope patent-text">
    
    [0522]
  </para-num> <div id="p-0507" num="0522" class="description-line style-scope patent-text">Genbank accession no. AAA60209</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0523]" class="style-scope patent-text">
    
    [0523]
  </para-num> <div id="p-0508" num="0523" class="description-line style-scope patent-text">Genbank version no. AAA60209.1 GI:190664</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0524]" class="style-scope patent-text">
    
    [0524]
  </para-num> <div id="p-0509" num="0524" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:48 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0525]" class="style-scope patent-text">
    
    [0525]
  </para-num> <div id="p-0510" num="0525" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0526]" class="style-scope patent-text">
    
    [0526]
  </para-num> <div id="p-0511" num="0526" class="description-line style-scope patent-text">Israeli R.S., et al <i class="style-scope patent-text">Cancer Res. </i>53 (2), 227-230 (1993)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0527]" class="style-scope patent-text">
    
    [0527]
  </para-num> <div id="p-0512" num="0527" class="description-line style-scope patent-text">Other information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0528]" class="style-scope patent-text">
    
    [0528]
  </para-num> <div id="p-0513" num="0528" class="description-line style-scope patent-text">Official Symbol: FOLH1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0529]" class="style-scope patent-text">
    
    [0529]
  </para-num> <div id="p-0514" num="0529" class="description-line style-scope patent-text">Other Aliases: GIG27, FGCP, FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA, mGCP</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0530]" class="style-scope patent-text">
    
    [0530]
  </para-num> <div id="p-0515" num="0530" class="description-line style-scope patent-text">Other Designations: N-acetylated alpha-linked acidic dipeptidase 1; N-acetylated-alpha-linked acidic dipeptidase I; NAALADase I; cell growth-inhibiting <figure-callout id="27" label="gene" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">gene</a></figure-callout> 27 protein; folylpoly-gamma-glutamate carboxypeptidase; glutamate carboxylase II; glutamate carboxypeptidase 2; glutamate carboxypeptidase II; membrane glutamate carboxypeptidase; prostate specific membrane antigen variant F; pteroylpoly-gamma-glutamate carboxypeptidase</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0531]" class="style-scope patent-text">
    
    [0531]
  </para-num> <div id="p-0516" num="0531" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0532]" class="style-scope patent-text">
    
    [0532]
  </para-num> <div id="p-0517" num="0532" class="description-line style-scope patent-text">U.S. Pat. No. 7,666,425:</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0533]" class="style-scope patent-text">
    
    [0533]
  </para-num> <div id="p-0518" num="0533" class="description-line style-scope patent-text">Antibodies produces by Hybridomas having the following ATCC references:ATCC accession No. HB-12101, ATCC accession No. HB-12109, ATCC accession No. HB-12127 and ATCC accession No. HB-12126.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0534]" class="style-scope patent-text">
    
    [0534]
  </para-num> <div id="p-0519" num="0534" class="description-line style-scope patent-text">Proscan: a monoclonal antibody selected from the group consisting of 8H12, 3E11, 17G1, 2964, 30C1 and 20F2 (U.S. Pat. No. 7,811,564; Moffett S., et al <i class="style-scope patent-text">Hybridoma </i>(Larchmt). 2007 Dec.; 26(6):363-72).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0535]" class="style-scope patent-text">
    
    [0535]
  </para-num> <div id="p-0520" num="0535" class="description-line style-scope patent-text">Cytogen: monoclonal antibodies 7E11-05 (ATCC accession No. HB 10494) and 9H10-A4</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0536]" class="style-scope patent-text">
    
    [0536]
  </para-num> <div id="p-0521" num="0536" class="description-line style-scope patent-text">(ATCC accession No. H611430)-U.S. Pat. No. 5,763,202</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0537]" class="style-scope patent-text">
    
    [0537]
  </para-num> <div id="p-0522" num="0537" class="description-line style-scope patent-text">GlycoMimetics: NUH2 -ATCC accession No. HB 9762 (U.S. Pat. No. 7,135,301)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0538]" class="style-scope patent-text">
    
    [0538]
  </para-num> <div id="p-0523" num="0538" class="description-line style-scope patent-text">Human Genome Science: HPRAJ70 - ATCC accession No. 97131 (U.S. Pat. No. 6,824,993); Amino acid sequence encoded by the cDNA clone (HPRAJ70) deposited as American Type Culture Collection (“ATCC”) Deposit No. 97131</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0539]" class="style-scope patent-text">
    
    [0539]
  </para-num> <div id="p-0524" num="0539" class="description-line style-scope patent-text">Medarex: Anti-PSMA antibodies that lack fucosyl residues-U.S. Pat. No. 7,875,278</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0540]" class="style-scope patent-text">
    
    [0540]
  </para-num> <div id="p-0525" num="0540" class="description-line style-scope patent-text">Mouse anti-PSMA antibodies include the 3F5.4G6, 3D7.1.1, 4E10-1.14, 3E11, 4D8, 3E6, 3C9, 2C7, 1G3, 3C4, 3C6, 4D4, 1G9, 5C8B9, 3G6, 4C8B9, and monoclonal antibodies. Hybridomas secreting 3F5.4G6, 3D7.1.1, 4E10-1.14, 3E11, 4D8, 3E6, 3C9, 2C7, 1G3, 3C4, 3C6, 4D4, 1G9, 5C8B9, 3G6 or 4C8B9 have been publicly deposited and are described in U.S. Pat. No. 6,159,508. Relevant hybridomas have been publicly deposited and are described in U.S. Pat. No. 6,107,090. Moreover, humanized anti-PSMA antibodies, including a humanized version of J591, are described in further detail in PCT Publication WO 02/098897.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0541]" class="style-scope patent-text">
    
    [0541]
  </para-num> <div id="p-0526" num="0541" class="description-line style-scope patent-text">Other mouse anti-human PSMA antibodies have been described in the art, such as mAb 107-1A4 (Wang, S. et al. (2001) <i class="style-scope patent-text">Int. J. Cancer </i>92:871-876) and mAb 2C9 (Kato, K. et al. (2003) <i class="style-scope patent-text">Int. J. Urol. </i>10:439-444).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0542]" class="style-scope patent-text">
    
    [0542]
  </para-num> <div id="p-0527" num="0542" class="description-line style-scope patent-text">Examples of human anti-PSMA monoclonal antibodies include the 4A3, 7F12, 8C12, 8A11, 16F9, 2A10, 2C6, 2F5 and 1C3 antibodies, isolated and structurally characterized as originally described in PCT Publications WO 01/09192 and WO 03/064606 and in U.S. Provisional Application Ser. No. 60/654,125, entitled “Human Monoclonal Antibodies to Prostate Specific Membrane Antigen (PSMA)”, filed on Feb. 18, 2005. The V.sub.H amino acid sequences of 4A3, 7F12, 8C12, 8A11, 16F9, 2A10, 2C6, 2F5 and 1C3 are shown in SEQ ID NOs: 1-9, respectively. The V.sub.L amino acid sequences of 4A3, 7F12, 8C12, 8A11, 16F9, 2A10, 2C6, 2F5 and 1C3 are shown in SEQ ID NOs: 10-18, respectively.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0543]" class="style-scope patent-text">
    
    [0543]
  </para-num> <div id="p-0528" num="0543" class="description-line style-scope patent-text">Other human anti-PSMA antibodies include the antibodies disclosed in PCT Publication WO 03/034903 and US Application No. 2004/0033229.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0544]" class="style-scope patent-text">
    
    [0544]
  </para-num> <div id="p-0529" num="0544" class="description-line style-scope patent-text">NW Biotherapeutics: A hybridoma cell line selected from the group consisting of 3F5.4G6 having ATCC accession number HB12060, 3D7-1.I. having ATCC accession number HB12309, 4E10-1.14 having ATCC accession number HB12310, 3E11 (ATCC HB12488), 4D8 (ATCC HB12487), 3E6 (ATCC HB12486), 3C9 (ATCC HB12484), 2C7 (ATCC HB12490), 1G3 (ATCC HB12489), 3C4 (ATCC HB12494), 3C6 (ATCC HB12491), 4D4 (ATCC HB12493), 1G9 (ATCC HB12495), 5C8B9 (ATCC HB12492) and 3G6 (ATCC HB12485)—see U.S. Pat. No. 6,150,508</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0545]" class="style-scope patent-text">
    
    [0545]
  </para-num> <div id="p-0530" num="0545" class="description-line style-scope patent-text">PSMA Development Company/Progenics/Cytogen—Seattle Genetics: mAb 3.9, produced by the hybridoma deposited under ATCC Accession No. PTA-3258 or mAb 10.3, produced by the hybridoma deposited under ATCC Accession No. PTA-3347 -U.S. Pat. No. 7,850,971</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0546]" class="style-scope patent-text">
    
    [0546]
  </para-num> <div id="p-0531" num="0546" class="description-line style-scope patent-text">PSMA Development Company—Compositions of PSMA antibodies (US 20080286284, Table 1)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0016-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0017-0001" num="0547" class="style-scope patent-text">This application is a divisional of U.S. patent application Ser. No. 10/395,894, filed on Mar. 21, 2003 (U.S. Pat. No. 7,850,971)</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0548]" class="style-scope patent-text">
    
    [0548]
  </para-num> <div id="p-0532" num="0548" class="description-line style-scope patent-text">University Hospital Freiburg, Germany—<figure-callout id="3" label="mAbs" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">mAbs</a></figure-callout> 3/A12, 3/E7, and 3/F11 (Wolf P., et al <i class="style-scope patent-text">Prostate. </i>2010 Apr. 1; 70(5):562-9).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0549]" class="style-scope patent-text">
    
    [0549]
  </para-num> <div id="p-0533" num="0549" class="description-line style-scope patent-text">(38) SST (Somatostatin Receptor; note that there are 5 subtypes)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0550]" class="style-scope patent-text">
    
    [0550]
  </para-num> <div id="p-0534" num="0550" class="description-line style-scope patent-text">(38.1) SSTR2 (Somatostatin receptor 2)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0551]" class="style-scope patent-text">
    
    [0551]
  </para-num> <div id="p-0535" num="0551" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0552]" class="style-scope patent-text">
    
    [0552]
  </para-num> <div id="p-0536" num="0552" class="description-line style-scope patent-text">Genbank accession no NM_001050</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0553]" class="style-scope patent-text">
    
    [0553]
  </para-num> <div id="p-0537" num="0553" class="description-line style-scope patent-text">Genbank version no. NM_001050.2 GI:44890054</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0554]" class="style-scope patent-text">
    
    [0554]
  </para-num> <div id="p-0538" num="0554" class="description-line style-scope patent-text">Genbank record update date: Aug. 19, 2012 01:37 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0555]" class="style-scope patent-text">
    
    [0555]
  </para-num> <div id="p-0539" num="0555" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0556]" class="style-scope patent-text">
    
    [0556]
  </para-num> <div id="p-0540" num="0556" class="description-line style-scope patent-text">Genbank accession no. NP_001041</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0557]" class="style-scope patent-text">
    
    [0557]
  </para-num> <div id="p-0541" num="0557" class="description-line style-scope patent-text">Genbank version no. NP_001041.1 GI:4557859</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0558]" class="style-scope patent-text">
    
    [0558]
  </para-num> <div id="p-0542" num="0558" class="description-line style-scope patent-text">Genbank record update date: Aug. 19, 2012 01:37 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0559]" class="style-scope patent-text">
    
    [0559]
  </para-num> <div id="p-0543" num="0559" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0560]" class="style-scope patent-text">
    
    [0560]
  </para-num> <div id="p-0544" num="0560" class="description-line style-scope patent-text">Yamada Y., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>89 (1), 251-255 (1992); Susini C., et al <i class="style-scope patent-text">Ann Oncol. </i>2006 Dec.; 17(12):1733-42</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0561]" class="style-scope patent-text">
    
    [0561]
  </para-num> <div id="p-0545" num="0561" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0562]" class="style-scope patent-text">
    
    [0562]
  </para-num> <div id="p-0546" num="0562" class="description-line style-scope patent-text">Official Symbol: SSTR2</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0563]" class="style-scope patent-text">
    
    [0563]
  </para-num> <div id="p-0547" num="0563" class="description-line style-scope patent-text">Other Designations: SRIF-1; SS2R; somatostatin receptor type 2</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0564]" class="style-scope patent-text">
    
    [0564]
  </para-num> <div id="p-0548" num="0564" class="description-line style-scope patent-text">(38.2) SSTR5 (Somatostatin receptor 5)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0565]" class="style-scope patent-text">
    
    [0565]
  </para-num> <div id="p-0549" num="0565" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0566]" class="style-scope patent-text">
    
    [0566]
  </para-num> <div id="p-0550" num="0566" class="description-line style-scope patent-text">Genbank accession no D16827</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0567]" class="style-scope patent-text">
    
    [0567]
  </para-num> <div id="p-0551" num="0567" class="description-line style-scope patent-text">Genbank version no. D16827.1 GI:487683</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0568]" class="style-scope patent-text">
    
    [0568]
  </para-num> <div id="p-0552" num="0568" class="description-line style-scope patent-text">Genbank record update date: Aug. 1, 2006 12:45 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0569]" class="style-scope patent-text">
    
    [0569]
  </para-num> <div id="p-0553" num="0569" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0570]" class="style-scope patent-text">
    
    [0570]
  </para-num> <div id="p-0554" num="0570" class="description-line style-scope patent-text">Genbank accession no. BAA04107</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0571]" class="style-scope patent-text">
    
    [0571]
  </para-num> <div id="p-0555" num="0571" class="description-line style-scope patent-text">Genbank version no. BAA04107.1 GI:487684</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0572]" class="style-scope patent-text">
    
    [0572]
  </para-num> <div id="p-0556" num="0572" class="description-line style-scope patent-text">Genbank record update date: Aug. 1, 2006 12:45 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0573]" class="style-scope patent-text">
    
    [0573]
  </para-num> <div id="p-0557" num="0573" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0574]" class="style-scope patent-text">
    
    [0574]
  </para-num> <div id="p-0558" num="0574" class="description-line style-scope patent-text">Yamada,Y., et al <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>195 (2), 844-852 (1993)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0575]" class="style-scope patent-text">
    
    [0575]
  </para-num> <div id="p-0559" num="0575" class="description-line style-scope patent-text">Other information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0576]" class="style-scope patent-text">
    
    [0576]
  </para-num> <div id="p-0560" num="0576" class="description-line style-scope patent-text">Official Symbol: SSTR5</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0577]" class="style-scope patent-text">
    
    [0577]
  </para-num> <div id="p-0561" num="0577" class="description-line style-scope patent-text">Other Aliases: SS-5-R</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0578]" class="style-scope patent-text">
    
    [0578]
  </para-num> <div id="p-0562" num="0578" class="description-line style-scope patent-text">Other Designations: Somatostatin receptor subtype 5; somatostatin receptor type 5</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0579]" class="style-scope patent-text">
    
    [0579]
  </para-num> <div id="p-0563" num="0579" class="description-line style-scope patent-text">(38.3) SSTR1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0580]" class="style-scope patent-text">
    
    [0580]
  </para-num> <div id="p-0564" num="0580" class="description-line style-scope patent-text">(38.4)SSTR3</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0581]" class="style-scope patent-text">
    
    [0581]
  </para-num> <div id="p-0565" num="0581" class="description-line style-scope patent-text">(38.5) SSTR4</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0582]" class="style-scope patent-text">
    
    [0582]
  </para-num> <div id="p-0566" num="0582" class="description-line style-scope patent-text">AvB6 -Both Subunits (39+40)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0583]" class="style-scope patent-text">
    
    [0583]
  </para-num> <div id="p-0567" num="0583" class="description-line style-scope patent-text">(39) ITGAV (Integrin, alpha V;</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0584]" class="style-scope patent-text">
    
    [0584]
  </para-num> <div id="p-0568" num="0584" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0585]" class="style-scope patent-text">
    
    [0585]
  </para-num> <div id="p-0569" num="0585" class="description-line style-scope patent-text">Genbank accession no M14648 J02826 M18365</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0586]" class="style-scope patent-text">
    
    [0586]
  </para-num> <div id="p-0570" num="0586" class="description-line style-scope patent-text">Genbank version no. M14648.1 GI:340306</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0587]" class="style-scope patent-text">
    
    [0587]
  </para-num> <div id="p-0571" num="0587" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:56 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0588]" class="style-scope patent-text">
    
    [0588]
  </para-num> <div id="p-0572" num="0588" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0589]" class="style-scope patent-text">
    
    [0589]
  </para-num> <div id="p-0573" num="0589" class="description-line style-scope patent-text">Genbank accession no. AAA36808</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0590]" class="style-scope patent-text">
    
    [0590]
  </para-num> <div id="p-0574" num="0590" class="description-line style-scope patent-text">Genbank version no. AAA36808.1 GI:340307</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0591]" class="style-scope patent-text">
    
    [0591]
  </para-num> <div id="p-0575" num="0591" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:56 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0592]" class="style-scope patent-text">
    
    [0592]
  </para-num> <div id="p-0576" num="0592" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0593]" class="style-scope patent-text">
    
    [0593]
  </para-num> <div id="p-0577" num="0593" class="description-line style-scope patent-text">Suzuki S., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>83 (22), 8614-8618 (1986)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0594]" class="style-scope patent-text">
    
    [0594]
  </para-num> <div id="p-0578" num="0594" class="description-line style-scope patent-text">Other information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0595]" class="style-scope patent-text">
    
    [0595]
  </para-num> <div id="p-0579" num="0595" class="description-line style-scope patent-text">Official Symbol: ITGAV</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0596]" class="style-scope patent-text">
    
    [0596]
  </para-num> <div id="p-0580" num="0596" class="description-line style-scope patent-text">Other Aliases: CD51, MSK8, VNRA, VTNR</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0597]" class="style-scope patent-text">
    
    [0597]
  </para-num> <div id="p-0581" num="0597" class="description-line style-scope patent-text">Other Designations: antigen identified by monoclonal antibody L230; integrin alpha-V; integrin alphaVbeta3; integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51); vitronectin receptor subunit alpha (40) ITGB6 (Integrin, beta 6)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0598]" class="style-scope patent-text">
    
    [0598]
  </para-num> <div id="p-0582" num="0598" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0599]" class="style-scope patent-text">
    
    [0599]
  </para-num> <div id="p-0583" num="0599" class="description-line style-scope patent-text">Genbank accession no NM_000888</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0600]" class="style-scope patent-text">
    
    [0600]
  </para-num> <div id="p-0584" num="0600" class="description-line style-scope patent-text">Genbank version no. NM_000888.3 GI:9966771</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0601]" class="style-scope patent-text">
    
    [0601]
  </para-num> <div id="p-0585" num="0601" class="description-line style-scope patent-text">Genbank record update date: Jun. 27, 2012 12:46 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0602]" class="style-scope patent-text">
    
    [0602]
  </para-num> <div id="p-0586" num="0602" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0603]" class="style-scope patent-text">
    
    [0603]
  </para-num> <div id="p-0587" num="0603" class="description-line style-scope patent-text">Genbank accession no. NP_000879</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0604]" class="style-scope patent-text">
    
    [0604]
  </para-num> <div id="p-0588" num="0604" class="description-line style-scope patent-text">Genbank version no. NP_000879.2 GI:9625002</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0605]" class="style-scope patent-text">
    
    [0605]
  </para-num> <div id="p-0589" num="0605" class="description-line style-scope patent-text">Genbank record update date: Jun. 27, 2012 12:46 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0606]" class="style-scope patent-text">
    
    [0606]
  </para-num> <div id="p-0590" num="0606" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0607]" class="style-scope patent-text">
    
    [0607]
  </para-num> <div id="p-0591" num="0607" class="description-line style-scope patent-text">Sheppard D. J., et al <i class="style-scope patent-text">Biol. Chem. </i>265 (20), 11502-11507 (1990)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0608]" class="style-scope patent-text">
    
    [0608]
  </para-num> <div id="p-0592" num="0608" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0609]" class="style-scope patent-text">
    
    [0609]
  </para-num> <div id="p-0593" num="0609" class="description-line style-scope patent-text">Official Symbol: ITGB6</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0610]" class="style-scope patent-text">
    
    [0610]
  </para-num> <div id="p-0594" num="0610" class="description-line style-scope patent-text">Other Designations: integrin beta-6</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0611]" class="style-scope patent-text">
    
    [0611]
  </para-num> <div id="p-0595" num="0611" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0612]" class="style-scope patent-text">
    
    [0612]
  </para-num> <div id="p-0596" num="0612" class="description-line style-scope patent-text">Biogen: U.S. Pat. No. 7,943,742 —Hybridoma clones 6.3G9 and 6.8G6 were deposited with the ATCC, accession numbers ATCC PTA−3649 and −3645, respectively.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0613]" class="style-scope patent-text">
    
    [0613]
  </para-num> <div id="p-0597" num="0613" class="description-line style-scope patent-text">Biogen: U.S. Pat. No. 7,465,449—In some embodiments, the antibody comprises the same heavy and light chain polypeptide sequences as an antibody produced by hybridoma 6.1A8, 6.3G9, 6.8G6, 6.261, 6.2610, 6.2A1, 6.2E5, 7.1G10, 7.7G5, or 7.105.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0614]" class="style-scope patent-text">
    
    [0614]
  </para-num> <div id="p-0598" num="0614" class="description-line style-scope patent-text">Centocor (J&amp;J): U.S. Pat. No. 7,550,142; U.S. Pat. No. 7,163,681</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0615]" class="style-scope patent-text">
    
    [0615]
  </para-num> <div id="p-0599" num="0615" class="description-line style-scope patent-text">For example in U.S. 7,550,142 —an antibody having human heavy chain and human light chain variable regions comprising the amino acid sequences shown in SEQ ID NO: 7 and SEQ ID NO: 8.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0616]" class="style-scope patent-text">
    
    [0616]
  </para-num> <div id="p-0600" num="0616" class="description-line style-scope patent-text">Seattle Genetics: 15H3 (Ryan M C., et al Cancer Res Apr. 15, 2012; 72(8 Supplement): 4630)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0617]" class="style-scope patent-text">
    
    [0617]
  </para-num> <div id="p-0601" num="0617" class="description-line style-scope patent-text">(41) CEACAM5 (Carcinoembryonic antigen-related cell adhesion molecule 5)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0618]" class="style-scope patent-text">
    
    [0618]
  </para-num> <div id="p-0602" num="0618" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0619]" class="style-scope patent-text">
    
    [0619]
  </para-num> <div id="p-0603" num="0619" class="description-line style-scope patent-text">Genbank accession no M17303</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0620]" class="style-scope patent-text">
    
    [0620]
  </para-num> <div id="p-0604" num="0620" class="description-line style-scope patent-text">Genbank version no. M17303.1 GI:178676</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0621]" class="style-scope patent-text">
    
    [0621]
  </para-num> <div id="p-0605" num="0621" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:47 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0622]" class="style-scope patent-text">
    
    [0622]
  </para-num> <div id="p-0606" num="0622" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0623]" class="style-scope patent-text">
    
    [0623]
  </para-num> <div id="p-0607" num="0623" class="description-line style-scope patent-text">Genbank accession no. AA659513</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0624]" class="style-scope patent-text">
    
    [0624]
  </para-num> <div id="p-0608" num="0624" class="description-line style-scope patent-text">Genbank version no. AA659513.1 GI:178677</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0625]" class="style-scope patent-text">
    
    [0625]
  </para-num> <div id="p-0609" num="0625" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:47 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0626]" class="style-scope patent-text">
    
    [0626]
  </para-num> <div id="p-0610" num="0626" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0627]" class="style-scope patent-text">
    
    [0627]
  </para-num> <div id="p-0611" num="0627" class="description-line style-scope patent-text">Beauchemin N., et al <i class="style-scope patent-text">Mol. Cell. Biol. </i>7 (9), 3221-3230 (1987)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0628]" class="style-scope patent-text">
    
    [0628]
  </para-num> <div id="p-0612" num="0628" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0629]" class="style-scope patent-text">
    
    [0629]
  </para-num> <div id="p-0613" num="0629" class="description-line style-scope patent-text">Official Symbol: CEACAM5</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0630]" class="style-scope patent-text">
    
    [0630]
  </para-num> <div id="p-0614" num="0630" class="description-line style-scope patent-text">Other Aliases: CD66e, CEA</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0631]" class="style-scope patent-text">
    
    [0631]
  </para-num> <div id="p-0615" num="0631" class="description-line style-scope patent-text">Other Designations: meconium antigen 100</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0632]" class="style-scope patent-text">
    
    [0632]
  </para-num> <div id="p-0616" num="0632" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0633]" class="style-scope patent-text">
    
    [0633]
  </para-num> <div id="p-0617" num="0633" class="description-line style-scope patent-text">AstraZeneca-Medlmmune:US 20100330103; US20080057063;
</div> </li> <ul class="style-scope patent-text"> <li id="ul0018-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0019-0001" num="0634" class="style-scope patent-text">US20020142359
        <ul class="style-scope patent-text"> <li id="ul0020-0001" num="0635" class="style-scope patent-text">for example an antibody having complementarity determining regions (CDRs) with the following sequences: heavy chain; CDR1-DNYMH, CDR2-WIDPENGDTE YAPKFRG, CDR3-LIYAGYLAMD Y; and light chain CDR1- SASSSVTYMH, CDR2-STSNLAS, CDR3-QQRSTYPLT.</li> <li id="ul0020-0002" num="0636" class="style-scope patent-text">Hybridoma 806.077 deposited as European Collection of Cell Cultures (ECACC) deposit no. 96022936.</li> </ul>
        </li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0637]" class="style-scope patent-text">
    
    [0637]
  </para-num> <div id="p-0618" num="0637" class="description-line style-scope patent-text">Research Corporation Technologies, Inc.:U.S. Pat. No. 5,047,507</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0638]" class="style-scope patent-text">
    
    [0638]
  </para-num> <div id="p-0619" num="0638" class="description-line style-scope patent-text">Bayer Corporation: U.S. Pat. No. 6,013,772</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0639]" class="style-scope patent-text">
    
    [0639]
  </para-num> <div id="p-0620" num="0639" class="description-line style-scope patent-text">BioAlliance: U.S. Pat. No. 7,982,017; U.S. Pat. No. 7,674,605
</div> </li> <ul class="style-scope patent-text"> <li id="ul0021-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0022-0001" num="0640" class="style-scope patent-text">U.S. Pat. No. 7,674,605
        <ul class="style-scope patent-text"> <li id="ul0023-0001" num="0641" class="style-scope patent-text">an antibody comprising the heavy chain variable region sequence from the amino acid sequence of SEQ ID NO: 1, and the light chain variable region sequence from the amino acid sequence of SEQ ID NO:2.</li> <li id="ul0023-0002" num="0642" class="style-scope patent-text">an antibody comprising the heavy chain variable region sequence from the amino acid sequence of SEQ ID NO:5, and the light chain variable region sequence from the amino acid sequence of SEQ ID NO:6.</li> </ul>
        </li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0643]" class="style-scope patent-text">
    
    [0643]
  </para-num> <div id="p-0621" num="0643" class="description-line style-scope patent-text">Celltech Therapeutics Limited: U.S. Pat. No. 5,877,293</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0644]" class="style-scope patent-text">
    
    [0644]
  </para-num> <div id="p-0622" num="0644" class="description-line style-scope patent-text">The Dow Chemical Company: U.S. Pat. No. 5,472,693; U.S. Pat. No. 6,417,337; U.S. Pat. No. 6,333,405
</div> </li> <ul class="style-scope patent-text"> <li id="ul0024-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0025-0001" num="0645" class="style-scope patent-text">U.S. Pat. No. 5,472,693—for example, ATCC No. CRL-11215</li> <li id="ul0025-0002" num="0646" class="style-scope patent-text">U.S. Pat. No. 6,417,337—for example, ATCC CRL-12208</li> <li id="ul0025-0003" num="0647" class="style-scope patent-text">U.S. Pat. No. 6,333,405—for example, ATCC CRL-12208</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0648]" class="style-scope patent-text">
    
    [0648]
  </para-num> <div id="p-0623" num="0648" class="description-line style-scope patent-text">Immunomedics, Inc: U.S. Pat. No. 7,534,431; U.S. Pat. No. 7,230,084; U.S. Pat. No. 7,300,644; U.S. Pat. No. 6,730,300;
</div> </li> <ul class="style-scope patent-text"> <li id="ul0026-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0027-0001" num="0649" class="style-scope patent-text">U.S. Pat. No. 20110189085
        <ul class="style-scope patent-text"> <li id="ul0028-0001" num="0650" class="style-scope patent-text">an antibody having CDRs of the light chain variable region comprise: CDR1 comprises KASQDVGTSVA (SEQ ID NO: 20); CDR2 comprises WTSTRHT (SEQ ID NO: 21); and CDR3 comprises QQYSLYRS (SEQ ID NO: 22); and the CDRs of the heavy chain variable region of said anti-CEA antibody comprise: CDR1 comprises TYWMS (SEQ ID NO: 23); CDR2 comprises EIHPDSSTINYAPSLKD (SEQ ID NO: 24); and CDR3 comprises LYFGFPWFAY (SEQ ID NO: 25).</li> </ul>
        </li> <li id="ul0027-0002" num="0651" class="style-scope patent-text">US20100221175; US20090092598; US20070202044; US20110064653;</li> <li id="ul0027-0003" num="0652" class="style-scope patent-text">US20090185974; US20080069775.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0653]" class="style-scope patent-text">
    
    [0653]
  </para-num> <div id="p-0624" num="0653" class="description-line style-scope patent-text">(42) MET (met proto-oncogene; hepatocyte growth factor receptor)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0654]" class="style-scope patent-text">
    
    [0654]
  </para-num> <div id="p-0625" num="0654" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0655]" class="style-scope patent-text">
    
    [0655]
  </para-num> <div id="p-0626" num="0655" class="description-line style-scope patent-text">Genbank accession no M35073</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0656]" class="style-scope patent-text">
    
    [0656]
  </para-num> <div id="p-0627" num="0656" class="description-line style-scope patent-text">Genbank version no. M35073.1 GI:187553</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0657]" class="style-scope patent-text">
    
    [0657]
  </para-num> <div id="p-0628" num="0657" class="description-line style-scope patent-text">Genbank record update date: Mar. 6, 2012 11:12 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0658]" class="style-scope patent-text">
    
    [0658]
  </para-num> <div id="p-0629" num="0658" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0659]" class="style-scope patent-text">
    
    [0659]
  </para-num> <div id="p-0630" num="0659" class="description-line style-scope patent-text">Genbank accession no. AAA59589</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0660]" class="style-scope patent-text">
    
    [0660]
  </para-num> <div id="p-0631" num="0660" class="description-line style-scope patent-text">Genbank version no. AAA59589.1 GI:553531</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0661]" class="style-scope patent-text">
    
    [0661]
  </para-num> <div id="p-0632" num="0661" class="description-line style-scope patent-text">Genbank record update date: Mar. 6, 2012 11:12 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0662]" class="style-scope patent-text">
    
    [0662]
  </para-num> <div id="p-0633" num="0662" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0663]" class="style-scope patent-text">
    
    [0663]
  </para-num> <div id="p-0634" num="0663" class="description-line style-scope patent-text">Dean M., et al <i class="style-scope patent-text">Nature </i>318 (6044), 385-388 (1985)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0664]" class="style-scope patent-text">
    
    [0664]
  </para-num> <div id="p-0635" num="0664" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0665]" class="style-scope patent-text">
    
    [0665]
  </para-num> <div id="p-0636" num="0665" class="description-line style-scope patent-text">Official Symbol: MET</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0666]" class="style-scope patent-text">
    
    [0666]
  </para-num> <div id="p-0637" num="0666" class="description-line style-scope patent-text">Other Aliases: AUTS9, HGFR, RCCP2, c-Met</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0667]" class="style-scope patent-text">
    
    [0667]
  </para-num> <div id="p-0638" num="0667" class="description-line style-scope patent-text">Other Designations: HGF receptor; HGF/SF receptor; SF receptor; hepatocyte growth factor receptor; met proto-oncogene tyrosine kinase; proto-oncogene c-Met; scatter factor receptor; tyrosine-protein kinase Met</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0668]" class="style-scope patent-text">
    
    [0668]
  </para-num> <div id="p-0639" num="0668" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0669]" class="style-scope patent-text">
    
    [0669]
  </para-num> <div id="p-0640" num="0669" class="description-line style-scope patent-text">Abgenix/Pfizer: US20100040629
</div> </li> <ul class="style-scope patent-text"> <li id="ul0029-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0030-0001" num="0670" class="style-scope patent-text">for example, the antibody produced by hybridoma 13.3.2 having American Type Culture Collection (ATCC) accession number PTA-5026; the antibody produced by hybridoma 9.1.2 having ATCC accession number PTA-5027; the antibody produced by hybridoma 8.70.2 having ATCC accession number PTA-5028; or the antibody produced by hybridoma 6.90.3 having ATCC accession number PTA-5029.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0671]" class="style-scope patent-text">
    
    [0671]
  </para-num> <div id="p-0641" num="0671" class="description-line style-scope patent-text">Amgen/Pfizer: US20050054019
</div> </li> <ul class="style-scope patent-text"> <li id="ul0031-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0032-0001" num="0672" class="style-scope patent-text">for example, an antibody comprising a heavy chain having the amino acid sequences set forth in SEQ ID NO: 2 where X2 is glutamate and X4 is serine and a light chain having the amino acid sequence set forth in SEQ ID NO: 4 where X8 is alanine, without the signal sequences; an antibody comprising a heavy chain having the amino acid sequences set forth in SEQ ID NO: 6 and a light chain having the amino acid sequence set forth in SEQ ID NO: 8, without the signal sequences; an antibody comprising a heavy chain having the amino acid sequences set forth in SEQ ID NO: 10 and a light chain having the amino acid sequence set forth in SEQ ID NO: 12, without the signal sequences; or an antibody comprising a heavy chain having the amino acid sequences set forth in SEQ ID NO: 14 and a light chain having the amino acid sequence set forth in SEQ ID NO: 16, without the signal sequences.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0673]" class="style-scope patent-text">
    
    [0673]
  </para-num> <div id="p-0642" num="0673" class="description-line style-scope patent-text">Agouron Pharmaceuticals (Now Pfizer): US20060035907</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0674]" class="style-scope patent-text">
    
    [0674]
  </para-num> <div id="p-0643" num="0674" class="description-line style-scope patent-text">Eli Lilly: US20100129369</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0675]" class="style-scope patent-text">
    
    [0675]
  </para-num> <div id="p-0644" num="0675" class="description-line style-scope patent-text">Genentech: U.S. Pat. No. 5,686,292; US20100028337; US20100016241; US20070129301; US20070098707; US20070092520, US20060270594; US20060134104; US20060035278; US20050233960; US20050037431
</div> </li> <ul class="style-scope patent-text"> <li id="ul0033-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0034-0001" num="0676" class="style-scope patent-text">U.S. Pat. No. 5,686,292—for example, ATCC HB-11894 and ATCC HB-11895</li> <li id="ul0034-0002" num="0677" class="style-scope patent-text">US 20100016241—for example, ATCC HB-11894 (hybridoma 1A3.3.13) or HB-11895 (hybridoma 5D5.11.6)</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0678]" class="style-scope patent-text">
    
    [0678]
  </para-num> <div id="p-0645" num="0678" class="description-line style-scope patent-text">National Defense Medical Center, Taiwan: Lu RM., et al Biomaterials. 2011 Apr; 32(12):3265-74.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0679]" class="style-scope patent-text">
    
    [0679]
  </para-num> <div id="p-0646" num="0679" class="description-line style-scope patent-text">Novartis: US20090175860
</div> </li> <ul class="style-scope patent-text"> <li id="ul0035-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0036-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0037-0001" num="0680" class="style-scope patent-text">for example, an antibody comprising the sequences of CDR1, CDR2 and CDR3 of heavy chain 4687, wherein the sequences of CDR1, CDR2, and CDR3 of heavy chain 4687 are residues 26-35, 50-65, and 98-102, respectively, of SEQ ID NO: 58; and the sequences of CDR1, CDR2, and CDR3 of light chain 5097, wherein the sequences of CDR1, CDR2, and CDR3 oflight chain 5097 are residues 24-39,55-61, and 94-100 of SEQ ID NO: 37.</li> </ul> </li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0681]" class="style-scope patent-text">
    
    [0681]
  </para-num> <div id="p-0647" num="0681" class="description-line style-scope patent-text">Pharmacia Corporation: US20040166544</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0682]" class="style-scope patent-text">
    
    [0682]
  </para-num> <div id="p-0648" num="0682" class="description-line style-scope patent-text">Pierre Fabre: US20110239316, US20110097262, US20100115639</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0683]" class="style-scope patent-text">
    
    [0683]
  </para-num> <div id="p-0649" num="0683" class="description-line style-scope patent-text">Sumsung: US 20110129481—for example a monoclonal antibody produced from a hybridoma cell having accession number KCLRF-BP-00219 or accession number of KCLRF-BP-00223.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0684]" class="style-scope patent-text">
    
    [0684]
  </para-num> <div id="p-0650" num="0684" class="description-line style-scope patent-text">Samsung: US 20110104176—for example an antibody produced by a hybridoma cell having Accession Number: KCLRF-BP-00220.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0685]" class="style-scope patent-text">
    
    [0685]
  </para-num> <div id="p-0651" num="0685" class="description-line style-scope patent-text">University of Turin Medical School: DN-30 Pacchiana G., et al <i class="style-scope patent-text">J Biol Chem. </i>2010 Nov. 12;285(46):36149-57</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0686]" class="style-scope patent-text">
    
    [0686]
  </para-num> <div id="p-0652" num="0686" class="description-line style-scope patent-text">Van Andel Research Institute: Jiao Y., et al <i class="style-scope patent-text">Mol Biotechnol. </i>2005 Sep.; 31(1):41-54.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0687]" class="style-scope patent-text">
    
    [0687]
  </para-num> <div id="p-0653" num="0687" class="description-line style-scope patent-text">(43) MUC1 (Mucin 1, cell surface associated)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0688]" class="style-scope patent-text">
    
    [0688]
  </para-num> <div id="p-0654" num="0688" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0689]" class="style-scope patent-text">
    
    [0689]
  </para-num> <div id="p-0655" num="0689" class="description-line style-scope patent-text">Genbank accession no J05581</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0690]" class="style-scope patent-text">
    
    [0690]
  </para-num> <div id="p-0656" num="0690" class="description-line style-scope patent-text">Genbank version no. J05581.1 GI:188869</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0691]" class="style-scope patent-text">
    
    [0691]
  </para-num> <div id="p-0657" num="0691" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:48 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0692]" class="style-scope patent-text">
    
    [0692]
  </para-num> <div id="p-0658" num="0692" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0693]" class="style-scope patent-text">
    
    [0693]
  </para-num> <div id="p-0659" num="0693" class="description-line style-scope patent-text">Genbank accession no. AAA59876</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0694]" class="style-scope patent-text">
    
    [0694]
  </para-num> <div id="p-0660" num="0694" class="description-line style-scope patent-text">Genbank version no. AAA59876.1 GI:188870</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0695]" class="style-scope patent-text">
    
    [0695]
  </para-num> <div id="p-0661" num="0695" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:48 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0696]" class="style-scope patent-text">
    
    [0696]
  </para-num> <div id="p-0662" num="0696" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0697]" class="style-scope patent-text">
    
    [0697]
  </para-num> <div id="p-0663" num="0697" class="description-line style-scope patent-text">Gendler S. J., et al <i class="style-scope patent-text">J.Biol. Chem. </i>265 (25), 15286-15293 (1990)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0698]" class="style-scope patent-text">
    
    [0698]
  </para-num> <div id="p-0664" num="0698" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0699]" class="style-scope patent-text">
    
    [0699]
  </para-num> <div id="p-0665" num="0699" class="description-line style-scope patent-text">Official Symbol: MUC1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0700]" class="style-scope patent-text">
    
    [0700]
  </para-num> <div id="p-0666" num="0700" class="description-line style-scope patent-text">Other Aliases: RP11-263K19.2, CD227, EMA, H23AG, KL-6, MAM6, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0701]" class="style-scope patent-text">
    
    [0701]
  </para-num> <div id="p-0667" num="0701" class="description-line style-scope patent-text">Other Designations: DF3 antigen; H23 antigen; breast carcinoma-associated antigen DF3; carcinoma-associated mucin; episialin; krebs von den Lungen-6; mucin 1, transmembrane; mucin-1; peanut-reactive urinary mucin; polymorphic epithelial mucin; tumor associated epithelial mucin; tumor-associated epithelial membrane antigen; tumor-associated mucin</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0702]" class="style-scope patent-text">
    
    [0702]
  </para-num> <div id="p-0668" num="0702" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0703]" class="style-scope patent-text">
    
    [0703]
  </para-num> <div id="p-0669" num="0703" class="description-line style-scope patent-text">AltaRex-Quest Pharma Tech: U.S. 6,716,966—for example an Alt-1 antibody produced by the hybridoma ATCC No PTA-975.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0704]" class="style-scope patent-text">
    
    [0704]
  </para-num> <div id="p-0670" num="0704" class="description-line style-scope patent-text">AltaRex-Quest Pharma Tech: U.S. Pat. No. 7,147,850</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0705]" class="style-scope patent-text">
    
    [0705]
  </para-num> <div id="p-0671" num="0705" class="description-line style-scope patent-text">CRT: 5E5 -Sorensen A L., et al Glycobiology vol. 16 no. 2 pp. 96-107, 2006; HMFG2 —Burchell J., et al <i class="style-scope patent-text">Cancer Res., </i>47, 5476-5482 (1987); see WO2015/159076</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0706]" class="style-scope patent-text">
    
    [0706]
  </para-num> <div id="p-0672" num="0706" class="description-line style-scope patent-text">Glycotope GT-MAB: GT-MAB 2.5-GEX (Website: http://www.glycotope.com/pipeline/pankomab-gex)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0707]" class="style-scope patent-text">
    
    [0707]
  </para-num> <div id="p-0673" num="0707" class="description-line style-scope patent-text">Immunogen: U.S. Pat. No. 7,202,346
</div> </li> <ul class="style-scope patent-text"> <li id="ul0038-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0039-0001" num="0708" class="style-scope patent-text">for example, antibody MJ-170: hybridoma cell line MJ-170 ATCC accession no. PTA-5286Monoclonal antibody MJ-171: hybridoma cell line MJ-171 ATCC accession no. PTA-5287; monoclonal antibody MJ-172: hybridoma cell line MJ-172 ATCC accession no. PTA-5288; or monoclonal antibody MJ-173: hybridoma cell line MJ-173 ATCC accession no. PTA-5302</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0709]" class="style-scope patent-text">
    
    [0709]
  </para-num> <div id="p-0674" num="0709" class="description-line style-scope patent-text">Immunomedics: U.S. Pat. No. 6,653,104</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0710]" class="style-scope patent-text">
    
    [0710]
  </para-num> <div id="p-0675" num="0710" class="description-line style-scope patent-text">Ramot Tel Aviv Uni: U.S. Pat. No. 7,897,351</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0711]" class="style-scope patent-text">
    
    [0711]
  </para-num> <div id="p-0676" num="0711" class="description-line style-scope patent-text">Regents Uni. CA: U.S. Pat. No. 7,183,388; US20040005647; US20030077676.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0712]" class="style-scope patent-text">
    
    [0712]
  </para-num> <div id="p-0677" num="0712" class="description-line style-scope patent-text">Roche GlycArt: U.S. Pat. No. 8,021,856</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0713]" class="style-scope patent-text">
    
    [0713]
  </para-num> <div id="p-0678" num="0713" class="description-line style-scope patent-text">Russian National Cancer Research Center: Imuteran-Ivanov P K., et al <i class="style-scope patent-text">Biotechnol J.</i>2007 Jul.; 2(7):863-70</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0714]" class="style-scope patent-text">
    
    [0714]
  </para-num> <div id="p-0679" num="0714" class="description-line style-scope patent-text">Technische Univ Braunschweig: (IIB6, HT186-B7, HT186-D11, HT186-G2, HT200-3A-C1, HT220-M-D1, HT220-M-G8)—Thie H., et al <i class="style-scope patent-text">PLoS One. </i>2011 Jan. 14; 6(1):e15921 (44) CA9 (Carbonic anhydrase IX)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0715]" class="style-scope patent-text">
    
    [0715]
  </para-num> <div id="p-0680" num="0715" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0716]" class="style-scope patent-text">
    
    [0716]
  </para-num> <div id="p-0681" num="0716" class="description-line style-scope patent-text">Genbank accession no. X66839</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0717]" class="style-scope patent-text">
    
    [0717]
  </para-num> <div id="p-0682" num="0717" class="description-line style-scope patent-text">Genbank version no. X66839.1 GI:1000701</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0718]" class="style-scope patent-text">
    
    [0718]
  </para-num> <div id="p-0683" num="0718" class="description-line style-scope patent-text">Genbank record update date: Feb. 2, 2011 10:15 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0719]" class="style-scope patent-text">
    
    [0719]
  </para-num> <div id="p-0684" num="0719" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0720]" class="style-scope patent-text">
    
    [0720]
  </para-num> <div id="p-0685" num="0720" class="description-line style-scope patent-text">Genbank accession no. CAA47315</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0721]" class="style-scope patent-text">
    
    [0721]
  </para-num> <div id="p-0686" num="0721" class="description-line style-scope patent-text">Genbank version no. CAA47315.1 GI:1000702</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0722]" class="style-scope patent-text">
    
    [0722]
  </para-num> <div id="p-0687" num="0722" class="description-line style-scope patent-text">Genbank record update date: Feb. 2, 2011 10:15 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0723]" class="style-scope patent-text">
    
    [0723]
  </para-num> <div id="p-0688" num="0723" class="description-line style-scope patent-text">Cross References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0724]" class="style-scope patent-text">
    
    [0724]
  </para-num> <div id="p-0689" num="0724" class="description-line style-scope patent-text">Pastorek J., et al <i class="style-scope patent-text">Oncogene </i>9 (10), 2877-2888 (1994)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0725]" class="style-scope patent-text">
    
    [0725]
  </para-num> <div id="p-0690" num="0725" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0726]" class="style-scope patent-text">
    
    [0726]
  </para-num> <div id="p-0691" num="0726" class="description-line style-scope patent-text">Official Symbol: CA9</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0727]" class="style-scope patent-text">
    
    [0727]
  </para-num> <div id="p-0692" num="0727" class="description-line style-scope patent-text">Other Aliases: CAIX, MN</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0728]" class="style-scope patent-text">
    
    [0728]
  </para-num> <div id="p-0693" num="0728" class="description-line style-scope patent-text">Other Designations: CA-IX; P54/58N; RCC-associated antigen G250; RCC-associated protein G250; carbonate dehydratase IX; <figure-callout id="9" label="carbonic anhydrase" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">carbonic anhydrase</a></figure-callout> 9; carbonic dehydratase; membrane antigen MN; pMW1; renal cell carcinoma-associated antigen G250</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0729]" class="style-scope patent-text">
    
    [0729]
  </para-num> <div id="p-0694" num="0729" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0730]" class="style-scope patent-text">
    
    [0730]
  </para-num> <div id="p-0695" num="0730" class="description-line style-scope patent-text">Abgenix/Amgen: US20040018198</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0731]" class="style-scope patent-text">
    
    [0731]
  </para-num> <div id="p-0696" num="0731" class="description-line style-scope patent-text">Affibody: Anti-CAIX Affibody molecules
</div> </li> <ul class="style-scope patent-text"> <li id="ul0040-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0041-0001" num="0732" class="style-scope patent-text">(http://www.affibody.com/en/Product-Portfolio/Pipeline/)</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0733]" class="style-scope patent-text">
    
    [0733]
  </para-num> <div id="p-0697" num="0733" class="description-line style-scope patent-text">Bayer: U.S. Pat. No. 7,462,696</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0734]" class="style-scope patent-text">
    
    [0734]
  </para-num> <div id="p-0698" num="0734" class="description-line style-scope patent-text">Bayer/Morphosys: 3ee9 mAb - Petrul H M., et al <i class="style-scope patent-text">Mol Cancer Ther. </i>2012 Feb.; 11(2):340-9</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0735]" class="style-scope patent-text">
    
    [0735]
  </para-num> <div id="p-0699" num="0735" class="description-line style-scope patent-text">Harvard Medical School: Antibodies G10, G36, G37, G39, G45, G57, G106, G119, G6, G27, G40 and G125. Xu C., et al PLoS One. 2010 Mar. 10; 5(3):e9625</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0736]" class="style-scope patent-text">
    
    [0736]
  </para-num> <div id="p-0700" num="0736" class="description-line style-scope patent-text">Institute of Virology, Slovak Academy of Sciences (Bayer)—U.S. Pat. No. 5,955,075
</div> </li> <ul class="style-scope patent-text"> <li id="ul0042-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0043-0001" num="0737" class="style-scope patent-text">for example, M75- ATCC Accession No. HB 11128 or MN12-ATCC Accession No. HB 11647</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0738]" class="style-scope patent-text">
    
    [0738]
  </para-num> <div id="p-0701" num="0738" class="description-line style-scope patent-text">Institute of Virology, Slovak Academy of Sciences: U.S. Pat. No. 7,816,493
</div> </li> <ul class="style-scope patent-text"> <li id="ul0044-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0045-0001" num="0739" class="style-scope patent-text">for example the M75 monoclonal antibody that is secreted from the hybridoma VU-M75, which was deposited at the American Type Culture Collection under ATCC No. HB 11128; or the V/10 monoclonal antibody secreted from the hybridoma V/10-VU, which was deposited at the International Depository Authority of the Belgian Coordinated Collection of Microorganisms (BCCM) at the Laboratorium voor Moleculaire Bioloqie-Plasmidencollectie (LMBP) at the Universeit Gent in Gent, Belgium, under Accession No. LMBP 6009CB.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0740]" class="style-scope patent-text">
    
    [0740]
  </para-num> <div id="p-0702" num="0740" class="description-line style-scope patent-text">Institute of Virology, Slovak Academy of Sciences US20080177046; US20080176310; US20080176258; US20050031623</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0741]" class="style-scope patent-text">
    
    [0741]
  </para-num> <div id="p-0703" num="0741" class="description-line style-scope patent-text">Novartis: US20090252738</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0742]" class="style-scope patent-text">
    
    [0742]
  </para-num> <div id="p-0704" num="0742" class="description-line style-scope patent-text">Wilex: U.S. Pat. No. 7,691,375-for example the antibody produced by the hybridoma cell line DSM ASC 2526.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0743]" class="style-scope patent-text">
    
    [0743]
  </para-num> <div id="p-0705" num="0743" class="description-line style-scope patent-text">Wilex: US20110123537; Rencarex: Kennett R H., et al <i class="style-scope patent-text">Curr Opin Mol Ther</i>. 2003 Feb; 5(1):70-5</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0744]" class="style-scope patent-text">
    
    [0744]
  </para-num> <div id="p-0706" num="0744" class="description-line style-scope patent-text">Xencor: US20090162382</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0745]" class="style-scope patent-text">
    
    [0745]
  </para-num> <div id="p-0707" num="0745" class="description-line style-scope patent-text">(45) EGFRvIII (Epidermal growth factor receptor (EGFR), <figure-callout id="3" label="transcript variant" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">transcript variant</a></figure-callout> 3, Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0746]" class="style-scope patent-text">
    
    [0746]
  </para-num> <div id="p-0708" num="0746" class="description-line style-scope patent-text">Genbank accession no. NM_201283</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0747]" class="style-scope patent-text">
    
    [0747]
  </para-num> <div id="p-0709" num="0747" class="description-line style-scope patent-text">Genbank version no. NM_201283.1 GI:41327733</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0748]" class="style-scope patent-text">
    
    [0748]
  </para-num> <div id="p-0710" num="0748" class="description-line style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:47 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0749]" class="style-scope patent-text">
    
    [0749]
  </para-num> <div id="p-0711" num="0749" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0750]" class="style-scope patent-text">
    
    [0750]
  </para-num> <div id="p-0712" num="0750" class="description-line style-scope patent-text">Genbank accession no. NP_958440</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0751]" class="style-scope patent-text">
    
    [0751]
  </para-num> <div id="p-0713" num="0751" class="description-line style-scope patent-text">Genbank version no. NP_958440.1 GI:41327734</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0752]" class="style-scope patent-text">
    
    [0752]
  </para-num> <div id="p-0714" num="0752" class="description-line style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:47 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0753]" class="style-scope patent-text">
    
    [0753]
  </para-num> <div id="p-0715" num="0753" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0754]" class="style-scope patent-text">
    
    [0754]
  </para-num> <div id="p-0716" num="0754" class="description-line style-scope patent-text">Batra S K., et al <i class="style-scope patent-text">Cell Growth Differ </i>1995;6:1251-1259.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0755]" class="style-scope patent-text">
    
    [0755]
  </para-num> <div id="p-0717" num="0755" class="description-line style-scope patent-text">ANTIBODIES:</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0756]" class="style-scope patent-text">
    
    [0756]
  </para-num> <div id="p-0718" num="0756" class="description-line style-scope patent-text">U.S. Pat. No. 7,628,986 and U.S. Pat. No. 7,736,644 (Amgen)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0757]" class="style-scope patent-text">
    
    [0757]
  </para-num> <div id="p-0719" num="0757" class="description-line style-scope patent-text">For example, a heavy chain variable region amino acid sequence selected from the group consisting of SEQ ID NO: 142 and variants &amp; a light chain variable region amino acid sequence selected from the group consisting of: SEQ ID NO: 144 and variants.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0758]" class="style-scope patent-text">
    
    [0758]
  </para-num> <div id="p-0720" num="0758" class="description-line style-scope patent-text">US20100111979 (Amgen)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0759]" class="style-scope patent-text">
    
    [0759]
  </para-num> <div id="p-0721" num="0759" class="description-line style-scope patent-text">For example, an antibody comprising a heavy chain amino acid sequence comprising:
</div> </li> <ul class="style-scope patent-text"> <li id="ul0046-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0047-0001" num="0760" class="style-scope patent-text">CDR1 consisting of a sequence selected from the group consisting of the amino acid sequences for the CDR1 region of antibodies 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17); CDR2 consisting of a sequence selected from the group consisting of the amino acid sequences for the CDR2 region of antibodies 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17); and</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0761]" class="style-scope patent-text">
    
    [0761]
  </para-num> <div id="p-0722" num="0761" class="description-line style-scope patent-text">CDR3 consisting of a sequence selected from the group consisting of the amino acid sequences for the CDR3 region of antibodies 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0762]" class="style-scope patent-text">
    
    [0762]
  </para-num> <div id="p-0723" num="0762" class="description-line style-scope patent-text">US20090240038 (Amgen)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0048-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0049-0001" num="0763" class="style-scope patent-text">For example, an antibody having at least one of the heavy or light chain polypeptides comprises an amino acid sequence that is at least 90% identical to the amino acid sequence selected from the group consisting of: SEQ ID NO: 2, SEQ ID NO: 19, SEQ ID NO: 142, SEQ ID NO: 144, and any combination thereof.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0764]" class="style-scope patent-text">
    
    [0764]
  </para-num> <div id="p-0724" num="0764" class="description-line style-scope patent-text">US20090175887 (Amgen)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0050-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0051-0001" num="0765" class="style-scope patent-text">For example, an antibody having a heavy chain amino acid sequence selected from the group consisting of the heavy chain amino acid sequence of antibody 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095 (SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17).</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0766]" class="style-scope patent-text">
    
    [0766]
  </para-num> <div id="p-0725" num="0766" class="description-line style-scope patent-text">US20090156790 (Amgen)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0052-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0053-0001" num="0767" class="style-scope patent-text">For example, antibody having heavy chain polypeptide and a light chain polypeptide, wherein at least one of the heavy or light chain polypeptides comprises an amino acid sequence that is at least 90% identical to the amino acid sequence selected from the group consisting of: SEQ ID NO: 2, SEQ ID NO: 19, SEQ ID NO: 142, SEQ ID NO: 144, and any combination thereof.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0768]" class="style-scope patent-text">
    
    [0768]
  </para-num> <div id="p-0726" num="0768" class="description-line style-scope patent-text">US20090155282, US20050059087 and US20050053608 (Amgen)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0054-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0055-0001" num="0769" class="style-scope patent-text">For example, an antibody heavy chain amino acid sequence selected from the group consisting of the heavy chain amino acid sequence of antibody 13.1.2 (SEQ ID NO: 138), 131 (SEQ ID NO: 2), 170 (SEQ ID NO: 4), 150 (SEQ ID NO: 5), 095</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0770]" class="style-scope patent-text">
    
    [0770]
  </para-num> <div id="p-0727" num="0770" class="description-line style-scope patent-text">(SEQ ID NO: 7), 250 (SEQ ID NO: 9), 139 (SEQ ID NO: 10), 211 (SEQ ID NO: 12), 124 (SEQ ID NO: 13), 318 (SEQ ID NO: 15), 342 (SEQ ID NO: 16), and 333 (SEQ ID NO: 17).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0771]" class="style-scope patent-text">
    
    [0771]
  </para-num> <div id="p-0728" num="0771" class="description-line style-scope patent-text">MR1-1 (U.S. Pat. No. 7,129,332; Duke)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0056-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0057-0001" num="0772" class="style-scope patent-text">For example, a variant antibody having the sequence of SEQ ID NO.18 with the substitutions S98P-T99Y in the CDR3 VH, and F92W in CDR3 VL.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0773]" class="style-scope patent-text">
    
    [0773]
  </para-num> <div id="p-0729" num="0773" class="description-line style-scope patent-text">L8A4, H10, Y10 (Wikstrand C J., et al <i class="style-scope patent-text">Cancer Res. </i>1995 Jul. 15;55(14):3140-8; Duke)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0774]" class="style-scope patent-text">
    
    [0774]
  </para-num> <div id="p-0730" num="0774" class="description-line style-scope patent-text">US20090311803 (Harvard University)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0058-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0059-0001" num="0775" class="style-scope patent-text">For example, SEQ ID NO:9 for antibody heavy chain variable region, and SEQ ID NO: 3 for light chain variable region amino acid sequences</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0776]" class="style-scope patent-text">
    
    [0776]
  </para-num> <div id="p-0731" num="0776" class="description-line style-scope patent-text">US20070274991 (EMD72000, also known as matuzumab; Harvard University)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0060-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0061-0001" num="0777" class="style-scope patent-text">For example, SEQ ID NOs: 3 &amp; 9 for light chain and heavy chain respectively</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0778]" class="style-scope patent-text">
    
    [0778]
  </para-num> <div id="p-0732" num="0778" class="description-line style-scope patent-text">U.S. Pat. No. 6,129,915 (Schering)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0779]" class="style-scope patent-text">
    
    [0779]
  </para-num> <div id="p-0733" num="0779" class="description-line style-scope patent-text">For example, SEQ. ID NOs: 1, 2, 3, 4, 5 and 6.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0780]" class="style-scope patent-text">
    
    [0780]
  </para-num> <div id="p-0734" num="0780" class="description-line style-scope patent-text">mAb CH12-Wang H., et al <i class="style-scope patent-text">FASEB J.</i>2012 Jan.;26(1):73-80 (Shanghai Cancer Institute).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0781]" class="style-scope patent-text">
    
    [0781]
  </para-num> <div id="p-0735" num="0781" class="description-line style-scope patent-text">RAbDMvIII-Gupta P., et al BMC Biotechnol. 2010 Oct. 7;10:72 (Stanford University Medical Center).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0782]" class="style-scope patent-text">
    
    [0782]
  </para-num> <div id="p-0736" num="0782" class="description-line style-scope patent-text">mAb Ua30-Ohman L., et al Tumour Biol. 2002 Mar.-Apr.; 23(2):61-9 (Uppsala University).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0783]" class="style-scope patent-text">
    
    [0783]
  </para-num> <div id="p-0737" num="0783" class="description-line style-scope patent-text">Han D G., et al Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jan.;30(1):25-9 (Xi'an Jiaotong University).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0784]" class="style-scope patent-text">
    
    [0784]
  </para-num> <div id="p-0738" num="0784" class="description-line style-scope patent-text">(46) CD33 (CD33 molecule)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0785]" class="style-scope patent-text">
    
    [0785]
  </para-num> <div id="p-0739" num="0785" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0786]" class="style-scope patent-text">
    
    [0786]
  </para-num> <div id="p-0740" num="0786" class="description-line style-scope patent-text">Genbank accession no. M_23197</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0787]" class="style-scope patent-text">
    
    [0787]
  </para-num> <div id="p-0741" num="0787" class="description-line style-scope patent-text">Genbank version no. NM__23197.1 GI:180097</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0788]" class="style-scope patent-text">
    
    [0788]
  </para-num> <div id="p-0742" num="0788" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:47 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0789]" class="style-scope patent-text">
    
    [0789]
  </para-num> <div id="p-0743" num="0789" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0790]" class="style-scope patent-text">
    
    [0790]
  </para-num> <div id="p-0744" num="0790" class="description-line style-scope patent-text">Genbank accession no. AAA51948</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0791]" class="style-scope patent-text">
    
    [0791]
  </para-num> <div id="p-0745" num="0791" class="description-line style-scope patent-text">Genbank version no. AAA51948.1 GI:188098</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0792]" class="style-scope patent-text">
    
    [0792]
  </para-num> <div id="p-0746" num="0792" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:47 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0793]" class="style-scope patent-text">
    
    [0793]
  </para-num> <div id="p-0747" num="0793" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0794]" class="style-scope patent-text">
    
    [0794]
  </para-num> <div id="p-0748" num="0794" class="description-line style-scope patent-text">Simmons D., et al <i class="style-scope patent-text">J. Immunol. </i>141 (8), 2797-2800 (1988)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0795]" class="style-scope patent-text">
    
    [0795]
  </para-num> <div id="p-0749" num="0795" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0796]" class="style-scope patent-text">
    
    [0796]
  </para-num> <div id="p-0750" num="0796" class="description-line style-scope patent-text">Official Symbol: CD33</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0797]" class="style-scope patent-text">
    
    [0797]
  </para-num> <div id="p-0751" num="0797" class="description-line style-scope patent-text">Other Aliases: SIGLEC-3, SIGLEC3, p67</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0798]" class="style-scope patent-text">
    
    [0798]
  </para-num> <div id="p-0752" num="0798" class="description-line style-scope patent-text">Other Designations: CD33 antigen (gp67); gp67; myeloid cell surface antigen CD33; sialic acid binding Ig-<figure-callout id="3" label="like lectin" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">like lectin</a></figure-callout> 3; sialic acid-binding Ig-like lectin</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0799]" class="style-scope patent-text">
    
    [0799]
  </para-num> <div id="p-0753" num="0799" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0800]" class="style-scope patent-text">
    
    [0800]
  </para-num> <div id="p-0754" num="0800" class="description-line style-scope patent-text">H195 (Lintuzumab)- Raza A., et al Leuk Lymphoma. 2009 Aug.;50(8):1336-44;</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0801]" class="style-scope patent-text">
    
    [0801]
  </para-num> <div id="p-0755" num="0801" class="description-line style-scope patent-text">U.S. Pat. No. 6,759,045 (Seattle Genetics/Immunomedics)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0802]" class="style-scope patent-text">
    
    [0802]
  </para-num> <div id="p-0756" num="0802" class="description-line style-scope patent-text">mAb OKT9: Sutherland, D. R. et al. <i class="style-scope patent-text">Proc Natl Acad Sci USA </i>78 (7): 4515-4519 1981, Schneider,C., et al <i class="style-scope patent-text">J Biol Chem </i>257, 8516-8522 (1982) mAb E6: Hoogenboom,H. R., et al <i class="style-scope patent-text">J Immunol </i>144, 3211-3217 (1990)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0803]" class="style-scope patent-text">
    
    [0803]
  </para-num> <div id="p-0757" num="0803" class="description-line style-scope patent-text">U.S. 6,590,088 (Human Genome Sciences)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0804]" class="style-scope patent-text">
    
    [0804]
  </para-num> <div id="p-0758" num="0804" class="description-line style-scope patent-text">For example, SEQ ID NOs: 1 and 2 and ATCC accession no. 97521</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0805]" class="style-scope patent-text">
    
    [0805]
  </para-num> <div id="p-0759" num="0805" class="description-line style-scope patent-text">U.S. Pat. No. 7,557,189 (Immunogen)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0806]" class="style-scope patent-text">
    
    [0806]
  </para-num> <div id="p-0760" num="0806" class="description-line style-scope patent-text">For example, an antibody or fragment thereof comprising a heavy chain variable region which comprises three CDRs having the amino acid sequences of SEQ ID NOs:1-3 and a light chain variable region comprising three CDRs having the amino acid sequences of SEQ ID NOs:4-6.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0807]" class="style-scope patent-text">
    
    [0807]
  </para-num> <div id="p-0761" num="0807" class="description-line style-scope patent-text">(47) CD19 (CD19 molecule)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0808]" class="style-scope patent-text">
    
    [0808]
  </para-num> <div id="p-0762" num="0808" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0809]" class="style-scope patent-text">
    
    [0809]
  </para-num> <div id="p-0763" num="0809" class="description-line style-scope patent-text">Genbank accession no. NM_001178098</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0810]" class="style-scope patent-text">
    
    [0810]
  </para-num> <div id="p-0764" num="0810" class="description-line style-scope patent-text">Genbank version no. NM_001178098.1 GI:296010920</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0811]" class="style-scope patent-text">
    
    [0811]
  </para-num> <div id="p-0765" num="0811" class="description-line style-scope patent-text">Genbank record update date: Sep. 10, 2012 12:43 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0812]" class="style-scope patent-text">
    
    [0812]
  </para-num> <div id="p-0766" num="0812" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0813]" class="style-scope patent-text">
    
    [0813]
  </para-num> <div id="p-0767" num="0813" class="description-line style-scope patent-text">Genbank accession no. NP_001171569</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0814]" class="style-scope patent-text">
    
    [0814]
  </para-num> <div id="p-0768" num="0814" class="description-line style-scope patent-text">Genbank version no. NP_001171569.1 GI:296010921</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0815]" class="style-scope patent-text">
    
    [0815]
  </para-num> <div id="p-0769" num="0815" class="description-line style-scope patent-text">Genbank record update date: Sep. 10, 2012 12:43 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0816]" class="style-scope patent-text">
    
    [0816]
  </para-num> <div id="p-0770" num="0816" class="description-line style-scope patent-text">Cross-References Tedder T F., et al <i class="style-scope patent-text">J. Immunol. </i>143 (2): 712-7 (1989)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0817]" class="style-scope patent-text">
    
    [0817]
  </para-num> <div id="p-0771" num="0817" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0818]" class="style-scope patent-text">
    
    [0818]
  </para-num> <div id="p-0772" num="0818" class="description-line style-scope patent-text">Official Symbol: CD19</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0819]" class="style-scope patent-text">
    
    [0819]
  </para-num> <div id="p-0773" num="0819" class="description-line style-scope patent-text">Other Aliases: B4, CVID3</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0820]" class="style-scope patent-text">
    
    [0820]
  </para-num> <div id="p-0774" num="0820" class="description-line style-scope patent-text">Other Designations: B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; T-cell surface antigen Leu-12; differentiation antigen CD19</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0821]" class="style-scope patent-text">
    
    [0821]
  </para-num> <div id="p-0775" num="0821" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0822]" class="style-scope patent-text">
    
    [0822]
  </para-num> <div id="p-0776" num="0822" class="description-line style-scope patent-text">Immunogen: HuB4 - Al-Katib A M., et al <i class="style-scope patent-text">Clin Cancer Res. </i>2009 Jun. 15;15(12):4038-45.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0823]" class="style-scope patent-text">
    
    [0823]
  </para-num> <div id="p-0777" num="0823" class="description-line style-scope patent-text">4G7: Kugler M., et al <i class="style-scope patent-text">Protein Eng Des Sel. </i>2009 Mar.;22(3):135-47</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0824]" class="style-scope patent-text">
    
    [0824]
  </para-num> <div id="p-0778" num="0824" class="description-line style-scope patent-text">For example, sequences in <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 3</figref> of of Knappik, A. et al. <i class="style-scope patent-text">J Mol Biol </i>2000 Feb.; 296(1):57-86</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0825]" class="style-scope patent-text">
    
    [0825]
  </para-num> <div id="p-0779" num="0825" class="description-line style-scope patent-text">AstraZeneca/Medlmmune: MEDI-551-Herbst R., et al <i class="style-scope patent-text">J Pharmacol Exp Ther. </i>2010 Oct.;335(1):213-22</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0826]" class="style-scope patent-text">
    
    [0826]
  </para-num> <div id="p-0780" num="0826" class="description-line style-scope patent-text">Glenmark Pharmaceuticals: GBR-401-Hou S., et al Mol Cancer Ther November 2011 (Meeting Abstract Supplement) C164</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0827]" class="style-scope patent-text">
    
    [0827]
  </para-num> <div id="p-0781" num="0827" class="description-line style-scope patent-text">U.S. Pat. No. 7,109,304 (Immunomedics)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0062-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0063-0001" num="0828" class="style-scope patent-text">For example, an antibody comprising the sequence of hA19Vk (SEQ ID NO:7) and the sequence of hA19VH (SEQ ID NO:10)</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0829]" class="style-scope patent-text">
    
    [0829]
  </para-num> <div id="p-0782" num="0829" class="description-line style-scope patent-text">U.S. Pat. No. 7,902,338 (Immunomedics)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0064-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0065-0001" num="0830" class="style-scope patent-text">For example, an antibody or antigen-binding fragment thereof that comprises the light chain complementarity determining region CDR sequences CDR1 of SEQ ID NO: 16 (KASQSVDYDGDSYLN); CDR2 of SEQ ID NO: 17 (DASNLVS); and CDR3 of SEQ ID NO: 18 (QQSTEDPWT) and the heavy chain CDR sequences CDR1 of SEQ ID NO: 19 (SYWMN); CDR2 of SEQ ID NO: 20 (QIWPGDGDTNYNGKFKG) and CDR3 of SEQ ID NO: 21 (RETTTVGRYYYAMDY) and also comprises human antibody framework (FR) and constant region sequences with one or more framework region amino acid residues substituted from the corresponding framework region sequences of the parent murine antibody, and wherein said substituted FR residues comprise the substitution of serine for phenylalanine at Kabat residue 91 of the heavy chain variable region.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0831]" class="style-scope patent-text">
    
    [0831]
  </para-num> <div id="p-0783" num="0831" class="description-line style-scope patent-text">Medarex: MDX-1342 —Cardarelli P M., et al <i class="style-scope patent-text">Cancer Immunol Immunother. </i>2010 Feb.; 59(2):257-65.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0832]" class="style-scope patent-text">
    
    [0832]
  </para-num> <div id="p-0784" num="0832" class="description-line style-scope patent-text">MorphoSys/Xencor: MOR-208/XmAb-5574-Zalevsky J., et al <i class="style-scope patent-text">Blood. </i>2009 Apr. 16; 113(16):3735-43</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0833]" class="style-scope patent-text">
    
    [0833]
  </para-num> <div id="p-0785" num="0833" class="description-line style-scope patent-text">U.S. Pat. No. 7,968,687 (Seattle Genetics)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0834]" class="style-scope patent-text">
    
    [0834]
  </para-num> <div id="p-0786" num="0834" class="description-line style-scope patent-text">An antibody or antigen-binding fragment comprising a heavy chain variable domain comprising the amino acid sequence of SEQ ID NO:9 and a light chain variable domain comprising the amino acid sequence of SEQ ID NO: 24.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0835]" class="style-scope patent-text">
    
    [0835]
  </para-num> <div id="p-0787" num="0835" class="description-line style-scope patent-text">4G7chim-Lang P., et al Blood. 2004 May 15; 103(10):3982-5 (University of Tubingen)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0066-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0067-0001" num="0836" class="style-scope patent-text">For example, <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 6</figref> and SEQ ID No: 80 of US20120082664</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0837]" class="style-scope patent-text">
    
    [0837]
  </para-num> <div id="p-0788" num="0837" class="description-line style-scope patent-text">Zhejiang University School of Medicine: 2E8- Zhang J., et al J Drug Target. 2010</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0838]" class="style-scope patent-text">
    
    [0838]
  </para-num> <div id="p-0789" num="0838" class="description-line style-scope patent-text">Nov.; 18(9):675-8</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0839]" class="style-scope patent-text">
    
    [0839]
  </para-num> <div id="p-0790" num="0839" class="description-line style-scope patent-text">(48) IL2RA (Interleukin 2 receptor, alpha); NCBI Reference Sequence: NM_000417.2);</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0840]" class="style-scope patent-text">
    
    [0840]
  </para-num> <div id="p-0791" num="0840" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0841]" class="style-scope patent-text">
    
    [0841]
  </para-num> <div id="p-0792" num="0841" class="description-line style-scope patent-text">Genbank accession no. NM_000417</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0842]" class="style-scope patent-text">
    
    [0842]
  </para-num> <div id="p-0793" num="0842" class="description-line style-scope patent-text">Genbank version no. NM_000417.2 GI:269973860</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0843]" class="style-scope patent-text">
    
    [0843]
  </para-num> <div id="p-0794" num="0843" class="description-line style-scope patent-text">Genbank record update date: Sep. 09, 2012 04:59 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0844]" class="style-scope patent-text">
    
    [0844]
  </para-num> <div id="p-0795" num="0844" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0845]" class="style-scope patent-text">
    
    [0845]
  </para-num> <div id="p-0796" num="0845" class="description-line style-scope patent-text">Genbank accession no. NP_000408</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0846]" class="style-scope patent-text">
    
    [0846]
  </para-num> <div id="p-0797" num="0846" class="description-line style-scope patent-text">Genbank version no. NP_000408.1 GI:4557667</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0847]" class="style-scope patent-text">
    
    [0847]
  </para-num> <div id="p-0798" num="0847" class="description-line style-scope patent-text">Genbank record update date: Sep. 09, 2012 04:59 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0848]" class="style-scope patent-text">
    
    [0848]
  </para-num> <div id="p-0799" num="0848" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0849]" class="style-scope patent-text">
    
    [0849]
  </para-num> <div id="p-0800" num="0849" class="description-line style-scope patent-text">Kuziel W. A., et al <i class="style-scope patent-text">J. Invest. Dermatol. </i>94 (6 SUPPL), 27S-32S (1990)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0850]" class="style-scope patent-text">
    
    [0850]
  </para-num> <div id="p-0801" num="0850" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0851]" class="style-scope patent-text">
    
    [0851]
  </para-num> <div id="p-0802" num="0851" class="description-line style-scope patent-text">Official Symbol: IL2RA</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0852]" class="style-scope patent-text">
    
    [0852]
  </para-num> <div id="p-0803" num="0852" class="description-line style-scope patent-text">Other Aliases: RP11-536K7.1, CD25, IDDM10, IL2R, TCGFR</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0853]" class="style-scope patent-text">
    
    [0853]
  </para-num> <div id="p-0804" num="0853" class="description-line style-scope patent-text">Other Designations: FIL-2 receptor subunit alpha; IL-2-RA; IL-2R subunit alpha; IL2-RA;</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0854]" class="style-scope patent-text">
    
    [0854]
  </para-num> <div id="p-0805" num="0854" class="description-line style-scope patent-text">TAC antigen; interleukin-2 receptor subunit alpha; p55</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0855]" class="style-scope patent-text">
    
    [0855]
  </para-num> <div id="p-0806" num="0855" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0856]" class="style-scope patent-text">
    
    [0856]
  </para-num> <div id="p-0807" num="0856" class="description-line style-scope patent-text">U.S. Pat. No.6,383,487 (Novartis/UCL: Baxilisimab [Simulect])</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0857]" class="style-scope patent-text">
    
    [0857]
  </para-num> <div id="p-0808" num="0857" class="description-line style-scope patent-text">U.S. Pat. No.6,521,230 (Novartis/UCL: Baxilisimab [Simulect])
</div> </li> <ul class="style-scope patent-text"> <li id="ul0068-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0069-0001" num="0858" class="style-scope patent-text">For example, an antibody having an antigen binding site comprises at least one domain which comprises CDR1 having the amino acid sequence in SEQ. ID. NO: 7, CDR2 having the amino acid sequence in SEQ. ID. NO: 8, and CDR3 chaving the amino acid sequence in SEQ. ID. NO: 9; or said CDR1, CDR2 and CDR3 taken in sequence as a whole comprise an amino acid sequence which is at least 90% identical to SEQ. ID. NOs: 7, 8 and 9 taken in sequence as a whole.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0859]" class="style-scope patent-text">
    
    [0859]
  </para-num> <div id="p-0809" num="0859" class="description-line style-scope patent-text">Daclizumab-Rech A J., et al <i class="style-scope patent-text">Ann N Y Acad Sci. </i>2009 Sep.; 1174:99-106 (Roche)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0860]" class="style-scope patent-text">
    
    [0860]
  </para-num> <div id="p-0810" num="0860" class="description-line style-scope patent-text">(49) AXL (AXL receptor tyrosine kinase)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0861]" class="style-scope patent-text">
    
    [0861]
  </para-num> <div id="p-0811" num="0861" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0862]" class="style-scope patent-text">
    
    [0862]
  </para-num> <div id="p-0812" num="0862" class="description-line style-scope patent-text">Genbank accession no. M76125</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0863]" class="style-scope patent-text">
    
    [0863]
  </para-num> <div id="p-0813" num="0863" class="description-line style-scope patent-text">Genbank version no. M76125.1 GI:292869</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0864]" class="style-scope patent-text">
    
    [0864]
  </para-num> <div id="p-0814" num="0864" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:53 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0865]" class="style-scope patent-text">
    
    [0865]
  </para-num> <div id="p-0815" num="0865" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0866]" class="style-scope patent-text">
    
    [0866]
  </para-num> <div id="p-0816" num="0866" class="description-line style-scope patent-text">Genbank accession no. AAA61243</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0867]" class="style-scope patent-text">
    
    [0867]
  </para-num> <div id="p-0817" num="0867" class="description-line style-scope patent-text">Genbank version no. AAA61243.1 GI:29870</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0868]" class="style-scope patent-text">
    
    [0868]
  </para-num> <div id="p-0818" num="0868" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:53 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0869]" class="style-scope patent-text">
    
    [0869]
  </para-num> <div id="p-0819" num="0869" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0870]" class="style-scope patent-text">
    
    [0870]
  </para-num> <div id="p-0820" num="0870" class="description-line style-scope patent-text">O'Bryan J. P., et al <i class="style-scope patent-text">Mol. Cell. Biol. </i>11 (10), 5016-5031 (1991); Bergsagel P. L., et al <i class="style-scope patent-text">J. Immunol. </i>148 (2), 590-596 (1992)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0871]" class="style-scope patent-text">
    
    [0871]
  </para-num> <div id="p-0821" num="0871" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0872]" class="style-scope patent-text">
    
    [0872]
  </para-num> <div id="p-0822" num="0872" class="description-line style-scope patent-text">Official Symbol: AXL</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0873]" class="style-scope patent-text">
    
    [0873]
  </para-num> <div id="p-0823" num="0873" class="description-line style-scope patent-text">Other Aliases: JTK11, UFO</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0874]" class="style-scope patent-text">
    
    [0874]
  </para-num> <div id="p-0824" num="0874" class="description-line style-scope patent-text">Other Designations: AXL oncogene; AXL transforming sequence/gene; oncogene AXL; tyrosine-protein kinase receptor UFO</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0875]" class="style-scope patent-text">
    
    [0875]
  </para-num> <div id="p-0825" num="0875" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0876]" class="style-scope patent-text">
    
    [0876]
  </para-num> <div id="p-0826" num="0876" class="description-line style-scope patent-text">YW327.6S2 - Ye X., et al <i class="style-scope patent-text">Oncogene. </i>2010 Sep. 23; 29(38):5254-64. (Genentech)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0877]" class="style-scope patent-text">
    
    [0877]
  </para-num> <div id="p-0827" num="0877" class="description-line style-scope patent-text">BergenBio: BGB324 (http://www.bergenbio.com/BGB324)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0878]" class="style-scope patent-text">
    
    [0878]
  </para-num> <div id="p-0828" num="0878" class="description-line style-scope patent-text">(50) CD30-TNFRSF8 (Tumor necrosis factor receptor superfamily, member 8)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0879]" class="style-scope patent-text">
    
    [0879]
  </para-num> <div id="p-0829" num="0879" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0880]" class="style-scope patent-text">
    
    [0880]
  </para-num> <div id="p-0830" num="0880" class="description-line style-scope patent-text">Genbank accession no. M83554</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0881]" class="style-scope patent-text">
    
    [0881]
  </para-num> <div id="p-0831" num="0881" class="description-line style-scope patent-text">Genbank version no. M83554.1 GI:180095</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0882]" class="style-scope patent-text">
    
    [0882]
  </para-num> <div id="p-0832" num="0882" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:53 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0883]" class="style-scope patent-text">
    
    [0883]
  </para-num> <div id="p-0833" num="0883" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0884]" class="style-scope patent-text">
    
    [0884]
  </para-num> <div id="p-0834" num="0884" class="description-line style-scope patent-text">Genbank accession no. AAA51947</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0885]" class="style-scope patent-text">
    
    [0885]
  </para-num> <div id="p-0835" num="0885" class="description-line style-scope patent-text">Genbank version no. AAA51947.1 GI:180096</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0886]" class="style-scope patent-text">
    
    [0886]
  </para-num> <div id="p-0836" num="0886" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:53 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0887]" class="style-scope patent-text">
    
    [0887]
  </para-num> <div id="p-0837" num="0887" class="description-line style-scope patent-text">Cross-References Durkop H., et al Cell 68 (3), 421-427 (1992)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0888]" class="style-scope patent-text">
    
    [0888]
  </para-num> <div id="p-0838" num="0888" class="description-line style-scope patent-text">Other information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0889]" class="style-scope patent-text">
    
    [0889]
  </para-num> <div id="p-0839" num="0889" class="description-line style-scope patent-text">Official Symbol: TNFRSF8</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0890]" class="style-scope patent-text">
    
    [0890]
  </para-num> <div id="p-0840" num="0890" class="description-line style-scope patent-text">Other Aliases: CD30, D1S166E, Ki-1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0891]" class="style-scope patent-text">
    
    [0891]
  </para-num> <div id="p-0841" num="0891" class="description-line style-scope patent-text">Other Designations: CD3OL receptor; Ki-1 antigen; cytokine receptor CD30; lymphocyte activation antigen CD30; tumor necrosis factor receptor superfamily member 8 (51) BCMA (B-cell maturation antigen)-TNFRSF17 (Tumor necrosis factor receptor superfamily, member 17)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0892]" class="style-scope patent-text">
    
    [0892]
  </para-num> <div id="p-0842" num="0892" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0893]" class="style-scope patent-text">
    
    [0893]
  </para-num> <div id="p-0843" num="0893" class="description-line style-scope patent-text">Genbank accession no. Z29574</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0894]" class="style-scope patent-text">
    
    [0894]
  </para-num> <div id="p-0844" num="0894" class="description-line style-scope patent-text">Genbank version no. Z29574.1 GI:471244</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0895]" class="style-scope patent-text">
    
    [0895]
  </para-num> <div id="p-0845" num="0895" class="description-line style-scope patent-text">Genbank record update date: Feb. 02, 2011 10:40 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0896]" class="style-scope patent-text">
    
    [0896]
  </para-num> <div id="p-0846" num="0896" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0897]" class="style-scope patent-text">
    
    [0897]
  </para-num> <div id="p-0847" num="0897" class="description-line style-scope patent-text">Genbank accession no. CAA82690</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0898]" class="style-scope patent-text">
    
    [0898]
  </para-num> <div id="p-0848" num="0898" class="description-line style-scope patent-text">Genbank version no. CAA82690.1 GI:471245</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0899]" class="style-scope patent-text">
    
    [0899]
  </para-num> <div id="p-0849" num="0899" class="description-line style-scope patent-text">Genbank record update date: Feb. 02, 2011 10:40 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0900]" class="style-scope patent-text">
    
    [0900]
  </para-num> <div id="p-0850" num="0900" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0901]" class="style-scope patent-text">
    
    [0901]
  </para-num> <div id="p-0851" num="0901" class="description-line style-scope patent-text">Laabi Y., et al Nucleic Acids Res. 22 (7), 1147-1154 (1994)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0902]" class="style-scope patent-text">
    
    [0902]
  </para-num> <div id="p-0852" num="0902" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0903]" class="style-scope patent-text">
    
    [0903]
  </para-num> <div id="p-0853" num="0903" class="description-line style-scope patent-text">Official Symbol: TNFRSF17</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0904]" class="style-scope patent-text">
    
    [0904]
  </para-num> <div id="p-0854" num="0904" class="description-line style-scope patent-text">Other Aliases: BCM, BCMA, CD269</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0905]" class="style-scope patent-text">
    
    [0905]
  </para-num> <div id="p-0855" num="0905" class="description-line style-scope patent-text">Other Designations: B cell maturation antigen; B-cell maturation factor; B-cell maturation protein; tumor necrosis factor receptor superfamily member 17</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0906]" class="style-scope patent-text">
    
    [0906]
  </para-num> <div id="p-0856" num="0906" class="description-line style-scope patent-text">(52) CT Ags-CTA (Cancer Testis Antigens)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0907]" class="style-scope patent-text">
    
    [0907]
  </para-num> <div id="p-0857" num="0907" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0908]" class="style-scope patent-text">
    
    [0908]
  </para-num> <div id="p-0858" num="0908" class="description-line style-scope patent-text">Fratta E., et al. <i class="style-scope patent-text">Mol Oncol. </i>2011 Apr.; 5(2):164-82; Lim S H., at al <i class="style-scope patent-text">Am J Blood Res. </i>2012; 2(1):29-35.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0909]" class="style-scope patent-text">
    
    [0909]
  </para-num> <div id="p-0859" num="0909" class="description-line style-scope patent-text">(53) CD174 (Lewis Y)-FUT3 (fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0910]" class="style-scope patent-text">
    
    [0910]
  </para-num> <div id="p-0860" num="0910" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0911]" class="style-scope patent-text">
    
    [0911]
  </para-num> <div id="p-0861" num="0911" class="description-line style-scope patent-text">Genbank accession no. NM000149</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0912]" class="style-scope patent-text">
    
    [0912]
  </para-num> <div id="p-0862" num="0912" class="description-line style-scope patent-text">Genbank version no. NM000149.3 GI:148277008</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0913]" class="style-scope patent-text">
    
    [0913]
  </para-num> <div id="p-0863" num="0913" class="description-line style-scope patent-text">Genbank record update date: Jun. 26, 2012 04:49 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0914]" class="style-scope patent-text">
    
    [0914]
  </para-num> <div id="p-0864" num="0914" class="description-line style-scope patent-text">Polypeptide Genbank accession no. NP_000140</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0915]" class="style-scope patent-text">
    
    [0915]
  </para-num> <div id="p-0865" num="0915" class="description-line style-scope patent-text">Genbank version no. NP_000140.1 GI:4503809</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0916]" class="style-scope patent-text">
    
    [0916]
  </para-num> <div id="p-0866" num="0916" class="description-line style-scope patent-text">Genbank record update date: Jun. 26, 2012 04:49 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0917]" class="style-scope patent-text">
    
    [0917]
  </para-num> <div id="p-0867" num="0917" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0918]" class="style-scope patent-text">
    
    [0918]
  </para-num> <div id="p-0868" num="0918" class="description-line style-scope patent-text">Kukowska-Latallo, J. F., et al <i class="style-scope patent-text">Genes Dev. </i>4 (8), 1288-1303 (1990)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0919]" class="style-scope patent-text">
    
    [0919]
  </para-num> <div id="p-0869" num="0919" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0920]" class="style-scope patent-text">
    
    [0920]
  </para-num> <div id="p-0870" num="0920" class="description-line style-scope patent-text">Official Symbol: FUT3</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0921]" class="style-scope patent-text">
    
    [0921]
  </para-num> <div id="p-0871" num="0921" class="description-line style-scope patent-text">Other Aliases: CD174, FT3B, FucT-Ill, LE, Les</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0922]" class="style-scope patent-text">
    
    [0922]
  </para-num> <div id="p-0872" num="0922" class="description-line style-scope patent-text">Other Designations: Lewis F T; alpha-(1,3/1,4)-fucosyltransferase; blood group Lewis alpha-4-fucosyltransferase; fucosyltransferase III; galactoside 3(4)-L-fucosyltransferase (54) CLEC14A (C-type lectin domain family 14, member A; Genbank accession no. NM175060)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0923]" class="style-scope patent-text">
    
    [0923]
  </para-num> <div id="p-0873" num="0923" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0924]" class="style-scope patent-text">
    
    [0924]
  </para-num> <div id="p-0874" num="0924" class="description-line style-scope patent-text">Genbank accession no. NM175060</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0925]" class="style-scope patent-text">
    
    [0925]
  </para-num> <div id="p-0875" num="0925" class="description-line style-scope patent-text">Genbank version no. NM175060.2 GI:371123930</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0926]" class="style-scope patent-text">
    
    [0926]
  </para-num> <div id="p-0876" num="0926" class="description-line style-scope patent-text">Genbank record update date: Apr 01, 2012 03:34 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0927]" class="style-scope patent-text">
    
    [0927]
  </para-num> <div id="p-0877" num="0927" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0928]" class="style-scope patent-text">
    
    [0928]
  </para-num> <div id="p-0878" num="0928" class="description-line style-scope patent-text">Genbank accession no. NP_778230</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0929]" class="style-scope patent-text">
    
    [0929]
  </para-num> <div id="p-0879" num="0929" class="description-line style-scope patent-text">Genbank version no. NP_778230.1 GI:28269707</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0930]" class="style-scope patent-text">
    
    [0930]
  </para-num> <div id="p-0880" num="0930" class="description-line style-scope patent-text">Genbank record update date: Apr. 01, 2012 03:34 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0931]" class="style-scope patent-text">
    
    [0931]
  </para-num> <div id="p-0881" num="0931" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0932]" class="style-scope patent-text">
    
    [0932]
  </para-num> <div id="p-0882" num="0932" class="description-line style-scope patent-text">Official Symbol: CLEC14A</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0933]" class="style-scope patent-text">
    
    [0933]
  </para-num> <div id="p-0883" num="0933" class="description-line style-scope patent-text">Other Aliases: UNQ236/PRO269, C14orf27, CEG1, EGFR-5</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0934]" class="style-scope patent-text">
    
    [0934]
  </para-num> <div id="p-0884" num="0934" class="description-line style-scope patent-text">Other Designations: C-type lectin domain family 14 member A; CIECT and EGF-like domain containing protein; epidermal growth factor receptor 5</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0935]" class="style-scope patent-text">
    
    [0935]
  </para-num> <div id="p-0885" num="0935" class="description-line style-scope patent-text">(55) GRP78-HSPAS (heat shock 70 kDa protein 5 (glucose-regulated protein, 78 kDa)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0936]" class="style-scope patent-text">
    
    [0936]
  </para-num> <div id="p-0886" num="0936" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0937]" class="style-scope patent-text">
    
    [0937]
  </para-num> <div id="p-0887" num="0937" class="description-line style-scope patent-text">Genbank accession no. NM005347</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0938]" class="style-scope patent-text">
    
    [0938]
  </para-num> <div id="p-0888" num="0938" class="description-line style-scope patent-text">Genbank version no. NM005347.4 GI:305855105</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0939]" class="style-scope patent-text">
    
    [0939]
  </para-num> <div id="p-0889" num="0939" class="description-line style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:42 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0940]" class="style-scope patent-text">
    
    [0940]
  </para-num> <div id="p-0890" num="0940" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0941]" class="style-scope patent-text">
    
    [0941]
  </para-num> <div id="p-0891" num="0941" class="description-line style-scope patent-text">Genbank accession no. NP_005338</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0942]" class="style-scope patent-text">
    
    [0942]
  </para-num> <div id="p-0892" num="0942" class="description-line style-scope patent-text">Genbank version no. NP_005338.1 GI:16507237</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0943]" class="style-scope patent-text">
    
    [0943]
  </para-num> <div id="p-0893" num="0943" class="description-line style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:42 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0944]" class="style-scope patent-text">
    
    [0944]
  </para-num> <div id="p-0894" num="0944" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0945]" class="style-scope patent-text">
    
    [0945]
  </para-num> <div id="p-0895" num="0945" class="description-line style-scope patent-text">Ting J., et al <i class="style-scope patent-text">DNA </i>7 (4), 275-286 (1988)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0946]" class="style-scope patent-text">
    
    [0946]
  </para-num> <div id="p-0896" num="0946" class="description-line style-scope patent-text">Other Infromation</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0947]" class="style-scope patent-text">
    
    [0947]
  </para-num> <div id="p-0897" num="0947" class="description-line style-scope patent-text">Official Symbol: HSPAS</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0948]" class="style-scope patent-text">
    
    [0948]
  </para-num> <div id="p-0898" num="0948" class="description-line style-scope patent-text">Other Aliases: BIP, GRP78, MIF2</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0949]" class="style-scope patent-text">
    
    [0949]
  </para-num> <div id="p-0899" num="0949" class="description-line style-scope patent-text">Other Designations: 78 kDa glucose-regulated protein; endoplasmic reticulum lumenal Ca(2+)-binding protein grp78; immunoglobulin heavy chain-binding protein (56) CD70 (CD70 molecule) L08096</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0950]" class="style-scope patent-text">
    
    [0950]
  </para-num> <div id="p-0900" num="0950" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0951]" class="style-scope patent-text">
    
    [0951]
  </para-num> <div id="p-0901" num="0951" class="description-line style-scope patent-text">Genbank accession no. L08096</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0952]" class="style-scope patent-text">
    
    [0952]
  </para-num> <div id="p-0902" num="0952" class="description-line style-scope patent-text">Genbank version no. L08096.1 GI:307127</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0953]" class="style-scope patent-text">
    
    [0953]
  </para-num> <div id="p-0903" num="0953" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2012 08:54 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0954]" class="style-scope patent-text">
    
    [0954]
  </para-num> <div id="p-0904" num="0954" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0955]" class="style-scope patent-text">
    
    [0955]
  </para-num> <div id="p-0905" num="0955" class="description-line style-scope patent-text">Genbank accession no. AAA36175</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0956]" class="style-scope patent-text">
    
    [0956]
  </para-num> <div id="p-0906" num="0956" class="description-line style-scope patent-text">Genbank version no. AAA36175.1 GI:307128</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0957]" class="style-scope patent-text">
    
    [0957]
  </para-num> <div id="p-0907" num="0957" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2012 08:54 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0958]" class="style-scope patent-text">
    
    [0958]
  </para-num> <div id="p-0908" num="0958" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0959]" class="style-scope patent-text">
    
    [0959]
  </para-num> <div id="p-0909" num="0959" class="description-line style-scope patent-text">Goodwin R. G., et al <i class="style-scope patent-text">Cell </i>73 (3), 447-456 (1993)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0960]" class="style-scope patent-text">
    
    [0960]
  </para-num> <div id="p-0910" num="0960" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0961]" class="style-scope patent-text">
    
    [0961]
  </para-num> <div id="p-0911" num="0961" class="description-line style-scope patent-text">Official Symbol: CD70</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0962]" class="style-scope patent-text">
    
    [0962]
  </para-num> <div id="p-0912" num="0962" class="description-line style-scope patent-text">Other Aliases: CD27L, CD27LG, TNFSF7</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0963]" class="style-scope patent-text">
    
    [0963]
  </para-num> <div id="p-0913" num="0963" class="description-line style-scope patent-text">Other Designations: CD27 ligand; CD27-L; CD70 antigen; Ki-24 antigen; surface antigen CD70; tumor necrosis factor (ligand) superfamily, member 7; tumor necrosis factor ligand superfamily member 7</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0964]" class="style-scope patent-text">
    
    [0964]
  </para-num> <div id="p-0914" num="0964" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0965]" class="style-scope patent-text">
    
    [0965]
  </para-num> <div id="p-0915" num="0965" class="description-line style-scope patent-text">MDX-1411 against CD70 (Medarex)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0966]" class="style-scope patent-text">
    
    [0966]
  </para-num> <div id="p-0916" num="0966" class="description-line style-scope patent-text">h1F6 (Oflazoglu, E., et al, Clin Cancer Res. 2008 Oct. 1; 14(19):6171-80; Seattle Genetics)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0070-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0071-0001" num="0967" class="style-scope patent-text">For example, see US20060083736 SEQ ID NOs: 1, 2, 11 and 12 and <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref>.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0968]" class="style-scope patent-text">
    
    [0968]
  </para-num> <div id="p-0917" num="0968" class="description-line style-scope patent-text">(57) Stem Cell specific antigens. For example:
</div> </li> <ul class="style-scope patent-text"> <li id="ul0072-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0073-0001" num="0969" class="style-scope patent-text">5T4 (see entry (63) below)</li> <li id="ul0073-0002" num="0970" class="style-scope patent-text">CD25 (see entry (48) above)</li> <li id="ul0073-0003" num="0971" class="style-scope patent-text">CD32
        <ul class="style-scope patent-text"> <li id="ul0074-0001" num="0972" class="style-scope patent-text">Polypeptide
            <ul class="style-scope patent-text"> <li id="ul0075-0001" num="0973" class="style-scope patent-text">Genbank accession no. ABK42161</li> <li id="ul0075-0002" num="0974" class="style-scope patent-text">Genbank version no. ABK42161.1 GI:117616286</li> <li id="ul0075-0003" num="0975" class="style-scope patent-text">Genbank record update date: Jul. 25, 2007 03:00 PM</li> </ul>
            </li> </ul>
        </li> <li id="ul0073-0004" num="0976" class="style-scope patent-text">LGR5/GPR49
        <ul class="style-scope patent-text"> <li id="ul0076-0001" num="0977" class="style-scope patent-text">Nucleotide
            <ul class="style-scope patent-text"> <li id="ul0077-0001" num="0978" class="style-scope patent-text">Genbank accession no. NM_003667</li> <li id="ul0077-0002" num="0979" class="style-scope patent-text">Genbank version no. NM_003667.2 GI:24475886</li> <li id="ul0077-0003" num="0980" class="style-scope patent-text">Genbank record update date: Jul. 22, 2012 03:38 PM</li> </ul>
            </li> <li id="ul0076-0002" num="0981" class="style-scope patent-text">Polypeptide
            <ul class="style-scope patent-text"> <li id="ul0078-0001" num="0982" class="style-scope patent-text">Genbank accession no. NP_003658</li> <li id="ul0078-0002" num="0983" class="style-scope patent-text">Genbank version no. NP_003658.1 GI:4504379</li> <li id="ul0078-0003" num="0984" class="style-scope patent-text">Genbank record update date: Jul. 22, 2012 03:38 PM</li> </ul>
            </li> </ul>
        </li> <li id="ul0073-0005" num="0985" class="style-scope patent-text">Prominin/CD133
        <ul class="style-scope patent-text"> <li id="ul0079-0001" num="0986" class="style-scope patent-text">Nucleotide
            <ul class="style-scope patent-text"> <li id="ul0080-0001" num="0987" class="style-scope patent-text">Genbank accession no. NM_006017</li> <li id="ul0080-0002" num="0988" class="style-scope patent-text">Genbank version no. NM_006017.2 GI:224994187</li> <li id="ul0080-0003" num="0989" class="style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:47 PM</li> </ul>
            </li> <li id="ul0079-0002" num="0990" class="style-scope patent-text">Polypeptide
            <ul class="style-scope patent-text"> <li id="ul0081-0001" num="0991" class="style-scope patent-text">Genbank accession no. NP_006008</li> <li id="ul0081-0002" num="0992" class="style-scope patent-text">Genbank version no. NP_006008.1 GI:5174387</li> <li id="ul0081-0003" num="0993" class="style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:47 PM</li> </ul>
            </li> </ul>
        </li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[0994]" class="style-scope patent-text">
    
    [0994]
  </para-num> <div id="p-0918" num="0994" class="description-line style-scope patent-text">(58) ASG-5</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0995]" class="style-scope patent-text">
    
    [0995]
  </para-num> <div id="p-0919" num="0995" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0996]" class="style-scope patent-text">
    
    [0996]
  </para-num> <div id="p-0920" num="0996" class="description-line style-scope patent-text">(Smith L. M., et.al <i class="style-scope patent-text">AACR </i>2010 <i class="style-scope patent-text">Annual Meeting </i>(abstract #2590); Gudas J. M., et.al. AACR 2010 <i class="style-scope patent-text">Annual Meeting </i>(abstract #4393)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0997]" class="style-scope patent-text">
    
    [0997]
  </para-num> <div id="p-0921" num="0997" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0998]" class="style-scope patent-text">
    
    [0998]
  </para-num> <div id="p-0922" num="0998" class="description-line style-scope patent-text">Anti-AGS-5 Antibody: M6.131 (Smith, L. M., et.al <i class="style-scope patent-text">AACR </i>2010 <i class="style-scope patent-text">Annual Meeting </i>(abstract #2590)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[0999]" class="style-scope patent-text">
    
    [0999]
  </para-num> <div id="p-0923" num="0999" class="description-line style-scope patent-text">(59) ENPP3 (Ectonucleotide pyrophosphatase/phosphodiesterase 3)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1000]" class="style-scope patent-text">
    
    [1000]
  </para-num> <div id="p-0924" num="1000" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1001]" class="style-scope patent-text">
    
    [1001]
  </para-num> <div id="p-0925" num="1001" class="description-line style-scope patent-text">Genbank accession no. AF005632</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1002]" class="style-scope patent-text">
    
    [1002]
  </para-num> <div id="p-0926" num="1002" class="description-line style-scope patent-text">Genbank version no. AF005632.2 GI:4432589</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1003]" class="style-scope patent-text">
    
    [1003]
  </para-num> <div id="p-0927" num="1003" class="description-line style-scope patent-text">Genbank record update date: Mar. 10, 2010 09:41 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1004]" class="style-scope patent-text">
    
    [1004]
  </para-num> <div id="p-0928" num="1004" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1005]" class="style-scope patent-text">
    
    [1005]
  </para-num> <div id="p-0929" num="1005" class="description-line style-scope patent-text">Genbank accession no. AAC51813</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1006]" class="style-scope patent-text">
    
    [1006]
  </para-num> <div id="p-0930" num="1006" class="description-line style-scope patent-text">Genbank version no. AAC51813.1 GI:2465540</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1007]" class="style-scope patent-text">
    
    [1007]
  </para-num> <div id="p-0931" num="1007" class="description-line style-scope patent-text">Genbank record update date: Mar. 10, 2010 09:41 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1008]" class="style-scope patent-text">
    
    [1008]
  </para-num> <div id="p-0932" num="1008" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1009]" class="style-scope patent-text">
    
    [1009]
  </para-num> <div id="p-0933" num="1009" class="description-line style-scope patent-text">Jin-Hua P., et al Genomics 45 (2), 412-415 (1997)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1010]" class="style-scope patent-text">
    
    [1010]
  </para-num> <div id="p-0934" num="1010" class="description-line style-scope patent-text">Other information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1011]" class="style-scope patent-text">
    
    [1011]
  </para-num> <div id="p-0935" num="1011" class="description-line style-scope patent-text">Official Symbol: ENPP3</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1012]" class="style-scope patent-text">
    
    [1012]
  </para-num> <div id="p-0936" num="1012" class="description-line style-scope patent-text">Other Aliases: RP5-988G15.3, B10, CD203c, NPP3, PD-IBETA, PDNP3</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1013]" class="style-scope patent-text">
    
    [1013]
  </para-num> <div id="p-0937" num="1013" class="description-line style-scope patent-text">Other Designations: <figure-callout id="3" label="E-NPP" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">E-NPP</a></figure-callout> 3; dJ1005H11.3 (phosphodiesterase I/nucleotide pyrophosphatase 3); dJ914N13.3 (phosphodiesterase I/nucleotide pyrophosphatase 3); ectonucleotide pyrophosphatase/<figure-callout id="3" label="phosphodiesterase family member" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">phosphodiesterase family member</a></figure-callout> 3; gp13ORB13-6; phosphodiesterase I beta; phosphodiesterase I/<figure-callout id="3" label="nucleotide pyrophosphatase" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">nucleotide pyrophosphatase</a></figure-callout> 3;</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1014]" class="style-scope patent-text">
    
    [1014]
  </para-num> <div id="p-0938" num="1014" class="description-line style-scope patent-text">phosphodiesterase-I beta</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1015]" class="style-scope patent-text">
    
    [1015]
  </para-num> <div id="p-0939" num="1015" class="description-line style-scope patent-text">(60) PRR4 (Proline rich 4 (lacrimal))</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1016]" class="style-scope patent-text">
    
    [1016]
  </para-num> <div id="p-0940" num="1016" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1017]" class="style-scope patent-text">
    
    [1017]
  </para-num> <div id="p-0941" num="1017" class="description-line style-scope patent-text">Genbank accession no. NM_007244</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1018]" class="style-scope patent-text">
    
    [1018]
  </para-num> <div id="p-0942" num="1018" class="description-line style-scope patent-text">Genbank version no. NM_007244.2 GI:154448885</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1019]" class="style-scope patent-text">
    
    [1019]
  </para-num> <div id="p-0943" num="1019" class="description-line style-scope patent-text">Genbank record update date: Jun. 28, 2012 12:39 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1020]" class="style-scope patent-text">
    
    [1020]
  </para-num> <div id="p-0944" num="1020" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1021]" class="style-scope patent-text">
    
    [1021]
  </para-num> <div id="p-0945" num="1021" class="description-line style-scope patent-text">Genbank accession no. NP_009175</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1022]" class="style-scope patent-text">
    
    [1022]
  </para-num> <div id="p-0946" num="1022" class="description-line style-scope patent-text">Genbank version no. NP_009175.2 GI:154448886</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1023]" class="style-scope patent-text">
    
    [1023]
  </para-num> <div id="p-0947" num="1023" class="description-line style-scope patent-text">Genbank record update date: Jun. 28, 2012 12:39 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1024]" class="style-scope patent-text">
    
    [1024]
  </para-num> <div id="p-0948" num="1024" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1025]" class="style-scope patent-text">
    
    [1025]
  </para-num> <div id="p-0949" num="1025" class="description-line style-scope patent-text">Dickinson D. P., et al <i class="style-scope patent-text">Invest. Ophthalmol. Vis. Sci. </i>36 (10), 2020-2031 (1995)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1026]" class="style-scope patent-text">
    
    [1026]
  </para-num> <div id="p-0950" num="1026" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1027]" class="style-scope patent-text">
    
    [1027]
  </para-num> <div id="p-0951" num="1027" class="description-line style-scope patent-text">Official Symbol: PRR4</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1028]" class="style-scope patent-text">
    
    [1028]
  </para-num> <div id="p-0952" num="1028" class="description-line style-scope patent-text">Other Aliases: LPRP, PROL4</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1029]" class="style-scope patent-text">
    
    [1029]
  </para-num> <div id="p-0953" num="1029" class="description-line style-scope patent-text">Other Designations: lacrimal proline-rich protein; nasopharyngeal carcinoma-associated proline-<figure-callout id="4" label="rich protein" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">rich protein</a></figure-callout> 4; proline-<figure-callout id="4" label="rich polypeptide" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">rich polypeptide</a></figure-callout> 4; proline-<figure-callout id="4" label="rich protein" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">rich protein</a></figure-callout> 4</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1030]" class="style-scope patent-text">
    
    [1030]
  </para-num> <div id="p-0954" num="1030" class="description-line style-scope patent-text">(61) GCC-GUCY2C (guanylate cyclase 2C (heat stable enterotoxin receptor)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1031]" class="style-scope patent-text">
    
    [1031]
  </para-num> <div id="p-0955" num="1031" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1032]" class="style-scope patent-text">
    
    [1032]
  </para-num> <div id="p-0956" num="1032" class="description-line style-scope patent-text">Genbank accession no. NM_004963</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1033]" class="style-scope patent-text">
    
    [1033]
  </para-num> <div id="p-0957" num="1033" class="description-line style-scope patent-text">Genbank version no. NM_004963.3 GI:222080082</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1034]" class="style-scope patent-text">
    
    [1034]
  </para-num> <div id="p-0958" num="1034" class="description-line style-scope patent-text">Genbank record update date: Sep. 02, 2012 01:50 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1035]" class="style-scope patent-text">
    
    [1035]
  </para-num> <div id="p-0959" num="1035" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1036]" class="style-scope patent-text">
    
    [1036]
  </para-num> <div id="p-0960" num="1036" class="description-line style-scope patent-text">Genbank accession no. NP_004954</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1037]" class="style-scope patent-text">
    
    [1037]
  </para-num> <div id="p-0961" num="1037" class="description-line style-scope patent-text">Genbank version no. NP_004954.2 GI:222080083</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1038]" class="style-scope patent-text">
    
    [1038]
  </para-num> <div id="p-0962" num="1038" class="description-line style-scope patent-text">Genbank record update date: Sep. 02, 2012 01:50 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1039]" class="style-scope patent-text">
    
    [1039]
  </para-num> <div id="p-0963" num="1039" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1040]" class="style-scope patent-text">
    
    [1040]
  </para-num> <div id="p-0964" num="1040" class="description-line style-scope patent-text">De Sauvage F. J., et al <i class="style-scope patent-text">J.Biol. Chem. </i>266 (27), 17912-17918 (1991); Singh S., et al <i class="style-scope patent-text">Biochem. Biophys. Res. Commun. </i>179 (3), 1455-1463 (1991)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1041]" class="style-scope patent-text">
    
    [1041]
  </para-num> <div id="p-0965" num="1041" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1042]" class="style-scope patent-text">
    
    [1042]
  </para-num> <div id="p-0966" num="1042" class="description-line style-scope patent-text">Official Symbol: GUCY2C</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1043]" class="style-scope patent-text">
    
    [1043]
  </para-num> <div id="p-0967" num="1043" class="description-line style-scope patent-text">Other Aliases: DIAR6, GUC2C, MUCIL, STAR</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1044]" class="style-scope patent-text">
    
    [1044]
  </para-num> <div id="p-0968" num="1044" class="description-line style-scope patent-text">Other Designations: GC-C; STA receptor; guanylyl cyclase C; hSTAR; heat-stable enterotoxin receptor; intestinal guanylate cyclase</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1045]" class="style-scope patent-text">
    
    [1045]
  </para-num> <div id="p-0969" num="1045" class="description-line style-scope patent-text">(62) Liv-1-SLC39A6 (Solute carrier family 39 (zinc transporter), member 6)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1046]" class="style-scope patent-text">
    
    [1046]
  </para-num> <div id="p-0970" num="1046" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1047]" class="style-scope patent-text">
    
    [1047]
  </para-num> <div id="p-0971" num="1047" class="description-line style-scope patent-text">Genbank accession no. U41060</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1048]" class="style-scope patent-text">
    
    [1048]
  </para-num> <div id="p-0972" num="1048" class="description-line style-scope patent-text">Genbank version no. U41060.2 GI:12711792</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1049]" class="style-scope patent-text">
    
    [1049]
  </para-num> <div id="p-0973" num="1049" class="description-line style-scope patent-text">Genbank record update date: Nov. 30, 2009 04:35 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1050]" class="style-scope patent-text">
    
    [1050]
  </para-num> <div id="p-0974" num="1050" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1051]" class="style-scope patent-text">
    
    [1051]
  </para-num> <div id="p-0975" num="1051" class="description-line style-scope patent-text">Genbank accession no. AAA96258</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1052]" class="style-scope patent-text">
    
    [1052]
  </para-num> <div id="p-0976" num="1052" class="description-line style-scope patent-text">Genbank version no. AAA96258.2 GI:12711793</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1053]" class="style-scope patent-text">
    
    [1053]
  </para-num> <div id="p-0977" num="1053" class="description-line style-scope patent-text">Genbank record update date: Nov. 30, 2009 04:35 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1054]" class="style-scope patent-text">
    
    [1054]
  </para-num> <div id="p-0978" num="1054" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1055]" class="style-scope patent-text">
    
    [1055]
  </para-num> <div id="p-0979" num="1055" class="description-line style-scope patent-text">Taylor K M., et al <i class="style-scope patent-text">Biochim Biophys Acta. </i>2003 Apr. 1; 1611(1-2):16-30</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1056]" class="style-scope patent-text">
    
    [1056]
  </para-num> <div id="p-0980" num="1056" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1057]" class="style-scope patent-text">
    
    [1057]
  </para-num> <div id="p-0981" num="1057" class="description-line style-scope patent-text">Official Symbol: SLC39A6</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1058]" class="style-scope patent-text">
    
    [1058]
  </para-num> <div id="p-0982" num="1058" class="description-line style-scope patent-text">Other Aliases: LIV-1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1059]" class="style-scope patent-text">
    
    [1059]
  </para-num> <div id="p-0983" num="1059" class="description-line style-scope patent-text">Other Designations: LIV-1 protein, estrogen regulated; ZIP-6; estrogen-regulated protein LIV-1; solute carrier family 39 (metal ion transporter), <figure-callout id="6" label="member" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">member</a></figure-callout> 6; <figure-callout id="39" label="solute carrier family" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">solute carrier family</a></figure-callout> 39 <figure-callout id="6" label="member" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">member</a></figure-callout> 6; zinc transporter ZIP6; zrt- and Irt-<figure-callout id="6" label="like protein" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">like protein</a></figure-callout> 6</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1060]" class="style-scope patent-text">
    
    [1060]
  </para-num> <div id="p-0984" num="1060" class="description-line style-scope patent-text">(63) 5T4, Trophoblast glycoprotein, TPBG-TPBG (trophoblast glycoprotein)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1061]" class="style-scope patent-text">
    
    [1061]
  </para-num> <div id="p-0985" num="1061" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1062]" class="style-scope patent-text">
    
    [1062]
  </para-num> <div id="p-0986" num="1062" class="description-line style-scope patent-text">Genbank accession no. AJ012159</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1063]" class="style-scope patent-text">
    
    [1063]
  </para-num> <div id="p-0987" num="1063" class="description-line style-scope patent-text">Genbank version no. AJ012159.1 GI:3805946</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1064]" class="style-scope patent-text">
    
    [1064]
  </para-num> <div id="p-0988" num="1064" class="description-line style-scope patent-text">Genbank record update date: Feb. 01, 2011 10:27 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1065]" class="style-scope patent-text">
    
    [1065]
  </para-num> <div id="p-0989" num="1065" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1066]" class="style-scope patent-text">
    
    [1066]
  </para-num> <div id="p-0990" num="1066" class="description-line style-scope patent-text">Genbank accession no. CAA09930</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1067]" class="style-scope patent-text">
    
    [1067]
  </para-num> <div id="p-0991" num="1067" class="description-line style-scope patent-text">Genbank version no. CAA09930.1 GI:3805947</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1068]" class="style-scope patent-text">
    
    [1068]
  </para-num> <div id="p-0992" num="1068" class="description-line style-scope patent-text">Genbank record update date: Feb. 01, 2011 10:27 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1069]" class="style-scope patent-text">
    
    [1069]
  </para-num> <div id="p-0993" num="1069" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1070]" class="style-scope patent-text">
    
    [1070]
  </para-num> <div id="p-0994" num="1070" class="description-line style-scope patent-text">King K. W.,et al <i class="style-scope patent-text">Biochim. Biophys. Acta </i>1445 (3), 257-270 (1999)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1071]" class="style-scope patent-text">
    
    [1071]
  </para-num> <div id="p-0995" num="1071" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1072]" class="style-scope patent-text">
    
    [1072]
  </para-num> <div id="p-0996" num="1072" class="description-line style-scope patent-text">Official Symbol: TPBG</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1073]" class="style-scope patent-text">
    
    [1073]
  </para-num> <div id="p-0997" num="1073" class="description-line style-scope patent-text">Other Aliases: 5T4, 5T4AG, M6P1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1074]" class="style-scope patent-text">
    
    [1074]
  </para-num> <div id="p-0998" num="1074" class="description-line style-scope patent-text">Other Designations: 5T4 oncofetal antigen; 5T4 oncofetal trophoblast glycoprotein; 5T4 oncotrophoblast glycoprotein</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1075]" class="style-scope patent-text">
    
    [1075]
  </para-num> <div id="p-0999" num="1075" class="description-line style-scope patent-text">See WO2015/155345</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1076]" class="style-scope patent-text">
    
    [1076]
  </para-num> <div id="p-1000" num="1076" class="description-line style-scope patent-text">(64) CD56-NCMA1 (Neural cell adhesion molecule 1)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1077]" class="style-scope patent-text">
    
    [1077]
  </para-num> <div id="p-1001" num="1077" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1078]" class="style-scope patent-text">
    
    [1078]
  </para-num> <div id="p-1002" num="1078" class="description-line style-scope patent-text">Genbank accession no. NM_000615</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1079]" class="style-scope patent-text">
    
    [1079]
  </para-num> <div id="p-1003" num="1079" class="description-line style-scope patent-text">Genbank version no. NM_000615.6 GI:336285433</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1080]" class="style-scope patent-text">
    
    [1080]
  </para-num> <div id="p-1004" num="1080" class="description-line style-scope patent-text">Genbank record update date: Sep. 23, 2012 02:32 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1081]" class="style-scope patent-text">
    
    [1081]
  </para-num> <div id="p-1005" num="1081" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1082]" class="style-scope patent-text">
    
    [1082]
  </para-num> <div id="p-1006" num="1082" class="description-line style-scope patent-text">Genbank accession no. NP_000606</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1083]" class="style-scope patent-text">
    
    [1083]
  </para-num> <div id="p-1007" num="1083" class="description-line style-scope patent-text">Genbank version no. NP_000606.3 GI:94420689</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1084]" class="style-scope patent-text">
    
    [1084]
  </para-num> <div id="p-1008" num="1084" class="description-line style-scope patent-text">Genbank record update date: Sep. 23, 2012 02:32 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1085]" class="style-scope patent-text">
    
    [1085]
  </para-num> <div id="p-1009" num="1085" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1086]" class="style-scope patent-text">
    
    [1086]
  </para-num> <div id="p-1010" num="1086" class="description-line style-scope patent-text">Dickson,G., et al, <i class="style-scope patent-text">Cell </i>50 (7), 1119-1130 (1987)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1087]" class="style-scope patent-text">
    
    [1087]
  </para-num> <div id="p-1011" num="1087" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1088]" class="style-scope patent-text">
    
    [1088]
  </para-num> <div id="p-1012" num="1088" class="description-line style-scope patent-text">Official Symbol: NCAM1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1089]" class="style-scope patent-text">
    
    [1089]
  </para-num> <div id="p-1013" num="1089" class="description-line style-scope patent-text">Other Aliases: CD56, MSK39, NCAM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1090]" class="style-scope patent-text">
    
    [1090]
  </para-num> <div id="p-1014" num="1090" class="description-line style-scope patent-text">Other Designations: antigen recognized by monoclonal antibody 5.1H11; neural cell adhesion molecule, NCAM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1091]" class="style-scope patent-text">
    
    [1091]
  </para-num> <div id="p-1015" num="1091" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1092]" class="style-scope patent-text">
    
    [1092]
  </para-num> <div id="p-1016" num="1092" class="description-line style-scope patent-text">Immunogen: HuN901 (Smith S V., et al <i class="style-scope patent-text">Curr Opin Mol Ther. </i>2005 Aug.; 7(4):394-401)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0082-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0083-0001" num="1093" class="style-scope patent-text">For example, see humanized from murine N901 antibody. See <figref idrefs="DRAWINGS" class="style-scope patent-text">FIGS. 1<i class="style-scope patent-text">b </i>and 1<i class="style-scope patent-text">e </i> </figref>of Roguska, M. A., et al. Proc Natl Acad Sci USA Feb. 1994; 91:969-973.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[1094]" class="style-scope patent-text">
    
    [1094]
  </para-num> <div id="p-1017" num="1094" class="description-line style-scope patent-text">(65) CanAg (Tumor associated antigen CA242)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1095]" class="style-scope patent-text">
    
    [1095]
  </para-num> <div id="p-1018" num="1095" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1096]" class="style-scope patent-text">
    
    [1096]
  </para-num> <div id="p-1019" num="1096" class="description-line style-scope patent-text">Haglund C., et al <i class="style-scope patent-text">Br J Cancer </i>60:845-851, 1989;Baeckstrom D., et al <i class="style-scope patent-text">J Biol Chem </i>266:21537-21547, 1991</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1097]" class="style-scope patent-text">
    
    [1097]
  </para-num> <div id="p-1020" num="1097" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1098]" class="style-scope patent-text">
    
    [1098]
  </para-num> <div id="p-1021" num="1098" class="description-line style-scope patent-text">huC242 (Tolcher A W et al., <i class="style-scope patent-text">J Clin Oncol. </i>2003 Jan. 15; 21(2):211-22; Immunogen)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0084-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0085-0001" num="1099" class="style-scope patent-text">For example, see US20080138898A1 SEQ ID NO: 1 and 2</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[1100]" class="style-scope patent-text">
    
    [1100]
  </para-num> <div id="p-1022" num="1100" class="description-line style-scope patent-text">(66) FOLR1 (Folate Receptor 1)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1101]" class="style-scope patent-text">
    
    [1101]
  </para-num> <div id="p-1023" num="1101" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1102]" class="style-scope patent-text">
    
    [1102]
  </para-num> <div id="p-1024" num="1102" class="description-line style-scope patent-text">Genbank accession no. J05013</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1103]" class="style-scope patent-text">
    
    [1103]
  </para-num> <div id="p-1025" num="1103" class="description-line style-scope patent-text">Genbank version no. J05013.1 GI:182417</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1104]" class="style-scope patent-text">
    
    [1104]
  </para-num> <div id="p-1026" num="1104" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:47 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1105]" class="style-scope patent-text">
    
    [1105]
  </para-num> <div id="p-1027" num="1105" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1106]" class="style-scope patent-text">
    
    [1106]
  </para-num> <div id="p-1028" num="1106" class="description-line style-scope patent-text">Genbank accession no. AAA35823</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1107]" class="style-scope patent-text">
    
    [1107]
  </para-num> <div id="p-1029" num="1107" class="description-line style-scope patent-text">Genbank version no. AAA35823.1 GI:182418</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1108]" class="style-scope patent-text">
    
    [1108]
  </para-num> <div id="p-1030" num="1108" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:47 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1109]" class="style-scope patent-text">
    
    [1109]
  </para-num> <div id="p-1031" num="1109" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1110]" class="style-scope patent-text">
    
    [1110]
  </para-num> <div id="p-1032" num="1110" class="description-line style-scope patent-text">Elwood P. C., et al <i class="style-scope patent-text">J. Biol. Chem. </i>264 (25), 14893-14901 (1989)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1111]" class="style-scope patent-text">
    
    [1111]
  </para-num> <div id="p-1033" num="1111" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1112]" class="style-scope patent-text">
    
    [1112]
  </para-num> <div id="p-1034" num="1112" class="description-line style-scope patent-text">Official Symbol: FOLR1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1113]" class="style-scope patent-text">
    
    [1113]
  </para-num> <div id="p-1035" num="1113" class="description-line style-scope patent-text">Other Aliases: FBP, FOLR</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1114]" class="style-scope patent-text">
    
    [1114]
  </para-num> <div id="p-1036" num="1114" class="description-line style-scope patent-text">Other Designations: FR-alpha; KB cells FBP; adult folate-binding protein; folate binding protein; folate receptor alpha; folate receptor, adult; ovarian tumor-associated antigen</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1115]" class="style-scope patent-text">
    
    [1115]
  </para-num> <div id="p-1037" num="1115" class="description-line style-scope patent-text">MOv18</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1116]" class="style-scope patent-text">
    
    [1116]
  </para-num> <div id="p-1038" num="1116" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1117]" class="style-scope patent-text">
    
    [1117]
  </para-num> <div id="p-1039" num="1117" class="description-line style-scope patent-text">M9346A-Whiteman K R., et al <i class="style-scope patent-text">Cancer Res </i>Apr. 15, 2012; 72(8 Supplement): 4628(Immunogen)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1118]" class="style-scope patent-text">
    
    [1118]
  </para-num> <div id="p-1040" num="1118" class="description-line style-scope patent-text">(67) GPNMB (Glycoprotein (transmembrane) nmb)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1119]" class="style-scope patent-text">
    
    [1119]
  </para-num> <div id="p-1041" num="1119" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1120]" class="style-scope patent-text">
    
    [1120]
  </para-num> <div id="p-1042" num="1120" class="description-line style-scope patent-text">Genbank accession no. X76534</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1121]" class="style-scope patent-text">
    
    [1121]
  </para-num> <div id="p-1043" num="1121" class="description-line style-scope patent-text">Genbank version no. X76534.1 GI:666042</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1122]" class="style-scope patent-text">
    
    [1122]
  </para-num> <div id="p-1044" num="1122" class="description-line style-scope patent-text">Genbank record update date: Feb. 02, 2011 10:10 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1123]" class="style-scope patent-text">
    
    [1123]
  </para-num> <div id="p-1045" num="1123" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1124]" class="style-scope patent-text">
    
    [1124]
  </para-num> <div id="p-1046" num="1124" class="description-line style-scope patent-text">Genbank accession no. CAA54044</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1125]" class="style-scope patent-text">
    
    [1125]
  </para-num> <div id="p-1047" num="1125" class="description-line style-scope patent-text">Genbank version no. CAA54044.1 GI:666043</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1126]" class="style-scope patent-text">
    
    [1126]
  </para-num> <div id="p-1048" num="1126" class="description-line style-scope patent-text">Genbank record update date: Feb. 02, 2011 10:10 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1127]" class="style-scope patent-text">
    
    [1127]
  </para-num> <div id="p-1049" num="1127" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1128]" class="style-scope patent-text">
    
    [1128]
  </para-num> <div id="p-1050" num="1128" class="description-line style-scope patent-text">Weterman M. A., et al Int. <i class="style-scope patent-text">J. Cancer </i>60 (1), 73-81 (1995)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1129]" class="style-scope patent-text">
    
    [1129]
  </para-num> <div id="p-1051" num="1129" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1130]" class="style-scope patent-text">
    
    [1130]
  </para-num> <div id="p-1052" num="1130" class="description-line style-scope patent-text">Official Symbol: GPNMB</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1131]" class="style-scope patent-text">
    
    [1131]
  </para-num> <div id="p-1053" num="1131" class="description-line style-scope patent-text">Other Aliases: UNQ1725/PRO9925, HGFIN, NMB</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1132]" class="style-scope patent-text">
    
    [1132]
  </para-num> <div id="p-1054" num="1132" class="description-line style-scope patent-text">Other Designations: glycoprotein NMB; glycoprotein nmb-like protein; osteoactivin; transmembrane glycoprotein HGFIN; transmembrane glycoprotein NMB</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1133]" class="style-scope patent-text">
    
    [1133]
  </para-num> <div id="p-1055" num="1133" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1134]" class="style-scope patent-text">
    
    [1134]
  </para-num> <div id="p-1056" num="1134" class="description-line style-scope patent-text">Celldex Therapeutics: CR011 (Tse K F., et al <i class="style-scope patent-text">Clin Cancer Res. </i>2006 Feb. 15; 12(4):1373-82)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0086-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0087-0001" num="1135" class="style-scope patent-text">For example, see EP1827492B1 SEQ ID NO: 22, 24, 26, 31, 33 and 35</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[1136]" class="style-scope patent-text">
    
    [1136]
  </para-num> <div id="p-1057" num="1136" class="description-line style-scope patent-text">(68) TIM-1-HAVCR1 (Hepatitis A virus cellular receptor 1)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1137]" class="style-scope patent-text">
    
    [1137]
  </para-num> <div id="p-1058" num="1137" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1138]" class="style-scope patent-text">
    
    [1138]
  </para-num> <div id="p-1059" num="1138" class="description-line style-scope patent-text">Genbank accession no. AF043724</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1139]" class="style-scope patent-text">
    
    [1139]
  </para-num> <div id="p-1060" num="1139" class="description-line style-scope patent-text">Genbank version no. AF043724.1 GI:2827453</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1140]" class="style-scope patent-text">
    
    [1140]
  </para-num> <div id="p-1061" num="1140" class="description-line style-scope patent-text">Genbank record update date: Mar. 10, 2010 06:24 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1141]" class="style-scope patent-text">
    
    [1141]
  </para-num> <div id="p-1062" num="1141" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1142]" class="style-scope patent-text">
    
    [1142]
  </para-num> <div id="p-1063" num="1142" class="description-line style-scope patent-text">Genbank accession no. AAC39862</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1143]" class="style-scope patent-text">
    
    [1143]
  </para-num> <div id="p-1064" num="1143" class="description-line style-scope patent-text">Genbank version no. AAC39862.1 GI:2827454</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1144]" class="style-scope patent-text">
    
    [1144]
  </para-num> <div id="p-1065" num="1144" class="description-line style-scope patent-text">Genbank record update date: Mar. 10, 2010 06:24 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1145]" class="style-scope patent-text">
    
    [1145]
  </para-num> <div id="p-1066" num="1145" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1146]" class="style-scope patent-text">
    
    [1146]
  </para-num> <div id="p-1067" num="1146" class="description-line style-scope patent-text">Feigelstock D., et al <i class="style-scope patent-text">J. Virol. </i>72 (8), 6621-6628 (1998)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1147]" class="style-scope patent-text">
    
    [1147]
  </para-num> <div id="p-1068" num="1147" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1148]" class="style-scope patent-text">
    
    [1148]
  </para-num> <div id="p-1069" num="1148" class="description-line style-scope patent-text">Official Symbol: HAVCR1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1149]" class="style-scope patent-text">
    
    [1149]
  </para-num> <div id="p-1070" num="1149" class="description-line style-scope patent-text">Other Aliases: HAVCR, HAVCR-1, KIM-1, KIM1, TIM, TIM-1, TIM1, TIMD-1, TIMD1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1150]" class="style-scope patent-text">
    
    [1150]
  </para-num> <div id="p-1071" num="1150" class="description-line style-scope patent-text">Other Designations: T cell immunoglobin domain and mucin domain protein 1; T-cell membrane protein 1; kidney injury molecule 1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1151]" class="style-scope patent-text">
    
    [1151]
  </para-num> <div id="p-1072" num="1151" class="description-line style-scope patent-text">(69) RG-1/Prostate tumor target Mindin-Mindin/RG-1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1152]" class="style-scope patent-text">
    
    [1152]
  </para-num> <div id="p-1073" num="1152" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1153]" class="style-scope patent-text">
    
    [1153]
  </para-num> <div id="p-1074" num="1153" class="description-line style-scope patent-text">Parry R., et al Cancer Res. 2005 Sep. 15; 65(18):8397-405</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1154]" class="style-scope patent-text">
    
    [1154]
  </para-num> <div id="p-1075" num="1154" class="description-line style-scope patent-text">(70) B7-H4-VTCN1 (V-set domain containing T cell activation inhibitor 1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1155]" class="style-scope patent-text">
    
    [1155]
  </para-num> <div id="p-1076" num="1155" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1156]" class="style-scope patent-text">
    
    [1156]
  </para-num> <div id="p-1077" num="1156" class="description-line style-scope patent-text">Genbank accession no. BX648021</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1157]" class="style-scope patent-text">
    
    [1157]
  </para-num> <div id="p-1078" num="1157" class="description-line style-scope patent-text">Genbank version no. BX648021.1 GI:34367180</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1158]" class="style-scope patent-text">
    
    [1158]
  </para-num> <div id="p-1079" num="1158" class="description-line style-scope patent-text">Genbank record update date: Feb. 02, 2011 08:40 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1159]" class="style-scope patent-text">
    
    [1159]
  </para-num> <div id="p-1080" num="1159" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1160]" class="style-scope patent-text">
    
    [1160]
  </para-num> <div id="p-1081" num="1160" class="description-line style-scope patent-text">Sica GL., et al <i class="style-scope patent-text">Immunity. </i>2003 Jun.; 18(6):849-61</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1161]" class="style-scope patent-text">
    
    [1161]
  </para-num> <div id="p-1082" num="1161" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1162]" class="style-scope patent-text">
    
    [1162]
  </para-num> <div id="p-1083" num="1162" class="description-line style-scope patent-text">Official Symbol: VTCN1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1163]" class="style-scope patent-text">
    
    [1163]
  </para-num> <div id="p-1084" num="1163" class="description-line style-scope patent-text">Other Aliases: RP11-229A19.4, B7-H4, B7H4, B7S1, B7X, B7h.5, PRO1291, VCTN1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1164]" class="style-scope patent-text">
    
    [1164]
  </para-num> <div id="p-1085" num="1164" class="description-line style-scope patent-text">Other Designations: B7 family member, H4; B7 superfamily member 1; T cell costimulatory molecule B7x; T-cell costimulatory molecule B7x; V-set domain-containing T-cell activation inhibitor 1; immune costimulatory protein B7-H4</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1165]" class="style-scope patent-text">
    
    [1165]
  </para-num> <div id="p-1086" num="1165" class="description-line style-scope patent-text">(71) PTK7 (PTK7 protein tyrosine kinase 7)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1166]" class="style-scope patent-text">
    
    [1166]
  </para-num> <div id="p-1087" num="1166" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1167]" class="style-scope patent-text">
    
    [1167]
  </para-num> <div id="p-1088" num="1167" class="description-line style-scope patent-text">Genbank accession no. AF447176</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1168]" class="style-scope patent-text">
    
    [1168]
  </para-num> <div id="p-1089" num="1168" class="description-line style-scope patent-text">Genbank version no. AF447176.1 GI:17432420</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1169]" class="style-scope patent-text">
    
    [1169]
  </para-num> <div id="p-1090" num="1169" class="description-line style-scope patent-text">Genbank record update date: Nov. 28, 2008 01:51 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1170]" class="style-scope patent-text">
    
    [1170]
  </para-num> <div id="p-1091" num="1170" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1171]" class="style-scope patent-text">
    
    [1171]
  </para-num> <div id="p-1092" num="1171" class="description-line style-scope patent-text">Genbank accession no. AAL39062</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1172]" class="style-scope patent-text">
    
    [1172]
  </para-num> <div id="p-1093" num="1172" class="description-line style-scope patent-text">Genbank version no. AAL39062.1 GI:17432421</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1173]" class="style-scope patent-text">
    
    [1173]
  </para-num> <div id="p-1094" num="1173" class="description-line style-scope patent-text">Genbank record update date: Nov. 28, 2008 01:51 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1174]" class="style-scope patent-text">
    
    [1174]
  </para-num> <div id="p-1095" num="1174" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1175]" class="style-scope patent-text">
    
    [1175]
  </para-num> <div id="p-1096" num="1175" class="description-line style-scope patent-text">Park S. K.,et al <i class="style-scope patent-text">J.Biochem. </i>119 (2), 235-239 (1996)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1176]" class="style-scope patent-text">
    
    [1176]
  </para-num> <div id="p-1097" num="1176" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1177]" class="style-scope patent-text">
    
    [1177]
  </para-num> <div id="p-1098" num="1177" class="description-line style-scope patent-text">Official Symbol: PTK7</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1178]" class="style-scope patent-text">
    
    [1178]
  </para-num> <div id="p-1099" num="1178" class="description-line style-scope patent-text">Other Aliases: CCK-4, CCK4</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1179]" class="style-scope patent-text">
    
    [1179]
  </para-num> <div id="p-1100" num="1179" class="description-line style-scope patent-text">Other Designations: <figure-callout id="4" label="colon carcinoma kinase" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">colon carcinoma kinase</a></figure-callout> 4; inactive tyrosine-protein kinase 7; pseudo tyrosine kinase receptor 7; tyrosine-protein kinase-like 7</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1180]" class="style-scope patent-text">
    
    [1180]
  </para-num> <div id="p-1101" num="1180" class="description-line style-scope patent-text">(72) CD37 (CD37 molecule)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1181]" class="style-scope patent-text">
    
    [1181]
  </para-num> <div id="p-1102" num="1181" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1182]" class="style-scope patent-text">
    
    [1182]
  </para-num> <div id="p-1103" num="1182" class="description-line style-scope patent-text">Genbank accession no. NM_001040031</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1183]" class="style-scope patent-text">
    
    [1183]
  </para-num> <div id="p-1104" num="1183" class="description-line style-scope patent-text">Genbank version no. NM_001040031.1 GI:91807109</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1184]" class="style-scope patent-text">
    
    [1184]
  </para-num> <div id="p-1105" num="1184" class="description-line style-scope patent-text">Genbank record update date: Jul. 29, 2012 02:08 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1185]" class="style-scope patent-text">
    
    [1185]
  </para-num> <div id="p-1106" num="1185" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1186]" class="style-scope patent-text">
    
    [1186]
  </para-num> <div id="p-1107" num="1186" class="description-line style-scope patent-text">Genbank accession no. NP_001035120</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1187]" class="style-scope patent-text">
    
    [1187]
  </para-num> <div id="p-1108" num="1187" class="description-line style-scope patent-text">Genbank version no. NP_001035120.1 GI:91807110</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1188]" class="style-scope patent-text">
    
    [1188]
  </para-num> <div id="p-1109" num="1188" class="description-line style-scope patent-text">Genbank record update date: Jul. 29, 2012 02:08 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1189]" class="style-scope patent-text">
    
    [1189]
  </para-num> <div id="p-1110" num="1189" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1190]" class="style-scope patent-text">
    
    [1190]
  </para-num> <div id="p-1111" num="1190" class="description-line style-scope patent-text">Schwartz-Albiez R., et al <i class="style-scope patent-text">J. Immunol. </i>140 (3), 905-914 (1988)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1191]" class="style-scope patent-text">
    
    [1191]
  </para-num> <div id="p-1112" num="1191" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1192]" class="style-scope patent-text">
    
    [1192]
  </para-num> <div id="p-1113" num="1192" class="description-line style-scope patent-text">Official Symbol: CD37</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1193]" class="style-scope patent-text">
    
    [1193]
  </para-num> <div id="p-1114" num="1193" class="description-line style-scope patent-text">Other Aliases: GP52-40, TSPAN26</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1194]" class="style-scope patent-text">
    
    [1194]
  </para-num> <div id="p-1115" num="1194" class="description-line style-scope patent-text">Other Designations: CD37 antigen; cell differentiation antigen 37; leukocyte antigen CD37; leukocyte surface antigen CD37; tetraspanin-26; tspan-26</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1195]" class="style-scope patent-text">
    
    [1195]
  </para-num> <div id="p-1116" num="1195" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1196]" class="style-scope patent-text">
    
    [1196]
  </para-num> <div id="p-1117" num="1196" class="description-line style-scope patent-text">Boehringer Ingelheim: mAb 37.1 (Heider K H., et al <i class="style-scope patent-text">Blood. </i>2011 Oct. 13; 118(15):4159-68)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1197]" class="style-scope patent-text">
    
    [1197]
  </para-num> <div id="p-1118" num="1197" class="description-line style-scope patent-text">Trubion: CD37-SMIP (G28-1 scFv-Ig) ((Zhao X., et al <i class="style-scope patent-text">Blood. </i>2007; 110: 2569-2577)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1198]" class="style-scope patent-text">
    
    [1198]
  </para-num> <div id="p-1119" num="1198" class="description-line style-scope patent-text">For example, see US20110171208A1 SEQ ID NO: 253</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1199]" class="style-scope patent-text">
    
    [1199]
  </para-num> <div id="p-1120" num="1199" class="description-line style-scope patent-text">Immunogen: K7153A (Deckert J., et al Cancer Res Apr. 15, 2012; 72(8 Supplement): 4625)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1200]" class="style-scope patent-text">
    
    [1200]
  </para-num> <div id="p-1121" num="1200" class="description-line style-scope patent-text">(73) CD138 -SDC1 (syndecan 1)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1201]" class="style-scope patent-text">
    
    [1201]
  </para-num> <div id="p-1122" num="1201" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1202]" class="style-scope patent-text">
    
    [1202]
  </para-num> <div id="p-1123" num="1202" class="description-line style-scope patent-text">Genbank accession no. AJ551176</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1203]" class="style-scope patent-text">
    
    [1203]
  </para-num> <div id="p-1124" num="1203" class="description-line style-scope patent-text">Genbank version no. AJ551176.1 GI:29243141</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1204]" class="style-scope patent-text">
    
    [1204]
  </para-num> <div id="p-1125" num="1204" class="description-line style-scope patent-text">Genbank record update date: Feb. 01, 2011 12:09 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1205]" class="style-scope patent-text">
    
    [1205]
  </para-num> <div id="p-1126" num="1205" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1206]" class="style-scope patent-text">
    
    [1206]
  </para-num> <div id="p-1127" num="1206" class="description-line style-scope patent-text">Genbank accession no. CAD80245</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1207]" class="style-scope patent-text">
    
    [1207]
  </para-num> <div id="p-1128" num="1207" class="description-line style-scope patent-text">Genbank version no. CAD80245.1 GI:29243142</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1208]" class="style-scope patent-text">
    
    [1208]
  </para-num> <div id="p-1129" num="1208" class="description-line style-scope patent-text">Genbank record update date: Feb. 01, 2011 12:09 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1209]" class="style-scope patent-text">
    
    [1209]
  </para-num> <div id="p-1130" num="1209" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1210]" class="style-scope patent-text">
    
    [1210]
  </para-num> <div id="p-1131" num="1210" class="description-line style-scope patent-text">O'Connell F P., et al <i class="style-scope patent-text">Am J Clin Pathol. </i>2004 Feb.;121(2):254-63</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1211]" class="style-scope patent-text">
    
    [1211]
  </para-num> <div id="p-1132" num="1211" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1212]" class="style-scope patent-text">
    
    [1212]
  </para-num> <div id="p-1133" num="1212" class="description-line style-scope patent-text">Official Symbol: SDC1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1213]" class="style-scope patent-text">
    
    [1213]
  </para-num> <div id="p-1134" num="1213" class="description-line style-scope patent-text">Other Aliases: CD138, SDC, SYND1, syndecan</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1214]" class="style-scope patent-text">
    
    [1214]
  </para-num> <div id="p-1135" num="1214" class="description-line style-scope patent-text">Other Designations: CD138 antigen; heparan sulfate proteoglycan fibroblast growth factor receptor; syndecan proteoglycan 1; syndecan-1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1215]" class="style-scope patent-text">
    
    [1215]
  </para-num> <div id="p-1136" num="1215" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1216]" class="style-scope patent-text">
    
    [1216]
  </para-num> <div id="p-1137" num="1216" class="description-line style-scope patent-text">Biotest: chimerized MAb (nBT062)-(Jagannath S., et al Poster ASH #3060, 2010; WIPO Patent Application WO/2010/128087)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0088-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0089-0001" num="1217" class="style-scope patent-text">For example, see US20090232810 SEQ ID NO: 1 and 2</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[1218]" class="style-scope patent-text">
    
    [1218]
  </para-num> <div id="p-1138" num="1218" class="description-line style-scope patent-text">Immunogen: B-B4 (Tassone P., et al Blood 104_3688-3696)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0090-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0091-0001" num="1219" class="style-scope patent-text">For example, see US20090175863A1 SEQ ID NO: 1 and 2</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[1220]" class="style-scope patent-text">
    
    [1220]
  </para-num> <div id="p-1139" num="1220" class="description-line style-scope patent-text">(74) CD74 (CD74 molecule, major histocompatibility complex, class II invariant chain)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1221]" class="style-scope patent-text">
    
    [1221]
  </para-num> <div id="p-1140" num="1221" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1222]" class="style-scope patent-text">
    
    [1222]
  </para-num> <div id="p-1141" num="1222" class="description-line style-scope patent-text">Genbank accession no. NM_004355</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1223]" class="style-scope patent-text">
    
    [1223]
  </para-num> <div id="p-1142" num="1223" class="description-line style-scope patent-text">Genbank version no. NM_004355.1 GI:343403784</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1224]" class="style-scope patent-text">
    
    [1224]
  </para-num> <div id="p-1143" num="1224" class="description-line style-scope patent-text">Genbank record update date: Sep. 23, 2012 02:30 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1225]" class="style-scope patent-text">
    
    [1225]
  </para-num> <div id="p-1144" num="1225" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1226]" class="style-scope patent-text">
    
    [1226]
  </para-num> <div id="p-1145" num="1226" class="description-line style-scope patent-text">Genbank accession no. NP_004346</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1227]" class="style-scope patent-text">
    
    [1227]
  </para-num> <div id="p-1146" num="1227" class="description-line style-scope patent-text">Genbank version no. NP_004346.1 GI:10835071</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1228]" class="style-scope patent-text">
    
    [1228]
  </para-num> <div id="p-1147" num="1228" class="description-line style-scope patent-text">Genbank record update date: Sep. 23, 2012 02:30 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1229]" class="style-scope patent-text">
    
    [1229]
  </para-num> <div id="p-1148" num="1229" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1230]" class="style-scope patent-text">
    
    [1230]
  </para-num> <div id="p-1149" num="1230" class="description-line style-scope patent-text">Kudo, J., et al <i class="style-scope patent-text">Nucleic Acids Res. </i>13 (24), 8827-8841 (1985)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1231]" class="style-scope patent-text">
    
    [1231]
  </para-num> <div id="p-1150" num="1231" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1232]" class="style-scope patent-text">
    
    [1232]
  </para-num> <div id="p-1151" num="1232" class="description-line style-scope patent-text">Official Symbol: CD74</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1233]" class="style-scope patent-text">
    
    [1233]
  </para-num> <div id="p-1152" num="1233" class="description-line style-scope patent-text">Other Aliases: DHLAG, HLADG, II, Ia-GAMMA</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1234]" class="style-scope patent-text">
    
    [1234]
  </para-num> <div id="p-1153" num="1234" class="description-line style-scope patent-text">Other Designations: CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); HLA class II histocompatibility antigen gamma chain; HLA-DR antigens-associated invariant chain; HLA-DR-gamma; Ia-associated invariant chain; MHC HLA-DR gamma chain; gamma chain of class II antigens; p33</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1235]" class="style-scope patent-text">
    
    [1235]
  </para-num> <div id="p-1154" num="1235" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1236]" class="style-scope patent-text">
    
    [1236]
  </para-num> <div id="p-1155" num="1236" class="description-line style-scope patent-text">Immunomedics: hLL1 (Milatuzumab,)-Berkova Z., et al <i class="style-scope patent-text">Expert Opin Investig Drugs. </i>2010 Jan.; 19(1):141-9)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0092-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0093-0001" num="1237" class="style-scope patent-text">For example, see US20040115193 SEQ ID NOs: 19, 20, 21, 22, 23 and 24</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[1238]" class="style-scope patent-text">
    
    [1238]
  </para-num> <div id="p-1156" num="1238" class="description-line style-scope patent-text">Genmab: HuMax-CD74 (see website)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1239]" class="style-scope patent-text">
    
    [1239]
  </para-num> <div id="p-1157" num="1239" class="description-line style-scope patent-text">(75) Claudins—CLs (Claudins)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1240]" class="style-scope patent-text">
    
    [1240]
  </para-num> <div id="p-1158" num="1240" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1241]" class="style-scope patent-text">
    
    [1241]
  </para-num> <div id="p-1159" num="1241" class="description-line style-scope patent-text">Offner S., et al <i class="style-scope patent-text">Cancer Immunol Immunother. </i>2005 May; 54(5):431-45, Suzuki H., et al <i class="style-scope patent-text">Ann N Y Acad Sci. </i>2012 Jul.;1258:65-70)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1242]" class="style-scope patent-text">
    
    [1242]
  </para-num> <div id="p-1160" num="1242" class="description-line style-scope patent-text">In humans, 24 members of the family have been described—see literature reference.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1243]" class="style-scope patent-text">
    
    [1243]
  </para-num> <div id="p-1161" num="1243" class="description-line style-scope patent-text">(76) EGFR (Epidermal growth factor receptor)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1244]" class="style-scope patent-text">
    
    [1244]
  </para-num> <div id="p-1162" num="1244" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1245]" class="style-scope patent-text">
    
    [1245]
  </para-num> <div id="p-1163" num="1245" class="description-line style-scope patent-text">Genbank accession no. NM_005228</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1246]" class="style-scope patent-text">
    
    [1246]
  </para-num> <div id="p-1164" num="1246" class="description-line style-scope patent-text">Genbank version no. NM_005228.3 GI:41927737</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1247]" class="style-scope patent-text">
    
    [1247]
  </para-num> <div id="p-1165" num="1247" class="description-line style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:47 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1248]" class="style-scope patent-text">
    
    [1248]
  </para-num> <div id="p-1166" num="1248" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1249]" class="style-scope patent-text">
    
    [1249]
  </para-num> <div id="p-1167" num="1249" class="description-line style-scope patent-text">Genbank accession no. NP_005219</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1250]" class="style-scope patent-text">
    
    [1250]
  </para-num> <div id="p-1168" num="1250" class="description-line style-scope patent-text">Genbank version no. NP_005219.2 GI:29725609</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1251]" class="style-scope patent-text">
    
    [1251]
  </para-num> <div id="p-1169" num="1251" class="description-line style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:47 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1252]" class="style-scope patent-text">
    
    [1252]
  </para-num> <div id="p-1170" num="1252" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1253]" class="style-scope patent-text">
    
    [1253]
  </para-num> <div id="p-1171" num="1253" class="description-line style-scope patent-text">Dhomen N S., et al <i class="style-scope patent-text">Crit Rev Oncog. </i>2012; 17(1):31-50</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1254]" class="style-scope patent-text">
    
    [1254]
  </para-num> <div id="p-1172" num="1254" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1255]" class="style-scope patent-text">
    
    [1255]
  </para-num> <div id="p-1173" num="1255" class="description-line style-scope patent-text">Official Symbol: EGFR</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1256]" class="style-scope patent-text">
    
    [1256]
  </para-num> <div id="p-1174" num="1256" class="description-line style-scope patent-text">Other Aliases: ERBB, ERBB1, HER1, PIG61, mENA</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1257]" class="style-scope patent-text">
    
    [1257]
  </para-num> <div id="p-1175" num="1257" class="description-line style-scope patent-text">Other Designations: avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; cell <figure-callout id="40" label="growth inhibiting protein" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">growth inhibiting protein</a></figure-callout> 40; cell proliferation-inducing protein 61; proto-oncogene c-ErbB-1; receptor tyrosine-protein kinase erbB-1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1258]" class="style-scope patent-text">
    
    [1258]
  </para-num> <div id="p-1176" num="1258" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1259]" class="style-scope patent-text">
    
    [1259]
  </para-num> <div id="p-1177" num="1259" class="description-line style-scope patent-text">BMS: Cetuximab (Erbitux)-Broadbridge V T., et al <i class="style-scope patent-text">Expert Rev Anticancer Ther. </i>2012</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1260]" class="style-scope patent-text">
    
    [1260]
  </para-num> <div id="p-1178" num="1260" class="description-line style-scope patent-text">May; 12(5):555-65.
</div> </li> <ul class="style-scope patent-text"> <li id="ul0094-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0095-0001" num="1261" class="style-scope patent-text">For example, see U.S. Pat. No. 6,217,866-ATTC deposit No. 9764.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[1262]" class="style-scope patent-text">
    
    [1262]
  </para-num> <div id="p-1179" num="1262" class="description-line style-scope patent-text">Amgen: Panitumumab (Vectibix)-Argiles G., et al <i class="style-scope patent-text">Future Oncol. </i>2012 Apr.; 8(4):373-89
</div> </li> <ul class="style-scope patent-text"> <li id="ul0096-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0097-0001" num="1263" class="style-scope patent-text">For example, see U.S. Pat. No. 6,235,883 SEQ ID NOs: 23-38.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[1264]" class="style-scope patent-text">
    
    [1264]
  </para-num> <div id="p-1180" num="1264" class="description-line style-scope patent-text">Genmab: Zalutumumab-Rivera F., et al <i class="style-scope patent-text">Expert Opin Biol Ther. </i>2009 May; 9(5):667-74.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1265]" class="style-scope patent-text">
    
    [1265]
  </para-num> <div id="p-1181" num="1265" class="description-line style-scope patent-text">Y M Biosciences: Nimotuzumab-Ramakrishnan M S., et al MAbs. 2009 Jan.-Feb.; 1(1):41-8.
</div> </li> <ul class="style-scope patent-text"> <li id="ul0098-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0099-0001" num="1266" class="style-scope patent-text">For example, see U.S. Pat. No. 5,891,996 SEQ ID NOs: 27-34.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[1267]" class="style-scope patent-text">
    
    [1267]
  </para-num> <div id="p-1182" num="1267" class="description-line style-scope patent-text">(77) Her3(ErbB3)-ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3(avian))</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1268]" class="style-scope patent-text">
    
    [1268]
  </para-num> <div id="p-1183" num="1268" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1269]" class="style-scope patent-text">
    
    [1269]
  </para-num> <div id="p-1184" num="1269" class="description-line style-scope patent-text">Genbank accession no. M34309</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1270]" class="style-scope patent-text">
    
    [1270]
  </para-num> <div id="p-1185" num="1270" class="description-line style-scope patent-text">Genbank version no. M34309.1 GI:183990</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1271]" class="style-scope patent-text">
    
    [1271]
  </para-num> <div id="p-1186" num="1271" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:47 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1272]" class="style-scope patent-text">
    
    [1272]
  </para-num> <div id="p-1187" num="1272" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1273]" class="style-scope patent-text">
    
    [1273]
  </para-num> <div id="p-1188" num="1273" class="description-line style-scope patent-text">Genbank accession no. AAA35979</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1274]" class="style-scope patent-text">
    
    [1274]
  </para-num> <div id="p-1189" num="1274" class="description-line style-scope patent-text">Genbank version no. AAA35979.1 GI:306841</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1275]" class="style-scope patent-text">
    
    [1275]
  </para-num> <div id="p-1190" num="1275" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:47 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1276]" class="style-scope patent-text">
    
    [1276]
  </para-num> <div id="p-1191" num="1276" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1277]" class="style-scope patent-text">
    
    [1277]
  </para-num> <div id="p-1192" num="1277" class="description-line style-scope patent-text">Plowman,G. D., et al., <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>87 (13), 4905-4909 (1990)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1278]" class="style-scope patent-text">
    
    [1278]
  </para-num> <div id="p-1193" num="1278" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1279]" class="style-scope patent-text">
    
    [1279]
  </para-num> <div id="p-1194" num="1279" class="description-line style-scope patent-text">Official Symbol: ERBB3</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1280]" class="style-scope patent-text">
    
    [1280]
  </para-num> <div id="p-1195" num="1280" class="description-line style-scope patent-text">Other Aliases: ErbB-3, HER3, LCCS2, MDA-BF-1, c-erbB-3, c-erbB3, erbB3-S, p180- ErbB3, p45-sErbB3, p85-sErbB3</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1281]" class="style-scope patent-text">
    
    [1281]
  </para-num> <div id="p-1196" num="1281" class="description-line style-scope patent-text">Other Designations: proto-oncogene-like protein c-ErbB-3; receptor tyrosine-protein kinase erbB-3; tyrosine kinase-type cell surface receptor HER3</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1282]" class="style-scope patent-text">
    
    [1282]
  </para-num> <div id="p-1197" num="1282" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1283]" class="style-scope patent-text">
    
    [1283]
  </para-num> <div id="p-1198" num="1283" class="description-line style-scope patent-text">Merimack Pharma: MM-121 (Schoeberl B., et al Cancer Res. 2010 Mar. 15;70(6):2485-2494)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1284]" class="style-scope patent-text">
    
    [1284]
  </para-num> <div id="p-1199" num="1284" class="description-line style-scope patent-text">For example, see US2011028129 SEQ ID NOs: 1, 2, 3, 4, 5, 6, 7 and 8.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1285]" class="style-scope patent-text">
    
    [1285]
  </para-num> <div id="p-1200" num="1285" class="description-line style-scope patent-text">(78) RON-MST1R (macrophage stimulating 1 receptor (c-met-related tyrosine kinase))</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1286]" class="style-scope patent-text">
    
    [1286]
  </para-num> <div id="p-1201" num="1286" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1287]" class="style-scope patent-text">
    
    [1287]
  </para-num> <div id="p-1202" num="1287" class="description-line style-scope patent-text">Genbank accession no. X70040</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1288]" class="style-scope patent-text">
    
    [1288]
  </para-num> <div id="p-1203" num="1288" class="description-line style-scope patent-text">Genbank version no. X70040.1 GI:36109</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1289]" class="style-scope patent-text">
    
    [1289]
  </para-num> <div id="p-1204" num="1289" class="description-line style-scope patent-text">Genbank record update date: Feb. 02, 2011 10:17 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1290]" class="style-scope patent-text">
    
    [1290]
  </para-num> <div id="p-1205" num="1290" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1291]" class="style-scope patent-text">
    
    [1291]
  </para-num> <div id="p-1206" num="1291" class="description-line style-scope patent-text">Genbank accession no. CCA49634</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1292]" class="style-scope patent-text">
    
    [1292]
  </para-num> <div id="p-1207" num="1292" class="description-line style-scope patent-text">Genbank version no. CCA49634.1 GI:36110</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1293]" class="style-scope patent-text">
    
    [1293]
  </para-num> <div id="p-1208" num="1293" class="description-line style-scope patent-text">Genbank record update date: Feb. 02, 2011 10:17 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1294]" class="style-scope patent-text">
    
    [1294]
  </para-num> <div id="p-1209" num="1294" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1295]" class="style-scope patent-text">
    
    [1295]
  </para-num> <div id="p-1210" num="1295" class="description-line style-scope patent-text">Ronsin C., et al Oncogene 8 (5), 1195-1202 (1993)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1296]" class="style-scope patent-text">
    
    [1296]
  </para-num> <div id="p-1211" num="1296" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1297]" class="style-scope patent-text">
    
    [1297]
  </para-num> <div id="p-1212" num="1297" class="description-line style-scope patent-text">Official Symbol: MST1R</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1298]" class="style-scope patent-text">
    
    [1298]
  </para-num> <div id="p-1213" num="1298" class="description-line style-scope patent-text">Other Aliases: CD136, CDw136, PTK8, RON</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1299]" class="style-scope patent-text">
    
    [1299]
  </para-num> <div id="p-1214" num="1299" class="description-line style-scope patent-text">Other Designations: MSP receptor; MST1 R variant RON30; MST1R variant RON62; PTK8 <figure-callout id="8" label="protein tyrosine kinase" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">protein tyrosine kinase</a></figure-callout> 8; RON variant E2E3; c-met-related tyrosine kinase; macrophage-stimulating protein receptor; p185-Ron; soluble RON variant 1; soluble RON variant 2; <figure-callout id="3" label="soluble RON variant" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">soluble RON variant</a></figure-callout> 3; <figure-callout id="4" label="soluble RONvariant" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">soluble RONvariant</a></figure-callout> 4</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1300]" class="style-scope patent-text">
    
    [1300]
  </para-num> <div id="p-1215" num="1300" class="description-line style-scope patent-text">(79) EPHA2 (EPH receptor A2)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1301]" class="style-scope patent-text">
    
    [1301]
  </para-num> <div id="p-1216" num="1301" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1302]" class="style-scope patent-text">
    
    [1302]
  </para-num> <div id="p-1217" num="1302" class="description-line style-scope patent-text">Genbank accession no. BC037166</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1303]" class="style-scope patent-text">
    
    [1303]
  </para-num> <div id="p-1218" num="1303" class="description-line style-scope patent-text">Genbank version no. BC037166.2 GI:33879863</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1304]" class="style-scope patent-text">
    
    [1304]
  </para-num> <div id="p-1219" num="1304" class="description-line style-scope patent-text">Genbank record update date: Mar. 06, 2012 01:59 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1305]" class="style-scope patent-text">
    
    [1305]
  </para-num> <div id="p-1220" num="1305" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1306]" class="style-scope patent-text">
    
    [1306]
  </para-num> <div id="p-1221" num="1306" class="description-line style-scope patent-text">Genbank accession no. AAH37166</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1307]" class="style-scope patent-text">
    
    [1307]
  </para-num> <div id="p-1222" num="1307" class="description-line style-scope patent-text">Genbank version no. AAH37166.1 GI:22713539</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1308]" class="style-scope patent-text">
    
    [1308]
  </para-num> <div id="p-1223" num="1308" class="description-line style-scope patent-text">Genbank record update date: Mar. 06, 2012 01:59 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1309]" class="style-scope patent-text">
    
    [1309]
  </para-num> <div id="p-1224" num="1309" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1310]" class="style-scope patent-text">
    
    [1310]
  </para-num> <div id="p-1225" num="1310" class="description-line style-scope patent-text">Strausberg R. L., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>99 (26), 16899-16903 (2002)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1311]" class="style-scope patent-text">
    
    [1311]
  </para-num> <div id="p-1226" num="1311" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1312]" class="style-scope patent-text">
    
    [1312]
  </para-num> <div id="p-1227" num="1312" class="description-line style-scope patent-text">Official Symbol: EPHA2</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1313]" class="style-scope patent-text">
    
    [1313]
  </para-num> <div id="p-1228" num="1313" class="description-line style-scope patent-text">Other Aliases: ARCC2, CTPA, CTPP1, ECK</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1314]" class="style-scope patent-text">
    
    [1314]
  </para-num> <div id="p-1229" num="1314" class="description-line style-scope patent-text">Other Designations: ephrin type-A receptor 2; epithelial cell receptor protein tyrosine kinase; soluble EPHA2 variant 1; tyrosine-protein kinase receptor ECK</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1315]" class="style-scope patent-text">
    
    [1315]
  </para-num> <div id="p-1230" num="1315" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1316]" class="style-scope patent-text">
    
    [1316]
  </para-num> <div id="p-1231" num="1316" class="description-line style-scope patent-text">Medimmune: 1C1 (Lee J W., et al <i class="style-scope patent-text">Clin Cancer Res. </i>2010 May 1; 16(9):2562-2570)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1317]" class="style-scope patent-text">
    
    [1317]
  </para-num> <div id="p-1232" num="1317" class="description-line style-scope patent-text">For example, see US20090304721A1 <figref idrefs="DRAWINGS" class="style-scope patent-text">FIGS. 7 and 8</figref>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1318]" class="style-scope patent-text">
    
    [1318]
  </para-num> <div id="p-1233" num="1318" class="description-line style-scope patent-text">(80) CD20-MS4A1 (membrane-spanning 4-domains, subfamily A, member 1)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1319]" class="style-scope patent-text">
    
    [1319]
  </para-num> <div id="p-1234" num="1319" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1320]" class="style-scope patent-text">
    
    [1320]
  </para-num> <div id="p-1235" num="1320" class="description-line style-scope patent-text">Genbank accession no. M27394</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1321]" class="style-scope patent-text">
    
    [1321]
  </para-num> <div id="p-1236" num="1321" class="description-line style-scope patent-text">Genbank version no. M27394.1 GI:179307</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1322]" class="style-scope patent-text">
    
    [1322]
  </para-num> <div id="p-1237" num="1322" class="description-line style-scope patent-text">Genbank record update date: Nov. 30, 2009 11:16 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1323]" class="style-scope patent-text">
    
    [1323]
  </para-num> <div id="p-1238" num="1323" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1324]" class="style-scope patent-text">
    
    [1324]
  </para-num> <div id="p-1239" num="1324" class="description-line style-scope patent-text">Genbank accession no. AAA35581</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1325]" class="style-scope patent-text">
    
    [1325]
  </para-num> <div id="p-1240" num="1325" class="description-line style-scope patent-text">Genbank version no. AAA35581.1 GI:179308</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1326]" class="style-scope patent-text">
    
    [1326]
  </para-num> <div id="p-1241" num="1326" class="description-line style-scope patent-text">Genbank record update date: Nov. 30, 2009 11:16 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1327]" class="style-scope patent-text">
    
    [1327]
  </para-num> <div id="p-1242" num="1327" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1328]" class="style-scope patent-text">
    
    [1328]
  </para-num> <div id="p-1243" num="1328" class="description-line style-scope patent-text">Tedder T. F., et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>85 (1), 208-212 (1988)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1329]" class="style-scope patent-text">
    
    [1329]
  </para-num> <div id="p-1244" num="1329" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1330]" class="style-scope patent-text">
    
    [1330]
  </para-num> <div id="p-1245" num="1330" class="description-line style-scope patent-text">Official Symbol: MS4A1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1331]" class="style-scope patent-text">
    
    [1331]
  </para-num> <div id="p-1246" num="1331" class="description-line style-scope patent-text">Other Aliases: B1, Bp35, CD20, CVIDS, LEU-16, MS4A2, S7</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1332]" class="style-scope patent-text">
    
    [1332]
  </para-num> <div id="p-1247" num="1332" class="description-line style-scope patent-text">Other Designations: B-lymphocyte antigen CD20; B-lymphocyte cell-surface antigen B1;</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1333]" class="style-scope patent-text">
    
    [1333]
  </para-num> <div id="p-1248" num="1333" class="description-line style-scope patent-text">CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1334]" class="style-scope patent-text">
    
    [1334]
  </para-num> <div id="p-1249" num="1334" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1335]" class="style-scope patent-text">
    
    [1335]
  </para-num> <div id="p-1250" num="1335" class="description-line style-scope patent-text">Genentech/Roche: Rituximab-Abdulla N E., et al <i class="style-scope patent-text">BioDrugs. </i>2012 Apr. 1;26(2):71-82.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1336]" class="style-scope patent-text">
    
    [1336]
  </para-num> <div id="p-1251" num="1336" class="description-line style-scope patent-text">For example, see U.S. Pat. No. 5,736,137, ATCC deposit No. HB-69119.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1337]" class="style-scope patent-text">
    
    [1337]
  </para-num> <div id="p-1252" num="1337" class="description-line style-scope patent-text">GSK/Genmab: Ofatumumab-Nightingale G., et al Ann Pharmacother. 2011</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1338]" class="style-scope patent-text">
    
    [1338]
  </para-num> <div id="p-1253" num="1338" class="description-line style-scope patent-text">Oct.; 45(10):1248-55.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1339]" class="style-scope patent-text">
    
    [1339]
  </para-num> <div id="p-1254" num="1339" class="description-line style-scope patent-text">For example, see US20090169550A1 SEQ ID NOs: 2, 4 and 5.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1340]" class="style-scope patent-text">
    
    [1340]
  </para-num> <div id="p-1255" num="1340" class="description-line style-scope patent-text">Immunomedics: Veltuzumab-Goldenberg D M., et al <i class="style-scope patent-text">Leuk Lymphoma. </i>2010 May; 51(5):747-55.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1341]" class="style-scope patent-text">
    
    [1341]
  </para-num> <div id="p-1256" num="1341" class="description-line style-scope patent-text">For example, see U.S. Pat. No. 7,919,273B2 SEQ ID NOs: 1, 2, 3, 4, 5 and 6.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1342]" class="style-scope patent-text">
    
    [1342]
  </para-num> <div id="p-1257" num="1342" class="description-line style-scope patent-text">(81) Tenascin C-TNC (Tenascin C)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1343]" class="style-scope patent-text">
    
    [1343]
  </para-num> <div id="p-1258" num="1343" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1344]" class="style-scope patent-text">
    
    [1344]
  </para-num> <div id="p-1259" num="1344" class="description-line style-scope patent-text">Genbank accession no. NM_002160</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1345]" class="style-scope patent-text">
    
    [1345]
  </para-num> <div id="p-1260" num="1345" class="description-line style-scope patent-text">Genbank version no. NM_002160.3 GI:340745336</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1346]" class="style-scope patent-text">
    
    [1346]
  </para-num> <div id="p-1261" num="1346" class="description-line style-scope patent-text">Genbank record update date: Sep. 23, 2012 02:33 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1347]" class="style-scope patent-text">
    
    [1347]
  </para-num> <div id="p-1262" num="1347" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1348]" class="style-scope patent-text">
    
    [1348]
  </para-num> <div id="p-1263" num="1348" class="description-line style-scope patent-text">Genbank accession no. NP_002151</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1349]" class="style-scope patent-text">
    
    [1349]
  </para-num> <div id="p-1264" num="1349" class="description-line style-scope patent-text">Genbank version no. NP_002151.2 GI:153946395</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1350]" class="style-scope patent-text">
    
    [1350]
  </para-num> <div id="p-1265" num="1350" class="description-line style-scope patent-text">Genbank record update date: Sep. 23, 2012 02:33 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1351]" class="style-scope patent-text">
    
    [1351]
  </para-num> <div id="p-1266" num="1351" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1352]" class="style-scope patent-text">
    
    [1352]
  </para-num> <div id="p-1267" num="1352" class="description-line style-scope patent-text">Nies D. E., et al <i class="style-scope patent-text">J. Biol. Chem. </i>266 (5), 2818-2823 (1991); Siri A., et al <i class="style-scope patent-text">Nucleic Acids Res. </i>19 (3), 525-531 (1991)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1353]" class="style-scope patent-text">
    
    [1353]
  </para-num> <div id="p-1268" num="1353" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1354]" class="style-scope patent-text">
    
    [1354]
  </para-num> <div id="p-1269" num="1354" class="description-line style-scope patent-text">Official Symbol: TNC</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1355]" class="style-scope patent-text">
    
    [1355]
  </para-num> <div id="p-1270" num="1355" class="description-line style-scope patent-text">Other Aliases: 150-225, GMEM, GP, HXB, JI, TN, TN—C</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1356]" class="style-scope patent-text">
    
    [1356]
  </para-num> <div id="p-1271" num="1356" class="description-line style-scope patent-text">Other Designations: GP 150-225; cytotactin; glioma-associated-extracellular matrix antigen; hexabrachion (tenascin); myotendinous antigen; neuronectin; tenascin; tenascin-C isoform 14/AD1/16</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1357]" class="style-scope patent-text">
    
    [1357]
  </para-num> <div id="p-1272" num="1357" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1358]" class="style-scope patent-text">
    
    [1358]
  </para-num> <div id="p-1273" num="1358" class="description-line style-scope patent-text">Philogen: G11 (von Lukowicz T., et al <i class="style-scope patent-text">J Nucl Med. </i>2007 Apr.; 48(4):582-7) and F16 (Pedretti M., et al Lung Cancer. 2009 Apr.; 64(1):28-33)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1359]" class="style-scope patent-text">
    
    [1359]
  </para-num> <div id="p-1274" num="1359" class="description-line style-scope patent-text">For example, see U.S. 7,968,685 SEQ ID NOs: 29, 35, 45 and 47.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1360]" class="style-scope patent-text">
    
    [1360]
  </para-num> <div id="p-1275" num="1360" class="description-line style-scope patent-text">(82) FAP (Fibroblast activation protein, alpha)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1361]" class="style-scope patent-text">
    
    [1361]
  </para-num> <div id="p-1276" num="1361" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1362]" class="style-scope patent-text">
    
    [1362]
  </para-num> <div id="p-1277" num="1362" class="description-line style-scope patent-text">Genbank accession no. U09278</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1363]" class="style-scope patent-text">
    
    [1363]
  </para-num> <div id="p-1278" num="1363" class="description-line style-scope patent-text">Genbank version no. U09278.1 GI:1888315</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1364]" class="style-scope patent-text">
    
    [1364]
  </para-num> <div id="p-1279" num="1364" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 09:22 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1365]" class="style-scope patent-text">
    
    [1365]
  </para-num> <div id="p-1280" num="1365" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1366]" class="style-scope patent-text">
    
    [1366]
  </para-num> <div id="p-1281" num="1366" class="description-line style-scope patent-text">Genbank accession no. AAB49652</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1367]" class="style-scope patent-text">
    
    [1367]
  </para-num> <div id="p-1282" num="1367" class="description-line style-scope patent-text">Genbank version no. AAB49652.1 GI:1888316</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1368]" class="style-scope patent-text">
    
    [1368]
  </para-num> <div id="p-1283" num="1368" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 09:22 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1369]" class="style-scope patent-text">
    
    [1369]
  </para-num> <div id="p-1284" num="1369" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1370]" class="style-scope patent-text">
    
    [1370]
  </para-num> <div id="p-1285" num="1370" class="description-line style-scope patent-text">Scanlan, M. J.,et al <i class="style-scope patent-text">Proc. Natl. Acad. Sci. U.S.A. </i>91 (12), 5657-5661 (1994)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1371]" class="style-scope patent-text">
    
    [1371]
  </para-num> <div id="p-1286" num="1371" class="description-line style-scope patent-text">Other information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1372]" class="style-scope patent-text">
    
    [1372]
  </para-num> <div id="p-1287" num="1372" class="description-line style-scope patent-text">Official Symbol: FAP</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1373]" class="style-scope patent-text">
    
    [1373]
  </para-num> <div id="p-1288" num="1373" class="description-line style-scope patent-text">Other Aliases: DPPIV, FAPA</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1374]" class="style-scope patent-text">
    
    [1374]
  </para-num> <div id="p-1289" num="1374" class="description-line style-scope patent-text">Other Designations: 170 kDa melanoma membrane-bound gelatinase; integral membrane serine protease; seprase</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1375]" class="style-scope patent-text">
    
    [1375]
  </para-num> <div id="p-1290" num="1375" class="description-line style-scope patent-text">(83) DKK-1 (Dickkopf 1 homolog (Xenopus laevis)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1376]" class="style-scope patent-text">
    
    [1376]
  </para-num> <div id="p-1291" num="1376" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1377]" class="style-scope patent-text">
    
    [1377]
  </para-num> <div id="p-1292" num="1377" class="description-line style-scope patent-text">Genbank accession no. NM_012242</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1378]" class="style-scope patent-text">
    
    [1378]
  </para-num> <div id="p-1293" num="1378" class="description-line style-scope patent-text">Genbank version no. NM_012242.2 GI:61676924</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1379]" class="style-scope patent-text">
    
    [1379]
  </para-num> <div id="p-1294" num="1379" class="description-line style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:48 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1380]" class="style-scope patent-text">
    
    [1380]
  </para-num> <div id="p-1295" num="1380" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1381]" class="style-scope patent-text">
    
    [1381]
  </para-num> <div id="p-1296" num="1381" class="description-line style-scope patent-text">Genbank accession no. NP_036374</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1382]" class="style-scope patent-text">
    
    [1382]
  </para-num> <div id="p-1297" num="1382" class="description-line style-scope patent-text">Genbank version no. NP_036374.1 GI:7110719</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1383]" class="style-scope patent-text">
    
    [1383]
  </para-num> <div id="p-1298" num="1383" class="description-line style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:48 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1384]" class="style-scope patent-text">
    
    [1384]
  </para-num> <div id="p-1299" num="1384" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1385]" class="style-scope patent-text">
    
    [1385]
  </para-num> <div id="p-1300" num="1385" class="description-line style-scope patent-text">Fedi P. et al <i class="style-scope patent-text">J.Biol. Chem. </i>274 (27), 19465-19472 (1999)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1386]" class="style-scope patent-text">
    
    [1386]
  </para-num> <div id="p-1301" num="1386" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1387]" class="style-scope patent-text">
    
    [1387]
  </para-num> <div id="p-1302" num="1387" class="description-line style-scope patent-text">Official Symbol: DKK1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1388]" class="style-scope patent-text">
    
    [1388]
  </para-num> <div id="p-1303" num="1388" class="description-line style-scope patent-text">Other Aliases: UNQ492/PRO1008, DKK-1, SK</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1389]" class="style-scope patent-text">
    
    [1389]
  </para-num> <div id="p-1304" num="1389" class="description-line style-scope patent-text">Other Designations: dickkopf related protein-1; dickkopf-1 like; dickkopf-like protein 1; dickkopf-related protein 1; hDkk-1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1390]" class="style-scope patent-text">
    
    [1390]
  </para-num> <div id="p-1305" num="1390" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1391]" class="style-scope patent-text">
    
    [1391]
  </para-num> <div id="p-1306" num="1391" class="description-line style-scope patent-text">Novartis: BHQ880 (Fulciniti M., et al <i class="style-scope patent-text">Blood. </i>2009 Jul. 9; 114(2):371-379)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1392]" class="style-scope patent-text">
    
    [1392]
  </para-num> <div id="p-1307" num="1392" class="description-line style-scope patent-text">For example, see US20120052070A1 SEQ ID NOs: 100 and 108.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1393]" class="style-scope patent-text">
    
    [1393]
  </para-num> <div id="p-1308" num="1393" class="description-line style-scope patent-text">(84) CD52 (CD52 molecule)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1394]" class="style-scope patent-text">
    
    [1394]
  </para-num> <div id="p-1309" num="1394" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1395]" class="style-scope patent-text">
    
    [1395]
  </para-num> <div id="p-1310" num="1395" class="description-line style-scope patent-text">Genbank accession no. NM_001803</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1396]" class="style-scope patent-text">
    
    [1396]
  </para-num> <div id="p-1311" num="1396" class="description-line style-scope patent-text">Genbank version no. NM_001803.2 GI:68342029</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1397]" class="style-scope patent-text">
    
    [1397]
  </para-num> <div id="p-1312" num="1397" class="description-line style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:48 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1398]" class="style-scope patent-text">
    
    [1398]
  </para-num> <div id="p-1313" num="1398" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1399]" class="style-scope patent-text">
    
    [1399]
  </para-num> <div id="p-1314" num="1399" class="description-line style-scope patent-text">Genbank accession no. NP_001794</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1400]" class="style-scope patent-text">
    
    [1400]
  </para-num> <div id="p-1315" num="1400" class="description-line style-scope patent-text">Genbank version no. NP_001794.2 GI:68342030</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1401]" class="style-scope patent-text">
    
    [1401]
  </para-num> <div id="p-1316" num="1401" class="description-line style-scope patent-text">Genbank record update date: Sep. 30, 2012 01:48 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1402]" class="style-scope patent-text">
    
    [1402]
  </para-num> <div id="p-1317" num="1402" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1403]" class="style-scope patent-text">
    
    [1403]
  </para-num> <div id="p-1318" num="1403" class="description-line style-scope patent-text">Xia M. Q., et al <i class="style-scope patent-text">Eur. J. Immunol. </i>21 (7), 1677-1684 (1991)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1404]" class="style-scope patent-text">
    
    [1404]
  </para-num> <div id="p-1319" num="1404" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1405]" class="style-scope patent-text">
    
    [1405]
  </para-num> <div id="p-1320" num="1405" class="description-line style-scope patent-text">Official Symbol: CD52</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1406]" class="style-scope patent-text">
    
    [1406]
  </para-num> <div id="p-1321" num="1406" class="description-line style-scope patent-text">Other Aliases: CDW52</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1407]" class="style-scope patent-text">
    
    [1407]
  </para-num> <div id="p-1322" num="1407" class="description-line style-scope patent-text">Other Designations: CAMPATH-1 antigen; CD52 antigen (CAMPATH-1 antigen); CDW52 antigen (CAMPATH-1 antigen); cambridge pathology 1 antigen; epididymal secretory protein E5; he5; human epididymis-specific protein 5</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1408]" class="style-scope patent-text">
    
    [1408]
  </para-num> <div id="p-1323" num="1408" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1409]" class="style-scope patent-text">
    
    [1409]
  </para-num> <div id="p-1324" num="1409" class="description-line style-scope patent-text">Alemtuzumab (Campath)-Skoetz N., et al <i class="style-scope patent-text">Cochrane Database Syst Rev. </i>2012 Feb. 15; 2:CD008078.
</div> </li> <ul class="style-scope patent-text"> <li id="ul0100-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0101-0001" num="1410" class="style-scope patent-text">For example, see Drugbank Acc. No. DB00087 (BIOD00109, BTD00109)</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[1411]" class="style-scope patent-text">
    
    [1411]
  </para-num> <div id="p-1325" num="1411" class="description-line style-scope patent-text">(85) CS1- SLAMF7 (SLAM family member 7)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1412]" class="style-scope patent-text">
    
    [1412]
  </para-num> <div id="p-1326" num="1412" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1413]" class="style-scope patent-text">
    
    [1413]
  </para-num> <div id="p-1327" num="1413" class="description-line style-scope patent-text">Genbank accession no. NM_021181</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1414]" class="style-scope patent-text">
    
    [1414]
  </para-num> <div id="p-1328" num="1414" class="description-line style-scope patent-text">Genbank version no. NM_021181.3 GI:1993571</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1415]" class="style-scope patent-text">
    
    [1415]
  </para-num> <div id="p-1329" num="1415" class="description-line style-scope patent-text">Genbank record update date: Jun. 29, 2012 11:24 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1416]" class="style-scope patent-text">
    
    [1416]
  </para-num> <div id="p-1330" num="1416" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1417]" class="style-scope patent-text">
    
    [1417]
  </para-num> <div id="p-1331" num="1417" class="description-line style-scope patent-text">Genbank accession no. NP_067004</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1418]" class="style-scope patent-text">
    
    [1418]
  </para-num> <div id="p-1332" num="1418" class="description-line style-scope patent-text">Genbank version no. NP_067004.3 GI:19923572</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1419]" class="style-scope patent-text">
    
    [1419]
  </para-num> <div id="p-1333" num="1419" class="description-line style-scope patent-text">Genbank record update date: Jun. 29, 2012 11:24 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1420]" class="style-scope patent-text">
    
    [1420]
  </para-num> <div id="p-1334" num="1420" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1421]" class="style-scope patent-text">
    
    [1421]
  </para-num> <div id="p-1335" num="1421" class="description-line style-scope patent-text">Boles K. S., et al <i class="style-scope patent-text">Immunogenetics </i>52 (3-4), 302-307 (2001)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1422]" class="style-scope patent-text">
    
    [1422]
  </para-num> <div id="p-1336" num="1422" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1423]" class="style-scope patent-text">
    
    [1423]
  </para-num> <div id="p-1337" num="1423" class="description-line style-scope patent-text">Official Symbol: SLAMF7</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1424]" class="style-scope patent-text">
    
    [1424]
  </para-num> <div id="p-1338" num="1424" class="description-line style-scope patent-text">Other Aliases: UNQ576/PRO1138, 19A, CD319, CRACC, CS1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1425]" class="style-scope patent-text">
    
    [1425]
  </para-num> <div id="p-1339" num="1425" class="description-line style-scope patent-text">Other Designations: 19A24 protein; CD2 subset 1; CD2-like receptor activating cytotoxic cells; CD2-like receptor-activating cytotoxic cells; membrane protein FOAP-12; novel LY9 (lymphocyte antigen 9) like protein; protein 19A</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1426]" class="style-scope patent-text">
    
    [1426]
  </para-num> <div id="p-1340" num="1426" class="description-line style-scope patent-text">ANTIBODIES</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1427]" class="style-scope patent-text">
    
    [1427]
  </para-num> <div id="p-1341" num="1427" class="description-line style-scope patent-text">BMS: elotuzumab/HuLuc63 (Benson D M., et al <i class="style-scope patent-text">J Clin Oncol. </i>2012 Jun. 1; 30(16):2013-2015)
</div> </li> <ul class="style-scope patent-text"> <li id="ul0102-0001" num="0000" class="style-scope patent-text"> <ul class="style-scope patent-text"> <li id="ul0103-0001" num="1428" class="style-scope patent-text">For example, see US20110206701 SEQ ID NOs: 9, 10, 11, 12, 13, 14, 15 and 16.</li> </ul> </li> </ul>

    <li class="style-scope patent-text"> <para-num num="[1429]" class="style-scope patent-text">
    
    [1429]
  </para-num> <div id="p-1342" num="1429" class="description-line style-scope patent-text">(86) Endoglin-ENG (Endoglin)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1430]" class="style-scope patent-text">
    
    [1430]
  </para-num> <div id="p-1343" num="1430" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1431]" class="style-scope patent-text">
    
    [1431]
  </para-num> <div id="p-1344" num="1431" class="description-line style-scope patent-text">Genbank accession no. AF035753</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1432]" class="style-scope patent-text">
    
    [1432]
  </para-num> <div id="p-1345" num="1432" class="description-line style-scope patent-text">Genbank version no. AF035753.1 GI:3452260</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1433]" class="style-scope patent-text">
    
    [1433]
  </para-num> <div id="p-1346" num="1433" class="description-line style-scope patent-text">Genbank record update date: Mar. 10, 2010 06:36 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1434]" class="style-scope patent-text">
    
    [1434]
  </para-num> <div id="p-1347" num="1434" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1435]" class="style-scope patent-text">
    
    [1435]
  </para-num> <div id="p-1348" num="1435" class="description-line style-scope patent-text">Genbank accession no. AAC32802</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1436]" class="style-scope patent-text">
    
    [1436]
  </para-num> <div id="p-1349" num="1436" class="description-line style-scope patent-text">Genbank version no. AAC32802.1 GI:3452261</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1437]" class="style-scope patent-text">
    
    [1437]
  </para-num> <div id="p-1350" num="1437" class="description-line style-scope patent-text">Genbank record update date: Mar. 10, 2010 06:36 PM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1438]" class="style-scope patent-text">
    
    [1438]
  </para-num> <div id="p-1351" num="1438" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1439]" class="style-scope patent-text">
    
    [1439]
  </para-num> <div id="p-1352" num="1439" class="description-line style-scope patent-text">Rius C., et al <i class="style-scope patent-text">Blood </i>92 (12), 4677-4690 (1998)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1440]" class="style-scope patent-text">
    
    [1440]
  </para-num> <div id="p-1353" num="1440" class="description-line style-scope patent-text">Official Symbol: ENG</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1441]" class="style-scope patent-text">
    
    [1441]
  </para-num> <div id="p-1354" num="1441" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1442]" class="style-scope patent-text">
    
    [1442]
  </para-num> <div id="p-1355" num="1442" class="description-line style-scope patent-text">Other Aliases: RP11-228B15.2, CD105, END, HHT1, ORW, ORW1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1443]" class="style-scope patent-text">
    
    [1443]
  </para-num> <div id="p-1356" num="1443" class="description-line style-scope patent-text">Other Designations: CD105 antigen</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1444]" class="style-scope patent-text">
    
    [1444]
  </para-num> <div id="p-1357" num="1444" class="description-line style-scope patent-text">(87) Annexin A1-ANXA1 (Annexin A1)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1445]" class="style-scope patent-text">
    
    [1445]
  </para-num> <div id="p-1358" num="1445" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1446]" class="style-scope patent-text">
    
    [1446]
  </para-num> <div id="p-1359" num="1446" class="description-line style-scope patent-text">Genbank accession no. X05908</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1447]" class="style-scope patent-text">
    
    [1447]
  </para-num> <div id="p-1360" num="1447" class="description-line style-scope patent-text">Genbank version no. X05908.1 GI:34387</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1448]" class="style-scope patent-text">
    
    [1448]
  </para-num> <div id="p-1361" num="1448" class="description-line style-scope patent-text">Genbank record update date: Feb. 02, 2011 10:02 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1449]" class="style-scope patent-text">
    
    [1449]
  </para-num> <div id="p-1362" num="1449" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1450]" class="style-scope patent-text">
    
    [1450]
  </para-num> <div id="p-1363" num="1450" class="description-line style-scope patent-text">Genbank accession no. CCA29338</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1451]" class="style-scope patent-text">
    
    [1451]
  </para-num> <div id="p-1364" num="1451" class="description-line style-scope patent-text">Genbank version no. CCA29338.1 GI:34388</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1452]" class="style-scope patent-text">
    
    [1452]
  </para-num> <div id="p-1365" num="1452" class="description-line style-scope patent-text">Genbank record update date: Feb. 02, 2011 10:02 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1453]" class="style-scope patent-text">
    
    [1453]
  </para-num> <div id="p-1366" num="1453" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1454]" class="style-scope patent-text">
    
    [1454]
  </para-num> <div id="p-1367" num="1454" class="description-line style-scope patent-text">Wallner B. P.,et al <i class="style-scope patent-text">Nature </i>320 (6057), 77-81 (1986)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1455]" class="style-scope patent-text">
    
    [1455]
  </para-num> <div id="p-1368" num="1455" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1456]" class="style-scope patent-text">
    
    [1456]
  </para-num> <div id="p-1369" num="1456" class="description-line style-scope patent-text">Official Symbol: ANXA1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1457]" class="style-scope patent-text">
    
    [1457]
  </para-num> <div id="p-1370" num="1457" class="description-line style-scope patent-text">Other Aliases: RP11-71A24.1, ANX1, LPC1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1458]" class="style-scope patent-text">
    
    [1458]
  </para-num> <div id="p-1371" num="1458" class="description-line style-scope patent-text">Other Designations: annexin I (lipocortin I); annexin-I; calpactin II; calpactin-2; chromobindin-9; lipocortin I; p35; phospholipase A2 inhibitory protein</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1459]" class="style-scope patent-text">
    
    [1459]
  </para-num> <div id="p-1372" num="1459" class="description-line style-scope patent-text">(88) V-CAM (CD106)-VCAM1 (Vascular cell adhesion molecule 1)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1460]" class="style-scope patent-text">
    
    [1460]
  </para-num> <div id="p-1373" num="1460" class="description-line style-scope patent-text">Nucleotide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1461]" class="style-scope patent-text">
    
    [1461]
  </para-num> <div id="p-1374" num="1461" class="description-line style-scope patent-text">Genbank accession no. M60335</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1462]" class="style-scope patent-text">
    
    [1462]
  </para-num> <div id="p-1375" num="1462" class="description-line style-scope patent-text">Genbank version no. M60335.1 GI:340193</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1463]" class="style-scope patent-text">
    
    [1463]
  </para-num> <div id="p-1376" num="1463" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:56 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1464]" class="style-scope patent-text">
    
    [1464]
  </para-num> <div id="p-1377" num="1464" class="description-line style-scope patent-text">Polypeptide</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1465]" class="style-scope patent-text">
    
    [1465]
  </para-num> <div id="p-1378" num="1465" class="description-line style-scope patent-text">Genbank accession no. AAA61269</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1466]" class="style-scope patent-text">
    
    [1466]
  </para-num> <div id="p-1379" num="1466" class="description-line style-scope patent-text">Genbank version no. AAA61269.1 GI:340194</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1467]" class="style-scope patent-text">
    
    [1467]
  </para-num> <div id="p-1380" num="1467" class="description-line style-scope patent-text">Genbank record update date: Jun. 23, 2010 08:56 AM</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1468]" class="style-scope patent-text">
    
    [1468]
  </para-num> <div id="p-1381" num="1468" class="description-line style-scope patent-text">Cross-References</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1469]" class="style-scope patent-text">
    
    [1469]
  </para-num> <div id="p-1382" num="1469" class="description-line style-scope patent-text">Hession C., et al <i class="style-scope patent-text">J. Biol. Chem. </i>266 (11), 6682-6685 (1991)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1470]" class="style-scope patent-text">
    
    [1470]
  </para-num> <div id="p-1383" num="1470" class="description-line style-scope patent-text">Other Information</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1471]" class="style-scope patent-text">
    
    [1471]
  </para-num> <div id="p-1384" num="1471" class="description-line style-scope patent-text">Official Symbol VCAM1</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1472]" class="style-scope patent-text">
    
    [1472]
  </para-num> <div id="p-1385" num="1472" class="description-line style-scope patent-text">Other Aliases: CD106, INCAM-100</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1473]" class="style-scope patent-text">
    
    [1473]
  </para-num> <div id="p-1386" num="1473" class="description-line style-scope patent-text">Other Designations: CD106 antigen; vascular cell adhesion protein 1</div>
    </li> <li class="style-scope patent-text"> <div id="p-1387" num="0000" class="description-line style-scope patent-text">
      <tables id="TABLE-US-00001" num="00001" class="style-scope patent-text">
        <patent-tables frame="none" colsep="0" rowsep="0" tabstyle="monospace" class="style-scope patent-text">
          <table align="left" colsep="0" rowsep="0" cols="1" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Antibody Sequences</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Anti-Integrin αvβ6</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RHAB6.2</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQSGSELKKPGASVKISCKASGFAFTDSYMHWVRQAPGQGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">MGWIDPENGDTEYAPKFQGRFVFSLDTSVSTAYLQISSLKAEDTAVY</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YCTRGTPTAVPNLRGDLQVLAQKVAGPYPFDYWGQGTLVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RHCB6.2</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQSGAEVKKPGASVKVSCKASGYTFIDSYMHWVRQAPGQRLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">MGWIDPENGDTEYAPKFQGRVTITTDTSASTAYMELSSLRSEDTAVY</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YCARGTPTAVPNLRGDLQVLAQKVAGPYPFDYWGQGTLVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RHF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQSGAEVKKPGASVKVSCKASGFNFIDSYMHWVRQAPGQRLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">MGWIDPENGDTEYAPKFQGRVTFTTDTSASTAYMELSSLRSEDTAVY</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YCNEGTPTGPYYFDYWGQGTLVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RHFB6</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQSGAEVKKPGASVKVSCKASGFNFIDSYMHWVRQAPGQRLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">MGWIDPENGDTEYAPKFQGRVTFTTDTSASTAYMELSSLRSEDTAVY</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YCNEGTPTAVPNLRGDLQVLAQKVAGPYYFDYWGQGTLVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RHAY100bP</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQSGSELKKPGASVKISCKASGFAFTDSYMHWVRQAPGQGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">MGWIDPENGDTEYAPKFQGRFVFSLDTSVSTAYLQISSLKAEDTAVY</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YCTRGTPTGPYPFDYWGQGTLVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RKF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ENVLTQSPGTLSLSPGERATLSCSASSSVSYMHWFQQKPGQAPRLLI</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YSTSNLASGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQRSSYP</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">LTFGGGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RKFL36L50</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ENVLTQSPGTLSLSPGERATLSCSASSSVSYMHWLQQKPGQAPRLLI</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YLTSNLASGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQRSSYP</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">LTFGGGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">RKC</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EIVLTQSPGTLSLSPGERATLSCSASSSVSYMHWFQQKPGQAPRLLI</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YSTSNLASGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQRSSYP</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">LTFGGGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Anti-CD33</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">CD33 Hum195 VH</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQSGAEVKKPGSSVKVSCKASGYTFTDYNMHWVRQAPGQGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IGYIYPYNGGTGYNQKFKSKATITADESTNTAYMELSSLRSEDTAVY</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YCARGRPAMDYWGQGTLVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">CD33 Hum195 VK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSLSASVGDRVTITCRASESVDNYGISFMNWFQQKPGKA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PKLLIYAASNQGSGVPSRFSGSGSGTDFTLTISSLQPDDFATYYCQQ</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">SKEVPWTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Anti-CD19</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">CD19 B4 resurfaced VH</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QVQLVQPGAEVVKPGASVKLSCKTSGYTFTSNWMHWVKQRPGQGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IGEIDPSDSYTNYNQNFKGKAKLTVDKSTSTAYMEVSSLRSDDTAVY</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YCARGSNPYYYAMDYWGQGTSVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">CD19 B4 resurfaced VK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EIVLTQSPAIMSASPGERVTMTCSASSGVNYMHWYQQKPGTSPRRWI</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YDTSKLASGVPARFSGSGSGTSYSLTISSMEPEDAATYYCHQRGSYT</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">FGGGTKLEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Anti-Her2</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Herceptin VH chain</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVY</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YCSRWGGDGFYAMDYWGQGTLVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Herceptin VL chain</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLL</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTT</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PPTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Anti-CD25</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Simulect VK (also known as Basiliximab)</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QIVSTQSPAIMSASPGEKVTMTCSASSSRSYMQWYQQKPGTSPKRWI</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YDTSKLASGVPARFSGSGSGTSYSLTISSMEAEDAATYYCHQRSSYT</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">FGGGTKLEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Simulect VH</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">QLQQSGTVLARPGASVKMSCKASGYSFTRYWMHWIKQRPGQGLEWIG</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">AIYPGNSDTSYNQKFEGKAKLTAVTSASTAYMELSSLTHEDSAVYYC</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">SRDYGYYFDFWGQGTTLTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Anti-PSMA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VH ′1</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVQLVQSGPEVKKPGATVKISCKTSGYTFTEYTIHWVKQAPGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IGNINPNNGGTTYNQKFEDKATLTVDKSTDTAYMELSSLRSEDTAVY</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">YCAAGWNFDYWGQGTLLTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VK ′1</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSLSTSVGDRVTLTCKASQDVGTAVDWYQQKPGPSPKLL</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYWASTRHTGIPSRFSGSGSGTDFTLTISSLQPEDFADYYCQQYNSY</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PLTFGPGTKVDIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VH1 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSMKLSCVASGFTFSNYWMNWVRQAPGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VAEIRSQSNNFATHYAESVKGRVTISRDDSKSIVYLQMNNLRAEDTG</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VH2 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCVASGFTFSNYWMNWVRQAPGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VAEIRSQSNNFATHYAESVKGRVTISRDDSKSIVYLQMNNLRAEDTA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VH3 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVQLVESGGGLVQPGGSLKLSCVASGFTFSNYWMNWVRQAPGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VAEIRSQSNNFATHYAESVKGRVTISRDDSKSIVYLQMNNLRAEDTA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VH4 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVQLVESGGGLVQPGGSLKLSCVASGFTFSNYWMNWVRQAPGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VAEIRSQSNNFATHYAESVKGRFTISRDDSKSIVYLQMNNLRAEDTA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VK1 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIVMTQFPSSMSASVGDRVTITCKASENVGTYVSWYQQKPDQSPKML</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYGASNRFTGVPDRFTGSGSATDFTLTISSLQTEDLADYYCGQSYTF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PYTFGQGTKLEMK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VK2 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIVMTQFPSSMSASVGDRVTITCKASENVGTYVSWYQQKPDQSPKML</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYGASNRFTGVPDRFSGSGSGTDFTLTISSLQAEDLADYYCGQSYTF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PYTFGQGTKLEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VK3 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIQMTQFPSAMSASVGDRVTITCKASENVGTYVSWYQQKPDQSPKML</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYGASNRFTGVPDRFSGSGSGTDFTLTISSLQAEDLADYYCGQSYTF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PYTFGQGTKLEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VK4 ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIQMTQFPSAMSASVGDRVTITCKASENVGTYVSWYQQKPDQSPKML</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYGASNRFTGVPDRFSGSGSGTDFTLTISSLQAEDEADYYCGQSYTF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PYTFGQGTKLEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VK DI ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIVMTQFPKSMSASAGERMTLTCKASENVGTYVSWYQQKPTQSPKML</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYGASNRFTGVPDRFSGSGSGTDFILTISSVQAEDLVDYYCGQSYTF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PYTFGGGTKLEMK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Deimmunised VH DI ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLEESGGGLVQPGGSMKISCVASGFTFSNYWMNWVRQSPEKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VAEIRSQSNNFATHYAESVKGRVIISRDDSKSSVYLQMNSLRAEDTA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">H</b>A ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVQLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VGEIRSQSNNFATHYAESVKGRFTISRDDSKNTAYLQMNSLKTEDTA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">H</b>B ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VAEIRSQSNNFATHYAESVKGRVIISRDDSKNTVYLQMNSLRTEDTA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">H</b>C ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVQLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VAEIRSQSNNFATHYAESVKGRVIISRDDSKNTVYLQMNSLRTEDTA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">H</b>D ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VGEIRSQSNNFATHYAESVKGRVIISRDDSKNTVYLQMNSLRTEDTA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">H</b>E ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VAEIRSQSNNFATHYAESVKGRFTISRDDSKNTVYLQMNSLRTEDTA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">H</b>F ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VAEIRSQSNNFATHYAESVKGRVIISRDDSKNTAYLQMNSLRTEDTA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">H</b>G ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">EVKLVESGGGLVQPGGSLKLSCAASGFTFSNYWMNWVRQASGKGLEW</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VAEIRSQSNNFATHYAESVKGRVIISRDDSKNTAYLQMNSLRTEDTA</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">VYYCTRRWNNFWGQGTTVTVSS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">K</b>A ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKLL</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYGASNRFTGVPSRFSGSGSATDFTLTINNLQPEDFATYYCGQSYTF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PYTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">K</b>B ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKLL</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYGASNRFTGVPSRFSGSGSATDFTLTINNLQPEDFATYYCGQSYTF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PYTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">K</b>C ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKML</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYGASNRFTGVPSRFSGSGSATDFTLTINNLQPEDFATYYCGQSYTF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PYTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">K</b>D ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">DIQMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKML</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYGASNRFTGVPSRFSGSGSATDFTLTINNLQPEDFATYYCGQSYTF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PYTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">K</b>E ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIVMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKLL</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYGASNRFTGVPDRFTGSGSATDFILTINNLQPEDFATYYCGQSYTF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PYTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">K</b>F ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIVMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKML</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYGASNRFTGVPSRFSGSGSATDFILTINNLQPEDFATYYCGQSYTF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PYTFGQGTKVEIK</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Humanised R<b class="style-scope patent-text">K</b>G ′5</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NIVMTQSPSSVSASVGDRVTITCKASENVGTYVSWYQQKPGTAPKML</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">IYGASNRFTGVPDRFTGSGSATDFTLTINNLQPEDFATYYCGQSYTF</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">PYTFGQGTKVEIK</td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[1474]" class="style-scope patent-text">
    
    [1474]
  </para-num> <div id="p-1388" num="1474" class="description-line style-scope patent-text">The parent antibody may also be a fusion protein comprising an albumin-binding peptide (ABP) sequence (Dennis et al. (2002) “Albumin Binding As A General Strategy For Improving The Pharmacokinetics Of Proteins” <i class="style-scope patent-text">J Biol Chem. </i>277:35035-35043; WO 01/45746). Antibodies of the invention include fusion proteins with ABP sequences taught by: (i) Dennis et al (2002) <i class="style-scope patent-text">J Biol Chem. </i>277:35035-35043 at Tables III and IV, page 35038; (ii) US 2004/0001827 at [0076]; and (iii) WO 01/45746 at pages 12-13, and all of which are incorporated herein by reference.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1475]" class="style-scope patent-text">
    
    [1475]
  </para-num> <div id="p-1389" num="1475" class="description-line style-scope patent-text">In one embodiment, the antibody has been raised to target specific the tumour related antigen α<sub class="style-scope patent-text">v</sub>β<sub class="style-scope patent-text">6</sub>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1476]" class="style-scope patent-text">
    
    [1476]
  </para-num> <div id="p-1390" num="1476" class="description-line style-scope patent-text">The cell binding agent may be labelled, for example to aid detection or purification of the agent either prior to incorporation as a conjugate, or as part of the conjugate. The label may be a biotin label. In another embodiment, the cell binding agent may be labelled with a radioisotope.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1477]" class="style-scope patent-text">
    
    [1477]
  </para-num> <div id="p-1391" num="1477" class="description-line style-scope patent-text">Connection of Linker Unit to Ligand Unit</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1478]" class="style-scope patent-text">
    
    [1478]
  </para-num> <div id="p-1392" num="1478" class="description-line style-scope patent-text">The Ligand unit is connected to the Linker unit through a disulfide bond.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1479]" class="style-scope patent-text">
    
    [1479]
  </para-num> <div id="p-1393" num="1479" class="description-line style-scope patent-text">In one embodiment, the connection between the Ligand unit and the Drug Linker is formed between a thiol group of a cysteine residue of the Ligand unit and a maleimide group of the Drug Linker unit.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1480]" class="style-scope patent-text">
    
    [1480]
  </para-num> <div id="p-1394" num="1480" class="description-line style-scope patent-text">The cysteine residues of the Ligand unit may be available for reaction with the functional group of the Linker unit to form a connection. In other embodiments, for example where the Ligand unit is an antibody, the thiol groups of the antibody may participate in interchain disulfide bonds. These interchain bonds may be converted to free thiol groups by e.g. treatment of the antibody with DTT prior to reaction with the functional group of the Linker unit.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1481]" class="style-scope patent-text">
    
    [1481]
  </para-num> <div id="p-1395" num="1481" class="description-line style-scope patent-text">In some embodiments, the cysteine residue is an introduced into the heavy or light chain of an antibody. Positions for cysteine insertion by substitution in antibody heavy or light chains include those described in Published U.S. Application No. 2007-0092940 and International Patent Publication WO2008070593, which are incorporated herein.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1482]" class="style-scope patent-text">
    
    [1482]
  </para-num> <div id="p-1396" num="1482" class="description-line style-scope patent-text">Methods of Treatment</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1483]" class="style-scope patent-text">
    
    [1483]
  </para-num> <div id="p-1397" num="1483" class="description-line style-scope patent-text">The compounds of the present invention may be used in a method of therapy. Also provided is a method of treatment, comprising administering to a subject in need of treatment a therapeutically-effective amount of a conjugate of formula I. The term “therapeutically effective amount” is an amount sufficient to show benefit to a patient. Such benefit may be at least amelioration of at least one symptom. The actual amount administered, and rate and time-course of administration, will depend on the nature and severity of what is being treated. Prescription of treatment, e.g. decisions on dosage, is within the responsibility of general practitioners and other medical doctors.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1484]" class="style-scope patent-text">
    
    [1484]
  </para-num> <div id="p-1398" num="1484" class="description-line style-scope patent-text">A conjugate may be administered alone or in combination with other treatments, either simultaneously or sequentially dependent upon the condition to be treated. Examples of treatments and therapies include, but are not limited to, chemotherapy (the administration of active agents, including, e.g. drugs; surgery; and radiation therapy.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1485]" class="style-scope patent-text">
    
    [1485]
  </para-num> <div id="p-1399" num="1485" class="description-line style-scope patent-text">Pharmaceutical compositions according to the present invention, and for use in accordance with the present invention, may comprise, in addition to the active ingredient, i.e. a conjugate of formula I, a pharmaceutically acceptable excipient, carrier, buffer, stabiliser or other materials well known to those skilled in the art. Such materials should be non-toxic and should not interfere with the efficacy of the active ingredient. The precise nature of the carrier or other material will depend on the route of administration, which may be oral, or by injection, e.g. cutaneous, subcutaneous, or intravenous.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1486]" class="style-scope patent-text">
    
    [1486]
  </para-num> <div id="p-1400" num="1486" class="description-line style-scope patent-text">Pharmaceutical compositions for oral administration may be in tablet, capsule, powder or liquid form. A tablet may comprise a solid carrier or an adjuvant. Liquid pharmaceutical compositions generally comprise a liquid carrier such as water, petroleum, animal or vegetable oils, mineral oil or synthetic oil. Physiological saline solution, dextrose or other saccharide solution or glycols such as ethylene glycol, propylene glycol or polyethylene glycol may be included. A capsule may comprise a solid carrier such a gelatin.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1487]" class="style-scope patent-text">
    
    [1487]
  </para-num> <div id="p-1401" num="1487" class="description-line style-scope patent-text">For intravenous, cutaneous or subcutaneous injection, or injection at the site of affliction, the active ingredient will be in the form of a parenterally acceptable aqueous solution which is pyrogen-free and has suitable pH, isotonicity and stability. Those of relevant skill in the art are well able to prepare suitable solutions using, for example, isotonic vehicles such as Sodium Chloride Injection, Ringer's Injection, Lactated Ringer's Injection. Preservatives, stabilisers, buffers, antioxidants and/or other additives may be included, as required.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1488]" class="style-scope patent-text">
    
    [1488]
  </para-num> <div id="p-1402" num="1488" class="description-line style-scope patent-text">The Conjugates can be used to treat proliferative disease and autoimmune disease. The term “proliferative disease” pertains to an unwanted or uncontrolled cellular proliferation of excessive or abnormal cells which is undesired, such as, neoplastic or hyperplastic growth, whether in vitro or in vivo.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1489]" class="style-scope patent-text">
    
    [1489]
  </para-num> <div id="p-1403" num="1489" class="description-line style-scope patent-text">Examples of proliferative conditions include, but are not limited to, benign, pre-malignant, and malignant cellular proliferation, including but not limited to, neoplasms and tumours (e.g., histocytoma, glioma, astrocyoma, osteoma), cancers (e.g. lung cancer, small cell lung cancer, gastrointestinal cancer, bowel cancer, colon cancer, breast carinoma, ovarian carcinoma, prostate cancer, testicular cancer, liver cancer, kidney cancer, bladder cancer, pancreatic cancer, brain cancer, sarcoma, osteosarcoma, Kaposi's sarcoma, melanoma), leukemias, psoriasis, bone diseases, fibroproliferative disorders (e.g. of connective tissues), and atherosclerosis. Other cancers of interest include, but are not limited to, haematological; malignancies such as leukemias and lymphomas, such as non-Hodgkin lymphoma, and subtypes such as DLBCL, marginal zone, mantle zone, and follicular, Hodgkin lymphoma, AML, and other cancers of B or T cell origin.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1490]" class="style-scope patent-text">
    
    [1490]
  </para-num> <div id="p-1404" num="1490" class="description-line style-scope patent-text">Examples of autoimmune disease include the following: rheumatoid arthritis, autoimmune demyelinative diseases (e.g., multiple sclerosis, allergic encephalomyelitis), psoriatic arthritis, endocrine ophthalmopathy, uveoretinitis, systemic lupus erythematosus, myasthenia gravis, Graves' disease, glomerulonephritis, autoimmune hepatological disorder, inflammatory bowel disease (e.g., Crohn's disease), anaphylaxis, allergic reaction, Sjögren's syndrome, type I diabetes mellitus, primary biliary cirrhosis, Wegener's granulomatosis, fibromyalgia, polymyositis, dermatomyositis, multiple endocrine failure, Schmidt's syndrome, autoimmune uveitis, Addison's disease, adrenalitis, thyroiditis, Hashimoto's thyroiditis, autoimmune thyroid disease, pernicious anemia, gastric atrophy, chronic hepatitis, lupoid hepatitis, atherosclerosis, subacute cutaneous lupus erythematosus, hypoparathyroidism, Dressler's syndrome, autoimmune thrombocytopenia, idiopathic thrombocytopenic purpura, hemolytic anemia, pemphigus vulgaris, pemphigus, dermatitis herpetiformis, alopecia arcata, pemphigoid, scleroderma, progressive systemic sclerosis, CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia), male and female autoimmune infertility, ankylosing spondolytis, ulcerative colitis, mixed connective tissue disease, polyarteritis nedosa, systemic necrotizing vasculitis, atopic dermatitis, atopic rhinitis, Goodpasture's syndrome, Chagas' disease, sarcoidosis, rheumatic fever, asthma, recurrent abortion, anti-phospholipid syndrome, farmer's lung, erythema multiforme, post cardiotomy syndrome, Cushing's syndrome, autoimmune chronic active hepatitis, bird-fancier's lung, toxic epidermal necrolysis, Alport's syndrome, alveolitis, allergic alveolitis, fibrosing alveolitis, interstitial lung disease, erythema nodosum, pyoderma gangrenosum, transfusion reaction, Takayasu's arteritis, polymyalgia rheumatica, temporal arteritis, schistosomiasis, giant cell arteritis, ascariasis, aspergillosis, Sampter's syndrome, eczema, lymphomatoid granulomatosis, Behcet's disease, Caplan's syndrome, Kawasaki's disease, dengue, encephalomyelitis, endocarditis, endomyocardial fibrosis, endophthalmitis, erythema elevatum et diutinum, psoriasis, erythroblastosis fetalis, eosinophilic faciitis, Shulman's syndrome, Felty's syndrome, filariasis, cyclitis, chronic cyclitis, heterochronic cyclitis, Fuch's cyclitis, IgA nephropathy, Henoch-Schonlein purpura, graft versus host disease, transplantation rejection, cardiomyopathy, Eaton-Lambert syndrome, relapsing polychondritis, cryoglobulinemia, Waldenstrom's macroglobulemia, Evan's syndrome, and autoimmune gonadal failure.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1491]" class="style-scope patent-text">
    
    [1491]
  </para-num> <div id="p-1405" num="1491" class="description-line style-scope patent-text">In some embodiments, the autoimmune disease is a disorder of B lymphocytes (e.g., systemic lupus erythematosus, Goodpasture's syndrome, rheumatoid arthritis, and type I diabetes), Th1-lymphocytes (e.g., rheumatoid arthritis, multiple sclerosis, psoriasis, Sjögren's syndrome, Hashimoto's thyroiditis, Graves' disease, primary biliary cirrhosis, Wegener's granulomatosis, tuberculosis, or graft versus host disease), or Th2-lymphocytes (e.g., atopic dermatitis, systemic lupus erythematosus, atopic asthma, rhinoconjunctivitis, allergic rhinitis, Omenn's syndrome, systemic sclerosis, or chronic graft versus host disease). Generally, disorders involving dendritic cells involve disorders of Th1-lymphocytes or Th2-lymphocytes. In some embodiments, the autoimmunie disorder is a T cell-mediated immunological disorder.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1492]" class="style-scope patent-text">
    
    [1492]
  </para-num> <div id="p-1406" num="1492" class="description-line style-scope patent-text">In some embodiments, the amount of the Conjugate administered ranges from about 0.01 to about 10 mg/kg per dose. In some embodiments, the amount of the Conjugate administered ranges from about 0.01 to about 5 mg/kg per dose. In some embodiments, the amount of the Conjugate administerd ranges from about 0.05 to about 5 mg/kg per dose. In some embodiments, the amount of the Conjugate administerd ranges from about 0.1 to about 5 mg/kg per dose. In some embodiments, the amount of the Conjugate administered ranges from about 0.1 to about 4 mg/kg per dose. In some embodiments, the amount of the Conjugate administered ranges from about 0.05 to about 3 mg/kg per dose. In some embodiments, the amount of the Conjugate administered ranges from about 0.1 to about 3 mg/kg per dose. In some embodiments, the amount of the Conjugate administered ranges from about 0.1 to about 2 mg/kg per dose.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1493]" class="style-scope patent-text">
    
    [1493]
  </para-num> <div id="p-1407" num="1493" class="description-line style-scope patent-text">Drug Loading</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1494]" class="style-scope patent-text">
    
    [1494]
  </para-num> <div id="p-1408" num="1494" class="description-line style-scope patent-text">The drug loading (p) is the average number of PBD drugs per cell binding agent, e.g. antibody. Where the compounds of the invention are bound to cysteines, drug loading may range from 1 to 8 drugs (D) per cell binding agent, i.e. where 1, 2, 3, 4, 5, 6, 7, and 8 drug moieties are covalently attached to the cell binding agent. Compositions of conjugates include collections of cell binding agents, e.g. antibodies, conjugated with a range of drugs, from 1 to 8. Where the compounds of the invention are bound to lysines, drug loading may range from 1 to 80 drugs (D) per cell binding agent, although an upper limit of 40, 20, 10 or 8 may be preferred. Compositions of conjugates include collections of cell binding agents, e.g. antibodies, conjugated with a range of drugs, from 1 to 80, 1 to 40, 1 to 20, 1 to 10 or 1 to 8.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1495]" class="style-scope patent-text">
    
    [1495]
  </para-num> <div id="p-1409" num="1495" class="description-line style-scope patent-text">The average number of drugs per antibody in preparations of ADC from conjugation reactions may be characterized by conventional means such as UV, reverse phase HPLC, HIC, mass spectroscopy, ELISA assay, and electrophoresis. The quantitative distribution of ADC in terms of p may also be determined. By ELISA, the averaged value of p in a particular preparation of ADC may be determined (Hamblett et al (2004) Clin. Cancer Res. 10:7063-7070; Sanderson et al (2005) Clin. Cancer Res. 11:843-852). However, the distribution of p (drug) values is not discernible by the antibody-antigen binding and detection limitation of ELISA. Also, ELISA assay for detection of antibody-drug conjugates does not determine where the drug moieties are attached to the antibody, such as the heavy chain or light chain fragments, or the particular amino acid residues. In some instances, separation, purification, and characterization of homogeneous ADC where p is a certain value from ADC with other drug loadings may be achieved by means such as reverse phase HPLC or electrophoresis. Such techniques are also applicable to other types of conjugates.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1496]" class="style-scope patent-text">
    
    [1496]
  </para-num> <div id="p-1410" num="1496" class="description-line style-scope patent-text">For some antibody-drug conjugates, p may be limited by the number of attachment sites on the antibody. For example, an antibody may have only one or several cysteine thiol groups, or may have only one or several sufficiently reactive thiol groups through which a linker may be attached. Higher drug loading, e.g. p &gt;5, may cause aggregation, insolubility, toxicity, or loss of cellular permeability of certain antibody-drug conjugates.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1497]" class="style-scope patent-text">
    
    [1497]
  </para-num> <div id="p-1411" num="1497" class="description-line style-scope patent-text">Typically, fewer than the theoretical maximum of drug moieties are conjugated to an antibody during a conjugation reaction. An antibody may contain, for example, many lysine residues that do not react with the Drug Linker. Only the most reactive lysine groups may react with an amine-reactive linker reagent. Also, only the most reactive cysteine thiol groups may react with a thiol-reactive linker reagent. Generally, antibodies do not contain many, if any, free and reactive cysteine thiol groups which may be linked to a drug moiety. Most cysteine thiol residues in the antibodies of the compounds exist as disulfide bridges and must be reduced with a reducing agent such as dithiothreitol (DTT) or TCEP, under partial or total reducing conditions. The loading (drug/antibody ratio) of an ADC may be controlled in several different manners, including: (i) limiting the molar excess of Drug Linker relative to antibody, (ii) limiting the conjugation reaction time or temperature, and (iii) partial or limiting reductive conditions for cysteine thiol modification.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1498]" class="style-scope patent-text">
    
    [1498]
  </para-num> <div id="p-1412" num="1498" class="description-line style-scope patent-text">Certain antibodies have reducible interchain disulfides, i.e. cysteine bridges. Antibodies may be made reactive for conjugation with linker reagents by treatment with a reducing agent such as DTT (dithiothreitol). Each cysteine bridge will thus form, theoretically, two reactive thiol nucleophiles. Additional nucleophilic groups can be introduced into antibodies through the reaction of lysines with 2-iminothiolane (Traut's reagent) resulting in conversion of an amine into a thiol. Reactive thiol groups may be introduced into the antibody (or fragment thereof) by engineering one, two, three, four, or more cysteine residues (e.g., preparing mutant antibodies comprising one or more non-native cysteine amino acid residues). U.S. Pat. No. 7,521,541 teaches engineering antibodies by introduction of reactive cysteine amino acids.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1499]" class="style-scope patent-text">
    
    [1499]
  </para-num> <div id="p-1413" num="1499" class="description-line style-scope patent-text">Cysteine amino acids may be engineered at reactive sites in an antibody and which do not form intrachain or intermolecular disulfide linkages (Junutula, et al., 2008b Nature Biotech., 26(8):925-932; Dornan et al (2009) Blood 114(13):2721-2729; U.S. Pat. No. 7,521,541; U.S. Pat. No. 7,723,485; WO2009/052249). The engineered cysteine thiols may react with linker reagents or the drug-linker reagents of the present invention which have thiol-reactive, electrophilic groups such as maleimide or alpha-halo amides to form ADC with cysteine engineered antibodies and the PBD drug moieties. The location of the drug moiety can thus be designed, controlled, and known. The drug loading can be controlled since the engineered cysteine thiol groups typically react with thiol-reactive linker reagents or drug-linker reagents in high yield. Engineering an IgG antibody to introduce a cysteine amino acid by substitution at a single site on the heavy or light chain gives two new cysteines on the symmetrical antibody. A drug loading near 2 can be achieved with near homogeneity of the conjugation product ADC.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1500]" class="style-scope patent-text">
    
    [1500]
  </para-num> <div id="p-1414" num="1500" class="description-line style-scope patent-text">Where more than one nucleophilic or electrophilic group of the antibody reacts with a drug-linker intermediate, or linker reagent followed by drug moiety reagent, then the resulting product is a mixture of ADC compounds with a distribution of drug moieties attached to an antibody, e.g. 1, 2, 3, etc. Liquid chromatography methods such as polymeric reverse phase (PLRP) and hydrophobic interaction (HIC) may separate compounds in the mixture by drug loading value. Preparations of ADC with a single drug loading value (p) may be isolated, however, these single loading value ADCs may still be heterogeneous mixtures because the drug moieties may be attached, via the linker, at different sites on the antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1501]" class="style-scope patent-text">
    
    [1501]
  </para-num> <div id="p-1415" num="1501" class="description-line style-scope patent-text">Thus the antibody-drug conjugate compositions of the invention include mixtures of antibody-drug conjugate compounds where the antibody has one or more PBD drug moieties and where the drug moieties may be attached to the antibody at various amino acid residues.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1502]" class="style-scope patent-text">
    
    [1502]
  </para-num> <div id="p-1416" num="1502" class="description-line style-scope patent-text">In one embodiment, the average number of dimer pyrrolobenzodiazepine groups per cell binding agent is in the range 1 to 20. In some embodiments the range is selected from 1 to 8, 2 to 8, 2 to 6, 2 to 4, and 4 to 8.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1503]" class="style-scope patent-text">
    
    [1503]
  </para-num> <div id="p-1417" num="1503" class="description-line style-scope patent-text">In some embodiments, there is one dimer pyrrolobenzodiazepine group per cell binding agent.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1504]" class="style-scope patent-text">
    
    [1504]
  </para-num> <div id="p-1418" num="1504" class="description-line style-scope patent-text">General Synthetic Routes</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1505]" class="style-scope patent-text">
    
    [1505]
  </para-num> <div id="p-1419" num="1505" class="description-line style-scope patent-text">The synthesis of PBD compounds is extensively discussed in the following references, which discussions are incorporated herein by reference:</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1506]" class="style-scope patent-text">
    
    [1506]
  </para-num> <div id="p-1420" num="1506" class="description-line style-scope patent-text">a) WO 00/12508 (pages 14 to 30);</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1507]" class="style-scope patent-text">
    
    [1507]
  </para-num> <div id="p-1421" num="1507" class="description-line style-scope patent-text">b) WO 2005/023814 (<figure-callout id="3" label="pages" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pages</a></figure-callout> 3 to 10);</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1508]" class="style-scope patent-text">
    
    [1508]
  </para-num> <div id="p-1422" num="1508" class="description-line style-scope patent-text">c) WO 2004/043963 (<figure-callout id="28" label="pages" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pages</a></figure-callout> 28 to 29); and</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1509]" class="style-scope patent-text">
    
    [1509]
  </para-num> <div id="p-1423" num="1509" class="description-line style-scope patent-text">d) WO 2005/085251 (<figure-callout id="30" label="pages" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">pages</a></figure-callout> 30 to 39).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1510]" class="style-scope patent-text">
    
    [1510]
  </para-num> <div id="p-1424" num="1510" class="description-line style-scope patent-text">Synthesis Route</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1511]" class="style-scope patent-text">
    
    [1511]
  </para-num> <div id="p-1425" num="1511" class="description-line style-scope patent-text">The Drug Linker compounds of the present invention may be synthesised according to the Examples.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1512]" class="style-scope patent-text">
    
    [1512]
  </para-num> <div id="p-1426" num="1512" class="description-line style-scope patent-text">Synthesis of Drug Conjugates</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1513]" class="style-scope patent-text">
    
    [1513]
  </para-num> <div id="p-1427" num="1513" class="description-line style-scope patent-text">Conjugates can be prepared as previously described. Antibodies can be conjugated to the Drug Linker compound as described in Doronina et al., Nature Biotechnology, 2003, 21, 778-784). Briefly, antibodies (4-5 mg/mL) in PBS containing 50 mM sodium borate at pH 7.4 are reduced with tris(carboxyethyl)phosphine hydrochloride (TCEP) at 37° C. The progress of the reaction, which reduces interchain disulfides, is monitored by reaction with 5,5′-dithiobis(2-nitrobenzoic acid) and allowed to proceed until the desired level of thiols/mAb is achieved. The reduced antibody is then cooled to 0° C. and alkylated with 1.5 equivalents of maleimide drug-linker per antibody thiol. After 1 hour, the reaction is quenched by the addition of 5 equivalents of N-acetyl cysteine. Quenched drug-linker is removed by gel filtration over a PD-10 column. The ADC is then sterile-filtered through a 0.22 μm syringe filter. Protein concentration can be determined by spectral analysis at 280 nm and 329 nm, respectively, with correction for the contribution of drug absorbance at 280 nm. Size exclusion chromatography can be used to determine the extent of antibody aggregation, and RP-HPLC can be used to determine the levels of remaining NAC-quenched drug-linker.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1514]" class="style-scope patent-text">
    
    [1514]
  </para-num> <div id="p-1428" num="1514" class="description-line style-scope patent-text">Further Preferences</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1515]" class="style-scope patent-text">
    
    [1515]
  </para-num> <div id="p-1429" num="1515" class="description-line style-scope patent-text">The following preferences may apply to all aspects of the invention as described above, or may relate to a single aspect. The preferences may be combined together in any combination.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1516]" class="style-scope patent-text">
    
    [1516]
  </para-num> <div id="p-1430" num="1516" class="description-line style-scope patent-text">In some embodiments, the C11 substituent may be in the following stereochemical arrangement relative to neighbouring groups:</div>
    </li> <li class="style-scope patent-text"> <div id="p-1431" num="0000" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00011" num="00011" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b8/8e/19/a0f7a0173f0271/US20190307890A1-20191010-C00011.png" class="style-scope patent-text"><img id="EMI-C00011" he="18.12mm" wi="23.28mm" file="US20190307890A1-20191010-C00011.TIF" alt="Figure US20190307890A1-20191010-C00011" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="93" height="72" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b8/8e/19/a0f7a0173f0271/US20190307890A1-20191010-C00011.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00011" attachment-type="cdx" file="US20190307890A1-20191010-C00011.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00011" attachment-type="mol" file="US20190307890A1-20191010-C00011.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[1517]" class="style-scope patent-text">
    
    [1517]
  </para-num> <div id="p-1432" num="1517" class="description-line style-scope patent-text">In other embodiments, the C11 substituent may be in the following stereochemical arrangement relative to neighbouring groups:</div>
    </li> <li class="style-scope patent-text"> <div id="p-1433" num="0000" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00012" num="00012" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/e9/96/a1/720f1cc0d78bf8/US20190307890A1-20191010-C00012.png" class="style-scope patent-text"><img id="EMI-C00012" he="21.25mm" wi="69.85mm" file="US20190307890A1-20191010-C00012.TIF" alt="Figure US20190307890A1-20191010-C00012" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="279" height="85" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/e9/96/a1/720f1cc0d78bf8/US20190307890A1-20191010-C00012.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00012" attachment-type="cdx" file="US20190307890A1-20191010-C00012.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00012" attachment-type="mol" file="US20190307890A1-20191010-C00012.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <heading id="h-0004" class="style-scope patent-text">EXAMPLES</heading>
    <li class="style-scope patent-text"> <para-num num="[1518]" class="style-scope patent-text">
    
    [1518]
  </para-num> <div id="p-1434" num="1518" class="description-line style-scope patent-text">Reaction progress was monitored by thin-layer chromatography (TLC) using <figure-callout id="60" label="Merck Kieselgel" filenames="US20190307890A1-20191010-D00001.png,US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Merck Kieselgel</a></figure-callout> 60 F254 silica gel, with fluorescent indicator on aluminium plates. Visualisation of TLC was achieved with UV light or iodine vapour unless otherwise stated. Flash chromatography was performed using <figure-callout id="60" label="Merck Kieselgel" filenames="US20190307890A1-20191010-D00001.png,US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Merck Kieselgel</a></figure-callout> 60 F254 silica gel. Extraction and chromatography solvents were bought and used without further purification from VWR, U.K. All chemicals were purchased from Aldrich.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1519]" class="style-scope patent-text">
    
    [1519]
  </para-num> <div id="p-1435" num="1519" class="description-line style-scope patent-text">Proton NMR chemical shift values were measured on the delta scale at 400 MHz using a Bruker AV400. The following abbreviations have been used: s, singlet; d, doublet; t, triplet; q, quartet; quin, quintet; m, multiplet; br, broad. Coupling constants are reported in Hz.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1520]" class="style-scope patent-text">
    
    [1520]
  </para-num> <div id="p-1436" num="1520" class="description-line style-scope patent-text">Column chromatography was performed on an Isolera (Biotage) automated system using normal phase SNAP cartridges.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1521]" class="style-scope patent-text">
    
    [1521]
  </para-num> <div id="p-1437" num="1521" class="description-line style-scope patent-text">The LC/MS Conditions were as Follow:</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1522]" class="style-scope patent-text">
    
    [1522]
  </para-num> <div id="p-1438" num="1522" class="description-line style-scope patent-text">LCMS data were obtained using a Shimadzu Nexera series LC/MS with a Shimadzu LCMS-2020 quadrupole MS, with Electrospray ionisation. Mobile phase A-0.1% formic acid in water. Mobile phase B-0.1% formic acid in acetonitrile.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1523]" class="style-scope patent-text">
    
    [1523]
  </para-num> <div id="p-1439" num="1523" class="description-line style-scope patent-text">Short run gradient: initial composition was 5% B held over 0.25 min, then increase from 5% B to 100% B over a 2 min period. The composition was held for 0.50 min at 100% B, then returned to 5% B in 0.05 minutes and hold there for 0.05 min. Total gradient run time equals 3 min. Flow rate 0.8 mL/min. Wavelength detection range: 190 to 800 nm. Oven temperature: 50° C. Column: Waters Acquity UPLC BEH Shield RP18 1.7 μm 2.1×50 mm.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1524]" class="style-scope patent-text">
    
    [1524]
  </para-num> <div id="p-1440" num="1524" class="description-line style-scope patent-text">Long run gradient: initial composition 5% B held over 1 min, then increase from 5% B to 100% B over a 9 min period. The composition was held for 2 min at 100% B, then returned to 5% B in 0.10 minutes and hold there for 3 min. Total gradient run time equals 15 min. Flow rate 0.6 mL/min. Wavelength detection range: 190 to 800 nm. Oven temperature: 50° C. Column: ACE Excel 2 C18-AR, 2 μ, 3.0×100 mm.</div>
    </li> <heading id="h-0005" class="style-scope patent-text">Example 1</heading>
    <li class="style-scope patent-text"> <para-num num="[1525]" class="style-scope patent-text">
    
    [1525]
  </para-num> <div id="p-1441" num="1525" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00013" num="00013" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/76/90/04/1639a735f4ad6e/US20190307890A1-20191010-C00013.png" class="style-scope patent-text"><img id="EMI-C00013" he="249.60mm" wi="157.48mm" file="US20190307890A1-20191010-C00013.TIF" alt="Figure US20190307890A1-20191010-C00013" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="630" height="998" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/76/90/04/1639a735f4ad6e/US20190307890A1-20191010-C00013.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00013" attachment-type="cdx" file="US20190307890A1-20191010-C00013.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00013" attachment-type="mol" file="US20190307890A1-20191010-C00013.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[1526]" class="style-scope patent-text">
    
    [1526]
  </para-num> <div id="p-1442" num="1526" class="description-line style-scope patent-text">Compound 1 is compound 13 of WO 2014/057073.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1527]" class="style-scope patent-text">
    
    [1527]
  </para-num> <div id="p-1443" num="1527" class="description-line style-scope patent-text">(a) (S)-2-(4-aminophenyl)-8-(3-(((S)-2-(4-fluorophenyl)-7-methoxy-5,11-dioxo-10-((2-(trimethylsily)ethoxy)methyl)-5,10,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-7-methoxy-10-((2-(trimethylsilyl)ethoxy)methyl)-1,11a-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-5,11(10H)-dione (2) Pd(PPh<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4 </sub>(14 mg, 0.012 mmol) was added to a stirred mixture of the aniline-triflate 1 (666 mg, 0.62 mmol), boronic ester (167 mg, 0.75 mmol) and Na<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3 </sub>(306 mg, 2.8 mmol) in a 2:1:1 mixture of toluene/MeOH/H<sub class="style-scope patent-text">2</sub>O (20 mL). The reaction mixture was allowed to stir at 30° C. under a nitrogen atmosphere for 2 hours after which time all of triflate 1 has reacted. The reaction mixture was then evaporated to dryness before the residue was taken up in CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(50 mL) and washed with H<sub class="style-scope patent-text">2</sub>O (2×50 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated under reduced pressure to provide the crude product. Purification by flash chromatography (gradient elution: 1:1 v/v Hexane/EtOAc to 100% EtOAc) afforded product 2 as a yellow foam (522.4 mg, 82%). LC/MS 2.04 min (ES+) m/z (relative intensity) 1006.55 ([M+H]<sup class="style-scope patent-text">+</sup>., 100%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1528]" class="style-scope patent-text">
    
    [1528]
  </para-num> <div id="p-1444" num="1528" class="description-line style-scope patent-text">(b) (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-((S)-8-(3-(((S)-2-(4-fluorophenyl)-7-methoxy-5,11-dioxo-10-((2-(trimethylsilyl)ethoxy)methyl)-5,10,11,11a-tetrahydro-1H- benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-7-methoxy-5,11-dioxo-10-((2-(trimethylsily)ethoxy)methyl)-5,10,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (3)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1529]" class="style-scope patent-text">
    
    [1529]
  </para-num> <div id="p-1445" num="1529" class="description-line style-scope patent-text">To a solution of 2 (522.4 mg, 0.52 mmol) in dry CH<sub class="style-scope patent-text">2</sub>C<sub class="style-scope patent-text">12 </sub>(20 mL) was added the protected peptide (255 g, 0.62 mmol) and EEDQ (154 mg, 0.62 mmol). The mixture was stirred at room temperature until completion (16 hours). The reaction mixture was then washed with H<sub class="style-scope patent-text">2</sub>O (2×25 mL), brine (25 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated under reduced pressure to provide the <figure-callout id="3" label="crude product" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">crude product</a></figure-callout> 3. Purification by flash chromatography (gradient elution: 100% CHCl<sub class="style-scope patent-text">3 </sub>to 93/7 CHCl<sub class="style-scope patent-text">3/</sub>MeOH) afforded <figure-callout id="3" label="product" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">product</a></figure-callout> 3 as a yellow foam (655.9 mg, 90%). LC/MS 2.19 min (ES+) m/z (relative intensity) 1398.85 ([M+H]<sup class="style-scope patent-text">+</sup>., 40%); 1432.35 ([M+Na])<sup class="style-scope patent-text">+</sup>., 40%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1530]" class="style-scope patent-text">
    
    [1530]
  </para-num> <div id="p-1446" num="1530" class="description-line style-scope patent-text">(c) (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-((S)-8-(3-(((S)-2-(4-fluorophenyl)-7-methoxy-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-7-methoxy-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (4)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1531]" class="style-scope patent-text">
    
    [1531]
  </para-num> <div id="p-1447" num="1531" class="description-line style-scope patent-text">A solution of Super-Hydride® (1.17 mL, 1M in THF) was added dropwise to a solution of SEM-dilactam 3 (655.9 mg, 0.47 mmol) in dry THF (3 mL) at −78° C. under an argon atmosphere. The addition was completed over 5 minutes in order to maintain the internal temperature of the reaction mixture constant. After 40 minutes, an aliquot was quenched with water for LC/MS analysis, which revealed that the reaction was complete. Water (20 mL) was added to the reaction mixture and the cold bath was removed. The organic layer was extracted with CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(3×50 mL) and the combined organics were washed with brine (100 mL), dried with MgSO<sub class="style-scope patent-text">4, </sub>filtered and the solvent removed by rotary evaporation under reduced pressure. The crude product was dissolved in MeOH (9 mL), CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(3 mL), water (1 mL) and enough silica gel to form a thick stirring suspension. After 5 days, the suspension was filtered through a sintered funnel and washed with CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2</sub>/MeOH (9:1) (100 mL) until the elution of the product was complete. The organic layer was washed with brine (2×50 mL), dried with MgSO<sub class="style-scope patent-text">4, </sub>filtered and the solvent removed by rotary evaporation under reduced pressure. Purification by silica gel column chromatography (isolera, CHCl<sub class="style-scope patent-text">3</sub>/MeOH 98:2 to 80:20) afforded <figure-callout id="4" label="product" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">product</a></figure-callout> 4 as a yellow solid (461.9 mg, 89%). LC/MS 1.74 min (ES+) m/z (relative intensity) 1106.40 ([M+H]<sup class="style-scope patent-text">+</sup>., 70%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1532]" class="style-scope patent-text">
    
    [1532]
  </para-num> <div id="p-1448" num="1532" class="description-line style-scope patent-text">(d) (S)-2-amino-N-((S)-1-((4-((S)-8-(3-(((S)-2-(4-fluorophenyl)-7-methoxy-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-7-methoxy-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2-yl)-3-methylbutanamide (5)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1533]" class="style-scope patent-text">
    
    [1533]
  </para-num> <div id="p-1449" num="1533" class="description-line style-scope patent-text">Excess piperidine was added (0.15 mL) to a solution of PBD 4 (461.9 mg, 0.41 mmol) in DMF (3 mL). The mixture was allowed to stir at room temperature for 20 minutes, at which point the reaction had gone to completion (as monitored by LC/MS). The reaction mixture was diluted with CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(50 mL) and the organic phase was washed with H<sub class="style-scope patent-text">2</sub>O (2×50 mL) until complete piperidine removal. The organic phase was dried over MgSO<sub class="style-scope patent-text">4, </sub>filtered and excess solvent removed by rotary evaporation under reduced pressure to afford crude product 5 which was used as such in the next step. LC/MS 1.16 min (ES+) m/z (relative intensity) 884.5 ([M+H]<sup class="style-scope patent-text">+</sup>., 10%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1534]" class="style-scope patent-text">
    
    [1534]
  </para-num> <div id="p-1450" num="1534" class="description-line style-scope patent-text">(e) 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-((S)-8-(3-(((S)-2-(4-fluoro-phenyl)-7-methoxy-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-7-methoxy-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide (6) EDCl hydrochloride (80 mg, 0.41 mmol) and 6-maleimidohexanoic acid (88 mg, 0.41 mmol) were added to a solution of crude 5 in dry CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(5 mL) under an argon atmosphere. Stirring was maintained until the reaction was complete (4 hours). The reaction was diluted with CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(50 mL) and the organic phase was washed with H<sub class="style-scope patent-text">2</sub>O (2×50 mL) and brine before being dried over MgSO<sub class="style-scope patent-text">4, </sub>filtered and excess solvent removed by rotary evaporation under reduced pressure by rotary evaporation under reduced pressure. The product was purified by silica gel chromatography column (100% CHCl<sub class="style-scope patent-text">3 </sub>to 95:5 CHCl<sub class="style-scope patent-text">3</sub>/MeOH) affording 6 (125.8 mg, %). LC/MS 1.52 min (ES+) m/z (relative intensity) 1077.35 ([M+H]<sup class="style-scope patent-text">+</sup>., 20%). LC/MS (long run) 6.99 min (ES+) m/z (relative intensity) 1077.80 ([M+H]<sup class="style-scope patent-text">30</sup>., 50%).</div>
    </li> <heading id="h-0006" class="style-scope patent-text">Example 2</heading>
    <li class="style-scope patent-text"> <para-num num="[1535]" class="style-scope patent-text">
    
    [1535]
  </para-num> <div id="p-1451" num="1535" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00014" num="00014" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/b6/13/30/1f65f8b8a39c6c/US20190307890A1-20191010-C00014.png" class="style-scope patent-text"><img id="EMI-C00014" he="249.26mm" wi="157.56mm" file="US20190307890A1-20191010-C00014.TIF" alt="Figure US20190307890A1-20191010-C00014" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="630" height="997" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/b6/13/30/1f65f8b8a39c6c/US20190307890A1-20191010-C00014.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00014" attachment-type="cdx" file="US20190307890A1-20191010-C00014.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00014" attachment-type="mol" file="US20190307890A1-20191010-C00014.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[1536]" class="style-scope patent-text">
    
    [1536]
  </para-num> <div id="p-1452" num="1536" class="description-line style-scope patent-text">(a) (S)-2-(4-aminophenyl)-8-(3-(((S)-2-(4-(trifluoromethoxy)phenyl)-7-methoxy-5,11-dioxo-10-((2-(trimethylsilyl)ethoxy)methyl)-5,10,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-7-methoxy-10-((2-(trimethylsilyl)ethoxy)methyl)-1,11a-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-5,11(10H)-dione (7) Pd(PPh<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4 </sub>(14 mg, 0.012 mmol) was added to a stirred mixture of the aniline-triflate 1 (666 mg, 0.62 mmol), boronic acid (155 mg, 0.75 mmol) and Na<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3 </sub>(306 mg, 2.8 mmol) in a 2:1:1 mixture of toluene/MeOH/H<sub class="style-scope patent-text">2</sub>O (20 mL). The reaction mixture was allowed to stir at 30° C. under a nitrogen atmosphere for 2 hours after which time all of triflate 1 has reacted. The reaction mixture was then evaporated to dryness before the residue was taken up in CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(50 mL) and washed with H<sub class="style-scope patent-text">2</sub>O (2×50 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated under reduced pressure to provide the crude product. Purification by flash chromatography (gradient elution: 1:1 v/v Hexane/EtOAc to 100% EtOAc) afforded product 7 as a yellow foam (501.1 mg, 74%). LC/MS 2.10 min (ES+) m/z (relative intensity) 1072.35 ([M+]<sup class="style-scope patent-text">+</sup>., 15%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1537]" class="style-scope patent-text">
    
    [1537]
  </para-num> <div id="p-1453" num="1537" class="description-line style-scope patent-text">(b) (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-((S)-8-(3-(((S)-2-(4-(trifluoromethoxy)phenyl)-7-methoxy-5,11-dioxo-10-((2-(trimethylsilyl)ethoxy)methyl)-5,10,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-7-methoxy-5,11-dioxo-10-((2-(trimethylsily)ethoxy)methyl)-5,10,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (8)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1538]" class="style-scope patent-text">
    
    [1538]
  </para-num> <div id="p-1454" num="1538" class="description-line style-scope patent-text">To a solution of 7 (501.1 mg, 0.46 mmol) in dry CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(5 mL) was added the protected peptide (210 mg, 0.51 mmol) and EEDQ (127 mg, 0.51 mmol). The mixture was stirred at room temperature until completion (16 hours). The reaction mixture was then washed with H<sub class="style-scope patent-text">2</sub>O (2×25 mL), brine (25 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated under reduced pressure to provide the crude product. Purification by flash chromatography (gradient elution: 100% CHCl<sub class="style-scope patent-text">3 </sub>to 93/7 CHCl<sub class="style-scope patent-text">3</sub>/MeOH) afforded <figure-callout id="8" label="product" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">product</a></figure-callout> 8 as a yellow foam (563 mg, 82%). LC/MS 2.23 min (ES+) m/z (relative intensity) 1465.30 ([M+H]<sup class="style-scope patent-text">+</sup>., 25%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1539]" class="style-scope patent-text">
    
    [1539]
  </para-num> <div id="p-1455" num="1539" class="description-line style-scope patent-text">(c) (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-((S)-8-(3-(((S)-2-(4-(trifluoromethoxy)phenyl)-7-methoxy-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-7-methoxy-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (9) A solution of Super-Hydride® (0.96 mL, 1M in THF) was added dropwise to a solution of SEM-dilactam 8 (563 mg, 0.38 mmol) in dry THF (3 mL) at −78° C. under an argon atmosphere. The addition was completed over 5 minutes in order to maintain the internal temperature of the reaction mixture constant. After 40 minutes, an aliquot was quenched with water for LC/MS analysis, which revealed that the reaction was complete. Water (20 mL) was added to the reaction mixture and the cold bath was removed. The organic layer was extracted with CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(3×50 mL) and the combined organics were washed with brine (100 mL), dried with MgSO<sub class="style-scope patent-text">4, </sub>filtered and the solvent removed by rotary evaporation under reduced pressure. The crude product was dissolved in MeOH (9 mL), CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(3 mL), water (1 mL) and enough silica gel to form a thick stirring suspension. After 5 days, the suspension was filtered through a sintered funnel and washed with CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2</sub>/MeOH (9:1) (100 mL) until the elution of the product was complete. The organic layer was washed with brine (2×50 mL), dried with MgSO<sub class="style-scope patent-text">4, </sub>filtered and the solvent removed by rotary evaporation under reduced pressure. Purification by silica gel column chromatography (isolera, CHCl<sub class="style-scope patent-text">3</sub>/MeOH 98:2 to 80:20) afforded <figure-callout id="9" label="product" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">product</a></figure-callout> 9 as a yellow solid (428 mg, 95%). LC/MS 1.83 min (ES+) m/z (relative intensity) 1172.25 ([M+H]<sup class="style-scope patent-text">+</sup>., 80%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1540]" class="style-scope patent-text">
    
    [1540]
  </para-num> <div id="p-1456" num="1540" class="description-line style-scope patent-text">(d) (S)-2-amino-N-((S)-1-((4-((S)-8-(3-(((S)-2-(4-(trifluoromethoxy)phenyl)-7-methoxy-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-7-methoxy-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2-yl)-3-methylbutanamide (10)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1541]" class="style-scope patent-text">
    
    [1541]
  </para-num> <div id="p-1457" num="1541" class="description-line style-scope patent-text">Excess piperidine was added (0.15 mL) to a solution of PBD 9 (428 mg, 0.36 mmol) in DMF (3 mL). The mixture was allowed to stir at room temperature for 20 minutes, at which point the reaction had gone to completion (as monitored by LC/MS). The reaction mixture was diluted with CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(50 mL) and the organic phase was washed with H<sub class="style-scope patent-text">2</sub>O (2×50 mL) until complete piperidine removal. The organic phase was dried over MgSO<sub class="style-scope patent-text">4, </sub>filtered and excess solvent removed by rotary evaporation under reduced pressure to afford crude product 10 which was used as such in the next step.: LC/MS 1.24 min (ES+) m/z (relative intensity) 950.35 ([M+H]<sup class="style-scope patent-text">+</sup>., 10%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1542]" class="style-scope patent-text">
    
    [1542]
  </para-num> <div id="p-1458" num="1542" class="description-line style-scope patent-text">(e) 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-((S)-8-(3-(((S)-2-(4-(trifluoromethoxy)phenyl)-7-methoxy-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-7-methoxy-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide (11)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1543]" class="style-scope patent-text">
    
    [1543]
  </para-num> <div id="p-1459" num="1543" class="description-line style-scope patent-text">EDCl hydrochloride (70 mg, 0.36 mmol) and 6-maleimidohexanoic acid (77 mg, 0.36 mmol) were added to a solution of crude 10 in dry CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(5 mL) under an argon atmosphere. Stirring was maintained until the reaction was complete (4 hours). The reaction was diluted with CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(50 mL) and the organic phase was washed with H<sub class="style-scope patent-text">2</sub>O (2×50 mL) and brine before being dried over MgSO<sub class="style-scope patent-text">4, </sub>filtered and excess solvent removed by rotary evaporation under reduced pressure by rotary evaporation under reduced pressure. The product was purified by silica gel chromatography column (100% CHCl<sub class="style-scope patent-text">3 </sub>to 95:5 CHCl<sub class="style-scope patent-text">3</sub>/MeOH) affording 11 (99 mg, 23%). LC/MS 1.61 min (ES+) m/z (relative intensity) 1143.25 ([M+H]<sup class="style-scope patent-text">+</sup>., 80%). LC/MS (long run) 7.46 min (ES+) m/z (relative intensity) 1143.25 ([M+H]<sup class="style-scope patent-text">+</sup>., 50%).</div>
    </li> <heading id="h-0007" class="style-scope patent-text">Example 3</heading>
    <li class="style-scope patent-text"> <para-num num="[1544]" class="style-scope patent-text">
    
    [1544]
  </para-num> <div id="p-1460" num="1544" class="description-line style-scope patent-text">
      <chemistry id="CHEM-US-00015" num="00015" class="style-scope patent-text">
        <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/6e/b3/85/0d3298df801538/US20190307890A1-20191010-C00015.png" class="style-scope patent-text"><img id="EMI-C00015" he="250.19mm" wi="157.23mm" file="US20190307890A1-20191010-C00015.TIF" alt="Figure US20190307890A1-20191010-C00015" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="629" height="1001" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/6e/b3/85/0d3298df801538/US20190307890A1-20191010-C00015.png"></a></div>
        <attachments class="style-scope patent-text">
          <attachment idref="CHEM-US-00015" attachment-type="cdx" file="US20190307890A1-20191010-C00015.CDX" class="style-scope patent-text"> </attachment>
          <attachment idref="CHEM-US-00015" attachment-type="mol" file="US20190307890A1-20191010-C00015.MOL" class="style-scope patent-text"> </attachment>
        </attachments>
      </chemistry>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[1545]" class="style-scope patent-text">
    
    [1545]
  </para-num> <div id="p-1461" num="1545" class="description-line style-scope patent-text">(a) (S)-2-(4-aminophenyl)-7-methoxy-8-(3-(((S)-7-methoxy-5,11-dioxo-2-(p-tolyl)-10-((2-(trimethylsily)ethoxy)methyl)-5,10,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4diazepin-8-yl)oxy)propoxy)-10-((2-(trimethylsilyl)ethoxy)methyl)-1,11a-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-5,11(10H)-dione (12)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1546]" class="style-scope patent-text">
    
    [1546]
  </para-num> <div id="p-1462" num="1546" class="description-line style-scope patent-text">Pd(PPh<sub class="style-scope patent-text">3</sub>)<sub class="style-scope patent-text">4 </sub>(22 mg, 0.018 mmol) was added to a stirred mixture of the aniline-triflate 1 (1 g, 0.94 mmol), boronic ester (246 mg, 1.1 mmol) and Na<sub class="style-scope patent-text">2</sub>CO<sub class="style-scope patent-text">3 </sub>(459 mg, 4.3 mmol) in a 2:1:1 mixture of toluene/MeOH/H<sub class="style-scope patent-text">2</sub>O (20 mL). The reaction mixture was allowed to stir at 30° C. under a nitrogen atmosphere for 2 hours after which time all of triflate 1 has reacted. The reaction mixture was then evaporated to dryness before the residue was taken up in CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(50 mL) and washed with H<sub class="style-scope patent-text">2</sub>O (2×50 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated under reduced pressure to provide the crude product. Purification by flash chromatography (gradient elution: 1:1 v/v Hexane/EtOAc to 100% EtOAc) afforded <figure-callout id="12" label="product" filenames="US20190307890A1-20191010-D00001.png,US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">product</a></figure-callout> 12 as a yellow foam (803.8 mg, 85%). LC/MS 2.07 min (ES+) m/z (relative intensity) 1002.35 ([M+]<sup class="style-scope patent-text">+</sup>., 20%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1547]" class="style-scope patent-text">
    
    [1547]
  </para-num> <div id="p-1463" num="1547" class="description-line style-scope patent-text">(b) (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-((S)-7-methoxy-8-(3-(((S)-7-methoxy-5,11-dioxo-2-(p-tolyl)-10-((2-(trimethylsilyl)ethoxy)methyl)-5,10,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-5,11-dioxo-10-((2-(trimethylsily)ethoxy)methyl)-5,10,11,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (13)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1548]" class="style-scope patent-text">
    
    [1548]
  </para-num> <div id="p-1464" num="1548" class="description-line style-scope patent-text">To a solution of 12 (803.8 mg, 0.80 mmol) in dry CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(25 mL) was added the protected peptide (361 mg, 0.88 mmol) and EEDQ (206 mg, 0.88 mmol). The mixture was stirred at room temperature until completion (16 hours). The reaction mixture was then washed with H<sub class="style-scope patent-text">2</sub>O (2×50 mL), brine (50 mL), dried (MgSO<sub class="style-scope patent-text">4</sub>), filtered and evaporated under reduced pressure to provide the crude product. Purification by flash chromatography (gradient elution: 100% CHCl3 to 93/7 CHCl<sub class="style-scope patent-text">3</sub>/MeOH) afforded product 13 as a yellow foam (852.4 mg, 76%). LC/MS 2.20 min (ES+) m/z (relative intensity) 1395.35 ([M+H]<sup class="style-scope patent-text">+</sup>., 85%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1549]" class="style-scope patent-text">
    
    [1549]
  </para-num> <div id="p-1465" num="1549" class="description-line style-scope patent-text">(c) (9H-fluoren-9-yl)methyl ((S)-1-(((S)-1-((4-((S)-7-methoxy-8-(3-(((S)-7-methoxy-5-oxo-2- (p-tolyl)-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-5-oxo- 5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2- yl)amino)-3-methyl-1-oxobutan-2-yl)carbamate (14) A solution of Super-Hydride® (01.52 mL, 1M in THF) was added dropwise to a solution of SEM-dilactam 13 (852.4 mg, 0.61 mmol) in dry THF (5 mL) at −78° C. under an argon atmosphere. The addition was completed over 5 minutes in order to maintain the internal temperature of the reaction mixture constant. After 40 minutes, an aliquot was quenched with water for LC/MS analysis, which revealed that the reaction was complete. Water (20 mL) was added to the reaction mixture and the cold bath was removed. The organic layer was extracted with CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(3 ×50 mL) and the combined organics were washed with brine (100 mL), dried with MgSO<sub class="style-scope patent-text">4, </sub>filtered and the solvent removed by rotary evaporation under reduced pressure. The crude product was dissolved in MeOH (9 mL), CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(3 mL), water (1 mL) and enough silica gel to form a thick stirring suspension. After 5 days, the suspension was filtered through a sintered funnel and washed with CH<sub class="style-scope patent-text">2</sub>CL<sub class="style-scope patent-text">2</sub>/MeOH (9:1) (100 mL) until the elution of the product was complete. The organic layer was washed with brine (2×50 mL), dried with MgSO<sub class="style-scope patent-text">4, </sub>filtered and the solvent removed by rotary evaporation under reduced pressure. Purification by silica gel column chromatography (isolera, CHCl<sub class="style-scope patent-text">3</sub>/MeOH 98:2 to 80:20) afforded product 14 as a yellow solid (672.1 mg, 100%). LC/MS 1.77min (ES+) m/z (relative intensity) 1102.40 ([M+H]<sup class="style-scope patent-text">30 </sup>., 10%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1550]" class="style-scope patent-text">
    
    [1550]
  </para-num> <div id="p-1466" num="1550" class="description-line style-scope patent-text">(d) (S)-2-amino-N-((S)-1-((4-((S)-7-methoxy-8-(3-(((S)-7-methoxy-5-oxo-2-(p-tolyl)-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-5-oxo-5,11a-dihydro-1H- benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2-yl)-3- methylbutanamide (15)</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1551]" class="style-scope patent-text">
    
    [1551]
  </para-num> <div id="p-1467" num="1551" class="description-line style-scope patent-text">Excess piperidine was added (0.25 mL) to a solution of PBD 14 (672.1 mg, 0.61 mmol) in DMF (3 mL). The mixture was allowed to stir at room temperature for 20 minutes, at which point the reaction had gone to completion (as monitored by LC/MS). The reaction mixture was diluted with CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(50 mL) and the organic phase was washed with H<sub class="style-scope patent-text">2</sub>O (2 x 50 mL) until complete piperidine removal. The organic phase was dried over MgSO<sub class="style-scope patent-text">4, </sub>filtered and excess solvent removed by rotary evaporation under reduced pressure to afford <figure-callout id="15" label="crude product" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">crude product</a></figure-callout> 15 which was used as such in the next step. LC/MS 1.19 min (ES+) m/z (relative intensity) 880.40 ([M+H]<sup class="style-scope patent-text">+</sup>., 20%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1552]" class="style-scope patent-text">
    
    [1552]
  </para-num> <div id="p-1468" num="1552" class="description-line style-scope patent-text">(e) 6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-N-((S)-1-(((S)-1-((4-((S)-7-methoxy-8-(3-(((S)-7-methoxy-5-oxo-2-(p-tolyl)-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl)oxy)propoxy)-5-oxo-5,11a-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-2-yl)phenyl)amino)-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide (16) EDCl hydrochloride (120 mg, 0.62 mmol) and 6-maleimidohexanoic acid (132 mg, 0.36 mmol) were added to a solution of <figure-callout id="15" label="crude" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">crude</a></figure-callout> 15 in dry CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(5 mL) under an argon atmosphere. Stirring was maintained until the reaction was complete (4 hours). The reaction was diluted with CH<sub class="style-scope patent-text">2</sub>Cl<sub class="style-scope patent-text">2 </sub>(50 mL) and the organic phase was washed with H<sub class="style-scope patent-text">2</sub>O (2 x 50 mL) and brine before being dried over MgSO<sub class="style-scope patent-text">4, </sub>filtered and excess solvent removed by rotary evaporation under reduced pressure by rotary evaporation under reduced pressure. The product was purified by silica gel chromatography column (100% CHCl<sub class="style-scope patent-text">3 </sub>to 95:5 CHCl<sub class="style-scope patent-text">3</sub>/MeOH) affording 16 (131.8 mg, 20%). LC/MS 1.55 min (ES+) m/z (relative intensity) 1073.50 ([M+H]<sup class="style-scope patent-text">+</sup>., 70%). LC/MS (long run) 7.19 min (ES+) m/z (relative intensity) 1073.40 ([M+H]<sup class="style-scope patent-text">+</sup>., 80%).</div>
    </li> <heading id="h-0008" class="style-scope patent-text">Example 4-Conjugation</heading>
    <li class="style-scope patent-text"> <para-num num="[1553]" class="style-scope patent-text">
    
    [1553]
  </para-num> <div id="p-1469" num="1553" class="description-line style-scope patent-text">ConjA, Tratuzumab-6</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1554]" class="style-scope patent-text">
    
    [1554]
  </para-num> <div id="p-1470" num="1554" class="description-line style-scope patent-text">A 50 mM solution of tris(2-carboxyethyl)phosphine hydrochloride (TCEP) in phosphate-buffered saline pH 7.4 (PBS) was added (50 molar equivalent/antibody, 18.3 micromoles, 183.3 μL) to a 22 mL solution of antibody, Trastuzumab (55 mg, 367 nanomoles) in reduction buffer containing PBS and 1 mM ethylenediaminetetraacetic acid (EDTA) and a final antibody concentration of 2.5 mg/mL. The reduction mixture was heated at +37° C. for 3 hours (or until full reduction is observed by UHPLC) in an incubator with gentle (135 rpm) shaking. After cooling down to room temperature, the reduced antibody was buffer exchanged, via spin filter centrifugation, into a reoxidation buffer containing PBS pH 7.4 and 1 mM EDTA to remove all the excess reducing agent. A 50 mM solution of dehydroascorbic acid (DHAA, 13 molar equivalent/antibody, 4.8 micromoles, 95.33 μL) in DMSO was added and the reoxidation mixture was allowed to react for 16 hours at room temperature with gentle (&lt;150 rpm) shaking at an antibody concentration of 2 mg/mL (or more DHAA added and reaction left for longer until full reoxidation of the cysteine thiols to reform the inter-chain cysteine disulfides is observed by UHPLC). The reoxidation mixture was then sterile-filtered and diluted in a conjugation buffer containing PBS pH 7.4, 1 mM EDTA for a final antibody concentration of 1.0-1.5 mg/mL. <figure-callout id="6" label="Compound" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 6 was added as a solution in propylene glycol (20 molar equivalent/antibody, 2.0 micromole, in 0.8 mL propylene glycol) to 9 mL of this reoxidised antibody solution (15 mg, 100 nanomoles), followed by DMSO and further addition of propylene glycol for a 10% (v/v) final DMSO concentration and 40-50% (v/v) final propylene glycol concentration to solubilise the payload. The solution was mixed for 5 hours at room temperature, after which the conjugation was quenched by addition of N-acetyl-L-cysteine (8 micromoles, 80 μL at 100 mM). The conjugation mixture was purified by spin filtration using a 15 mL Amicon Ultracell 50 kDa MWCO spin filter, then further purified by tangential flow filtration (TFF) to &gt;50 diavolumes using a Spectrum Labs KrosFlo Research Ili system with a 30 kDa MWCO, 115 cm<sup class="style-scope patent-text">2 </sup>surface area hollow fibre filter module at 50 mL/min in PBS with a transmembrane pressure (TMP) of 0.5-1.0 bar, and sterile-filtered and analysed. UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150 mm×2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of ConjA (Tratuzumab-6) at 280 nm and 330 nm (<figure-callout id="6" label="Compound" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 6 specific) shows unconjugated light chains and a mixture of unconjugated heavy chains and heavy chains attached to a single molecule of <figure-callout id="6" label="Compound" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 6, consistent with a drug-per-antibody ratio (DAR) of 1.62 molecules of <figure-callout id="6" label="Compound" filenames="US20190307890A1-20191010-D00002.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 6 per antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1555]" class="style-scope patent-text">
    
    [1555]
  </para-num> <div id="p-1471" num="1555" class="description-line style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel G3000SWXL 5 μm 7.8×300 mm column (with a 7 μm 6.0×40 mm guard column) eluting with sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjA (Tratuzumab-6) at 280 nm shows a monomer purity of 95%. UHPLC SEC analysis gives a concentration of final ConjA (Tratuzumab-6) at 0.58 mg/mL in 18.0 mL, obtained mass of ConjA (Tratuzumab-6) is 10.5 mg (70% yield).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1556]" class="style-scope patent-text">
    
    [1556]
  </para-num> <div id="p-1472" num="1556" class="description-line style-scope patent-text">ConjB, Tratuzumab-11</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1557]" class="style-scope patent-text">
    
    [1557]
  </para-num> <div id="p-1473" num="1557" class="description-line style-scope patent-text">A 50 mM solution of tris(2-carboxyethyl)phosphine hydrochloride (TCEP) in phosphate-buffered saline pH 7.4 (PBS) was added (50 molar equivalent/antibody, 18.3 micromoles, 183.3 μL) to a 22 mL solution of antibody (55 mg, 367 nanomoles) in reduction buffer containing PBS and 1 mM ethylenediaminetetraacetic acid (EDTA) and a final antibody concentration of 2.5 mg/mL. The reduction mixture was heated at +37 ° C. for 3 hours (or until full reduction is observed by UHPLC) in an incubator with gentle (135 rpm) shaking. After cooling down to room temperature, the reduced antibody was buffer exchanged, via spin filter centrifugation, into a reoxidation buffer containing PBS pH 7.4 and 1 mM EDTA to remove all the excess reducing agent. A 50 mM solution of dehydroascorbic acid (DHAA, 13 molar equivalent/antibody, 4.8 micromoles, 95.33 μL) in DMSO was added and the reoxidation mixture was allowed to react for 16 hours at room temperature with gentle (&lt;150 rpm) shaking at an antibody concentration of 2 mg/mL (or more DHAA added and reaction left for longer until full reoxidation of the cysteine thiols to reform the inter-chain cysteine disulfides is observed by UHPLC). The reoxidation mixture was then sterile-filtered and diluted in a conjugation buffer containing PBS pH 7.4, 1 mM EDTA for a final antibody concentration of 1.0-1.5 mg/mL. Compound 11 was added as a solution in propylene glycol (20 molar equivalent/antibody, 2.0 micromole, in 0.8 mL propylene glycol) to 9 mL of this reoxidised antibody solution (15 mg, 100 nanomoles), followed by DMSO and further addition of propylene glycol for a 10% (v/v) final DMSO concentration and 40-50% (v/v) final propylene glycol concentration to solubilise the payload. The solution was mixed for 5 hours at room temperature, after which the conjugation was quenched by addition of N-acetyl-L-cysteine (8 micromoles, 80 μL at 100 mM). The conjugation mixture was purified by spin filtration using a 15 mL Amicon Ultracell 50 kDa MWCO spin filter, then further purified by tangential flow filtration (TFF) to &gt;50 diavolumes using a Spectrum Labs KrosFlo Research Ili system with a 30 kDa MWCO, 115 cm<sup class="style-scope patent-text">2 </sup>surface area hollow fibre filter module at 50 mL/min in PBS with a transmembrane pressure (TMP) of 0.5-1.0 bar, and sterile-filtered and analysed.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1558]" class="style-scope patent-text">
    
    [1558]
  </para-num> <div id="p-1474" num="1558" class="description-line style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150 mm x 2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of ConjB (Tratuzumab-11) at 280 nm and 330 nm (Compound 11 specific) shows unconjugated light chains and a mixture of unconjugated heavy chains and heavy chains attached to a single molecule of Compound 11, consistent with a drug-per-antibody ratio (DAR) of 1.53 molecules of Compound 11 per antibody.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1559]" class="style-scope patent-text">
    
    [1559]
  </para-num> <div id="p-1475" num="1559" class="description-line style-scope patent-text">UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel G3000SWXL 5 μm 7.8×300 mm column (with a 7 μm 6.0×40 mm guard column) eluting with sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjB (Tratuzumab-11) at 280 nm shows a monomer purity of over 95%. UHPLC SEC analysis gives a concentration of final ConjB (Tratuzumab-11) at 0.49 mg/mL in 19.0 mL, obtained mass of ConjB</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1560]" class="style-scope patent-text">
    
    [1560]
  </para-num> <div id="p-1476" num="1560" class="description-line style-scope patent-text">(Tratuzumab-11) is 9.3 mg (62% yield).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1561]" class="style-scope patent-text">
    
    [1561]
  </para-num> <div id="p-1477" num="1561" class="description-line style-scope patent-text">ConjC, Tratuzumab-11</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1562]" class="style-scope patent-text">
    
    [1562]
  </para-num> <div id="p-1478" num="1562" class="description-line style-scope patent-text">A 50 mM solution of tris(2-carboxyethyl)phosphine hydrochloride (TCEP) in phosphate-buffered saline pH 7.4 (PBS) was added (50 molar equivalent/antibody, 10.0 micromoles, 100 μL) to a 6.9 mL solution of antibody (30 mg, 200 nanomoles) in reduction buffer containing PBS and 1 mM ethylenediaminetetraacetic acid (EDTA) and a final antibody concentration of 4.35 mg/mL. The reduction mixture was heated at +37 ° C. for 3 hours (or until full reduction is observed by UHPLC) in an incubator with gentle (135 rpm) shaking. After cooling down to room temperature, the reduced antibody was buffer exchanged, via spin filter centrifugation, into a reoxidation buffer containing PBS pH 7.4 and 1 mM EDTA to remove all the excess reducing agent. A 50 mM solution of dehydroascorbic acid (DHAA, 13 molar equivalent/antibody, 2.6 micromoles, 52 μL) in DMSO was added and the reoxidation mixture was allowed to react for 16 hours at room temperature with gentle (&lt;150 rpm) shaking at an antibody concentration of 2 mg/mL (or more DHAA added and reaction left for longer until full reoxidation of the cysteine thiols to reform the inter-chain cysteine disulfides is observed by UHPLC). The reoxidation mixture was then sterile-filtered and diluted in a conjugation buffer containing PBS pH 7.4, 1 mM EDTA for a final antibody concentration of 1.0-1.5 mg/mL. <figure-callout id="16" label="Compound" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 16 was added as a solution in DMSO (12.5 molar equivalent/antibody, 1.25 micromoles, in 1.0 mL DMSO) to 9 mL of this reoxidised antibody solution (15 mg, 100 nanomoles) for a 10% (v/v) final DMSO concentration. The solution was mixed for 1.25 hours at room temperature, after which the conjugation was quenched by addition of N-acetyl-L-cysteine (8 micromoles, 80 μL at 100 mM). The conjugation mixture was purified by spin filtration using a 15 mL Amicon Ultracell 50 kDa MWCO spin filter, then further purified by tangential flow filtration (TFF) to &gt;50 diavolumes using a Spectrum Labs KrosFlo Research Ili system with a 30 kDa MWCO, 115 cm<sup class="style-scope patent-text">2 </sup>surface area hollow fibre filter module at 50 mL/min in PBS with a transmembrane pressure (TMP) of 0.5-1.0 bar, and sterile-filtered and analysed. UHPLC analysis on a Shimadzu Prominence system using a Phenomenex Aeris 3.6u XB-C18 150 mm×2.1 mm column eluting with a gradient of water and acetonitrile on a reduced sample of ConjC (Tratuzumab-16) at 280 nm and 330 nm (<figure-callout id="16" label="Compound" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 16 specific) shows unconjugated light chains and a mixture of unconjugated heavy chains and heavy chains attached to a single molecule of <figure-callout id="16" label="Compound" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 16, consistent with a drug-per-antibody ratio (DAR) of 1.64 molecules of <figure-callout id="16" label="Compound" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Compound</a></figure-callout> 16 per antibody. UHPLC analysis on a Shimadzu Prominence system using a Tosoh Bioscience TSKgel G3000SWXL 5μm 7.8×300 mm column (with a 7 μm 6.0×40 mm guard column) eluting with sterile-filtered SEC buffer containing 200 mM potassium phosphate pH 6.95, 250 mM potassium chloride and 10% isopropanol (v/v) on a sample of ConjC (Tratuzumab-16) at 280 nm shows a monomer purity of 91%. UHPLC SEC analysis gives a concentration of final ConjC (Tratuzumab-16) at 0.57 mg/mL in 18.5 mL, obtained mass of ConjC (Tratuzumab-16) is 10.6 mg (71% yield).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1563]" class="style-scope patent-text">
    
    [1563]
  </para-num> <div id="p-1479" num="1563" class="description-line style-scope patent-text">Example 3-In Vitro Testing</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1564]" class="style-scope patent-text">
    
    [1564]
  </para-num> <div id="p-1480" num="1564" class="description-line style-scope patent-text">Medium from sub-confluent (80-90% confluency) cell culture in a T75 flask was aspirated and the flask rinsed with PBS (about 20 ml) and emptied. Trypsin-EDTA (5 ml) was added, the flask returned to a 37° C., CO<sub class="style-scope patent-text">2 </sub>(5%)-gassed incubator for up to about 5 minutes, then rapped sharply to dislodge and dissociate cells from the plastic. The cell suspension was transferred to a sterile 50 ml screw-top centrifuge tube, diluted with growth medium to a final volume of 15 ml, then centrifuged (400 g for 5 min). The supernatant was aspirated and the pellet re-suspended in 10 ml culture medium. Repeated pipetting may be necessary to produce monodisperse cell suspensions. The cell concentration and viability are measured by trypan blue staining, and counting using the LUNA-II™ Automated Cell Counter. Cells were diluted to 2×10<sup class="style-scope patent-text">5</sup>/ml, dispensed (50 μl /well) into 96-well flat-bottom plates and incubated overnight before use.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1565]" class="style-scope patent-text">
    
    [1565]
  </para-num> <div id="p-1481" num="1565" class="description-line style-scope patent-text">A stock solution (1 ml) of antibody drug conjugate (ADC) (20 μg/ml) was made by dilution of filter-sterilised ADC into cell culture medium. A set of 8×10-fold dilutions of stock ADC were made in a 24-well plate by serial transfer of 100 μl into 900 μl of cell culture medium. ADC dilution was dispensed (50 μl/well) into 4 replicate wells of the 96-well plate, containing 50 μl cell suspension, seeded the previous day. Control wells received 50 μl cell culture medium. The 96-well plate containing cells and ADCs was incubated at 37° C. in the CO2-gassed incubator for the exposure time.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1566]" class="style-scope patent-text">
    
    [1566]
  </para-num> <div id="p-1482" num="1566" class="description-line style-scope patent-text">At the end of the incubation period, cell viability was measured by MTS assay. MTS (Promega) was dispensed (20 μl per well) into each well and incubated for 4 hours at 37° C. in the CO<sub class="style-scope patent-text">2</sub>-gassed incubator. The optical absorbance of each well was measured at 490 nm. Percentage cell survival was calculated from the mean absorbance in the 4 ADC-treated wells compared to the mean absorbance in the 4 control, untreated wells (100%).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1567]" class="style-scope patent-text">
    
    [1567]
  </para-num> <div id="p-1483" num="1567" class="description-line style-scope patent-text">The IC<sub class="style-scope patent-text">50 </sub>was determined from the dose-response data using a non-linear curve fit algorithm: sigmoidal, 4PL X is log<sub class="style-scope patent-text">10 </sub>(ADC concentration) in GraphPad Prism.</div>
    </li> <li class="style-scope patent-text"> <div id="p-1484" num="0000" class="description-line style-scope patent-text">
      <tables id="TABLE-US-00002" num="00002" class="style-scope patent-text">
        <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table align="left" colsep="0" rowsep="0" cols="4" class="description-table style-scope patent-text" width="100%">
            <thead class="style-scope patent-text">
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">ADC</td>
                <td class="description-td style-scope patent-text">Cell growth</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">Cell Line</td>
                <td class="description-td style-scope patent-text">Description</td>
                <td class="description-td style-scope patent-text">Exposure</td>
                <td class="description-td style-scope patent-text">medium</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td>
              </tr>
            </thead>
            
              <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">MDA-MB-468</td>
                <td class="description-td style-scope patent-text">HER2 negative,</td>
                <td class="description-td style-scope patent-text">4 days</td>
                <td class="description-td style-scope patent-text">RPMI 1640 with</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATCC HTB-132</td>
                <td class="description-td style-scope patent-text">Breast carcinoma</td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">glutamax, 10% FBS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">SK-BR-3</td>
                <td class="description-td style-scope patent-text"> <figure-callout id="4" label="Breast carcinoma" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Breast carcinoma</a></figure-callout> </td>
                <td class="description-td style-scope patent-text">4 days</td>
                <td class="description-td style-scope patent-text">McCoy's 5A with</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATCC HTB-30</td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">Glutamax, 10% FBS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">NCI-N87</td>
                <td class="description-td style-scope patent-text">Gastric carcinoma</td>
                <td class="description-td style-scope patent-text">7 days</td>
                <td class="description-td style-scope patent-text">RPMI 1640 with</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text">ATCC CRL-5822</td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">glutamax, 10% FBS</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td namest="1" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="4"> </td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    </li> <li class="style-scope patent-text"> <div id="p-1485" num="0000" class="description-line style-scope patent-text">
      <tables id="TABLE-US-00003" num="00003" class="style-scope patent-text">
        <patent-tables frame="none" colsep="0" rowsep="0" class="style-scope patent-text">
          <table align="left" colsep="0" rowsep="0" cols="2" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td namest="offset" nameend="1" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="2"> </td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">Cytotoxicity IC<sub class="style-scope patent-text">50 </sub>(nM)</td>
              </tr>
            
          </tbody></table>
          <table align="left" colsep="0" rowsep="0" cols="5" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">Cell line</td>
                <td class="description-td style-scope patent-text">ConjA</td>
                <td class="description-td style-scope patent-text">ConjB</td>
                <td class="description-td style-scope patent-text">ConjC</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td namest="offset" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td>
              </tr>
            
          </tbody></table>
          <table align="left" colsep="0" rowsep="0" cols="5" class="description-table style-scope patent-text" width="100%">
            <tbody class="style-scope patent-text"><tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">NCI-N87</td>
                <td class="description-td style-scope patent-text">0.007548</td>
                <td class="description-td style-scope patent-text">0.1064</td>
                <td class="description-td style-scope patent-text">0.01479</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">SK-BR-3</td>
                <td class="description-td style-scope patent-text">0.06795</td>
                <td class="description-td style-scope patent-text">0.1362</td>
                <td class="description-td style-scope patent-text">0.05614</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td class="description-td style-scope patent-text">MDA MB 468</td>
                <td class="description-td style-scope patent-text">&gt;67</td>
                <td class="description-td style-scope patent-text">&gt;67</td>
                <td class="description-td style-scope patent-text">&gt;67</td>
              </tr>
              <tr class="description-tr style-scope patent-text">
                <td class="description-td style-scope patent-text"> </td>
                <td namest="offset" nameend="4" align="center" rowsep="1" class="description-td style-scope patent-text" colspan="5"> </td>
              </tr>
            
          </tbody></table>
        </patent-tables>
      </tables>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[1568]" class="style-scope patent-text">
    
    [1568]
  </para-num> <div id="p-1486" num="1568" class="description-line style-scope patent-text">Example 4-Xenograft Testing</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1569]" class="style-scope patent-text">
    
    [1569]
  </para-num> <div id="p-1487" num="1569" class="description-line style-scope patent-text">Mice</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1570]" class="style-scope patent-text">
    
    [1570]
  </para-num> <div id="p-1488" num="1570" class="description-line style-scope patent-text">Female severe combined immune-deficient mice (Fox Chase SCID®, C.B-17/Icr-Prkdcscid, Charles River) were ten weeks old with a body weight (BW) range of 16.2 to 21.9 grams on Day 1 of the study. The animals were fed ad libitum water (reverse osmosis, 1 ppm Cl), and NIH 31 Modified and Irradiated Lab Diet® consisting of 18.0% crude protein, 5.0% crude fat, and 5.0% crude fibre. The mice were housed on irradiated Enricho'cobs™ Laboratory Animal Bedding in static micro-isolators on a 12-hour light cycle at 20-22° C. (68-72° F.) and 40-60% humidity. CR Discovery Services specifically complies with the recommendations of the Guide for Care and Use of Laboratory Animals with respect to restraint, husbandry, surgical procedures, feed and fluid regulation, and veterinary care. The animal care and use program at CR Discovery Services is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), which assures compliance with accepted standards for the care and use of laboratory animals.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1571]" class="style-scope patent-text">
    
    [1571]
  </para-num> <div id="p-1489" num="1571" class="description-line style-scope patent-text">NCI-N87 Xenografts</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1572]" class="style-scope patent-text">
    
    [1572]
  </para-num> <div id="p-1490" num="1572" class="description-line style-scope patent-text">Tumour Cell Culture</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1573]" class="style-scope patent-text">
    
    [1573]
  </para-num> <div id="p-1491" num="1573" class="description-line style-scope patent-text">Human NCI-N87 gastric carcinoma lymphoma cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 units/mL penicillin, 100 pg/mL streptomycin sulfate and 25 pg/mL gentamicin. The cells were grown in tissue culture flasks in a humidified incubator at 37° C., in an atmosphere of 5% CO2 and 95% air.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1574]" class="style-scope patent-text">
    
    [1574]
  </para-num> <div id="p-1492" num="1574" class="description-line style-scope patent-text">In Vivo Implantation and Tumour Growth The NCI-N87 cells used for implantation were harvested during log phase growth and re-suspended in phosphate buffered saline (PBS) containing 50% Matrigel™ (BD Biosciences). On the day of tumour implant, each test mouse was injected subcutaneously in the right flank with 1×10<sup class="style-scope patent-text">7 </sup>cells (0.1 ml cell suspension), and tumour growth was monitored as the average size approached the target range of 100 to 150 mm<sup class="style-scope patent-text">3</sup>. Fourteen days later, designated as Day 1 of the study, mice were sorted according to calculated tumour size into groups each consisting of ten animals with individual tumour volumes ranging from 108 to 144 mm<sup class="style-scope patent-text">3 </sup>and group mean tumour volumes of 124-126 mm<sup class="style-scope patent-text">3</sup>. Tumours were measured in two dimensions using calipers, and volume was calculated using the formula:</div>
    </li> <li class="style-scope patent-text"> <div id="p-1493" num="0000" class="description-line style-scope patent-text">
      <maths id="MATH-US-00001" num="00001" class="style-scope patent-text">
        <math overflow="scroll" class="style-scope patent-text">
          <mrow class="style-scope patent-text">
            <mrow class="style-scope patent-text">
              <mi class="style-scope patent-text">Tumour</mi>
              <mo class="style-scope patent-text"></mo>
              <mstyle class="style-scope patent-text">
                <mspace width="0.8em" height="0.8ex" class="style-scope patent-text"> </mspace>
              </mstyle>
              <mo class="style-scope patent-text"></mo>
              <mi class="style-scope patent-text">Volume</mi>
              <mo class="style-scope patent-text"></mo>
              <mstyle class="style-scope patent-text">
                <mspace width="0.8em" height="0.8ex" class="style-scope patent-text"> </mspace>
              </mstyle>
              <mo class="style-scope patent-text"></mo>
              <mrow class="style-scope patent-text">
                <mo class="style-scope patent-text">(</mo>
                <msup class="style-scope patent-text">
                  <mi class="style-scope patent-text">mm</mi>
                  <mn class="style-scope patent-text">3</mn>
                </msup>
                <mo class="style-scope patent-text">)</mo>
              </mrow>
            </mrow>
            <mo class="style-scope patent-text">=</mo>
            <mfrac class="style-scope patent-text">
              <mrow class="style-scope patent-text">
                <msup class="style-scope patent-text">
                  <mi class="style-scope patent-text">w</mi>
                  <mn class="style-scope patent-text">2</mn>
                </msup>
                <mo class="style-scope patent-text">×</mo>
                <mi class="style-scope patent-text">l</mi>
              </mrow>
              <mn class="style-scope patent-text">2</mn>
            </mfrac>
          </mrow>
        </math>
      </maths>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[1575]" class="style-scope patent-text">
    
    [1575]
  </para-num> <div id="p-1494" num="1575" class="description-line style-scope patent-text">where w=width and l=length, in mm, of the tumour. Tumour weight may be estimated with the assumption that 1 mg is equivalent to 1 mm<sup class="style-scope patent-text">3 </sup>of tumour volume.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1576]" class="style-scope patent-text">
    
    [1576]
  </para-num> <div id="p-1495" num="1576" class="description-line style-scope patent-text">Treatment</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1577]" class="style-scope patent-text">
    
    [1577]
  </para-num> <div id="p-1496" num="1577" class="description-line style-scope patent-text">Treatment began on Day 1 in groups of 10 mice (n=10) with established subcutaneous NCI-N87 tumours (range 108-144 mm<sup class="style-scope patent-text">3</sup>). Agents were administered intravenously once on Day 1 (qd×1). A vehicle-treated group served as the control group for efficacy analysis. Tumours were measured twice per week until the study was ended on Day 81. Each mouse was euthanized when its tumour reached the endpoint volume of 800 mm<sup class="style-scope patent-text">3 </sup>or on the final day, whichever came first. The time to endpoint (TTE) was calculated for each mouse.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1578]" class="style-scope patent-text">
    
    [1578]
  </para-num> <div id="p-1497" num="1578" class="description-line style-scope patent-text">Treatment outcome was determined from percent tumour growth delay (% TGD), defined as the percent increase in median TTE for treated versus control mice, with differences between groups deemed statistically significant at P≤0.05 using logrank survival analysis. Mice were monitored for complete regression (CR) and partial regression (PR) responses.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1579]" class="style-scope patent-text">
    
    [1579]
  </para-num> <div id="p-1498" num="1579" class="description-line style-scope patent-text">Treatment tolerability was assessed by body weight measurements and frequent observation for signs of treatment-related side effects. Treatment tolerability was assessed by body weight measurements and frequent observation for signs of treatment-related side effects. All regimens were well tolerated. The median TTE for vehicle-treated controls was 40.7 days, establishing a maximum possible TGD of 40.3 days (99%) for the 81-day study.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1580]" class="style-scope patent-text">
    
    [1580]
  </para-num> <div id="p-1499" num="1580" class="description-line style-scope patent-text">Both ConjA ADC treatment regimens tested produced significant survival benefit compared to vehicle-treated controls (Logrank (Mantel-Cox) Test P&lt;0.001) and resulted in the maximum possible TGD. The 0.3 mg/kg group had a single PR regression response. The 1.0 mg/kg group had 40% regression responses consisting of three PRs and one CR which remained a TFS at study end. The 0.3 and 1.0 mg/kg groups had 5/9 and 10/10 81-day survivors, respectively with MTVs of 650 and 304 mm<sup class="style-scope patent-text">3</sup>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1581]" class="style-scope patent-text">
    
    [1581]
  </para-num> <div id="p-1500" num="1581" class="description-line style-scope patent-text">ConjB at 0.3 mg/kg produced no survival benefit compared to vehicle-treated controls (P=0.2463) but at 1.0 mg/kg produced a significant survival benefit compared to vehicle-treated controls (P=0.0057). There were no tumour regression responses in either group. Only the 1.0 mg/kg group had 81-day survivors (2/10 with an MTV of 625 mm<sup class="style-scope patent-text">3</sup>).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1582]" class="style-scope patent-text">
    
    [1582]
  </para-num> <div id="p-1501" num="1582" class="description-line style-scope patent-text">ConjC at 0.3 mg/kg and 1.0 mg/kg produced significant survival benefit compared to vehicle-treated controls (P=0.0013 and P&lt;0.001 respectively). The median TTEs for the 0.3 and 1.0 mg/kg groups were 65.6 and 81.0 days, corresponding to TGDs of 24.9 days (61%) and 40.3 days (99%). The 0.3 mg/kg group had one regression response (PR) whereas the 1.0 mg/kg group had 5/9 regressions consisting of five PRs. The 0.3 and 1.0 mg/kg groups had 3/10 and 9/9 81-day survivors, respectively, with MTVs of 486 and 75 mm<sup class="style-scope patent-text">3</sup>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1583]" class="style-scope patent-text">
    
    [1583]
  </para-num> <div id="p-1502" num="1583" class="description-line style-scope patent-text">The minimum effective dose was defined as the minimum dosage required to produce tumour stasis for twenty-eight days after test article administration. Based on visual inspection of the mean and median tumour volume plots and percent change of tumour volume from Day 1, ConjA at 0.3 mg/kg and ConjC at 1.0 mg/kg, appeared to be the dosages that achieved a response consistent with the minimum effective dose. The minimum effective dose of ConjB was not determined in this regimen.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1584]" class="style-scope patent-text">
    
    [1584]
  </para-num> <div id="p-1503" num="1584" class="description-line style-scope patent-text">The results are illustrated in <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 1</figref>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1585]" class="style-scope patent-text">
    
    [1585]
  </para-num> <div id="p-1504" num="1585" class="description-line style-scope patent-text">A further study was carried out with ConjB. Mice and xenografts were as described above for Study 1. Grafted mice were sorted into groups of ten animals with individual tumour volumes ranging from 108 to 172 mm<sup class="style-scope patent-text">3 </sup>and group mean tumour volumes of 133 mm<sup class="style-scope patent-text">3</sup>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1586]" class="style-scope patent-text">
    
    [1586]
  </para-num> <div id="p-1505" num="1586" class="description-line style-scope patent-text">Both regimens were acceptably tolerated. The median TTE for the vehicle control group was 45.2 days, establishing a maximum possible TGD of 32.8 days (73%) for the 78-day study. The median TTE for both ConjB treated groups was 78.0 days, corresponding to the maximum possible TGD. The 3 mg/kg group had 80% regressions consisting of six PRs and two CRs; there were no TFS at study end. The 5 mg/kg group had 100% regression responses consisting of two PRs and eight CRs, six of which remained TFSs at study end. The 3.0 and 5.0 g/kg groups each had ten 78-day survivors with MTVs of 126 and 5 mm<sup class="style-scope patent-text">3 </sup>respectively.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1587]" class="style-scope patent-text">
    
    [1587]
  </para-num> <div id="p-1506" num="1587" class="description-line style-scope patent-text">The results are illustrated in <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 2</figref>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1588]" class="style-scope patent-text">
    
    [1588]
  </para-num> <div id="p-1507" num="1588" class="description-line style-scope patent-text">The minimum effective dose was defined as the minimum dosage required to produce tumour stasis for twenty-eight days after test article administration. Based on visual inspection of the mean and median tumour volume plots and percent change of tumour volume from Day 1, the minimum effective dose of ConjB was not determined in this regimen. However, give the results of this and the previous study the minimum effective dose of ConjB is between 1 and 3 mg/kg.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1589]" class="style-scope patent-text">
    
    [1589]
  </para-num> <div id="p-1508" num="1589" class="description-line style-scope patent-text">JIMT-1 Xenografts</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1590]" class="style-scope patent-text">
    
    [1590]
  </para-num> <div id="p-1509" num="1590" class="description-line style-scope patent-text">Tumour Cell Culture</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1591]" class="style-scope patent-text">
    
    [1591]
  </para-num> <div id="p-1510" num="1591" class="description-line style-scope patent-text">JIMT-1 human breast carcinoma cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% fetal bovine serum, 2 mM glutamine, 100 units/ml penicillin G sodium, 100 μg/mL streptomycin sulfate, and 25 μg/mL gentamicin. The cells were cultured in tissue culture flasks in a humidified incubator at 37° C., in an atmosphere of 5% CO<sub class="style-scope patent-text">2 </sub>and 95% air.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1592]" class="style-scope patent-text">
    
    [1592]
  </para-num> <div id="p-1511" num="1592" class="description-line style-scope patent-text">In Vivo Implantation and Tumour Growth</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1593]" class="style-scope patent-text">
    
    [1593]
  </para-num> <div id="p-1512" num="1593" class="description-line style-scope patent-text">On the day of implant, JIMT-1 cells were harvested during log phase growth and resuspended in phosphate buffered saline (PBS) at a concentration of 1×10<sup class="style-scope patent-text">8 </sup>cells/ml in 50% Matrigel™ (BD Biosciences). Xenografts were initiated by subcutaneously implanting 1×10<sup class="style-scope patent-text">7</sup>JIMT-1 cells (0.1 ml suspension) into the right flank of each test animal. Tumours were monitored as their volumes approached the target range of 100 to 150 mm<sup class="style-scope patent-text">3 </sup>and were measured in two dimensions using calipers. Tumour volume was calculated using the formula:</div>
    </li> <li class="style-scope patent-text"> <div id="p-1513" num="0000" class="description-line style-scope patent-text">
      <maths id="MATH-US-00002" num="00002" class="style-scope patent-text">
        <math overflow="scroll" class="style-scope patent-text">
          <mrow class="style-scope patent-text">
            <mrow class="style-scope patent-text">
              <mi class="style-scope patent-text">Tumour</mi>
              <mo class="style-scope patent-text"></mo>
              <mstyle class="style-scope patent-text">
                <mspace width="0.8em" height="0.8ex" class="style-scope patent-text"> </mspace>
              </mstyle>
              <mo class="style-scope patent-text"></mo>
              <mi class="style-scope patent-text">Volume</mi>
              <mo class="style-scope patent-text"></mo>
              <mstyle class="style-scope patent-text">
                <mspace width="0.8em" height="0.8ex" class="style-scope patent-text"> </mspace>
              </mstyle>
              <mo class="style-scope patent-text"></mo>
              <mrow class="style-scope patent-text">
                <mo class="style-scope patent-text">(</mo>
                <msup class="style-scope patent-text">
                  <mi class="style-scope patent-text">mm</mi>
                  <mn class="style-scope patent-text">3</mn>
                </msup>
                <mo class="style-scope patent-text">)</mo>
              </mrow>
            </mrow>
            <mo class="style-scope patent-text">=</mo>
            <mfrac class="style-scope patent-text">
              <mrow class="style-scope patent-text">
                <msup class="style-scope patent-text">
                  <mi class="style-scope patent-text">w</mi>
                  <mn class="style-scope patent-text">2</mn>
                </msup>
                <mo class="style-scope patent-text">×</mo>
                <mi class="style-scope patent-text">l</mi>
              </mrow>
              <mn class="style-scope patent-text">2</mn>
            </mfrac>
          </mrow>
        </math>
      </maths>
    </div>
    </li> <li class="style-scope patent-text"> <para-num num="[1594]" class="style-scope patent-text">
    
    [1594]
  </para-num> <div id="p-1514" num="1594" class="description-line style-scope patent-text">where w=width and 1=length, in mm, of the tumour. Tumour weight may be estimated with the assumption that 1 mg is equivalent to 1 mm<sup class="style-scope patent-text">3 </sup>of tumour volume.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1595]" class="style-scope patent-text">
    
    [1595]
  </para-num> <div id="p-1515" num="1595" class="description-line style-scope patent-text">Treatment Fourteen days after tumour implantation, designated as Day 1 of the study, the animals were sorted into groups (n=10) with individual tumour volumes of 75 to 162 mm<sup class="style-scope patent-text">3 </sup>and group mean tumour volumes of 115 to 117 mm<sup class="style-scope patent-text">3</sup>. ConjC was administered intravenously in a single dose of 0.3 or 1 mg/kg on Day 1. A vehicle-treated group served as tumour growth controls. Tumours were measured twice per week until the study was ended on <figure-callout id="64" label="Day" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">Day</a></figure-callout> 64. Each mouse was euthanized when its tumour reached the endpoint volume of 1000 mm<sup class="style-scope patent-text">3 </sup>or on the final day, whichever came first. The time to endpoint (TTE) was calculated for each mouse.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1596]" class="style-scope patent-text">
    
    [1596]
  </para-num> <div id="p-1516" num="1596" class="description-line style-scope patent-text">Treatment outcome was determined from percent tumour growth delay (% TGD), defined as the percent increase in median TTE for treated versus control mice, with differences between groups deemed statistically significant at P≤0.05 using logrank survival analysis. Mice were monitored for complete regression (CR) and partial regression (PR) responses.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1597]" class="style-scope patent-text">
    
    [1597]
  </para-num> <div id="p-1517" num="1597" class="description-line style-scope patent-text">An animal with a CR at study end was additionally classified as a tumour-free survivor</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1598]" class="style-scope patent-text">
    
    [1598]
  </para-num> <div id="p-1518" num="1598" class="description-line style-scope patent-text">(TFS). Treatment tolerability was assessed by body weight measurements and frequent observation for signs of treatment-related side effects.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1599]" class="style-scope patent-text">
    
    [1599]
  </para-num> <div id="p-1519" num="1599" class="description-line style-scope patent-text">Both regimens were acceptably tolerated. The median TTE for controls was 55.7 days, establishing a maximum possible TGD of 8.3 days (15%) for the 64-day study. Both ADC regimens evaluated produced significant survival benefit compared to control (P&lt;0.001) and a maximal 15% TGD.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1600]" class="style-scope patent-text">
    
    [1600]
  </para-num> <div id="p-1520" num="1600" class="description-line style-scope patent-text">The 0.3 mg/kg group showed median tumour sizes that remained static throughout the study, had no objective regression responses but all animals remained end of study survivors with an MTV of 158 mm<sup class="style-scope patent-text">3</sup>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1601]" class="style-scope patent-text">
    
    [1601]
  </para-num> <div id="p-1521" num="1601" class="description-line style-scope patent-text">The 1.0 mg/kg group showed a reduction in tumour size which remained throughout the study and produced 90% regressions consisting of three PRs and six CRs, five of which were classified as TFS at study end. All ten of the 1.0 mg/kg group animals remained end of study survivors with an MTV of 9 mm<sup class="style-scope patent-text">3</sup>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1602]" class="style-scope patent-text">
    
    [1602]
  </para-num> <div id="p-1522" num="1602" class="description-line style-scope patent-text">The minimum effective dose was defined as the minimum dosage required to produce tumour stasis for twenty-eight days after test article administration. Based on visual inspection of the mean and median tumour volume plots and percent change of tumour volume from Day 1, the minimum effective dose of ConjC was 0.3 mg/kg.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1603]" class="style-scope patent-text">
    
    [1603]
  </para-num> <div id="p-1523" num="1603" class="description-line style-scope patent-text">The results are illustrated in <figref idrefs="DRAWINGS" class="style-scope patent-text">FIG. 3</figref>.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1604]" class="style-scope patent-text">
    
    [1604]
  </para-num> <div id="p-1524" num="1604" class="description-line style-scope patent-text">Example 5-Toxicity studies/Therapeutic Index</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1605]" class="style-scope patent-text">
    
    [1605]
  </para-num> <div id="p-1525" num="1605" class="description-line style-scope patent-text">A single dose toxicity study can be used to determine the maximum tolerated dose (MTD) and safety profile of the conjugtaes. Male Sprague Dawley rats (Harlan, Inc) may be dosed once by slow bolus intravenous injection via the tail vein with vehicle control (25 mM Histidine-HCl, 7% sucrose, 0.02<figure-callout id="80" label="% Polysorbate" filenames="US20190307890A1-20191010-D00001.png" class="style-scope patent-text"><a title="Show image containing callout" class="style-scope figure-callout">% Polysorbate</a></figure-callout> 80, pH 6.0) or test material. Parameters that may be evaluated during the study included mortality, physical examinations, cageside observations, body weights, body weight changes, clinical pathology (clinical chemistry, hematology, and coagulation), and gross pathology findings.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1606]" class="style-scope patent-text">
    
    [1606]
  </para-num> <div id="p-1526" num="1606" class="description-line style-scope patent-text">Tolerability can be determined based on toxicity end points, including body weight loss (&gt;10%) and bone marrow suppression.</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1607]" class="style-scope patent-text">
    
    [1607]
  </para-num> <div id="p-1527" num="1607" class="description-line style-scope patent-text">Therapeutic Index</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1608]" class="style-scope patent-text">
    
    [1608]
  </para-num> <div id="p-1528" num="1608" class="description-line style-scope patent-text">The Therapeutic Index can be calculated by dividing the maximum tolerated single dose (MTD) of non-targeted ADC in rat, by the minimal effective single dose (MED) of the a targeted ADC. The MED is the single dose necessary to achieve tumour stasis in an in vivo model at 28 days (for NCI-N87 xenograft).</div>
    </li> <li class="style-scope patent-text"> <para-num num="[1609]" class="style-scope patent-text">
    
    [1609]
  </para-num> <div id="p-1529" num="1609" class="description-line style-scope patent-text">All documents and other references mentioned above are herein incorporated by reference.</div>
    
  </li> </ul>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(19)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result" hidden="">translated from </div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><div mxw-id="PCLM205518384" lang="EN" load-source="patent-office" class="claims style-scope patent-text">
    <div class="claim style-scope patent-text"> <div id="CLM-00001" num="00001" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">1</b>. A conjugate of formula I:
<div class="claim-text style-scope patent-text"> <br class="style-scope patent-text">L-(D<sup class="style-scope patent-text">L</sup>)<sub class="style-scope patent-text">p </sub>  (I)
</div> </div>
      <div class="claim-text style-scope patent-text">wherein Lisa Ligand unit, D is a Drug Linker unit of formula IIa, IIb or IIc:</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00016" num="00016" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/9c/e4/94/b3f923567fd810/US20190307890A1-20191010-C00016.png" class="style-scope patent-text"><img id="EMI-C00016" he="206.42mm" wi="157.65mm" file="US20190307890A1-20191010-C00016.TIF" alt="Figure US20190307890A1-20191010-C00016" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="631" height="826" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/9c/e4/94/b3f923567fd810/US20190307890A1-20191010-C00016.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00016" attachment-type="cdx" file="US20190307890A1-20191010-C00016.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00016" attachment-type="mol" file="US20190307890A1-20191010-C00016.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">wherein p is an integer of from 1 to 20.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00002" num="00002" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">2</b>. A conjugate according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein the Ligand Unit is an antibody or an active fragment thereof.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00003" num="00003" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">3</b>. The conjugate according to <claim-ref idref="CLM-00002" class="style-scope patent-text">claim 2</claim-ref>, wherein the antibody or antibody fragment is an antibody or antibody fragment for a tumour-associated antigen.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00004" num="00004" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">4</b>. The conjugate according to <claim-ref idref="CLM-00003" class="style-scope patent-text">claim 3</claim-ref> wherein the antibody or antibody fragment is an antibody which binds to one or more tumor-associated antigens or cell-surface receptors selected from (1)-(88):
<div class="claim-text style-scope patent-text">(1) BMPR1B;</div>
<div class="claim-text style-scope patent-text">(2) E16;</div>
<div class="claim-text style-scope patent-text">(3) STEAP1;</div>
<div class="claim-text style-scope patent-text">(4) 0772P;</div>
<div class="claim-text style-scope patent-text">(5) MPF;</div>
<div class="claim-text style-scope patent-text">(6) Napi3b;</div>
<div class="claim-text style-scope patent-text">(7) Sema 5b;</div>
<div class="claim-text style-scope patent-text">(8) PSCA hlg;</div>
<div class="claim-text style-scope patent-text">(9) ETBR;</div>
<div class="claim-text style-scope patent-text">(10) MSG783;</div>
<div class="claim-text style-scope patent-text">(11) STEAP2;</div>
<div class="claim-text style-scope patent-text">(12) TrpM4;</div>
<div class="claim-text style-scope patent-text">(13) CRIPTO;</div>
<div class="claim-text style-scope patent-text">(14) CD21;</div>
<div class="claim-text style-scope patent-text">(15) CD79b;</div>
<div class="claim-text style-scope patent-text">(16) FcRH2;</div>
<div class="claim-text style-scope patent-text">(17) HER2;</div>
<div class="claim-text style-scope patent-text">(18) NCA;</div>
<div class="claim-text style-scope patent-text">(19) MDP;</div>
<div class="claim-text style-scope patent-text">(20) IL20R-alpha;</div>
<div class="claim-text style-scope patent-text">(21) Brevican;</div>
<div class="claim-text style-scope patent-text">(22) EphB2R;</div>
<div class="claim-text style-scope patent-text">(23) ASLG659;</div>
<div class="claim-text style-scope patent-text">(24) PSCA;</div>
<div class="claim-text style-scope patent-text">(25) GEDA;</div>
<div class="claim-text style-scope patent-text">(26) BAFF-R;</div>
<div class="claim-text style-scope patent-text">(27) CD22;</div>
<div class="claim-text style-scope patent-text">(28) CD79a;</div>
<div class="claim-text style-scope patent-text">(29) CXCR5;</div>
<div class="claim-text style-scope patent-text">(30) HLA-DOB;</div>
<div class="claim-text style-scope patent-text">(31) P2X5;</div>
<div class="claim-text style-scope patent-text">(32) CD72;</div>
<div class="claim-text style-scope patent-text">(33) LY64;</div>
<div class="claim-text style-scope patent-text">(34) FcRH1;</div>
<div class="claim-text style-scope patent-text">(35) IRTA2;</div>
<div class="claim-text style-scope patent-text">(36) TENB2;</div>
<div class="claim-text style-scope patent-text">(37) PSMA-FOLH1;</div>
<div class="claim-text style-scope patent-text">(38) SST;</div>
<div class="claim-text style-scope patent-text">(38.1) SSTR2;</div>
<div class="claim-text style-scope patent-text">(38.2) SSTR5;</div>
<div class="claim-text style-scope patent-text">(38.3) SSTR1;</div>
<div class="claim-text style-scope patent-text">(38.4)SSTR3;</div>
<div class="claim-text style-scope patent-text">(38.5) SSTR4;</div>
<div class="claim-text style-scope patent-text">(39) ITGAV;</div>
<div class="claim-text style-scope patent-text">(40) ITGB6;</div>
<div class="claim-text style-scope patent-text">(41) CEACAM5;</div>
<div class="claim-text style-scope patent-text">(42) MET;</div>
<div class="claim-text style-scope patent-text">(43) MUC1;</div>
<div class="claim-text style-scope patent-text">(44) CA9;</div>
<div class="claim-text style-scope patent-text">(45) EGFRvIII;</div>
<div class="claim-text style-scope patent-text">(46) CD33;</div>
<div class="claim-text style-scope patent-text">(47) CD19;</div>
<div class="claim-text style-scope patent-text">(48) IL2RA;</div>
<div class="claim-text style-scope patent-text">(49) AXL;</div>
<div class="claim-text style-scope patent-text">(50) CD30-TNFRSF8;</div>
<div class="claim-text style-scope patent-text">(51) BCMA-TNFRSF17;</div>
<div class="claim-text style-scope patent-text">(52) CT Ags-CTA;</div>
<div class="claim-text style-scope patent-text">(53) CD174 (Lewis Y)-FUT3;</div>
<div class="claim-text style-scope patent-text">(54) CLEC14A;</div>
<div class="claim-text style-scope patent-text">(55) GRP78-HSPAS;</div>
<div class="claim-text style-scope patent-text">(56) CD70;</div>
<div class="claim-text style-scope patent-text">(57) Stem Cell specific antigens;</div>
<div class="claim-text style-scope patent-text">(58) ASG-5;</div>
<div class="claim-text style-scope patent-text">(59) ENPP3;</div>
<div class="claim-text style-scope patent-text">(60) PRR4;</div>
<div class="claim-text style-scope patent-text">(61) GCC-GUCY2C;</div>
<div class="claim-text style-scope patent-text">(62) Liv-1-SLC39A6;</div>
<div class="claim-text style-scope patent-text">(63) 5T4;</div>
<div class="claim-text style-scope patent-text">(64) CD56 -NCMA1;</div>
<div class="claim-text style-scope patent-text">(65) CanAg;</div>
<div class="claim-text style-scope patent-text">(66) FOLR1;</div>
<div class="claim-text style-scope patent-text">(67) GPNMB;</div>
<div class="claim-text style-scope patent-text">(68) TIM-1-HAVCR1;</div>
<div class="claim-text style-scope patent-text">(69) RG-1/Prostate tumor target Mindin-Mindin/RG-1;</div>
<div class="claim-text style-scope patent-text">(70) B7-H4-VTCN1;</div>
<div class="claim-text style-scope patent-text">(71) PTK7;</div>
<div class="claim-text style-scope patent-text">(72) CD37;</div>
<div class="claim-text style-scope patent-text">(73) CD138-SDC1;</div>
<div class="claim-text style-scope patent-text">(74) CD74;</div>
<div class="claim-text style-scope patent-text">(75) Claudins-CLs;</div>
<div class="claim-text style-scope patent-text">(76) EGFR;</div>
<div class="claim-text style-scope patent-text">(77) Her3;</div>
<div class="claim-text style-scope patent-text">(78) RON-MST1R;</div>
<div class="claim-text style-scope patent-text">(79) EPHA2;</div>
<div class="claim-text style-scope patent-text">(80) CD20-MS4A1;</div>
<div class="claim-text style-scope patent-text">(81) Tenascin C-TNC;</div>
<div class="claim-text style-scope patent-text">(82) FAP;</div>
<div class="claim-text style-scope patent-text">(83) DKK-1;</div>
<div class="claim-text style-scope patent-text">(84) CD52;</div>
<div class="claim-text style-scope patent-text">(85) CS1- SLAMF7;</div>
<div class="claim-text style-scope patent-text">(86) Endoglin-ENG;</div>
<div class="claim-text style-scope patent-text">(87) Annexin A1-ANXA1;</div>
<div class="claim-text style-scope patent-text">(88) V-CAM (CD106)-VCAM1.</div>
</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00005" num="00005" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">5</b>. The conjugate of <claim-ref idref="CLM-00002" class="style-scope patent-text">claim 2</claim-ref>, wherein the antibody or antibody fragment is a cysteine-engineered antibody.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00006" num="00006" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">6</b>. The conjugate of <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein p is an integer from 1 to 8.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00007" num="00007" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">7</b>. The conjugate according to <claim-ref idref="CLM-00006" class="style-scope patent-text">claim 6</claim-ref>, wherein p is 1, 2, 3, or 4.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00008" num="00008" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">8</b>. A composition comprising a mixture of conjugates according to <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, wherein the average p in the mixture of conjugate compounds is about 1 to about 8.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00009" num="00009" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">9</b>. The conjugate of <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>, for use in therapy.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00010" num="00010" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">10</b>. A pharmaceutical composition comprising the conjugate of of <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref> and a pharmaceutically acceptable diluent, carrier, or excipient.</div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div id="CLM-11-13" num="11-13" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">11</b>.-<b class="style-scope patent-text">13</b>. (canceled)</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00014" num="00014" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">14</b>. A method of medical treatment comprising administering to a patient the pharmaceutical composition of <claim-ref idref="CLM-00010" class="style-scope patent-text">claim 10</claim-ref>.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00015" num="00015" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">15</b>. The method of <claim-ref idref="CLM-00014" class="style-scope patent-text">claim 14</claim-ref> wherein the method of medical treatment is for treating cancer.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00016" num="00016" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">16</b>. The method of <claim-ref idref="CLM-00015" class="style-scope patent-text">claim 15</claim-ref>, wherein the patient is administered a chemotherapeutic agent, in combination with the conjugate.</div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div id="CLM-00017" num="00017" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">17</b>. (canceled)</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00018" num="00018" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">18</b>. A method of treating a mammal having a proliferative disease, comprising administering to the mammal an effective amount of a conjugate of <claim-ref idref="CLM-00001" class="style-scope patent-text">claim 1</claim-ref>.</div>
    </div>
    </div> <div class="claim style-scope patent-text"> <div id="CLM-00019" num="00019" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">19</b>. A compound of formula IIIa, IIIb or IIIc:</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00017" num="00017" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/05/7f/f4/bc9f3adcfa8294/US20190307890A1-20191010-C00017.png" class="style-scope patent-text"><img id="EMI-C00017" he="205.57mm" wi="157.90mm" file="US20190307890A1-20191010-C00017.TIF" alt="Figure US20190307890A1-20191010-C00017" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="632" height="822" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/05/7f/f4/bc9f3adcfa8294/US20190307890A1-20191010-C00017.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00017" attachment-type="cdx" file="US20190307890A1-20191010-C00017.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00017" attachment-type="mol" file="US20190307890A1-20191010-C00017.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00020" num="00020" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">20</b>. A method of synthesizing a conjugate of formula I:
<div class="claim-text style-scope patent-text"> <br class="style-scope patent-text">L-(D<sup class="style-scope patent-text">L</sup>)<sub class="style-scope patent-text">p </sub>  (I)
</div> </div>
      <div class="claim-text style-scope patent-text">wherein Lisa Ligand unit, D is a Drug Linker unit of formula IIa, IIb or IIIc:</div>
      <div class="claim-text style-scope patent-text">
        <chemistry id="CHEM-US-00018" num="00018" class="style-scope patent-text">
          <div class="patent-image style-scope patent-text"><a href="https://patentimages.storage.googleapis.com/09/99/8a/765f5e8fe4f585/US20190307890A1-20191010-C00018.png" class="style-scope patent-text"><img id="EMI-C00018" he="206.42mm" wi="157.65mm" file="US20190307890A1-20191010-C00018.TIF" alt="Figure US20190307890A1-20191010-C00018" img-content="chem" img-format="tif" orientation="portrait" inline="no" width="631" height="826" class="patent-full-image style-scope patent-text" src="https://patentimages.storage.googleapis.com/09/99/8a/765f5e8fe4f585/US20190307890A1-20191010-C00018.png"></a></div>
          <attachments class="style-scope patent-text">
            <attachment idref="CHEM-US-00018" attachment-type="cdx" file="US20190307890A1-20191010-C00018.CDX" class="style-scope patent-text"> </attachment>
            <attachment idref="CHEM-US-00018" attachment-type="mol" file="US20190307890A1-20191010-C00018.MOL" class="style-scope patent-text"> </attachment>
          </attachments>
        </chemistry>
      </div>
      <div class="claim-text style-scope patent-text">wherein p is an integer of from 1 to 20, which comprises conjugating a compound according to <claim-ref idref="CLM-00019" class="style-scope patent-text">claim 19</claim-ref> with a cell-binding agent.</div>
    </div>
    </div> <div class="claim-dependent style-scope patent-text"> <div id="CLM-00021" num="00021" class="claim style-scope patent-text">
      <div class="claim-text style-scope patent-text"> <b class="style-scope patent-text">21</b>. A method of treating a mammal having a proliferative disease, comprising administering to the mammal an effective amount of a pharmaceutical composition according to <claim-ref idref="CLM-00010" class="style-scope patent-text">claim 10</claim-ref>.</div>
    </div>
  </div> </div>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (10)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DK1879901T3/en"><a id="link" href="#" class="style-scope state-modifier">DK1879901T3</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005-04-21</span>
                    <span class="td style-scope patent-result">2010-05-03</span>
                    <span class="td style-scope patent-result">Spirogen Ltd</span>
                    <span class="td style-scope patent-result">
  pyrrolobenzodiazepines
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2558475A1/en"><a id="link" href="#" class="style-scope state-modifier">EP2558475A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2013-02-20</span>
                    <span class="td style-scope patent-result">Spirogen Sàrl</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines used to treat proliferative diseases 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP5870400B2/en"><a id="link" href="#" class="style-scope state-modifier">JP5870400B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-04-15</span>
                    <span class="td style-scope patent-result">2016-03-01</span>
                    <span class="td style-scope patent-result">シアトル ジェネティクス，インコーポレーテッド</span>
                    <span class="td style-scope patent-result">
  Targeted pyrrolobenzodiazepine conjugates
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2013055990A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2013055990A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2013-04-18</span>
                    <span class="td style-scope patent-result">Seattle Genetics, Inc.</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and targeted conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN103997893B/en"><a id="link" href="#" class="style-scope state-modifier">CN103997893B</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2011-10-14</span>
                    <span class="td style-scope patent-result">2019-04-12</span>
                    <span class="td style-scope patent-result">西雅图基因公司</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines Zhuo and targeting conjugate 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2016502504A/en"><a id="link" href="#" class="style-scope state-modifier">JP2016502504A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2016-01-28</span>
                    <span class="td style-scope patent-result">エイディーシー・セラピューティクス・エス・アー・エール・エルＡｄｃ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｓａｒｌ</span>
                    <span class="td style-scope patent-result">
  Pyrrolobenzodiazepine-antibody conjugate
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP2906249B1/en"><a id="link" href="#" class="style-scope state-modifier">EP2906249B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2018-06-27</span>
                    <span class="td style-scope patent-result">MedImmune Limited</span>
                    <span class="td style-scope patent-result">Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA3060520C/en"><a id="link" href="#" class="style-scope state-modifier">CA3060520C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-12</span>
                    <span class="td style-scope patent-result">2022-05-17</span>
                    <span class="td style-scope patent-result">Medimmune Limited</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RS58873B1/en"><a id="link" href="#" class="style-scope state-modifier">RS58873B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2013-02-22</span>
                    <span class="td style-scope patent-result">2019-08-30</span>
                    <span class="td style-scope patent-result">Abbvie Stemcentrx Llc</span>
                    <span class="td style-scope patent-result">Antidll3-antibody-pbd conjugates and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015112822A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015112822A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014-01-24</span>
                    <span class="td style-scope patent-result">2015-07-30</span>
                    <span class="td style-scope patent-result">Kolltan Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Antibody-drug conjugates targeting kit receptor and uses thereof 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (3)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US11752197B2/en"><a id="link" href="#" class="style-scope state-modifier">US11752197B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-08-12</span>
                    <span class="td style-scope patent-result">2023-09-12</span>
                    <span class="td style-scope patent-result">Regeneron Pharmaceuticals, Inc.</span>
                    <span class="td style-scope patent-result">Macrophage stimulating 1 receptor (MST1R) variants and uses thereof 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201718960D0/en"><a id="link" href="#" class="style-scope state-modifier">GB201718960D0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2017-11-16</span>
                    <span class="td style-scope patent-result">2018-01-03</span>
                    <span class="td style-scope patent-result">Medimmune Ltd</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2021080608A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2021080608A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-10-25</span>
                    <span class="td style-scope patent-result">2021-04-29</span>
                    <span class="td style-scope patent-result">Medimmune, Llc</span>
                    <span class="td style-scope patent-result">Branched moiety for use in conjugates 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10543279B2/en"><a id="link" href="#" class="style-scope state-modifier">US10543279B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-01-28</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates and their use for the treatment of cancer 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20230143309A1/en"><a id="link" href="#" class="style-scope state-modifier">US20230143309A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023-05-11</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine antibody conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10799595B2/en"><a id="link" href="#" class="style-scope state-modifier">US10799595B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-10-13</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10695439B2/en"><a id="link" href="#" class="style-scope state-modifier">US10695439B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-06-30</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20160250345A1/en"><a id="link" href="#" class="style-scope state-modifier">US20160250345A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-09-01</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20190098275A/en"><a id="link" href="#" class="style-scope state-modifier">KR20190098275A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-08-21</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines and conjugates thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20190307890A1/en"><a id="link" href="#" class="style-scope state-modifier">US20190307890A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-10-10</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US10392393B2/en"><a id="link" href="#" class="style-scope state-modifier">US10392393B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-08-27</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepines 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20220211864A1/en"><a id="link" href="#" class="style-scope state-modifier">US20220211864A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-07-07</span>
                    <span class="td style-scope patent-result">Antibody-drug conjugates with immune-mediated therapy agents 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (3)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/GB201619490D0/en"><a id="link" href="#" class="style-scope state-modifier">GBGB1619490.4A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2016-11-17</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        GB1619490.4<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2016-11-17</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2018091646A1/en"><a id="link" href="#" class="style-scope state-modifier">PCT/EP2017/079572</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2017-11-17</span>
                    <span class="td style-scope patent-result">Pyrrolobenzodiazepine conjugates 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="legalEvents" class="scroll-target style-scope patent-result">
              Legal Events
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Date</span>
                    <span class="th style-scope patent-result">Code</span>
                    <span class="th style-scope patent-result">Title</span>
                    <span class="th style-scope patent-result">Description</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2019-06-03</span>
                    <span class="td nowrap style-scope patent-result">AS</span>
                    <span class="td nowrap style-scope patent-result">Assignment</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Owner name</strong>: MEDIMMUNE LIMITED, UNITED KINGDOM</p>
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HOWARD, PHILIP WILSON;CAILLEAU, THAIS;SIGNING DATES FROM 20171128 TO 20171130;REEL/FRAME:049341/0839</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2022-02-23</span>
                    <span class="td nowrap style-scope patent-result">STPP</span>
                    <span class="td nowrap style-scope patent-result">Information on status: patent application and granting procedure in general</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: NON FINAL ACTION MAILED</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">2022-10-26</span>
                    <span class="td nowrap style-scope patent-result">STCB</span>
                    <span class="td nowrap style-scope patent-result">Information on status: application discontinuation</span>
                    <span class="td style-scope patent-result">
                      
                      <p class="style-scope patent-result"><strong class="style-scope patent-result">Free format text</strong>: ABANDONED  --  FAILURE TO RESPOND TO AN OFFICE ACTION</p>
                      <template is="dom-repeat" as="attr" class="style-scope patent-result"></template>
                    </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
              <h3 id="concepts" class="scroll-target layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">Concepts</div>
                <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
              </h3>
              <div class="layout horizontal style-scope patent-result">
                <div class="flex style-scope patent-result">
                  <span id="conceptsWarning" class="righthead tooltip-hint style-scope patent-result">machine-extracted</span>
                  <overlay-tooltip positioning-target="#conceptsWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The concepts are extracted by a computer and may be incomplete or incorrect.
    </div>
  </overlay-tooltip>
                </div>
                <span class="headerButton style-scope patent-result"><a href="#" target="_blank" style="display: inline-block;" class="style-scope patent-result"><iron-icon icon="icons:file-download" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M19 9h-4V3H9v6H5l7 7 7-7zM5 18v2h14v-2H5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download</a></span>
                <span class="style-scope patent-result">
                  <dropdown-menu multi="true" label="Filter table" show-label="true" change-action="RESULT_CONCEPT_MENU" class="style-scope patent-result">
    
    <span class="label style-scope dropdown-menu">
      <span class="style-scope dropdown-menu">Filter table</span>
      <span id="selected" class="style-scope dropdown-menu" hidden="">
        <span style="margin: 0 4px 0 2px" class="style-scope dropdown-menu">·</span>
        <span class="style-scope dropdown-menu"></span>
      </span>
      <iron-icon icon="icons:arrow-drop-down" class="style-scope dropdown-menu x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 10l5 5 5-5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><iron-icon icon="icons:arrow-drop-up" class="style-scope dropdown-menu x-scope iron-icon-0" hidden=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
    </span>
    <iron-dropdown allow-outside-scroll="" horizontal-align="left" vertical-align="top" class="style-scope dropdown-menu" aria-disabled="false" aria-hidden="true" style="outline: none; display: none;">
    

    <div id="contentWrapper" class="style-scope iron-dropdown">
      <div class="dropdown-content style-scope dropdown-menu" slot="dropdown-content" id="menu" multi="">
        <div class="style-scope dropdown-menu">
          
            <div class="item style-scope dropdown-menu">Chemical compound</div>
          <template is="dom-repeat" class="style-scope dropdown-menu"></template>
        </div>
      </div>
    </div>
  </iron-dropdown>
  </dropdown-menu>
                </span>
              </div>
              <div class="responsive-table style-scope patent-result">
                <div class="table style-scope patent-result">
                  <div class="thead style-scope patent-result">
                    <div class="tr style-scope patent-result">
                      <span class="th style-scope patent-result">Name</span>
                      <span class="th style-scope patent-result">Image</span>
                      <span class="th style-scope patent-result">Sections</span>
                      <span class="th style-scope patent-result">Count</span>
                      <span class="th style-scope patent-result">Query match</span>
                    </div>
                  </div>
                  <div class="tbody style-scope patent-result">
                    <template is="dom-repeat" initial-count="25" class="style-scope patent-result"></template>
                    
                      <div class$="tr layout horizontal conceptDomain" class="style-scope patent-result">
                        <a href="#" class="td flex style-scope patent-result">
                          Show all concepts from the description section
                        </a>
                      </div>
                    <template is="dom-if" class="style-scope patent-result"></template>
                  </div>
                </div>
              </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.17774714" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.17774714" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=708352379" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>